00000002|Epidurography|Epidurography|1|01. 01182|1
00000003|invasive procedure on brain|invasive procedure on brain|0|01. 02990|1
00000004|spinal puncture|spinal puncture|2|01. 03310|1
00000005|invasive procedure on spine|invasive procedure on spine|0|01. 03990|1
00000007|sympathectomy|sympathectomy|0|01. 05290|1
00000008|open procedure on central nervous system|open procedure on central nervous system|0|01. 05900|1
00000009|cholera|cholera|0|01.001900|1
00000010|typhoid fever|typhoid fever|0|01.002000|1
00000011|paratyphoid fever|paratyphoid fever|0|01.002900|1
00000012|gastroenteritis due to Shigella|gastroenteritis due to Shigella|0|01.004900|1
00000013|botulism|botulism|0|01.005100|1
00000014|acute intestinal amebiasis|acute intestinal amebiasis|0|01.006000|1
00000015|acute intestinal amebiasis due to Entamoeba histolytica|acute intestinal amebiasis due to Entamoeba histolytica|0|01.006001|1
00000016|chronic intestinal amebiasis|chronic intestinal amebiasis|0|01.006100|2
00000017|liver abscess amebiasis|liver abscess amebiasis|0|01.006300|1
00000018|liver abscess amebiasis due to Entamoeba histolytica|liver abscess amebiasis due to Entamoeba histolytica|0|01.006301|1
00000019|extraintestinal amebiasis|extraintestinal amebiasis|0|01.006900|1
00000020|balantidiasis|balantidiasis|0|01.007000|1
00000021|giardiasis|giardiasis|0|01.007100|1
00000022|isosporiasis|isosporiasis|0|01.007200|1
00000024|staphylococcal enterocolitis|staphylococcal enterocolitis|0|01.008410|1
00000025|enteric campylobacteriosis|enteric campylobacteriosis|0|01.008430|1
00000026|Clostridioides difficile infection|Clostridioides difficile infection|0|01.008450|1
00000028|bacterial diarrhea|bacterial diarrhea|0|01.008500|1
00000029|bacterial gastroenteritis|bacterial gastroenteritis|0|01.008501|1
00000031|rotavirus vaccination|rotavirus vaccination|0|01.008611|1
00000033|dysentery|dysentery|0|01.009001|1
00000034|infectious gastroenteritis|infectious gastroenteritis|0|01.009003|1
00000035|traveler's diarrhea|traveler's diarrhea|0|01.009200|1
00000036|prevention of traveler's diarrhea|prevention of traveler's diarrhea|0|01.009201|1
00000037|infectious diarrhea|infectious diarrhea|0|01.009300|1
00000038|pulmonary tuberculosis|pulmonary tuberculosis|0|01.011900|3
00000039|active tuberculosis|active tuberculosis|0|01.011901|1
00000040|disseminated tuberculosis|disseminated tuberculosis|0|01.011902|1
00000041|untreated active tuberculosis|untreated active tuberculosis|0|01.011903|1
00000042|inactive tuberculosis|inactive tuberculosis|0|01.011904|3
00000043|tuberculosis prophylaxis|tuberculosis prophylaxis|0|01.011905|1
00000044|Tuberculosis Retreatment|Tuberculosis Retreatment|1|01.011906|1
00000045|tuberculosis meningitis|tuberculosis meningitis|0|01.013000|1
00000046|tuberculosis of skin|tuberculosis of skin|0|01.017000|1
00000047|tuberculosis of the eye|tuberculosis of the eye|0|01.017300|3
00000048|tuberculosis of the ear|tuberculosis of the ear|0|01.017400|3
00000049|plague|plague|0|01.020900|1
00000050|tularemia|tularemia|0|01.021900|1
00000051|inhaled anthrax|inhaled anthrax|0|01.022100|1
00000052|gastrointestinal anthrax|gastrointestinal anthrax|0|01.022200|1
00000053|anthrax septicemia|anthrax septicemia|0|01.022300|1
00000054|meningitis due to anthrax|meningitis due to anthrax|0|01.022800|1
00000055|anthrax|anthrax|0|01.022900|1
00000056|post-exposure anthrax prevention|post-exposure anthrax prevention|0|01.022901|1
00000057|brucellosis|brucellosis|0|01.023900|1
00000058|rat-bite fever|rat-bite fever|0|01.026900|1
00000059|listeriosis|listeriosis|0|01.027000|1
00000060|Listeria meningitis|Listeria meningitis|0|01.027001|1
00000061|Listeria endocarditis|Listeria endocarditis|0|01.027002|1
00000062|erysipeloid|erysipeloid|0|01.027100|1
00000063|Erysipelothrix endocarditis|Erysipelothrix endocarditis|0|01.027101|1
00000064|pasteurellosis|pasteurellosis|0|01.027200|1
00000065|Pasteurella multocida osteomyelitis|Pasteurella multocida osteomyelitis|0|01.027800|1
00000066|Pasteurella multocida endocarditis|Pasteurella multocida endocarditis|0|01.027801|1
00000067|erythema nodosum leprosum|erythema nodosum leprosum|0|01.030800|2
00000068|prevent recurrence of cutaneous ENL lesions|prevention of cutaneous erythema nodosum leprosum lesion recurrence|0|01.030801|2
00000069|multibacillary leprosy|multibacillary leprosy|0|01.030802|2
00000070|leprosy|leprosy|0|01.030900|2
00000071|Dapsone Resistant Leprosy|Dapsone Resistant Leprosy|0|01.030901|2
00000072|mycobacterium avium complex infection|disseminated mycobacterium avium complex infection|0|01.031000|1
00000073|prevention of Mycobacterium avium complex disease|prevention of Mycobacterium avium complex disease|0|01.031001|3
00000074|mycobacteriosis|mycobacteriosis|0|01.031900|1
00000075|atypical mycobacterial infection|atypical mycobacterial infection|0|01.031901|1
00000077|Diphtheritic Myocarditis|Diphtheritic Myocarditis|0|01.032810|1
00000078|diphtheria|diphtheria|0|01.032900|1
00000079|post-exposure diphtheria prevention|post-exposure diphtheria prevention|0|01.032901|1
00000080|diphtheria carrier state|diphtheria carrier state|0|01.032902|1
00000081|pertussis|pertussis|0|01.033900|1
00000082|pharyngitis due to Streptococcus pyogenes|pharyngitis due to Streptococcus pyogenes|0|01.034000|1
00000083|tonsillitis due to Streptococcus pyogenes|tonsillitis due to Streptococcus pyogenes|0|01.034001|1
00000084|scarlet fever|scarlet fever|0|01.034100|1
00000085|erysipelas|erysipelas|0|01.035000|1
00000086|meningococcal meningitis|meningococcal meningitis|0|01.036000|1
00000087|prevention of meningococcal meningitis|prevention of meningococcal meningitis|0|01.036001|3
00000088|meningococcemia|meningococcemia|0|01.036200|1
00000089|upper respiratory Neisseria meningitidis infection|upper respiratory infection due to Neisseria meningitidis|0|01.036890|1
00000090|tetanus|tetanus|0|01.037000|1
00000092|streptococcal septicemia|streptococcal septicemia|0|01.038000|1
00000093|staphylococcal septicemia|staphylococcal septicemia|0|01.038100|1
00000094|Staphylococcus aureus septicemia|Staphylococcus aureus septicemia|0|01.038110|1
00000096|Bacteroides septicemia|Bacteroides septicemia|0|01.038300|1
00000097|Clostridium septicemia|Clostridium septicemia|0|01.038301|1
00000098|sepsis caused by anaerobic bacteria|sepsis caused by anaerobic bacteria|0|01.038302|1
00000099|sepsis caused by Enterobacter|sepsis caused by Enterobacter|0|01.038400|1
00000100|Haemophilus septicemia|Haemophilus septicemia|0|01.038410|1
00000101|E. coli septicemia|E. coli septicemia|0|01.038420|1
00000102|Pseudomonas aeruginosa septicemia|Pseudomonas aeruginosa septicemia|0|01.038430|1
00000103|sepsis caused by Serratia|sepsis caused by Serratia|0|01.038440|1
00000104|Klebsiella pneumoniae septicemia|Klebsiella pneumoniae septicemia|0|01.038490|1
00000105|Proteus septicemia|Proteus septicemia|0|01.038491|1
00000106|Providencia septicemia|Providencia septicemia|0|01.038492|1
00000107|Morganella septicemia|Morganella septicemia|0|01.038493|1
00000108|Enterococcus septicemia|Enterococcus septicemia|0|01.038800|1
00000109|Salmonella septicemia|Salmonella septicemia|0|01.038801|1
00000110|bacterial sepsis|bacterial sepsis|0|01.038900|1
00000111|fungal sepsis|fungal sepsis|0|01.038901|1
00000112|erythrasma|erythrasma|0|01.039000|1
00000113|pulmonary actinomycosis|pulmonary actinomycosis|0|01.039100|1
00000114|abdominal actinomycosis|abdominal actinomycosis|0|01.039200|1
00000115|cervicofacial actinomycosis|cervicofacial actinomycosis|0|01.039300|1
00000116|actinomycosis|actinomycosis|0|01.039900|1
00000117|actinomycotic mycetoma|actinomycotic mycetoma|0|01.039901|1
00000118|nocardiosis|nocardiosis|0|01.039902|1
00000119|genital actinomycosis|genital actinomycosis|0|01.039903|1
00000120|gas gangrene caused by Clostridium perfringens|gas gangrene caused by Clostridium perfringens|0|01.040000|1
00000122|streptococcal toxic shock syndrome|streptococcal toxic shock syndrome|0|01.040891|1
00000123|streptococcal infection|streptococcal infection|0|01.041000|1
00000125|vancomycin-resistant Enterococcus faecium infection|vancomycin-resistant Enterococcus faecium infection|0|01.041040|1
00000126|Staphylococcus infections|Staphylococcus infections|0|01.041100|1
00000127|Severe Staphylococcus Infections|Severe Staphylococcus Infections|0|01.041101|1
00000128|methicillin-resistant S. aureus nasal colonization|methicillin-resistant Staphylococcus aureus nasal colonization|0|01.041110|2
00000129|pneumococcal infection|pneumococcal infection|0|01.041200|1
00000130|Pneumococcus endocarditis|Pneumococcus endocarditis|0|01.041201|1
00000131|Klebsiella infection|Klebsiella infection|0|01.041300|1
00000132|E. coli infection|E. coli infection|0|01.041400|1
00000133|Haemophilus Influenzae Infections|Haemophilus Influenzae Infections|0|01.041500|1
00000134|Haemophilus influenzae type b infection|Haemophilus influenzae type b infection|0|01.041501|1
00000135|Proteus Mirabilis Infections|Proteus Mirabilis Infections|0|01.041600|1
00000136|Indole Positive Proteus Infections|Indole Positive Proteus Infections|0|01.041601|1
00000137|Pseudomonas aeruginosa infection|Pseudomonas aeruginosa infection|0|01.041700|1
00000138|B. fragilis infection|B. fragilis infection|0|01.041820|1
00000139|Bacteroides brain abscess|Bacteroides brain abscess|0|01.041821|1
00000140|Clostridium perfringens empyema|Clostridium perfringens empyema|0|01.041830|1
00000141|Anaerobic Infections|Anaerobic Infections|0|01.041840|1
00000144|aerobic gram-negative bacillary infection|aerobic gram-negative bacillary infection|0|01.041850|1
00000145|Enterobacter infection|Enterobacter infection|0|01.041851|1
00000146|penicillinase producing Enterobacter infection|penicillinase producing Enterobacter infection|0|01.041852|1
00000147|Ureaplasma urealyticum infection|Ureaplasma urealyticum infection|0|01.041853|1
00000148|Campylobacter fetus infection|Campylobacter fetus infection|0|01.041854|1
00000153|BCG infection|BCG infection|0|01.041893|1
00000154|bacterial infection|bacterial infection|0|01.041900|3
00000155|Uncontrolled Bacterial Infections|Uncontrolled Bacterial Infections|0|01.041901|3
00000156|Aerobic Gram-Positive Cocci Infection|Aerobic Gram-Positive Cocci Infection|0|01.041904|1
00000157|HIV infection|HIV infection|0|01.042000|2
00000158|diarrhea from HIV|diarrhea from HIV|0|01.042001|2
00000159|Anemia Associated with HIV Infection|Anemia Associated with HIV Infection|0|01.042002|2
00000160|anorexia from HIV|anorexia from HIV|0|01.042004|2
00000161|cachexia due to HIV|cachexia due to HIV|0|01.042007|2
00000162|weight loss due to HIV|weight loss due to HIV|0|01.042008|2
00000164|non-infective meningitis|non-infective meningitis|0|01.047900|1
00000165|chickenpox|chickenpox|0|01.052900|1
00000166|postherpetic neuralgia|postherpetic neuralgia|0|01.053190|1
00000167|herpes zoster ophthalmicus|herpes zoster ophthalmicus|0|01.053200|1
00000168|herpes zoster keratoconjunctivitis|herpes zoster keratoconjunctivitis|0|01.053210|1
00000169|herpes zoster keratitis|herpes zoster keratitis|0|01.053211|1
00000170|herpes zoster oticus|herpes zoster oticus|0|01.053710|1
00000171|herpes zoster|herpes zoster|0|01.053900|1
00000172|herpes zoster in immunocompromised patient|herpes zoster in immunocompromised patient|0|01.053902|1
00000173|eczema herpeticum|eczema herpeticum|0|01.054000|1
00000174|genital herpes simplex|genital herpes simplex|0|01.054100|1
00000175|recurrent herpes genitalis|recurrent herpes genitalis|0|01.054101|2
00000176|suppression of recurrent herpes simplex infection|suppression of recurrent herpes simplex infection|0|01.054102|2
00000177|herpes simplex encephalitis|herpes simplex encephalitis|0|01.054300|1
00000178|ocular herpes simplex|ocular herpes simplex|0|01.054400|2
00000179|herpes simplex dendritic keratitis|herpes simplex dendritic keratitis|0|01.054420|2
00000180|herpes simplex keratitis|herpes simplex keratitis|0|01.054430|2
00000181|mucocutaneous herpes simplex|mucocutaneous herpes simplex|0|01.054790|3
00000182|recurrent mucocutaneous herpes simplex|recurrent mucocutaneous herpes simplex|0|01.054791|3
00000183|herpes simplex infection|herpes simplex infection|0|01.054900|3
00000184|herpes labialis|herpes labialis|0|01.054901|3
00000185|disseminated neonatal herpes simplex infection|disseminated neonatal herpes simplex infection|0|01.054902|1
00000187|recurrent herpes simplex|recurrent herpes simplex|0|01.054904|3
00000190|Crimean-Congo Fever|Crimean-Congo Fever|0|01.065000|1
00000191|Rift Valley fever|Rift Valley fever|0|01.066300|1
00000192|chronic hepatitis B|chronic hepatitis B|0|01.070300|2
00000193|chronic hepatitis C|chronic hepatitis C|0|01.070540|2
00000194|viral hepatitis|viral hepatitis|0|01.070900|3
00000196|psittacosis|psittacosis|0|01.073900|1
00000197|infectious mononucleosis|infectious mononucleosis|0|01.075000|1
00000198|trachoma|trachoma|0|01.076900|1
00000199|inclusion conjunctivitis caused by Chlamydia trachomatis|inclusion conjunctivitis caused by Chlamydia trachomatis|0|01.077000|1
00000200|chlamydial conjunctivitis|chlamydial conjunctivitis|0|01.077980|1
00000201|condylomata acuminata|condylomata acuminata|0|01.078100|2
00000202|verruca vulgaris|verruca vulgaris|0|01.078101|1
00000203|bleeding warts|bleeding warts|0|01.078103|3
00000204|external condylomata acuminata|external condylomata acuminata|0|01.078104|2
00000205|verruca plana|verruca plana|0|01.078190|1
00000206|cytomegalovirus disease|cytomegalovirus disease|0|01.078500|3
00000207|cytomegalovirus retinitis|cytomegalovirus retinitis|0|01.078501|1
00000208|prevention of cytomegalovirus disease|prevention of cytomegalovirus disease|0|01.078502|2
00000209|prevention of CMV disease after organ transplant|prevention of CMV disease after organ transplant|0|01.078503|2
00000210|hemorrhagic fever with renal syndrome|hemorrhagic fever with renal syndrome|0|01.078600|1
00000211|Lassa Fever|Lassa Fever|0|01.078892|1
00000212|respiratory syncytial virus infection|respiratory syncytial virus infection|0|01.079600|1
00000213|chlamydial infections|chlamydial infections|0|01.079900|1
00000214|viral infection|viral infection|0|01.079990|3
00000216|louse-borne typhus|louse-borne typhus|0|01.080000|1
00000217|murine typhus|murine typhus|0|01.081000|1
00000218|recrudescent typhus|recrudescent typhus|0|01.081100|1
00000219|scrub typhus|scrub typhus|0|01.081200|1
00000220|typhus infections|typhus infections|0|01.081900|1
00000221|Rocky Mountain spotted fever|Rocky Mountain spotted fever|0|01.082000|1
00000222|Q fever|Q fever|0|01.083000|1
00000223|rickettsialpox|rickettsialpox|0|01.083200|1
00000224|rickettsial infection|rickettsial infection|0|01.083900|1
00000225|Plasmodium falciparum malaria|Plasmodium falciparum malaria|0|01.084000|1
00000226|Plasmodium falciparum malaria prevention|Plasmodium falciparum malaria prevention|0|01.084001|1
00000227|chloroquine-resistant Plasmodium falciparum malaria|chloroquine-resistant Plasmodium falciparum malaria|0|01.084002|1
00000228|chloro-resistant falciparum malaria prevention|chloroquine-resistant Plasmodium falciparum malaria prevention|0|01.084003|1
00000229|Plasmodium vivax malaria|Plasmodium vivax malaria|0|01.084100|1
00000230|Plasmodium vivax malaria prevention|Plasmodium vivax malaria prevention|0|01.084101|1
00000231|Plasmodium malariae malaria|Plasmodium malariae malaria|0|01.084200|1
00000232|Plasmodium malariae malaria prevention|Plasmodium malariae malaria prevention|0|01.084201|1
00000233|Plasmodium ovale malaria|Plasmodium ovale malaria|0|01.084300|1
00000234|Plasmodium ovale malaria prevention|Plasmodium ovale malaria prevention|0|01.084301|1
00000235|malaria|malaria|0|01.084600|3
00000236|malaria prevention|malaria prevention|0|01.084601|3
00000237|blackwater fever|blackwater fever|0|01.084800|1
00000238|visceral leishmaniasis|visceral leishmaniasis|0|01.085000|1
00000239|leishmaniasis|leishmaniasis|0|01.085900|1
00000240|cutaneous leishmaniasis|cutaneous leishmaniasis|0|01.085901|1
00000241|African trypanosomiasis|African trypanosomiasis|0|01.086500|1
00000242|relapsing fever|relapsing fever|0|01.087900|1
00000243|bartonellosis|bartonellosis|0|01.088000|1
00000244|Lyme disease|Lyme disease|0|01.088810|1
00000245|Lyme arthritis|Lyme arthritis|0|01.088811|2
00000246|refractory Lyme arthritis|refractory Lyme arthritis|0|01.088812|2
00000247|Lyme carditis|Lyme carditis|0|01.088813|1
00000248|babesiosis|babesiosis|0|01.088820|1
00000249|symptomatic congenital syphilis|symptomatic congenital syphilis|0|01.090000|1
00000250|asymptomatic congenita syphilis|asymptomatic congenita syphilis|0|01.090100|1
00000251|congenital neurosyphilis|congenital neurosyphilis|0|01.090400|1
00000252|primary genital syphilis|primary genital syphilis|0|01.091000|1
00000253|secondary syphilis|secondary syphilis|0|01.091300|1
00000254|latent syphilis|latent syphilis|0|01.092000|1
00000255|latent early syphilis|latent early syphilis|0|01.092900|1
00000256|neurosyphilis|neurosyphilis|0|01.094900|1
00000257|latent late syphilis|latent late syphilis|0|01.096000|1
00000258|tertiary syphilis|tertiary syphilis|0|01.097000|1
00000259|syphilis|syphilis|0|01.097900|1
00000260|acute lower genitourinary gonorrhea|acute lower genitourinary gonorrhea|0|01.098000|1
00000261|acute gonococcal urethritis|acute gonococcal urethritis|0|01.098003|1
00000265|acute gonococcal epididymo-orchitis|acute gonococcal epididymo-orchitis|0|01.098130|1
00000267|acute gonococcal cervicitis|acute gonococcal cervicitis|0|01.098150|1
00000268|acute gonococcal endometritis|acute gonococcal endometritis|0|01.098160|1
00000280|gonococcal conjunctivitis neonatorum|gonococcal conjunctivitis neonatorum|0|01.098400|1
00000281|adult gonococcal conjunctivitis|adult gonococcal conjunctivitis|0|01.098401|1
00000282|gonococcal arthritis|gonococcal arthritis|0|01.098500|1
00000284|gonococcal pharyngitis|gonococcal pharyngitis|0|01.098600|1
00000285|rectal gonorrhea|rectal gonorrhea|0|01.098700|1
00000286|gonococcal meningitis|gonococcal meningitis|0|01.098820|1
00000288|gonococcal endocarditis|gonococcal endocarditis|0|01.098840|1
00000289|disseminated gonococcal infection|disseminated gonococcal infection|0|01.098890|1
00000290|chancroid|chancroid|0|01.099000|1
00000291|lymphogranuloma venereum|lymphogranuloma venereum|0|01.099100|2
00000292|granuloma inguinale|granuloma inguinale|0|01.099200|2
00000293|Reiter's disease|Reiter's disease|0|01.099300|1
00000294|Chlamydia trachomatis urethritis|Chlamydia trachomatis urethritis|0|01.099410|1
00000295|rectal Chlamydia trachomatis infection|rectal Chlamydia trachomatis infection|0|01.099520|1
00000296|chlamydia cervicitis|chlamydia cervicitis|0|01.099530|1
00000297|genitourinary Chlamydia trachomatis infection|genitourinary Chlamydia trachomatis infection|0|01.099550|1
00000298|acute necrotizing ulcerative gingivitis|acute necrotizing ulcerative gingivitis|0|01.101000|1
00000299|fusospirochetal pharyngitis|fusospirochetal pharyngitis|0|01.101001|1
00000300|latent yaws|latent yaws|0|01.102800|1
00000301|yaws|yaws|0|01.102900|1
00000302|tertiary yaws|tertiary yaws|0|01.102901|1
00000303|pinta|pinta|0|01.103900|1
00000304|bejel|bejel|0|01.104000|1
00000305|latent bejel|latent bejel|0|01.104001|1
00000306|tertiary bejel|tertiary bejel|0|01.104002|1
00000307|tinea barbae|tinea barbae|0|01.110000|1
00000308|tinea capitis|tinea capitis|0|01.110001|1
00000309|onychomycosis due to dermatophyte|onychomycosis due to dermatophyte|0|01.110100|1
00000310|toenail onychomycosis|toenail onychomycosis|0|01.110101|1
00000311|fingernail onychomycosis|fingernail onychomycosis|0|01.110102|1
00000312|tinea manuum|tinea manuum|0|01.110200|1
00000313|tinea cruris|tinea cruris|0|01.110300|1
00000314|tinea pedis|tinea pedis|0|01.110400|1
00000315|tinea corporis|tinea corporis|0|01.110500|1
00000316|dermatophytosis|dermatophytosis|0|01.110900|1
00000317|tinea versicolor|tinea versicolor|0|01.111000|1
00000318|fungal infection of skin|fungal infection of skin|0|01.111900|3
00000319|oral candidiasis|oral candidiasis|0|01.112000|1
00000320|oropharyngeal candidiasis|oropharyngeal candidiasis|0|01.112001|1
00000321|prevention of oropharyngeal candidiasis|prevention of oropharyngeal candidiasis|0|01.112002|1
00000322|vulvovaginal candidiasis|vulvovaginal candidiasis|0|01.112100|1
00000323|Recurrent Vulvovaginal Candidiasis|Recurrent Vulvovaginal Candidiasis|0|01.112101|2
00000324|prevention of vulvovaginal candidiasis|prevention of vulvovaginal candidiasis|0|01.112102|2
00000325|cutaneous candidiasis|cutaneous candidiasis|0|01.112300|1
00000326|disseminated candidiasis|disseminated candidiasis|0|01.112500|1
00000327|prevention of disseminated candidiasis|prevention of disseminated candidiasis|0|01.112501|2
00000328|esophageal candidiasis|esophageal candidiasis|0|01.112840|1
00000329|gastrointestinal candidiasis|gastrointestinal candidiasis|0|01.112850|1
00000330|nasal candidiasis|nasal candidiasis|0|01.112890|1
00000331|pharyngeal candidiasis|pharyngeal candidiasis|0|01.112891|1
00000332|candidiasis|candidiasis|0|01.112900|1
00000333|coccidioidomycosis|coccidioidomycosis|0|01.114900|1
00000334|histoplasmosis|histoplasmosis|0|01.115900|1
00000335|chronic pulmonary histoplasmosis|chronic pulmonary histoplasmosis|0|01.115950|2
00000336|disseminated Histoplasma capsulatum infection|disseminated Histoplasma capsulatum infection|0|01.115990|1
00000337|blastomycosis|blastomycosis|0|01.116000|1
00000338|pulmonary blastomycosis|pulmonary blastomycosis|0|01.116001|1
00000339|disseminated blastomycosis|disseminated blastomycosis|0|01.116002|1
00000340|paracoccidioidomycosis|paracoccidioidomycosis|0|01.116100|1
00000341|disseminated sporotrichosis|disseminated sporotrichosis|0|01.117100|1
00000342|lymphocutaneous sporotrichosis|lymphocutaneous sporotrichosis|0|01.117101|1
00000343|chromoblastomycosis|chromoblastomycosis|0|01.117200|1
00000344|aspergillosis|aspergillosis|0|01.117300|1
00000345|refractory aspergillosis|refractory aspergillosis|0|01.117301|1
00000346|pulmonary aspergillosis|pulmonary aspergillosis|0|01.117302|1
00000347|disseminated aspergillosis|disseminated aspergillosis|0|01.117303|1
00000348|invasive pulmonary aspergillosis|invasive pulmonary aspergillosis|0|01.117304|1
00000349|cryptococcosis|cryptococcosis|0|01.117500|1
00000350|petriellidosis|petriellidosis|0|01.117600|1
00000351|mucormycosis|mucormycosis|0|01.117700|1
00000352|fungal infection|fungal infection|0|01.117900|3
00000353|opportunistic fungal infection|opportunistic fungal infection|0|01.118000|1
00000354|Schistosomiasis due to S. Haematobium|Schistosomiasis due to S. Haematobium|0|01.120000|1
00000355|Schistosomiasis due to S. Mansoni|Schistosomiasis due to S. Mansoni|0|01.120100|1
00000356|Schistosomiasis due to S. Japonicum|Schistosomiasis due to S. Japonicum|0|01.120200|1
00000357|infection caused by Schistosoma mekongi|infection caused by Schistosoma mekongi|0|01.120800|1
00000358|schistosomiasis|schistosomiasis|0|01.120900|1
00000359|opisthorchiasis|opisthorchiasis|0|01.121000|1
00000360|clonorchiasis due to C. sinensis|clonorchiasis due to C. sinensis|0|01.121100|1
00000361|paragonimiasis|paragonimiasis|0|01.121200|1
00000362|metagonimiasis|metagonimiasis|0|01.121500|1
00000363|Echinococcus granulosus infection of the liver|Echinococcus granulosus infection of the liver|0|01.122000|1
00000364|Echinococcus granulosus infection of the lung|Echinococcus granulosus infection of the lung|0|01.122100|1
00000365|Echinococcus granulosus infection of the peritoneum|Echinococcus granulosus infection of the peritoneum|0|01.122300|1
00000366|Echinococcus granulosus infection|Echinococcus granulosus infection|0|01.122400|1
00000367|alveolar echinococcosis|alveolar echinococcosis|0|01.122600|1
00000368|Taenia infection|Taenia infection|0|01.123000|1
00000369|cysticercosis infection|cysticercosis infection|0|01.123100|1
00000370|neurocysticercosis|neurocysticercosis|0|01.123101|1
00000371|ocular cysticercosis|ocular cysticercosis|0|01.123102|3
00000372|Diphyllobothrium infections|Diphyllobothrium infections|0|01.123400|1
00000373|hymenolepiasis infection|hymenolepiasis infection|0|01.123600|1
00000374|dipylidiasis infections|dipylidiasis infections|0|01.123800|1
00000375|trichinosis|trichinosis|0|01.124000|1
00000376|Bancroft's filariasis|Bancroft's filariasis|0|01.125000|1
00000377|loiasis|loiasis|0|01.125200|1
00000378|onchocerciasis|onchocerciasis|0|01.125300|1
00000379|dracunculiasis|dracunculiasis|0|01.125700|1
00000380|Ancylostoma duodenale infection|Ancylostoma duodenale infection|0|01.126000|1
00000381|uncinariasis|uncinariasis|0|01.126001|1
00000382|Necator americanus infection|Necator americanus infection|0|01.126100|1
00000383|cutaneous larva migrans|cutaneous larva migrans|0|01.126900|1
00000384|ascariasis|ascariasis|0|01.127000|1
00000385|strongyloidiasis|strongyloidiasis|0|01.127200|1
00000386|trichuriasis|trichuriasis|0|01.127300|1
00000387|enterobiasis|enterobiasis|0|01.127400|1
00000388|capillariasis|capillariasis|0|01.127500|1
00000389|trichostrongyliasis|trichostrongyliasis|0|01.127600|1
00000390|infection by Moniliformis|infection by Moniliformis|0|01.127700|1
00000391|toxocariasis|toxocariasis|0|01.128000|1
00000392|gnathostomiasis|gnathostomiasis|0|01.128100|1
00000393|mixed intestinal helminthiasis|mixed intestinal helminthiasis|0|01.128900|1
00000394|intestinal parasitic infection|intestinal parasitic infection|0|01.129000|1
00000395|toxoplasmosis|toxoplasmosis|0|01.130900|1
00000396|Toxoplasma Gondii|Toxoplasma Gondii|1|01.130901|1
00000397|toxoplasmosis prevention|toxoplasmosis prevention|0|01.130902|1
00000398|trichomoniasis|trichomoniasis|0|01.131900|1
00000399|pediculosis capitis|pediculosis capitis|0|01.132000|1
00000400|pediculosis corporis|pediculosis corporis|0|01.132100|1
00000401|pediculosis pubis|pediculosis pubis|0|01.132200|1
00000402|pediculosis prevention|pediculosis prevention|0|01.132900|1
00000403|scabies|scabies|0|01.133000|1
00000404|sarcoidosis|sarcoidosis|0|01.135000|1
00000405|arthritis sarcoidosis|arthritis sarcoidosis|0|01.135001|1
00000406|Behcet syndrome|Behcet syndrome|0|01.136100|3
00000407|amebae infection|amebae infection|0|01.136200|1
00000408|Pneumocystis jirovecii pneumonia|Pneumocystis jirovecii pneumonia|0|01.136300|1
00000409|extrapulmonary pneumocystosis|extrapulmonary pneumocystosis|0|01.136301|1
00000410|Pneumocystis jirovecii pneumonia prevention|Pneumocystis jirovecii pneumonia prevention|0|01.136302|2
00000411|protozoal infection|protozoal infection|0|01.136800|3
00000412|infection|infection|0|01.136900|3
00000413|severe infection|severe infection|0|01.136901|1
00000414|perioperative infection|perioperative infection|0|01.136902|1
00000415|colorectal perioperative infection|colorectal perioperative infection|0|01.136903|1
00000416|adjunct treatment to inhibit renal drug excretion|adjunct treatment to inhibit renal drug excretion|0|01.136904|1
00000418|systemic infection|systemic infection|0|01.136907|2
00000419|chronic infection|chronic infection|0|01.136908|2
00000420|administration site infection|administration site infection|0|01.136909|1
00000421|parasitic infection|parasitic infection|0|01.136910|3
00000422|thyroid surgery|thyroid surgery|0|02. 06980|1
00000423|diagnostic test for Cushing's syndrome|diagnostic test for Cushing's syndrome|0|02. 07190|1
00000424|adrenalectomy|adrenalectomy|0|02. 07220|2
00000425|malignant esophageal neoplasm|malignant esophageal neoplasm|0|02.150900|2
00000426|metastatic colorectal cancer|metastatic colorectal cancer|0|02.154000|2
00000428|diagnostic test for pancreatic islet cell adenoma|diagnostic test for pancreatic islet cell adenoma|0|02.157401|2
00000430|diarrhea from pancreatic VIPoma|diarrhea from pancreatic VIPoma|0|02.157901|3
00000431|osteosarcoma of bone|osteosarcoma of bone|0|02.170900|2
00000432|Ewing's sarcoma|Ewing's sarcoma|0|02.170901|2
00000433|soft or connective tissue sarcoma|soft or connective tissue sarcoma|0|02.171900|2
00000434|sarcoma botryoides|sarcoma botryoides|0|02.171901|2
00000435|rhabdomyosarcoma|rhabdomyosarcoma|0|02.171902|2
00000436|hypercalcemia associated with sarcoidosis|hypercalcemia associated with sarcoidosis|0|02.171903|1
00000437|malignant melanoma|malignant melanoma|0|02.172900|2
00000439|metastatic malignant melanoma|metastatic malignant melanoma|0|02.172903|2
00000440|superficial benign epitheliomatosis|superficial benign epitheliomatosis|0|02.173900|2
00000441|superficial basal cell carcinoma|superficial basal cell carcinoma|0|02.173901|2
00000445|Kaposi's sarcoma skin lesion|Kaposi's sarcoma skin lesion|0|02.176000|2
00000446|Kaposi's sarcoma|Kaposi's sarcoma|0|02.176900|2
00000447|ovarian germ cell tumor carcinoma|ovarian germ cell tumor carcinoma|0|02.183000|2
00000448|seminoma of testis|seminoma of testis|0|02.186900|2
00000449|Wilms' tumor|Wilms' tumor|0|02.189000|2
00000450|renal cell carcinoma|renal cell carcinoma|0|02.189001|2
00000451|metastatic renal cell carcinoma|metastatic renal cell carcinoma|0|02.189002|2
00000452|malignant neoplasm of urinary system|malignant neoplasm of urinary system|0|02.189900|2
00000453|retinoblastoma|retinoblastoma|0|02.190500|2
00000454|malignant brain neoplasm|malignant brain neoplasm|0|02.191900|2
00000455|anaplastic astrocytoma|anaplastic astrocytoma|0|02.191901|1
00000457|glioblastoma multiforme|glioblastoma multiforme|0|02.191911|2
00000458|lymphomatous meningitis|lymphomatous meningitis|0|02.192100|2
00000459|neoplasm metastatic to CNS|neoplasm metastatic to CNS|0|02.192900|2
00000460|neuroblastoma|neuroblastoma|0|02.194000|2
00000461|renal metastases|renal metastases|0|02.198000|2
00000462|cerebral metastases|cerebral metastases|0|02.198300|2
00000463|bone metastases|bone metastases|0|02.198500|2
00000464|vertebral metastases|vertebral metastases|0|02.198501|2
00000466|osteolytic bone metastases of breast cancer|osteolytic bone metastases of breast cancer|0|02.198503|2
00000467|metastatic breast carcinoma|metastatic breast carcinoma|0|02.198810|2
00000468|hypercalcemia associated with metastatic breast cancer|hypercalcemia associated with metastatic breast cancer|0|02.198811|2
00000469|metastatic endometrial carcinoma|metastatic endometrial carcinoma|0|02.198820|2
00000470|malignancy|malignancy|0|02.199100|2
00000471|Hodgkin's lymphoma|Hodgkin's lymphoma|0|02.201900|2
00000472|mycosis fungoides|mycosis fungoides|0|02.202100|1
00000473|Mycosis Fungoides Palliative Treatment|Mycosis Fungoides Palliative Treatment|0|02.202101|1
00000474|cutaneous T-cell lymphoma|cutaneous T-cell lymphoma|0|02.202102|2
00000475|hairy cell leukemia|hairy cell leukemia|0|02.202400|2
00000476|Letterer-Siwe disease|Letterer-Siwe disease|0|02.202500|1
00000477|systemic mastocytosis|systemic mastocytosis|0|02.202600|1
00000478|non-Hodgkin's lymphoma|non-Hodgkin's lymphoma|0|02.202800|2
00000479|relapse or refractory non-Hodgkin's lymphoma|relapse or refractory non-Hodgkin's lymphoma|0|02.202801|1
00000480|multiple myeloma|multiple myeloma|0|02.203000|2
00000481|osteolytic lesions of multiple myeloma|osteolytic lesions of multiple myeloma|0|02.203001|2
00000482|acute lymphoid leukemia|acute lymphoid leukemia|0|02.204000|1
00000483|chronic lymphoid leukemia|chronic lymphoid leukemia|0|02.204100|2
00000484|chronic lymphocytic leukemia|chronic lymphocytic leukemia|0|02.204101|2
00000485|acute myeloid leukemia|acute myeloid leukemia|0|02.205000|1
00000486|acute promyelocytic leukemia|acute promyelocytic leukemia|0|02.205001|1
00000487|acute myelomonocytic leukemia|acute myelomonocytic leukemia|0|02.205002|1
00000488|chronic myelocytic leukemia|chronic myelocytic leukemia|0|02.205100|2
00000489|blastic phase chronic myeloid leukemia|blastic phase chronic myeloid leukemia|0|02.205102|2
00000490|accelerated phase chronic myelocytic leukemia|accelerated phase chronic myelocytic leukemia|0|02.205103|2
00000492|acute monocytic leukemia|acute monocytic leukemia|0|02.206000|1
00000493|erythroid leukemia|erythroid leukemia|0|02.207000|1
00000494|acute leukemia|acute leukemia|0|02.208000|1
00000495|meningeal leukemia|meningeal leukemia|0|02.208800|3
00000496|leukemia|leukemia|0|02.208900|3
00000497|familial adenomatous polyposis|familial adenomatous polyposis|0|02.211300|2
00000498|benign hepatic cell adenoma|benign hepatic cell adenoma|0|02.211500|2
00000499|insulinoma|insulinoma|0|02.211700|2
00000500|laryngeal papillomatosis|laryngeal papillomatosis|0|02.212100|1
00000501|benign mammary dysplasia|benign mammary dysplasia|0|02.217000|2
00000502|uterine leiomyoma|uterine leiomyoma|0|02.218900|2
00000504|pituitary prolactinoma|pituitary prolactinoma|0|02.227300|2
00000505|pheochromocytoma|pheochromocytoma|0|02.227900|2
00000506|diagnostic test for pheochromocytoma|diagnostic test for pheochromocytoma|0|02.227901|1
00000507|hypertension secondary to pheochromocytoma|hypertension secondary to pheochromocytoma|0|02.227902|2
00000508|prevention of hypertension in pheochromocytoma|prevention of hypertension in pheochromocytoma|0|02.227903|2
00000509|pheochromocytoma adjunct therapy|pheochromocytoma adjunct therapy|0|02.227904|2
00000510|hemangioma|hemangioma|0|02.228000|2
00000511|carcinoma in situ of the esophagus|carcinoma in situ of the esophagus|0|02.230100|2
00000512|malignant neoplasm of liver|malignant neoplasm of liver|0|02.230800|2
00000513|biliary tract malignancy|biliary tract malignancy|0|02.230801|2
00000514|gastric cancer|gastric cancer|0|02.230900|2
00000515|colorectal cancer|colorectal cancer|0|02.230901|3
00000516|adenocarcinoma of pancreas|adenocarcinoma of pancreas|0|02.230902|2
00000517|primary malignant neoplasm of gastrointestinal tract|primary malignant neoplasm of gastrointestinal tract|0|02.230903|2
00000518|thyroid carcinoma|thyroid carcinoma|0|02.231000|2
00000519|paralaryngeal carcinoma|paralaryngeal carcinoma|0|02.231001|2
00000520|laryngeal carcinoma|laryngeal carcinoma|0|02.231002|2
00000521|malignant neoplasm of lung|malignant neoplasm of lung|0|02.231200|2
00000522|small cell lung carcinoma|small cell lung carcinoma|0|02.231201|2
00000523|non-small cell lung cancer|non-small cell lung cancer|0|02.231202|2
00000524|bronchogenic carcinoma|bronchogenic carcinoma|0|02.231203|2
00000526|carcinoma of breast|carcinoma of breast|0|02.233000|2
00000527|malignant tumor of male breast|malignant tumor of male breast|0|02.233001|2
00000528|family history of malignant tumor of breast|family history of malignant tumor of breast|0|02.233003|2
00000529|prevention of breast cancer in high risk women|prevention of breast cancer in high risk women|0|02.233004|3
00000530|carcinoma of cervix|carcinoma of cervix|0|02.233100|2
00000531|malignant neoplasm of the uterus|malignant neoplasm of the uterus|0|02.233200|2
00000532|carcinoma of corpus uteri|carcinoma of corpus uteri|0|02.233201|2
00000533|malignant neoplasm of the ovary|malignant neoplasm of the ovary|0|02.233300|2
00000534|endometrial carcinoma|endometrial carcinoma|0|02.233301|2
00000535|primary malignant neoplasm of vagina|primary malignant neoplasm of vagina|0|02.233302|2
00000536|squamous cell carcinoma of vulva|squamous cell carcinoma of vulva|0|02.233303|2
00000537|prostatic carcinoma|prostatic carcinoma|0|02.233400|2
00000538|metastatic prostate carcinoma|metastatic prostate carcinoma|0|02.233401|2
00000539|advanced prostatic carcinoma|advanced prostatic carcinoma|0|02.233402|2
00000540|penile carcinoma|penile carcinoma|0|02.233500|2
00000541|carcinoma in situ of the glans penis|carcinoma in situ of the glans penis|0|02.233501|2
00000542|malignant tumor of testis|malignant tumor of testis|0|02.233600|2
00000543|testicular germ cell tumor|testicular germ cell tumor|0|02.233601|2
00000544|malignant tumor of urinary bladder|malignant tumor of urinary bladder|0|02.233700|2
00000546|adrenal cortex carcinoma|adrenal cortex carcinoma|0|02.234800|2
00000547|abdominal visceral cancer|abdominal visceral cancer|0|02.234801|2
00000548|malignant tumor of head and-or neck|malignant tumor of head and-or neck|0|02.234802|2
00000550|carcinoma|carcinoma|0|02.234900|2
00000551|humoral hypercalcemia of malignancy|humoral hypercalcemia of malignancy|1|02.234902|2
00000552|squamous cell carcinoma|squamous cell carcinoma|0|02.234903|2
00000553|craniopharyngioma|craniopharyngioma|0|02.237000|3
00000554|multiple endocrine neoplasia|multiple endocrine neoplasia|0|02.237400|2
00000555|neoplasm of breast|neoplasm of breast|0|02.238300|2
00000556|polycythemia vera|polycythemia vera|0|02.238400|1
00000557|palliative treatment of polycythemia vera|palliative treatment of polycythemia vera|0|02.238401|1
00000558|myeloproliferative neoplasm|myeloproliferative neoplasm|0|02.238700|2
00000560|thrombocytosis in myeloproliferative disease|thrombocytosis in myeloproliferative disease|0|02.238702|2
00000563|spinal cord neoplasm|spinal cord neoplasm|0|02.239200|2
00000564|skin and skin structure neoplasm|skin and skin structure neoplasm|0|02.239201|1
00000565|gestational trophoblastic neoplasia|gestational trophoblastic neoplasia|0|02.239500|2
00000566|neoplasm of brain|neoplasm of brain|0|02.239600|2
00000568|central nervous system neoplasm|central nervous system neoplasm|0|02.239700|2
00000569|pituitary neoplasm|pituitary neoplasm|0|02.239702|2
00000570|neoplasm|neoplasm|0|02.239900|2
00000571|humoral hypercalcemia of malignancy|humoral hypercalcemia of malignancy|0|02.239901|2
00000572|estrogen-dependent neoplasm|estrogen-dependent neoplasm|0|02.239902|2
00000573|Chemotherapy for Cancer|Chemotherapy for Cancer|2|02.239903|3
00000574|ectopic ACTH syndrome|ectopic ACTH syndrome|0|02.239905|1
00000575|lacrimal surgery|lacrimal surgery|0|03. 09990|1
00000576|surgical procedure on eye proper|surgical procedure on eye proper|0|03. 16990|1
00000577|simple goiter|simple goiter|0|03.240000|2
00000578|goiter|goiter|0|03.240900|2
00000579|thyrotoxicosis|thyrotoxicosis|0|03.242800|1
00000580|hyperthyroidism|hyperthyroidism|0|03.242900|2
00000581|thyrotoxicosis crisis|thyrotoxicosis crisis|0|03.242901|1
00000583|congenital hypothyroidism|congenital hypothyroidism|0|03.243000|2
00000584|hypothyroidism|hypothyroidism|0|03.244900|2
00000585|untreated hypothyroidism|untreated hypothyroidism|0|03.244901|3
00000587|myxedema|myxedema|0|03.244904|2
00000588|myxedema coma|myxedema coma|0|03.244905|1
00000589|mild hypothyroidism|mild hypothyroidism|0|03.244906|2
00000590|nonsuppurative thyroiditis|nonsuppurative thyroiditis|0|03.245000|1
00000591|thyroiditis|thyroiditis|0|03.245900|1
00000592|disorder of thyroid gland|disorder of thyroid gland|0|03.246900|2
00000593|thyroid gland radiation protection|thyroid gland radiation protection|0|03.246903|1
00000594|type 2 diabetes mellitus|type 2 diabetes mellitus|0|03.250000|2
00000595|type 1 diabetes mellitus|type 1 diabetes mellitus|0|03.250010|2
00000596|diabetic ketoacidosis|diabetic ketoacidosis|0|03.250100|1
00000597|hyperosmolar hyperglycemic state|hyperosmolar hyperglycemic state|0|03.250200|1
00000598|diabetic coma|diabetic coma|0|03.250300|1
00000599|diabetic nephropathy|diabetic nephropathy|0|03.250400|2
00000600|diabetic retinopathy|diabetic retinopathy|0|03.250500|2
00000601|hemorrhagic diabetic retinopathy|hemorrhagic diabetic retinopathy|0|03.250501|1
00000603|diabetic neuropathic ulcer of lower extremity|diabetic neuropathic ulcer of lower extremity|0|03.250800|1
00000604|diabetes mellitus|diabetes mellitus|0|03.250900|2
00000605|severe diabetes mellitus|severe diabetes mellitus|0|03.250901|2
00000606|uncontrolled diabetes mellitus|uncontrolled diabetes mellitus|0|03.250902|3
00000607|hypoglycemic disorder|hypoglycemic disorder|0|03.251200|3
00000608|Zollinger-Ellison syndrome|Zollinger-Ellison syndrome|0|03.251500|3
00000609|hyperparathyroidism|hyperparathyroidism|0|03.252000|3
00000610|osteitis fibrosa cystica|osteitis fibrosa cystica|0|03.252001|2
00000611|hypoparathyroidism|hypoparathyroidism|0|03.252100|2
00000612|pseudohypoparathyroidism|pseudohypoparathyroidism|0|03.252101|1
00000613|acromegaly|acromegaly|0|03.253000|1
00000614|hyperprolactinemia|hyperprolactinemia|0|03.253100|3
00000615|pituitary insufficiency|pituitary insufficiency|0|03.253200|2
00000616|untreated hypopituitarism|untreated hypopituitarism|0|03.253201|2
00000617|pituitary dwarfism|pituitary dwarfism|0|03.253300|2
00000618|adult growth hormone deficiency|adult growth hormone deficiency|0|03.253301|3
00000620|gonadotropin releasing factor deficiency|gonadotropin releasing factor deficiency|0|03.253400|3
00000621|hypogonadotropic hypogonadism|hypogonadotropic hypogonadism|0|03.253401|2
00000622|diabetes insipidus|diabetes insipidus|0|03.253500|2
00000623|partial central diabetes insipidus|partial central diabetes insipidus|0|03.253501|2
00000624|SIADH syndrome|SIADH syndrome|0|03.253600|3
00000625|hypothalamic-pituitary insufficiency|hypothalamic-pituitary insufficiency|0|03.253700|2
00000626|pituitary gland enlarged|pituitary gland enlarged|0|03.253800|3
00000627|hypercortisolism|hypercortisolism|0|03.255000|2
00000628|diagnostic test for primary aldosteronism|diagnostic test for primary aldosteronism|0|03.255100|1
00000629|Bartter's syndrome|Bartter's syndrome|0|03.255101|3
00000630|adrenogenital disorder|adrenogenital disorder|0|03.255200|3
00000631|virilism|virilism|0|03.255201|1
00000633|primary adrenocortical insufficiency|primary adrenocortical insufficiency|0|03.255401|3
00000634|diagnostic test for secondary adrenal suppression|diagnostic test for secondary adrenocortical insufficiency|0|03.255402|3
00000635|severe adrenal insufficiency|severe adrenal insufficiency|0|03.255403|3
00000636|acute adrenocortical insufficiency|acute adrenocortical insufficiency|0|03.255404|1
00000637|adrenocortical insufficiency|adrenocortical insufficiency|0|03.255405|3
00000638|disorder of adrenal gland|disorder of adrenal gland|0|03.255900|1
00000639|ovarian hyperstimulation|ovarian hyperstimulation|0|03.256100|1
00000640|female hypogonadism|female hypogonadism|0|03.256300|1
00000641|primary ovarian failure|primary ovarian failure|0|03.256301|1
00000642|hypoestrogenism|hypoestrogenism|0|03.256302|3
00000643|polycystic ovarian syndrome|polycystic ovarian syndrome|0|03.256400|2
00000644|corpus luteum insufficiency syndrome|corpus luteum insufficiency syndrome|0|03.256800|3
00000645|amenorrhea secondary to ovarian dysfunction|amenorrhea secondary to ovarian dysfunction|0|03.256801|2
00000646|infertility secondary to progesterone deficiency|infertility secondary to progesterone deficiency|0|03.256900|2
00000647|male hypogonadism|male hypogonadism|0|03.257200|1
00000648|diagnostic test for hypothalamic pituitary gonadal axis|diagnostic test for hypothalamic pituitary gonadal axis|0|03.257201|1
00000649|primary hypogonadism due to bilateral torsion of testes|primary hypogonadism due to bilateral torsion of testes|0|03.257202|2
00000650|primary hypogonadism due to orchitis|primary hypogonadism due to orchitis|0|03.257203|2
00000652|delayed puberty|delayed puberty|0|03.259000|2
00000653|precocious puberty|precocious puberty|0|03.259100|2
00000654|carcinoid syndrome|carcinoid syndrome|0|03.259200|3
00000655|endocrine disorders|endocrine disorders|0|03.259900|3
00000656|female hormonal imbalance|female hormonal imbalance|0|03.259901|3
00000657|androgen deficiency|androgen deficiency|0|03.259902|3
00000658|Prolactin Stimulation|Prolactin Stimulation|1|03.259904|1
00000659|diagnostic test for gonadotropin deficiency|diagnostic test for gonadotropin deficiency|0|03.259905|1
00000660|protein-calorie malnutrition|protein-calorie malnutrition|0|03.263900|3
00000661|vitamin A deficiency|vitamin A deficiency|0|03.264900|3
00000662|thiamine deficiency|thiamine deficiency|0|03.265100|3
00000663|niacin deficiency|niacin deficiency|0|03.265200|3
00000664|biotin deficiency|biotin deficiency|0|03.266000|3
00000665|riboflavin deficiency|riboflavin deficiency|0|03.266001|3
00000666|pyridoxine deficiency|pyridoxine deficiency|0|03.266100|3
00000667|folate deficiency|folate deficiency|0|03.266200|3
00000668|pantothenic acid deficiency|pantothenic acid deficiency|0|03.266202|3
00000669|vitamin B12 deficiency|vitamin B12 deficiency|0|03.266203|3
00000670|vitamin C deficiency|vitamin C deficiency|0|03.267000|3
00000672|rickets|rickets|0|03.268000|2
00000673|vitamin D dependent rickets|vitamin D dependent rickets|0|03.268001|1
00000674|osteomalacia|osteomalacia|0|03.268200|3
00000679|vitamin D deficiency|vitamin D deficiency|0|03.268900|3
00000680|disorder of vitamin D|disorder of vitamin D|0|03.268901|3
00000681|vitamin K deficiency|vitamin K deficiency|0|03.269000|3
00000682|vitamin E deficiency|vitamin E deficiency|0|03.269100|3
00000683|vitamin deficiency|vitamin deficiency|0|03.269200|3
00000684|iodine deficiency|iodine deficiency|0|03.269300|3
00000685|selenium deficiency|selenium deficiency|0|03.269301|3
00000686|zinc deficiency|zinc deficiency|0|03.269302|3
00000688|carnitine deficiency|carnitine deficiency|0|03.269901|3
00000689|cystinuria|cystinuria|0|03.270000|1
00000690|cystinosis|cystinosis|0|03.270001|1
00000691|phenylketonuria|phenylketonuria|0|03.270100|2
00000692|albinism|albinism|0|03.270200|2
00000693|maple syrup urine disease|maple syrup urine disease|0|03.270300|3
00000694|homocystinuria|homocystinuria|0|03.270400|2
00000695|hyperammonemia|hyperammonemia|0|03.270600|3
00000696|hyperalaninemia|hyperalaninemia|0|03.270800|3
00000697|glucose-6-phosphate dehydrogenase (G6PD) deficiency|glucose-6-phosphate dehydrogenase (G6PD) deficiency|0|03.271000|2
00000698|hereditary fructose intolerance|hereditary fructose intolerance|0|03.271200|2
00000699|malabsorption of glucose|malabsorption of glucose|0|03.271300|2
00000700|hyperoxaluria|hyperoxaluria|0|03.271800|2
00000701|hypercholesterolemia|hypercholesterolemia|0|03.272000|2
00000702|homozygous familial hypercholesterolemia|homozygous familial hypercholesterolemia|0|03.272001|2
00000703|hypertriglyceridemia|hypertriglyceridemia|0|03.272100|2
00000704|Predisposition To Hypertriglyceridemia|Predisposition To Hypertriglyceridemia|2|03.272101|2
00000705|mixed hyperlipidemia|mixed hyperlipidemia|0|03.272200|2
00000706|primary dysbetalipoproteinemia|primary dysbetalipoproteinemia|0|03.272201|2
00000707|hyperlipidemia|hyperlipidemia|0|03.272400|2
00000708|essential fatty acid deficiency|essential fatty acid deficiency|0|03.272500|3
00000709|Gaucher's disease|Gaucher's disease|0|03.272700|2
00000710|disorder of lipid metabolism|disorder of lipid metabolism|0|03.272900|2
00000711|monoclonal gammopathy|monoclonal gammopathy|0|03.273100|2
00000712|hypoalbuminemia|hypoalbuminemia|0|03.273800|3
00000713|acute gouty arthritis|acute gouty arthritis|0|03.274000|1
00000714|chronic gouty arthritis|chronic gouty arthritis|0|03.274001|2
00000715|uric acid nephropathy|uric acid nephropathy|0|03.274110|2
00000716|gout|gout|0|03.274900|3
00000717|pseudogout|pseudogout|0|03.274902|2
00000718|prevention of acute gout attack|prevention of acute gout attack|0|03.274904|3
00000719|hemochromatosis|hemochromatosis|0|03.275000|2
00000720|hemosiderosis|hemosiderosis|0|03.275001|2
00000721|Wilson's disease|Wilson's disease|0|03.275100|2
00000722|copper deficiency|copper deficiency|0|03.275101|3
00000723|hypomagnesemia|hypomagnesemia|0|03.275200|3
00000724|hypermagnesemia|hypermagnesemia|0|03.275201|3
00000725|hypophosphatemia|hypophosphatemia|0|03.275300|3
00000726|hyperphosphatemia|hyperphosphatemia|0|03.275301|3
00000727|x-linked hypophosphatemic osteomalacia|x-linked hypophosphatemic osteomalacia|0|03.275302|2
00000728|calcium metabolism disorder|calcium metabolism disorder|0|03.275400|3
00000729|hypercalcemia treatment adjunct|hypercalcemia treatment adjunct|0|03.275403|1
00000730|hypercalcinuria|hypercalcinuria|0|03.275404|3
00000731|hypocalcemia from ESRD with dialysis|hypocalcemia from end-stage renal disease with dialysis|0|03.275405|1
00000732|hypocalcemia|hypocalcemia|0|03.275410|3
00000733|hypercalcemia|hypercalcemia|0|03.275420|3
00000735|hypernatremia|hypernatremia|0|03.276000|3
00000736|hyponatremia|hyponatremia|0|03.276100|3
00000737|acidosis|acidosis|0|03.276200|1
00000738|ketoacidosis|ketoacidosis|0|03.276201|1
00000739|ketosis|ketosis|0|03.276202|1
00000740|lactic acidosis|lactic acidosis|0|03.276203|1
00000741|respiratory acidosis|respiratory acidosis|0|03.276204|1
00000742|metabolic acidosis|metabolic acidosis|0|03.276205|1
00000743|alkalosis|alkalosis|0|03.276300|1
00000744|respiratory alkalosis|respiratory alkalosis|0|03.276302|3
00000746|dehydration|dehydration|0|03.276500|3
00000747|severe dehydration|severe dehydration|0|03.276501|1
00000748|acute dehydration|acute dehydration|0|03.276502|1
00000750|body fluid retention|body fluid retention|0|03.276600|3
00000751|pre-existing fluid retention|pre-existing fluid retention|0|03.276602|3
00000752|water intoxication|water intoxication|0|03.276603|1
00000753|hyperkalemia|hyperkalemia|0|03.276700|3
00000754|Pre-Existing Hyperkalemia|Pre-Existing Hyperkalemia|1|03.276701|3
00000755|familial hyperkalemic periodic paralysis|familial hyperkalemic periodic paralysis|0|03.276702|2
00000756|hypokalemia|hypokalemia|0|03.276800|3
00000758|hypokalemia prevention|hypokalemia prevention|0|03.276802|1
00000759|disorder of electrolytes|disorder of electrolytes|0|03.276900|3
00000760|Electrolyte Depletion Treatment|Electrolyte Depletion Treatment|0|03.276901|1
00000761|hypochloremia|hypochloremia|0|03.276902|3
00000762|disorder of acid-base balance|disorder of acid-base balance|0|03.276903|3
00000763|hyperchloremia|hyperchloremia|0|03.276904|3
00000764|fluid volume disorder|fluid volume disorder|0|03.276905|3
00000765|cystic fibrosis|cystic fibrosis|0|03.277000|2
00000766|respiratory cystic fibrosis|respiratory cystic fibrosis|0|03.277001|2
00000767|intestinal cystic fibrosis|intestinal cystic fibrosis|0|03.277002|2
00000769|hepatobiliary cystic fibrosis|hepatobiliary cystic fibrosis|0|03.277004|2
00000772|synergy for P. aeruginosa infection in cystic fibrosis|synergy for P. aeruginosa infection in cystic fibrosis|0|03.277007|2
00000773|porphyria|porphyria|0|03.277100|2
00000774|porphyria cutanea tarda|porphyria cutanea tarda|0|03.277101|1
00000775|hepatic porphyria|hepatic porphyria|0|03.277102|2
00000776|acute intermittent porphyria|acute intermittent porphyria|0|03.277103|2
00000777|erythropoietic protoporphyria|erythropoietic protoporphyria|0|03.277104|2
00000778|variegate porphyria|variegate porphyria|0|03.277105|2
00000779|amyloidosis|amyloidosis|0|03.277300|1
00000780|hereditary angioedema|hereditary angioedema|0|03.277600|2
00000781|Methemoglobin Reductase Deficiency|Methemoglobin Reductase Deficiency|1|03.277601|2
00000782|NADH methemoglobin reductase deficiency|NADH methemoglobin reductase deficiency|0|03.277602|2
00000783|butyrylcholinesterase deficiency|butyrylcholinesterase deficiency|0|03.277603|2
00000786|glycogen storage disease type V with muscle pain|glycogen storage disease type V with muscle pain|0|03.277606|2
00000787|prevention of angioedema attack in hereditary angioedema|prevention of angioedema attacks in patient with hereditary angioedema|0|03.277607|2
00000788|metabolic disorder|metabolic disorder|0|03.277900|2
00000789|obesity|obesity|0|03.278000|2
00000791|hypervitaminosis A|hypervitaminosis A|0|03.278200|3
00000792|carotenodermia|carotenodermia|0|03.278300|2
00000793|hypervitaminosis D|hypervitaminosis D|0|03.278400|3
00000794|agammaglobulinemia|agammaglobulinemia|0|03.279000|3
00000796|IgA deficiency|IgA deficiency|0|03.279010|2
00000797|adenosine deaminase deficiency|adenosine deaminase deficiency|0|03.279200|2
00000798|disorder of immune function|disorder of immune function|0|03.279300|3
00000800|immunosuppression|immunosuppression|0|03.279302|3
00000801|immunocompromised patient|immunocompromised patient|0|03.279303|3
00000802|autoimmune disease|autoimmune disease|0|03.279400|2
00000803|iron deficiency anemia|iron deficiency anemia|0|04.280900|3
00000804|pernicious anemia|pernicious anemia|0|04.281000|2
00000805|Folic Acid Treated Pernicious Anemia|Folic Acid Treated Pernicious Anemia|2|04.281001|2
00000806|folic acid deficient megaloblastic anemia|folic acid deficient megaloblastic anemia|0|04.281200|3
00000807|megaloblastic anemia|megaloblastic anemia|0|04.281900|1
00000808|anemia due to renal failure|anemia due to renal failure|0|04.281901|3
00000809|chemotherapy-induced anemia|chemotherapy-induced anemia|0|04.281902|1
00000810|glucose-6-phosphate dehydrogenase deficiency anemia|glucose-6-phosphate dehydrogenase (G6PD) deficiency anemia|0|04.282200|2
00000811|Favism Anemia|Favism Anemia|1|04.282201|1
00000812|Pyruvate Carboxylase Deficiency Anemia|Pyruvate Carboxylase Deficiency Anemia|2|04.282300|2
00000813|thalassemia|thalassemia|0|04.282400|2
00000814|sickle cell disease|sickle cell disease|0|04.282600|2
00000815|pneumococcal infection prevention in sickle cell disease|pneumococcal infection prevention in sickle cell disease|0|04.282601|2
00000816|hand-foot syndrome in sickle disease|hand-foot syndrome in sickle disease|0|04.282610|3
00000817|sickle cell disease with crisis|sickle cell disease with crisis|0|04.282620|1
00000818|hemolytic anemia|hemolytic anemia|0|04.282900|3
00000819|autoimmune hemolytic anemia|autoimmune hemolytic anemia|0|04.283000|2
00000820|hemolytic uremic syndrome|hemolytic uremic syndrome|0|04.283110|3
00000821|hemolysis|hemolysis|0|04.283200|3
00000822|hemolysis prevention|hemolysis prevention|0|04.283201|3
00000823|acquired hemolytic anemia|acquired hemolytic anemia|0|04.283900|3
00000824|Constitutional Aplastic Anemia|Constitutional Aplastic Anemia|2|04.284000|2
00000825|Diamond Blackfan anemia|Diamond Blackfan anemia|0|04.284001|2
00000828|Fanconi syndrome|Fanconi syndrome|0|03.270004|2
00000829|pancytopenia|pancytopenia|0|04.284800|3
00000830|erythroblastic anemia|erythroblastic anemia|0|04.284801|1
00000832|aplastic anemia secondary to drugs|aplastic anemia secondary to drugs|0|04.284803|3
00000836|bone marrow depression|bone marrow depression|0|04.284807|3
00000837|severe bone marrow depression|severe bone marrow depression|0|04.284809|3
00000838|aplastic anemia|aplastic anemia|0|04.284900|3
00000839|bone marrow hypoplasia|bone marrow hypoplasia|0|04.284901|3
00000840|sideroblastic anemia|sideroblastic anemia|0|04.285000|2
00000841|anemia from frequent blood donations|anemia from frequent blood donations|0|04.285100|1
00000842|anemia|anemia|0|04.285900|3
00000843|severe anemia|severe anemia|0|04.285901|3
00000845|anemia due to bleeding uterine leiomyoma|anemia due to bleeding uterine leiomyoma|0|04.285906|1
00000846|hemophilia|hemophilia|0|04.286000|2
00000847|hemorrhaging in hemophilia|hemorrhaging in hemophilia|0|04.286001|1
00000848|hemophilia A|hemophilia A|0|04.286002|2
00000849|bleeding episode in hemophilia A|bleeding episode in hemophilia A|0|04.286003|1
00000850|hemophilia B|hemophilia B|0|04.286100|2
00000851|bleeding episode in hemophilia B|bleeding episode in hemophilia B|0|04.286101|1
00000854|hypoprothrombinemia|hypoprothrombinemia|0|04.286300|3
00000855|antithrombin III deficiency|antithrombin III deficiency|0|04.286301|2
00000857|afibrinogenemia|afibrinogenemia|0|04.286303|2
00000858|von Willebrand's disease|von Willebrand's disease|0|04.286400|2
00000859|hyperheparinemia|hyperheparinemia|0|04.286500|1
00000860|disseminated intravascular coagulation|disseminated intravascular coagulation|0|04.286600|1
00000862|vitamin K deficiency induced hypoprothrombinemia|vitamin K deficiency induced hypoprothrombinemia|0|04.286701|1
00000863|increased risk of bleeding due to coagulation disorder|increased risk of bleeding due to coagulation disorder|0|04.286900|2
00000864|high risk of bleed from severe coagulation defect|increased risk of bleeding due to severe coagulation disorder|0|04.286901|2
00000865|high risk of bleed from uncontrolled coagulation defect|increased risk of bleeding due to uncontrolled coagulation disorder|0|04.286902|1
00000866|fibrinogen excess|fibrinogen excess|0|04.286905|2
00000867|increased risk of bleeding|increased risk of bleeding|0|04.286906|2
00000868|bleeding prevention in hemophilia|bleeding prevention in hemophilia|0|04.286907|3
00000869|qualitative platelet disorder|qualitative platelet disorder|0|04.287100|3
00000870|platelet aggregation inhibition|platelet aggregation inhibition|0|04.287102|1
00000871|platelet disorder|platelet disorder|0|04.287103|1
00000872|purpura|purpura|0|04.287200|1
00000873|idiopathic thrombocytopenic purpura|idiopathic thrombocytopenic purpura|0|04.287300|3
00000874|acquired thrombocytopenia|acquired thrombocytopenia|0|04.287400|3
00000876|prevent cancer chemotherapy-induced thrombocytopenia|prevention of cancer chemotherapy-induced thrombocytopenia|0|04.287402|1
00000877|heparin-induced thrombocytopenia|heparin-induced thrombocytopenia|0|04.287403|1
00000878|thrombocytopenic disorder|thrombocytopenic disorder|0|04.287500|3
00000879|severe thrombocytopenia|severe thrombocytopenia|0|04.287501|3
00000881|Hemorrhagic Diathesis|Hemorrhagic Diathesis|1|04.287902|2
00000882|agranulocytosis|agranulocytosis|0|04.288000|3
00000883|severe chronic neutropenia|severe chronic neutropenia|0|04.288001|2
00000884|drug-induced neutropenia|drug-induced neutropenia|0|04.288002|3
00000885|AIDS-associated neutropenia|AIDS-associated neutropenia|0|04.288003|2
00000886|leukopenia|leukopenia|0|04.288004|3
00000887|granulocytopenic disorder|granulocytopenic disorder|0|04.288005|3
00000888|eosinopenia|eosinopenia|0|04.288006|3
00000889|chemotherapy-induced neutropenia|chemotherapy-induced neutropenia|0|04.288007|1
00000890|febrile neutropenic patient presumed infection treatment|febrile neutropenic patient presumed infection treatment|0|04.288008|1
00000891|neutropenia secondary to AML treatment|neutropenia secondary to AML treatment|0|04.288009|1
00000892|severe granulocytopenia|severe granulocytopenia|0|04.288010|2
00000893|congenital neutropenia|congenital neutropenia|0|04.288011|2
00000894|idiopathic neutropenia|idiopathic neutropenia|0|04.288012|1
00000895|cyclic neutropenia|cyclic neutropenia|0|04.288013|1
00000896|severe leukopenia|severe leukopenia|0|04.288014|3
00000897|neutropenic disorder|neutropenic disorder|0|04.288015|3
00000898|chronic granulomatous disease|chronic granulomatous disease|0|04.288100|2
00000899|eosinophilia|eosinophilia|0|04.288300|1
00000900|leukocytosis|leukocytosis|0|04.288800|1
00000901|lymphocytosis|lymphocytosis|0|04.288801|1
00000902|lymphopenia|lymphopenia|0|04.288802|3
00000903|secondary polycythemia|secondary polycythemia|0|04.289000|1
00000905|splenic infarction|splenic infarction|0|04.289590|3
00000906|methemoglobinemia|methemoglobinemia|0|04.289700|1
00000907|thrombophilia|thrombophilia|0|04.289800|3
00000908|blood dyscrasias|blood dyscrasias|0|04.289900|3
00000909|essential thrombocytosis|essential thrombocytosis|0|04.289903|2
00000910|thrombocytosis|thrombocytosis|0|04.289904|1
00000912|infection prevention from tooth extraction|infection prevention from tooth extraction|0|05. 23090|1
00000918|senile dementia with psychosis|senile dementia with psychosis|0|05.290900|2
00000919|alcohol withdrawal syndrome|alcohol withdrawal syndrome|0|05.291000|1
00000923|alcohol withdrawal delirium|alcohol withdrawal delirium|0|05.291800|1
00000926|opioid withdrawal symptoms|opioid withdrawal symptoms|0|05.292001|1
00000927|nicotine withdrawal symptoms|nicotine withdrawal symptoms|0|05.292002|1
00000931|induce anterograde amnesia|induce anterograde amnesia|0|05.292830|1
00000932|induce amnesia for cardioversion|induce amnesia for cardioversion|0|05.292831|1
00000933|induce amnesia for endoscopy|induce amnesia for endoscopy|0|05.292832|1
00000935|drug-induced psychosis|drug-induced psychosis|0|05.292900|1
00000937|acute cognitive impairment|acute cognitive impairment|0|05.293001|1
00000939|toxic psychosis|toxic psychosis|0|05.293901|3
00000942|profound dementia|profound dementia|0|05.294101|2
00000943|dementia|dementia|0|05.294800|2
00000944|organic psychotic condition|organic psychotic condition|0|05.294900|3
00000945|simple schizophrenia|simple schizophrenia|0|05.295000|2
00000946|paranoid schizophrenia|paranoid schizophrenia|0|05.295300|2
00000947|acute schizophrenia|acute schizophrenia|0|05.295400|1
00000948|schizophrenia|schizophrenia|0|05.295900|3
00000949|chronic schizophrenia|chronic schizophrenia|0|05.295920|2
00000950|manic disorder|manic disorder|0|05.296000|2
00000951|hypomania|hypomania|0|05.296010|2
00000952|major depressive disorder|major depressive disorder|0|05.296200|2
00000953|mania associated with bipolar disorder|mania associated with bipolar disorder|0|05.296400|3
00000954|bipolar disorder|bipolar disorder|0|05.296700|2
00000955|mood changes|mood changes|0|05.296990|3
00000958|delusional disorder|delusional disorder|0|05.297101|2
00000959|paranoid disorder|paranoid disorder|0|05.297900|2
00000960|depressive type psychosis|depressive type psychosis|0|05.298000|3
00000961|excitement|excitement|0|05.298100|3
00000962|psychotic disorder|psychotic disorder|0|05.298900|2
00000963|severe psychosis|severe psychosis|0|05.298902|2
00000964|infantile autism|infantile autism|0|05.299000|2
00000967|anxiety|anxiety|0|05.300000|3
00000968|severe anxiety|severe anxiety|0|05.300001|3
00000969|apprehension|apprehension|0|05.300002|1
00000970|panic disorder|panic disorder|0|05.300010|1
00000971|generalized anxiety disorder|generalized anxiety disorder|0|05.300020|1
00000972|dissociation|dissociation|0|05.300100|1
00000973|phobia|phobia|0|05.300200|2
00000974|agoraphobia|agoraphobia|0|05.300220|2
00000975|social phobia|social phobia|0|05.300230|2
00000976|obsessive-compulsive disorder|obsessive-compulsive disorder|0|05.300300|2
00000977|neurotic depression|neurotic depression|0|05.300402|3
00000978|anxiety with depression|anxiety with depression|0|05.300401|3
00000979|depersonalization|depersonalization|0|05.300600|3
00000980|psychiatric disorder|psychiatric disorder|0|05.300900|3
00000982|suicidal|suicidal|0|05.300903|3
00000984|Abnormal Mental State|Abnormal Mental State|1|05.300905|3
00000985|suicidal ideation|suicidal ideation|0|05.300906|3
00000986|psychoneurotic personality disorder|psychoneurotic personality disorder|0|05.300907|3
00000987|homicidal ideation|homicidal ideation|0|05.300908|3
00000989|false sense of well-being|false sense of well-being|0|05.301301|3
00000990|Mood Swings|Mood Swings|1|05.301590|3
00000991|personality disorders|personality disorders|0|05.301902|3
00000992|abnormal sexual function|abnormal sexual function|0|05.302700|3
00000993|libido changes|libido changes|0|05.302701|3
00000994|premature ejaculation|premature ejaculation|0|05.302750|3
00000995|disorder of ejaculation|disorder of ejaculation|0|05.302790|3
00000996|alcohol use disorder|alcohol use disorder|0|05.303900|3
00000997|Chronic Alcoholism|Chronic Alcoholism|1|05.303901|2
00000998|Active Alcoholism|Active Alcoholism|1|05.303910|1
00000999|opioid dependence|opioid dependence|0|05.304000|2
00001000|neonatal opioid dependence|neonatal opioid dependence|0|05.304001|2
00001001|drug dependence|drug dependence|0|05.304900|2
00001002|alcohol intoxication|alcohol intoxication|0|05.305000|1
00001004|nicotine dependence|nicotine dependence|0|05.305101|1
00001005|drug abuse|drug abuse|0|05.305900|3
00001007|benzodiazepine abuse|benzodiazepine abuse|0|05.305903|3
00001008|bruxism|bruxism|0|05.306800|3
00001009|stuttering|stuttering|0|05.307000|2
00001010|anorexia nervosa|anorexia nervosa|0|05.307100|3
00001011|motor tic disorder|motor tic disorder|0|05.307200|3
00001012|Gilles de la Tourette syndrome|Gilles de la Tourette syndrome|0|05.307230|2
00001013|nightmares|nightmares|0|05.307470|3
00001014|eating disorder|eating disorder|0|05.307500|2
00001015|bulimia nervosa|bulimia nervosa|0|05.307510|2
00001016|tension-type headache|tension-type headache|0|05.307810|3
00001017|pain with tension and anxiety|pain with tension and anxiety|0|05.307811|3
00001018|agitation|agitation|0|05.307900|3
00001019|euphoria|euphoria|0|05.307901|3
00001020|post traumatic stress disorder|post traumatic stress disorder|0|05.309810|1
00001021|Chronic Brain Syndrome|Chronic Brain Syndrome|2|05.310900|2
00001022|depression|depression|0|05.311000|3
00001023|severe depression|severe depression|0|05.311001|3
00001024|aggressive behavior|aggressive behavior|0|05.312000|3
00001025|hostility|hostility|0|05.312001|3
00001026|behavioral disorders|behavioral disorders|0|05.312900|3
00001028|attention-deficit hyperactivity disorder|attention-deficit hyperactivity disorder|0|05.314010|2
00001029|hyperkinesis|hyperkinesis|0|05.314900|3
00001031|Tracheostomy Care|Tracheostomy Care|2|06. 31301|1
00001032|bronchial studies|bronchial studies|0|06. 33231|1
00001033|H. influenzae meningitis|H. influenzae meningitis|0|06.320000|1
00001034|pneumococcal meningitis|pneumococcal meningitis|0|06.320100|1
00001035|streptococcal meningitis|streptococcal meningitis|0|06.320200|1
00001036|staphylococcal meningitis|staphylococcal meningitis|0|06.320300|1
00001037|meningitis due to Bacteroides|meningitis due to Bacteroides|0|06.320810|1
00001038|Escherichia coli meningitis|Escherichia coli meningitis|0|06.320820|1
00001039|Pseudomonas aeruginosa meningitis|Pseudomonas aeruginosa meningitis|0|06.320821|1
00001041|meningitis due to Klebsiella|meningitis due to Klebsiella|0|06.320823|1
00001042|cryptococcal meningitis|cryptococcal meningitis|0|06.321000|1
00001043|fungal meningitis|fungal meningitis|0|06.321100|1
00001044|meningitis|meningitis|0|06.322900|1
00001045|chemical arachnoiditis|chemical arachnoiditis|0|06.322902|1
00001046|encephalitis|encephalitis|0|06.323900|1
00001047|meningoencephalitis|meningoencephalitis|0|06.323902|1
00001048|myelitis|myelitis|0|06.323903|3
00001049|brain abscess|brain abscess|0|06.324900|1
00001050|subacute necrotizing encephalomyelopathy|subacute necrotizing encephalomyelopathy|0|06.330800|2
00001051|Alzheimer's disease|Alzheimer's disease|0|06.331000|2
00001052|obstructive hydrocephalus|obstructive hydrocephalus|0|06.331400|1
00001053|Reye's syndrome|Reye's syndrome|0|06.331810|1
00001054|parkinsonism|parkinsonism|0|06.332000|2
00001055|Idiopathic Parkinsonism Syndrome Diagnostic|Idiopathic Parkinsonism Syndrome Diagnostic|2|06.332001|1
00001056|postencephalitic parkinsonism|postencephalitic parkinsonism|0|06.332002|2
00001057|idiopathic parkinsonism|idiopathic parkinsonism|0|06.332003|2
00001058|arteriosclerotic parkinsonism|arteriosclerotic parkinsonism|0|06.332004|2
00001060|perioperative myoclonia|perioperative myoclonia|0|06.333201|1
00001061|myoclonus|myoclonus|0|06.333202|1
00001062|chorea associated with Huntington's disease|chorea associated with Huntington's disease|0|06.333400|2
00001063|chorea|chorea|0|06.333500|2
00001064|paroxysmal choreoathetosis|paroxysmal choreoathetosis|0|06.333501|2
00001065|chorea prevention|chorea prevention|0|06.333502|2
00001066|congenital athetosis|congenital athetosis|0|06.333700|2
00001067|blepharospasm|blepharospasm|0|06.333810|1
00001068|tardive dyskinesia|tardive dyskinesia|0|06.333820|3
00001069|spasmodic torticollis|spasmodic torticollis|0|06.333830|2
00001070|extrapyramidal disease|extrapyramidal disease|0|06.333900|3
00001071|neuroleptic malignant syndrome|neuroleptic malignant syndrome|0|06.333920|3
00001072|serotonin syndrome|serotonin syndrome|0|06.333991|1
00001073|hereditary ataxias|hereditary ataxias|0|06.334200|2
00001074|amyotrophic lateral sclerosis|amyotrophic lateral sclerosis|0|06.335200|2
00001075|carotid sinus hypersensitivity|carotid sinus hypersensitivity|0|06.337000|2
00001076|vagal reflex bradycardia|vagal reflex bradycardia|0|06.337001|1
00001077|autonomic neuropathy|autonomic neuropathy|0|06.337900|2
00001078|multiple sclerosis|multiple sclerosis|0|06.340000|2
00001079|fatigue due to multiple sclerosis|fatigue due to multiple sclerosis|0|06.340001|2
00001080|relapsing remitting multiple sclerosis|relapsing remitting multiple sclerosis|0|06.340002|2
00001081|demyelinating disorder|demyelinating disorder|0|06.341900|2
00001082|hemiplegia|hemiplegia|0|06.342900|2
00001083|paraplegia|paraplegia|0|06.344100|2
00001084|cauda equina syndrome|cauda equina syndrome|0|06.344600|2
00001085|paralysis|paralysis|0|06.344900|3
00001086|spastic paralysis in children|spastic paralysis in children|0|06.344901|3
00001087|severe and progressing paralysis|severe and progressing paralysis|0|06.344902|2
00001088|spastic paralysis|spastic paralysis|0|06.344903|3
00001089|Lennox-Gastaut epilepsy|Lennox-Gastaut epilepsy|0|06.345002|2
00001091|atonic seizure|atonic seizure|0|06.345004|2
00001092|tonic-clonic epilepsy|tonic-clonic epilepsy|0|06.345100|2
00001093|myoclonic epilepsy|myoclonic epilepsy|0|06.345101|2
00001094|myoclonic epilepsy adjunct treatment|myoclonic epilepsy adjunct treatment|0|06.345102|2
00001095|absence epilepsy|absence epilepsy|0|06.345200|2
00001096|atypical absence seizures|atypical absence seizures|0|06.345201|2
00001098|absence epilepsy with multiple seizure types|absence epilepsy with multiple seizure types|0|06.345203|2
00001099|status epilepticus|status epilepticus|0|06.345300|2
00001100|Psychomotor Epilepsy|Psychomotor Epilepsy|1|06.345400|2
00001101|simple-partial epilepsy|simple-partial epilepsy|0|06.345500|2
00001102|complex-partial epilepsy|complex-partial epilepsy|0|06.345501|2
00001103|focal epilepsy|focal epilepsy|0|06.345502|2
00001104|Jacksonian epilepsy|Jacksonian epilepsy|0|06.345503|2
00001105|epilepsy|epilepsy|0|06.345900|3
00001106|uncontrolled epilepsy|uncontrolled epilepsy|0|06.345903|3
00001107|mixed epilepsy|mixed epilepsy|0|06.345905|2
00001108|seizure occurring during neurosurgery|seizure occurring during neurosurgery|0|06.345906|1
00001109|lower seizure threshold|lower seizure threshold|0|06.345908|1
00001111|cluster headache|cluster headache|0|06.346200|1
00001112|basilar migraine|basilar migraine|0|06.346201|1
00001114|hemiplegic migraine|hemiplegic migraine|0|06.346800|1
00001116|migraine|migraine|0|06.346900|1
00001117|migraine prevention|migraine prevention|0|06.346901|2
00001118|cataplexy|cataplexy|0|06.347000|3
00001119|narcolepsy syndrome|narcolepsy syndrome|0|06.347001|2
00001120|hypoxia of brain|hypoxia of brain|0|06.348100|1
00001121|idiopathic intracranial hypertension|idiopathic intracranial hypertension|0|06.348200|3
00001122|encephalopathy|encephalopathy|0|06.348300|2
00001123|leukoencephalopathy|leukoencephalopathy|0|06.348301|1
00001125|cerebral edema|cerebral edema|0|06.348500|1
00001126|cerebral lesions|cerebral lesions|0|06.348800|3
00001127|cerebral trauma|cerebral trauma|0|06.348801|1
00001128|intracerebral mass|intracerebral mass|0|06.348802|3
00001129|organic mental disorder|organic mental disorder|0|06.348900|2
00001130|brain damage in children|brain damage in children|0|06.348901|2
00001131|cerebral ventricular distension|cerebral ventricular distension|0|06.348902|3
00001132|increased cerebrospinal fluid pressure|increased cerebrospinal fluid pressure|0|06.349890|1
00001133|gliosis|gliosis|0|06.349891|3
00001134|disorder of the central nervous system|disorder of the central nervous system|0|06.349900|3
00001135|severe CNS disorder|severe CNS disorder|0|06.349905|1
00001136|CNS trauma|CNS trauma|0|06.349906|1
00001137|CNS toxicity|CNS toxicity|0|06.349907|1
00001138|trigeminal neuralgia|trigeminal neuralgia|0|06.350100|3
00001140|increased gastric tonus|increased gastric tonus|0|06.352300|1
00001141|carpal tunnel syndrome|carpal tunnel syndrome|0|06.354000|3
00001142|radial nerve palsy|radial nerve palsy|0|06.354300|2
00001143|neuropathy|neuropathy|0|06.355900|2
00001144|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease|0|06.356100|2
00001145|polyneuropathy|polyneuropathy|0|06.356900|3
00001146|peripheral neuropathy|peripheral neuropathy|0|06.356901|2
00001147|peripheral motor neuropathy|peripheral motor neuropathy|0|06.356902|2
00001148|Guillain-Barre syndrome|Guillain-Barre syndrome|0|06.357000|2
00001149|myasthenia gravis|myasthenia gravis|0|06.358000|2
00001150|diagnostic test for myasthenia gravis|diagnostic test for myasthenia gravis|0|06.358001|1
00001152|Eaton-Lambert syndrome|Eaton-Lambert syndrome|0|06.358100|2
00001153|neuromuscular disease|neuromuscular disease|0|06.358900|3
00001154|neuromuscular transmission deficiency|neuromuscular transmission deficiency|0|06.358901|2
00001155|neuromuscular blockade|neuromuscular blockade|0|06.358902|1
00001156|reversal of neuromuscular block by nondepolarizing drug|reversal of neuromuscular blockade induced by nondepolarizing drug|0|06.358903|1
00001157|Duchenne muscular dystrophy|Duchenne muscular dystrophy|0|06.359100|2
00001158|myotonia congenita - autosomal dominant form|myotonia congenita - autosomal dominant form|0|06.359200|2
00001159|familial periodic paralysis|familial periodic paralysis|0|06.359300|2
00001161|myopathy|myopathy|0|06.359900|3
00001162|muscular paralysis|muscular paralysis|0|06.359901|1
00001163|ophthalmia sympathetic|ophthalmia sympathetic|0|06.360110|2
00001164|ocular onchocerciasis|ocular onchocerciasis|0|06.360130|3
00001166|endophthalmitis|endophthalmitis|0|06.360191|1
00001167|ocular hypotony|ocular hypotony|0|06.360300|3
00001168|phthisis bulbi|phthisis bulbi|0|06.360410|3
00001169|globe perforation|globe perforation|0|06.360891|1
00001170|retinal hole|retinal hole|0|06.361310|2
00001171|retinal tear|retinal tear|0|06.361320|2
00001172|retinal detachment|retinal detachment|0|06.361900|1
00001173|retinal disorder|retinal disorder|0|06.362100|2
00001174|choroidal neovascularization|choroidal neovascularization|0|06.362160|2
00001175|retinal vascular occlusion|retinal vascular occlusion|0|06.362300|3
00001176|retinal thrombosis|retinal thrombosis|0|06.362301|1
00001177|neovascular age-related macular degeneration|neovascular age-related macular degeneration|0|06.362520|2
00001178|maculopathy|maculopathy|0|06.362550|2
00001179|retinal hemorrhage|retinal hemorrhage|0|06.362810|1
00001181|cystoid macular edema|cystoid macular edema|0|06.362830|1
00001182|pigmentary retinopathy|pigmentary retinopathy|0|06.362890|2
00001184|Retinal Changes|Retinal Changes|1|06.362901|3
00001186|chorioretinitis|chorioretinitis|0|06.363200|1
00001187|choroiditis|choroiditis|0|06.363201|1
00001188|choroidal degeneration|choroidal degeneration|0|06.363400|1
00001189|choroid folds|choroid folds|0|06.363900|1
00001190|iritis|iritis|0|06.364000|1
00001191|uveitis|uveitis|0|06.364300|1
00001192|Iridocyclitis|Iridocyclitis|0|06.364301|1
00001194|uveitis with posterior synechiae|uveitis with posterior synechiae|0|06.364303|1
00001195|cyclitis|cyclitis|0|06.364304|1
00001196|refractory uveitis|refractory uveitis|0|06.364305|1
00001197|hyphema|hyphema|0|06.364410|1
00001198|synechiae of iris|synechiae of iris|0|06.364700|2
00001199|posterior synechiae|posterior synechiae|0|06.364710|1
00001200|prevention of posterior synechiae|prevention of posterior synechiae|0|06.364711|3
00001201|pupil abnormalities|pupil abnormalities|0|06.364750|3
00001202|iris hyperpigmentation|iris hyperpigmentation|0|06.364800|3
00001203|iris cyst|iris cyst|0|06.364801|3
00001204|ocular hypertension|ocular hypertension|0|06.365040|3
00001205|open angle glaucoma|open angle glaucoma|0|06.365100|2
00001206|angle-closure glaucoma|angle-closure glaucoma|0|06.365200|3
00001207|malignant glaucoma|malignant glaucoma|0|06.365201|2
00001208|primary angle-closure glaucoma|primary angle-closure glaucoma|0|06.365202|2
00001209|aphakic glaucoma|aphakic glaucoma|0|06.365501|2
00001210|secondary glaucoma|secondary glaucoma|0|06.365600|2
00001211|glaucoma|glaucoma|0|06.365900|2
00001212|glaucoma with iridocyclitis|glaucoma with iridocyclitis|0|06.365901|2
00001213|aggravated glaucoma|aggravated glaucoma|0|06.365902|2
00001214|predisposition to glaucoma|predisposition to glaucoma|0|06.365903|2
00001216|cataracts|cataracts|0|06.366900|2
00001217|myopia|myopia|0|06.367100|3
00001218|accommodation disorder|accommodation disorder|0|06.367500|3
00001219|cycloplegia|cycloplegia|0|06.367510|3
00001222|amblyopia|amblyopia|0|06.368000|3
00001223|day blindness|day blindness|0|06.368100|3
00001224|sudden visual loss|sudden visual loss|0|06.368110|1
00001225|transient blindness|transient blindness|0|06.368120|1
00001226|photophobia|photophobia|0|06.368130|3
00001227|ocular discomfort|ocular discomfort|0|06.368131|3
00001228|post-op photophobia|post-op photophobia|0|06.368132|3
00001229|asthenopia|asthenopia|0|06.368133|3
00001230|visual halos|visual halos|0|06.368150|1
00001231|polyopia|polyopia|0|06.368151|3
00001232|diplopia|diplopia|0|06.368200|3
00001233|visual field defect|visual field defect|0|06.368400|3
00001234|scotomata|scotomata|0|06.368441|2
00001235|acquired chromatopsia|acquired chromatopsia|0|06.368550|2
00001236|xanthopsia|xanthopsia|0|06.368590|3
00001238|night blindness|night blindness|0|06.368601|3
00001240|blurred vision|blurred vision|0|06.368800|3
00001241|visual changes|visual changes|0|06.368900|3
00001242|after image|after image|0|06.368901|3
00001243|Visual Disturbance of Seeing Spots|Visual Disturbance of Seeing Spots|2|06.368902|3
00001244|amaurosis|amaurosis|0|06.369000|1
00001245|vision impairment|vision impairment|0|06.369900|3
00001246|reduced visual acuity|reduced visual acuity|0|06.369901|3
00001247|temporary visual acuity loss|temporary visual acuity loss|0|06.369902|1
00001248|corneal ulcer|corneal ulcer|0|06.370000|3
00001249|bacterial corneal ulcer infection|bacterial corneal ulcer infection|0|06.370001|3
00001250|epithelial keratopathy|epithelial keratopathy|0|06.370200|2
00001251|punctate keratitis|punctate keratitis|0|06.370210|1
00001252|punctate epithelial keratopathy|punctate epithelial keratopathy|0|06.370211|1
00001253|vernal keratoconjunctivitis|vernal keratoconjunctivitis|0|06.370320|1
00001254|exposure keratoconjunctivitis|exposure keratoconjunctivitis|0|06.370340|1
00001255|Neuroparalytic Keratitis|Neuroparalytic Keratitis|2|06.370350|1
00001256|keratoconjunctivitis|keratoconjunctivitis|0|06.370400|1
00001257|allergic keratoconjunctivitis|allergic keratoconjunctivitis|0|06.370401|1
00001258|keratitis|keratitis|0|06.370900|1
00001259|bacterial keratitis|bacterial keratitis|0|06.370901|1
00001260|fungal keratitis|fungal keratitis|0|06.370902|1
00001261|vaccinia virus keratitis|vaccinia virus keratitis|0|06.370903|1
00001262|vernal keratitis|vernal keratitis|0|06.370904|1
00001263|corneal opacity|corneal opacity|0|06.371000|3
00001264|corneal nebula|corneal nebula|0|06.371010|3
00001265|corneal deposits|corneal deposits|0|06.371100|3
00001266|corneal staining|corneal staining|0|06.371101|3
00001267|corneal edema|corneal edema|0|06.371200|3
00001268|infiltrate of cornea|infiltrate of cornea|0|06.371201|3
00001269|corneal degeneration|corneal degeneration|0|06.371400|3
00001270|disorder of cornea|disorder of cornea|0|06.371401|2
00001271|corneal erosion|corneal erosion|0|06.371420|3
00001272|keratoconus|keratoconus|0|06.371600|2
00001273|Corneal Hypoesthesia|Corneal Hypoesthesia|1|06.371810|3
00001274|Corneal Abnormalities|Corneal Abnormalities|1|06.371900|3
00001275|corneal sensitivity|corneal sensitivity|0|06.371901|3
00001277|corneal dellen|corneal dellen|0|06.371903|3
00001278|decreased corneal sensitivity|decreased corneal sensitivity|0|06.371904|3
00001279|acute conjunctivitis|acute conjunctivitis|0|06.372000|1
00001280|follicular conjunctivitis|follicular conjunctivitis|0|06.372020|1
00001281|mucopurulent conjunctivitis|mucopurulent conjunctivitis|0|06.372030|1
00001282|vernal conjunctivitis|vernal conjunctivitis|0|06.372130|1
00001283|allergic conjunctivitis|allergic conjunctivitis|0|06.372140|1
00001284|blepharoconjunctivitis|blepharoconjunctivitis|0|06.372200|1
00001285|conjunctivitis|conjunctivitis|0|06.372300|1
00001286|bacterial conjunctivitis|bacterial conjunctivitis|0|06.372301|1
00001287|bacterial keratoconjunctivitis|bacterial keratoconjunctivitis|0|06.372302|1
00001288|ocular rosacea|ocular rosacea|0|06.372310|1
00001289|fungal conjunctivitis|fungal conjunctivitis|0|06.372390|1
00001291|conjunctival hyperemia|conjunctival hyperemia|0|06.372710|3
00001292|conjunctival congestion during surgery|conjunctival congestion during surgery|0|06.372711|1
00001293|subconjunctival hemorrhage|subconjunctival hemorrhage|0|06.372720|1
00001294|conjunctival hemorrhage|conjunctival hemorrhage|0|06.372721|1
00001295|chemosis|chemosis|0|06.372730|1
00001296|conjunctival blanching|conjunctival blanching|0|06.372800|3
00001297|conjunctival abnormalities|conjunctival abnormalities|0|06.372900|3
00001298|blepharitis|blepharitis|0|06.373000|1
00001299|bacterial blepharitis|bacterial blepharitis|0|06.373001|1
00001300|fungal blepharitis|fungal blepharitis|0|06.373002|1
00001301|hordeolum|hordeolum|0|06.373110|1
00001302|meibomianitis|meibomianitis|0|06.373120|1
00001303|eyelid dermatitis|eyelid dermatitis|0|06.373310|1
00001304|entropion|entropion|0|06.374000|3
00001305|ectropion|ectropion|0|06.374100|3
00001306|lagophthalmos|lagophthalmos|0|06.374200|3
00001307|blepharoptosis|blepharoptosis|0|06.374300|1
00001308|eyelid retraction|eyelid retraction|0|06.374410|3
00001309|blinking decreased|blinking decreased|0|06.374450|3
00001310|hyperpigmentation of eyelid|hyperpigmentation of eyelid|0|06.374520|2
00001311|hypertrichosis of eyelid eyelashes|hypertrichosis of eyelid eyelashes|0|06.374540|3
00001312|eyelid edema|eyelid edema|0|06.374820|3
00001313|eyelid abnormalities|eyelid abnormalities|0|06.374890|3
00001314|eyelid closing|eyelid closing|0|06.374892|3
00001315|eyelid discoloration|eyelid discoloration|0|06.374893|3
00001317|eyelash crusting|eyelash crusting|0|06.374895|1
00001318|eyelid erythema|eyelid erythema|0|06.374896|1
00001319|dry eye|dry eye|0|06.375150|1
00001320|eye tearing|eye tearing|0|06.375200|1
00001321|dacryocystitis|dacryocystitis|0|06.375300|1
00001322|nasolacrimal duct stenosis|nasolacrimal duct stenosis|0|06.375560|3
00001323|tear discoloration|tear discoloration|0|06.375900|1
00001324|nystagmus|nystagmus|0|06.375901|1
00001325|periorbital edema|periorbital edema|0|06.376330|3
00001326|papilledema|papilledema|0|06.377000|1
00001327|optic atrophy|optic atrophy|0|06.377100|2
00001328|Leber's hereditary optic atrophy|Leber's hereditary optic atrophy|0|06.377160|2
00001329|optic neuritis|optic neuritis|0|06.377300|3
00001330|giant papillary conjunctivitis|giant papillary conjunctivitis|0|06.377310|1
00001331|toxic amblyopia|toxic amblyopia|0|06.377340|1
00001332|tobacco amblyopia|tobacco amblyopia|0|06.377341|2
00001334|optic neuropathy|optic neuropathy|0|06.377490|2
00001335|optic nerve damage|optic nerve damage|0|06.377491|2
00001336|cortical blindness|cortical blindness|0|06.377750|1
00001337|esotropia|esotropia|0|06.378000|3
00001338|eyes vertical deviation|eyes vertical deviation|0|06.378870|2
00001339|strabismus|strabismus|0|06.378900|2
00001341|vitreous detachment|vitreous detachment|0|06.379210|2
00001342|vitreous hemorrhage|vitreous hemorrhage|0|06.379230|3
00001343|vitritis|vitritis|0|06.379290|1
00001344|aphakia|aphakia|0|06.379310|2
00001345|disorder of lens|disorder of lens|0|06.379390|3
00001346|anisocoria|anisocoria|0|06.379410|3
00001347|miosis|miosis|0|06.379420|1
00001348|miosis induction during ocular surgery|miosis induction during ocular surgery|0|06.379421|1
00001349|mydriasis|mydriasis|0|06.379430|1
00001350|perioperative mydriasis|perioperative mydriasis|0|06.379431|1
00001351|mydriasis during ocular surgery|mydriasis during ocular surgery|0|06.379432|1
00001352|superficial ocular infection|superficial ocular infection|0|06.379800|3
00001353|fungal infection of eye|fungal infection of eye|0|06.379801|1
00001354|viral ocular infection|viral ocular infection|0|06.379802|1
00001355|ocular disorders|ocular disorders|0|06.379900|3
00001356|ocular pain|ocular pain|0|06.379910|3
00001357|postoperative ocular pain|postoperative ocular pain|0|06.379911|1
00001358|ocular inflammation|ocular inflammation|0|06.379920|1
00001359|post-op ocular inflammation|post-op ocular inflammation|0|06.379921|1
00001360|severe ocular inflammation|severe ocular inflammation|0|06.379922|1
00001361|ocular redness|ocular redness|0|06.379930|1
00001362|ocular discharge|ocular discharge|0|06.379931|1
00001363|ocular irritation|ocular irritation|0|06.379991|1
00001364|ocular hemorrhage|ocular hemorrhage|0|06.379992|1
00001365|eyelid crusting|eyelid crusting|0|06.379993|1
00001366|ocular itching|ocular itching|0|06.379994|3
00001368|otitis externa|otitis externa|0|06.380100|3
00001369|allergic otitis externa|allergic otitis externa|0|06.380101|1
00001370|acute Staphylococcus aureus otitis externa|acute Staphylococcus aureus otitis externa|0|06.380102|1
00001371|acute Pseudomonas aeruginosa otitis externa|acute Pseudomonas aeruginosa otitis externa|0|06.380103|1
00001372|acute Proteus mirabilis otitis externa|acute Proteus mirabilis otitis externa|0|06.380104|1
00001373|otitis externa seborrhea|otitis externa seborrhea|0|06.380130|1
00001374|otitis externa eczema|otitis externa eczema|0|06.380220|1
00001375|erythema of ear|erythema of ear|0|06.380390|1
00001376|impacted cerumen|impacted cerumen|0|06.380400|1
00001377|ceruminosis|ceruminosis|0|06.380401|2
00001378|Haemophilus influenzae acute otitis media|Haemophilus influenzae acute otitis media|0|06.382000|1
00001379|Streptococcus acute otitis media|Streptococcus acute otitis media|0|06.382001|1
00001380|Moraxella catarrhalis acute otitis media|Moraxella catarrhalis acute otitis media|0|06.382002|1
00001381|Staphylococcus acute otitis media|Staphylococcus acute otitis media|0|06.382003|1
00001382|pneumococcal acute otitis media|pneumococcal acute otitis media|0|06.382004|1
00001383|chronic tubotympanic suppurative otitis media|chronic tubotympanic suppurative otitis media|0|06.382100|2
00001384|chronic suppurative otitis media|chronic suppurative otitis media|0|06.382300|2
00001385|acute bacterial otitis media|acute bacterial otitis media|0|06.382900|1
00001386|fungal infection in the ear|fungal infection in the ear|0|06.382901|1
00001387|viral infection in the ear|viral infection in the ear|0|06.382902|3
00001388|inner ear disturbance|inner ear disturbance|0|06.382903|3
00001389|acute suppurative otitis media with tympanostomy tubes|acute suppurative otitis media with tympanostomy tubes|0|06.382904|1
00001390|mastoidectomy cavity infections|mastoidectomy cavity infections|0|06.383900|1
00001391|bullous myringitis|bullous myringitis|0|06.384010|1
00001392|perforated eardrum|perforated eardrum|0|06.384200|3
00001394|cinchonism|cinchonism|0|06.386900|2
00001395|tinnitus|tinnitus|0|06.388300|3
00001396|hearing disorder|hearing disorder|0|06.388400|3
00001397|hyperacusis|hyperacusis|0|06.388420|3
00001398|disorder of the vestibulocochlear nerve|disorder of the vestibulocochlear nerve|0|06.388500|3
00001400|earache|earache|0|06.388700|1
00001401|ear irritation|ear irritation|0|06.388900|1
00001402|ear itching|ear itching|0|06.388901|3
00001403|ear stinging|ear stinging|0|06.388902|1
00001404|ototoxicity|ototoxicity|0|06.388903|1
00001405|auditory neurotoxicity|auditory neurotoxicity|0|06.389120|3
00001406|hearing loss|hearing loss|0|06.389900|3
00001407|prosthetic heart valve present|prosthetic heart valve present|0|07. 35200|2
00001408|Percutaneous Coronary Intervention|Percutaneous Coronary Intervention|0|07. 36000|1
00001409|PTCA adjunct|percutaneous transluminal coronary angioplasty adjunct|2|07. 36020|1
00001410|coronary atherectomy adjunct|coronary atherectomy adjunct|0|07. 36021|1
00001411|cardiac function studies|cardiac function studies|0|07. 37290|1
00001412|myocardial perfusion image, adjunct|myocardial perfusion image, adjunct|0|07. 37291|1
00001413|cardiac pacemaker|cardiac pacemaker|0|07. 37800|2
00001414|open heart surgery infection prevention|open heart surgery infection prevention|0|07. 37900|1
00001416|occluded arteriovenous cannula|occluded arteriovenous cannula|0|07. 38931|1
00001417|dissolution of clot in intravenous catheter|dissolution of clot in intravenous catheter|0|07. 38932|1
00001418|puncture of artery in noncompressible site|puncture of artery in noncompressible site|0|07. 38980|1
00001419|puncture of vein in noncompressible site|puncture of vein in noncompressible site|0|07. 38990|1
00001420|indwelling vascular catheter|indwelling vascular catheter|0|07. 38991|3
00001421|Coronary Angioplasty|Coronary Angioplasty|0|07. 39590|1
00001422|angioplasty failure|angioplasty failure|0|07. 39592|1
00001423|renal dialysis|renal dialysis|0|07. 39950|1
00001424|vascular surgery|vascular surgery|0|07. 39990|1
00001425|rheumatic fever|rheumatic fever|0|07.390000|1
00001426|rheumatoid vasculitis|rheumatoid vasculitis|0|07.390001|1
00001427|rheumatic fever prevention|rheumatic fever prevention|0|07.390002|1
00001428|mitral stenosis|mitral stenosis|0|07.396000|2
00001429|mitral valve and aortic valve insufficiency|mitral valve and aortic valve insufficiency|0|07.396300|3
00001430|acute rheumatic carditis|acute rheumatic carditis|0|07.398900|2
00001431|malignant essential hypertension|malignant essential hypertension|0|07.401000|1
00001432|hypertension|hypertension|0|07.401900|3
00001433|hypertension due to scleroderma|hypertension due to scleroderma|0|07.401901|3
00001434|paroxysmal hypertension|paroxysmal hypertension|0|07.401902|3
00001435|severe uncontrolled hypertension|severe uncontrolled hypertension|0|07.401903|3
00001436|mild hypertension|mild hypertension|0|07.401906|2
00001437|hypertensive crisis|hypertensive crisis|0|07.401908|1
00001438|hypertensive emergency with renal disease|hypertensive emergency with renal disease|0|07.401910|1
00001439|hypertensive emergency with pulmonary disease|hypertensive emergency with pulmonary disease|0|07.401911|1
00001440|supine hypertension|supine hypertension|0|07.401912|1
00001441|hypertension due to aortic coarctation|hypertension due to aortic coarctation|0|07.401913|2
00001442|hypertension due to arteriovenous shunt|hypertension due to arteriovenous shunt|0|07.401914|2
00001443|Hypertensive Cardiovascular Disease|Hypertensive Cardiovascular Disease|2|07.402900|2
00001444|hypertensive cardio-renal disease|hypertensive cardio-renal disease|0|07.404900|2
00001445|perioperative hypertension|perioperative hypertension|0|07.405991|3
00001446|intraoperative hypertension|intraoperative hypertension|0|07.405992|3
00001447|acute myocardial infarction|acute myocardial infarction|0|07.410900|1
00001448|myocardial reinfarction prevention|myocardial reinfarction prevention|0|07.410901|3
00001450|30 day risk period post-myocardial infarction|30 day risk period post-myocardial infarction|0|07.410904|1
00001451|Acute MI with Pulmonary Congestion|Acute Myocardial Infarct with Pulmonary Congestion|1|07.410905|1
00001452|coronary artery occlusion|coronary artery occlusion|0|07.410907|3
00001453|acute coronary arterial thrombosis|acute coronary arterial thrombosis|0|07.410908|1
00001454|non Q-wave myocardial infarction|non Q-wave myocardial infarction|0|07.410909|1
00001455|myocardial infarction prevention|myocardial infarction prevention|0|07.410910|2
00001456|acute coronary syndrome|acute coronary syndrome|0|07.411100|1
00001457|coronary thrombosis without myocardial infarction|coronary thrombosis without myocardial infarction|0|07.411810|1
00001458|chronic myocardial ischemia|chronic myocardial ischemia|0|07.411890|3
00001459|Prinzmetal angina|Prinzmetal angina|0|07.413100|3
00001460|angina|angina|0|07.413900|3
00001461|progressive angina pectoris|progressive angina pectoris|0|07.413901|2
00001462|unstable angina pectoris|unstable angina pectoris|0|07.413902|2
00001463|Chronic Stable Angina Pectoris|Chronic Stable Angina Pectoris|2|07.413903|2
00001464|Acute Angina Pectoris|Acute Angina Pectoris|2|07.413904|1
00001465|Angina Pectoris Prevention|Angina Pectoris Prevention|1|07.413905|2
00001467|unstable angina pectoris during PTCA|unstable angina pectoris during PTCA|0|07.413907|1
00001469|coronary artery disease|coronary artery disease|0|07.414000|2
00001470|obliterative coronary artery disease|obliterative coronary artery disease|0|07.414001|2
00001471|severe coronary artery disease|severe coronary artery disease|0|07.414002|2
00001472|treatment to slow progression of coronary artery disease|treatment to slow progression of coronary artery disease|0|07.414003|2
00001473|myocardial ischemia|myocardial ischemia|0|07.414800|3
00001475|pulmonary thromboembolism|pulmonary thromboembolism|0|07.415100|1
00001476|acute pulmonary thromboembolism|acute pulmonary thromboembolism|0|07.415101|1
00001477|pulmonary thromboembolism prevention|pulmonary thromboembolism prevention|0|07.415102|3
00001478|pulmonary hypertension|pulmonary hypertension|0|07.416000|2
00001479|cardiopulmonary impairment|cardiopulmonary impairment|0|07.416900|3
00001480|cor pulmonale|cor pulmonale|0|07.416901|2
00001481|severe cardiopulmonary disease|severe cardiopulmonary disease|0|07.416902|2
00001482|acute pericarditis|acute pericarditis|0|07.420900|1
00001483|bacterial endocarditis|bacterial endocarditis|0|07.421000|1
00001484|subacute infective endocarditis|subacute infective endocarditis|0|07.421001|1
00001485|prevention of bacterial endocarditis|prevention of bacterial endocarditis|0|07.421002|3
00001486|streptococcal endocarditis|streptococcal endocarditis|0|07.421003|1
00001487|enterococcal endocarditis|enterococcal endocarditis|0|07.421004|1
00001488|Staphylococcus aureus endocarditis|Staphylococcus aureus endocarditis|0|07.421005|1
00001489|Bacteroides endocarditis|Bacteroides endocarditis|0|07.421006|1
00001490|Haemophilus endocarditis|Haemophilus endocarditis|0|07.421007|1
00001492|constrictive pericarditis|constrictive pericarditis|0|07.423200|1
00001493|Streptococcus pericarditis|Streptococcus pericarditis|0|07.423800|1
00001494|pericarditis|pericarditis|0|07.423900|1
00001495|pericardial malignant effusion|pericardial malignant effusion|0|07.423901|1
00001496|pericardial tamponade|pericardial tamponade|0|07.423902|3
00001497|Normal or Low Capillary Wedge Pressure|Normal or Low Capillary Wedge Pressure|2|07.423903|3
00001498|pericardial effusion|pericardial effusion|0|07.423904|3
00001499|Cardiac Tamponade|Cardiac Tamponade|1|07.423905|1
00001500|mitral valve prolapse|mitral valve prolapse|0|07.424000|3
00001501|aortic valve stenosis|aortic valve stenosis|0|07.424100|3
00001502|severe aortic valve stenosis|severe aortic valve stenosis|0|07.424101|2
00001503|Aortic Valvular Stenosis|Aortic Valvular Stenosis|1|07.424102|3
00001504|pulmonic valve stenosis|pulmonic valve stenosis|0|07.424300|2
00001505|endocarditis|endocarditis|0|07.424900|1
00001506|fungal endocarditis|fungal endocarditis|0|07.424901|1
00001507|valvular heart disease|valvular heart disease|0|07.424902|2
00001508|valvular regurgitation|valvular regurgitation|0|07.424903|3
00001509|prosthetic heart valve endocarditis|prosthetic heart valve endocarditis|0|07.424904|1
00001510|staphylococcal prosthetic heart valve endocarditis|staphylococcal prosthetic heart valve endocarditis|0|07.424905|1
00001511|Diphtheroid prosthetic heart valve endocarditis|Diphtheroid prosthetic heart valve endocarditis|0|07.424906|1
00001512|Idiopathic Hypertrophic Subaortic Stenosis|Idiopathic Hypertrophic Subaortic Stenosis|1|07.425100|2
00001513|cardiomyopathy|cardiomyopathy|0|07.425400|2
00001514|hypertrophic cardiomyopathy|hypertrophic cardiomyopathy|0|07.425401|2
00001515|doxorubicin-induced cardiomyopathy|doxorubicin-induced cardiomyopathy|0|07.425402|3
00001516|Hypertrophic Obstructive Cardiomyopathy|Hypertrophic Obstructive Cardiomyopathy|1|07.425403|2
00001517|complete atrioventricular block|complete atrioventricular block|0|07.426000|1
00001519|atrioventricular conduction defect|atrioventricular conduction defect|0|07.426100|2
00001520|atrioventricular block|atrioventricular block|0|07.426102|2
00001521|incomplete AV heart block|incomplete AV heart block|0|07.426130|2
00001522|second degree atrioventricular heart block|second degree atrioventricular heart block|0|07.426131|2
00001523|right bundle branch block|right bundle branch block|0|07.426400|2
00001524|right bundle branch block with left hemiblock|right bundle branch block with left hemiblock|0|07.426401|2
00001525|bundle branch block|bundle branch block|0|07.426500|2
00001527|sinus arrest|sinus arrest|0|07.426601|1
00001528|Wolff-Parkinson-White pattern|Wolff-Parkinson-White pattern|0|07.426700|3
00001529|atrial fibrillation with Wolff-Parkinson-White|atrial fibrillation with Wolff-Parkinson-White|0|07.426701|3
00001530|atrial fibrillation with Lown-Ganong-Levine syndrome|atrial fibrillation with Lown-Ganong-Levine syndrome|0|07.426810|3
00001531|complete atrioventricular dissociation|complete atrioventricular dissociation|0|07.426890|3
00001532|heart block|heart block|0|07.426900|3
00001533|severe heart block|severe heart block|0|07.426901|3
00001535|Adams-Stokes syndrome|Adams-Stokes syndrome|0|07.426904|3
00001536|syncope due to heart block|syncope due to heart block|0|07.426905|3
00001537|abnormal ECG|abnormal ECG|0|07.426906|3
00001538|paroxysmal supraventricular tachycardia|paroxysmal supraventricular tachycardia|0|07.427000|3
00001539|paroxysmal atrial tachycardia|paroxysmal atrial tachycardia|0|07.427001|1
00001540|paroxysmal atrial fibrillation|paroxysmal atrial fibrillation|0|07.427002|1
00001541|paroxysmal atrial flutter|paroxysmal atrial flutter|0|07.427003|1
00001542|supraventricular tachycardia|supraventricular tachycardia|0|07.427004|1
00001543|ventricular tachycardia|ventricular tachycardia|0|07.427100|3
00001544|atypical ventricular tachycardia|atypical ventricular tachycardia|2|07.427101|3
00001545|torsades de pointes|torsades de pointes|0|07.427102|3
00001546|predisposed to torsades de pointes cardiac arrhythmias|predisposed to torsades de pointes cardiac arrhythmias|0|07.427103|3
00001547|life-threatening ventricular tachycardia|life-threatening ventricular tachycardia|0|07.427104|1
00001548|paroxysmal ventricular tachycardia|paroxysmal ventricular tachycardia|0|07.427105|1
00001549|paroxysmal tachycardia|paroxysmal tachycardia|0|07.427200|3
00001550|atrial fibrillation|atrial fibrillation|0|07.427310|3
00001551|atrial fibrillation with mitral stenosis|atrial fibrillation with mitral stenosis|0|07.427311|2
00001552|atrial fibrillation with embolization|atrial fibrillation with embolization|0|07.427312|2
00001553|atrial flutter|atrial flutter|0|07.427320|3
00001554|ventricular fibrillation|ventricular fibrillation|0|07.427410|3
00001555|prevention of ventricular fibrillation|prevention of ventricular fibrillation|0|07.427411|2
00001557|cardiac arrest|cardiac arrest|0|07.427500|1
00001558|extrasystoles|extrasystoles|0|07.427600|3
00001559|premature atrial contractions|premature atrial contractions|0|07.427610|3
00001560|ventricular premature beats|ventricular premature beats|0|07.427690|3
00001561|Ventricular Extrasystole|Ventricular Extrasystole|1|07.427691|3
00001562|sick sinus syndrome|sick sinus syndrome|0|07.427810|3
00001563|bradycardia|bradycardia|0|07.427890|3
00001564|sinus tachycardia|sinus tachycardia|0|07.427891|3
00001565|sinus bradycardia|sinus bradycardia|0|07.427892|3
00001566|prolonged QT interval|prolonged QT interval|0|07.427893|3
00001567|sinus node dysfunction|sinus node dysfunction|0|07.427895|3
00001568|ventricular bigeminy|ventricular bigeminy|0|07.427896|3
00001569|ST segment changes|ST segment changes|0|07.427897|3
00001570|pulsus trigeminus|pulsus trigeminus|0|07.427898|3
00001572|cardiac arrhythmia|cardiac arrhythmia|0|07.427900|3
00001573|arrhythmias during surgery|arrhythmias during surgery|0|07.427902|1
00001574|ventricular arrhythmias|ventricular arrhythmias|0|07.427903|3
00001575|supraventricular arrhythmias|supraventricular arrhythmias|0|07.427904|3
00001576|life-threatening cardiac arrhythmias|life-threatening cardiac arrhythmias|0|07.427905|3
00001578|chronic heart failure|chronic heart failure|0|07.428000|2
00001579|severe chronic heart failure|severe chronic heart failure|0|07.428001|2
00001580|acutely decompensated chronic heart failure|acutely decompensated chronic heart failure|0|07.428002|1
00001581|chronic heart failure not due to hypertension|chronic heart failure not due to hypertension|0|07.428003|2
00001582|peripheral edema due to chronic heart failure|peripheral edema due to chronic heart failure|0|07.428005|1
00001583|pulmonary edema due to chronic heart failure|pulmonary edema due to chronic heart failure|0|07.428006|1
00001584|chronic heart failure following myocardial infarction|chronic heart failure following myocardial infarction|0|07.428007|1
00001585|cardiac asthma|cardiac asthma|0|07.428100|2
00001586|left ventricular failure|left ventricular failure|0|07.428101|3
00001587|anxiety due to cardiac asthma|anxiety due to cardiac asthma|0|07.428102|1
00001588|heart failure|heart failure|0|07.428900|2
00001589|acute decompensated heart failure|acute decompensated heart failure|0|07.428901|1
00001590|myocarditis|myocarditis|0|07.429000|2
00001591|myocardial dysfunction|myocardial dysfunction|0|07.429001|3
00001593|Myocardial Injury|Myocardial Injury|1|07.429100|1
00001594|disease of cardiovascular system|disease of cardiovascular system|0|07.429200|3
00001595|severe cardiovascular disease|severe cardiovascular disease|0|07.429201|3
00001596|Cardiovascular Instability|Cardiovascular Instability|2|07.429202|3
00001597|Cardiovascular Disease with Bradycardia|Cardiovascular Disease with Bradycardia|1|07.429204|2
00001598|CV Disease Leading to Slower Circulation|Cardiovascular Disease Leading to Slower Circulation|2|07.429205|2
00001599|cardiomegaly|cardiomegaly|0|07.429300|2
00001601|left ventricular hypertrophy|left ventricular hypertrophy|0|07.429302|2
00001602|cardiac decompensation post cardiac surgery|cardiac decompensation post cardiac surgery|0|07.429400|3
00001603|carditis|carditis|0|07.429890|1
00001604|cardiotoxicity|cardiotoxicity|0|07.429891|1
00001606|cardiac disease|cardiac disease|0|07.429900|3
00001607|severe cardiac disease|severe cardiac disease|0|07.429901|2
00001608|Active Cardiac Disease|Active Cardiac Disease|1|07.429902|1
00001609|cardiac decompensation|cardiac decompensation|0|07.429903|1
00001610|organic cardiac disease|organic cardiac disease|0|07.429905|2
00001611|low cardiac output|low cardiac output|0|07.429907|2
00001612|decreased cardiac function|decreased cardiac function|0|07.429908|2
00001613|Cardiac Irritability|Cardiac Irritability|2|07.429909|3
00001614|congenital long QT syndrome|congenital long QT syndrome|0|07.42990A|2
00001616|subarachnoid intracranial hemorrhage|subarachnoid intracranial hemorrhage|0|07.430000|1
00001617|intracerebral hemorrhage|intracerebral hemorrhage|0|07.431000|1
00001618|hemorrhagic stroke|hemorrhagic stroke|0|07.431001|1
00001619|subdural intracranial hemorrhage|subdural intracranial hemorrhage|0|07.432100|1
00001620|intracranial bleeding|intracranial bleeding|0|07.432900|1
00001621|cerebral thrombosis|cerebral thrombosis|0|07.434000|1
00001622|prevention of cerebral thrombosis|prevention of cerebral thrombosis|0|07.434001|2
00001624|acute cerebral infarction|acute cerebral infarction|0|07.434900|1
00001625|cerebrovascular occlusion|cerebrovascular occlusion|0|07.434901|3
00001626|cerebral thromboembolism prevention|cerebral thromboembolism prevention|0|07.434902|2
00001627|transient cerebral ischemia|transient cerebral ischemia|0|07.435900|3
00001628|spasm of cerebral arteries|spasm of cerebral arteries|0|07.435902|1
00001629|cerebrovascular accident|cerebrovascular accident|0|07.436000|1
00001630|prevention of cerebrovascular accident|prevention of cerebrovascular accident|0|07.436004|2
00001631|cerebral arteriosclerosis|cerebral arteriosclerosis|0|07.437000|2
00001632|severe cerebral arteriosclerosis|severe cerebral arteriosclerosis|0|07.437001|2
00001633|cerebral ischemia|cerebral ischemia|0|07.437100|2
00001635|brain aneurysm|brain aneurysm|0|07.437300|3
00001636|cerebral arteritis|cerebral arteritis|0|07.437400|1
00001637|cerebrovascular disorder|cerebrovascular disorder|0|07.437900|3
00001638|severe cerebrovascular disease|severe cerebrovascular disease|0|07.437902|2
00001639|renal artery stenosis|renal artery stenosis|0|07.440100|2
00001640|arteriosclerosis obliterans|arteriosclerosis obliterans|0|07.440900|2
00001641|severe arteriosclerotic vascular disease|severe arteriosclerotic vascular disease|0|07.440901|2
00001642|secondary prevention of atherosclerotic CV disease|secondary prevention of atherosclerotic cardiovascular disease|0|07.440902|1
00001643|atherosclerotic cardiovascular disease|atherosclerotic cardiovascular disease|0|07.440903|2
00001644|aortic aneurysm with dissection|aortic aneurysm with dissection|0|07.441900|1
00001645|arterial aneurysm|arterial aneurysm|0|07.442900|3
00001646|Raynaud's phenomenon|Raynaud's phenomenon|0|07.443000|1
00001647|severe Raynaud's phenomenon|severe Raynaud's phenomenon|0|07.443001|1
00001648|Buerger's disease|Buerger's disease|0|07.443100|2
00001649|vasospasm|vasospasm|0|07.443900|3
00001650|intermittent claudication treatment adjunct|intermittent claudication treatment adjunct|0|07.443902|2
00001651|peripheral vasoconstriction|peripheral vasoconstriction|0|07.443904|1
00001652|intermittent claudication|intermittent claudication|0|07.443905|2
00001653|peripheral arterial embolism|peripheral arterial embolism|0|07.444220|1
00001654|peripheral arterial thromboembolism prevention|peripheral arterial thromboembolism prevention|0|07.444221|3
00001655|thromboembolic disorder|thromboembolic disorder|0|07.444900|1
00001656|acute arterial thromboembolism|acute arterial thromboembolism|0|07.444901|1
00001658|Intra-Arterial Device Blood Clot Prevention|Intra-Arterial Device Blood Clot Prevention|1|07.444906|1
00001659|cholesterol embolism|cholesterol embolism|0|07.444907|1
00001660|arterial thrombosis|arterial thrombosis|0|07.444908|1
00001661|polyarteritis nodosa|polyarteritis nodosa|0|07.446000|2
00001662|Kawasaki disease|Kawasaki disease|0|07.446100|1
00001663|hypersensitivity angiitis|hypersensitivity angiitis|0|07.446200|1
00001664|goodpasture's syndrome|goodpasture's syndrome|0|07.446210|3
00001665|granulomatosis with polyangiitis|granulomatosis with polyangiitis|0|07.446400|1
00001666|giant cell arteritis|giant cell arteritis|0|07.446500|2
00001667|Stenosis in Distal Blood Vessel to Lesion|Stenosis in Distal Blood Vessel to Lesion|2|07.447101|2
00001668|arterial erosion by tumor growth|arterial erosion by tumor growth|0|07.447200|3
00001669|vasculitis|vasculitis|0|07.447600|3
00001670|cutaneous vasculitis|cutaneous vasculitis|0|07.447601|1
00001671|chronic cutaneous vasculitis|chronic cutaneous vasculitis|0|07.447602|2
00001673|renal vasculitis|renal vasculitis|0|07.447800|1
00001674|vascular disease|vascular disease|0|07.447900|2
00001675|peripheral vascular disease|peripheral vascular disease|0|07.447901|2
00001676|occlusive peripheral vascular disease|occlusive peripheral vascular disease|0|07.447902|2
00001677|telangiectasia|telangiectasia|0|07.448900|3
00001678|capillary leak syndrome|capillary leak syndrome|0|07.448901|3
00001679|thrombophlebitis|thrombophlebitis|0|07.451900|3
00001680|Thromboembolic Condition|Thromboembolic Condition|1|07.451903|1
00001681|septic thrombophlebitis|septic thrombophlebitis|0|07.451905|1
00001682|hepatic vein thrombosis|hepatic vein thrombosis|0|07.453000|1
00001683|hepatic veno-occlusive disease|hepatic veno-occlusive disease|0|07.453800|2
00001684|leg vein thrombosis|leg vein thrombosis|0|07.453801|1
00001685|thrombotic disorder|thrombotic disorder|0|07.453900|1
00001686|deep venous thrombosis|deep venous thrombosis|0|07.453901|1
00001687|predisposition to thrombosis|predisposition to thrombosis|0|07.453902|2
00001688|deep vein thrombosis prevention|deep vein thrombosis prevention|0|07.453903|1
00001689|thrombotic thrombocytopenic purpura|thrombotic thrombocytopenic purpura|0|07.453904|1
00001691|IV Device Blood Clotting Prevention|IV Device Blood Clotting Prevention|1|07.453906|1
00001692|deep vein thrombosis with pulmonary embolism|deep vein thrombosis with pulmonary embolism|0|07.453907|1
00001693|thrombosis in heparin-induced thrombocytopenia|thrombosis in heparin-induced thrombocytopenia|0|07.453908|1
00001694|heparin-induced thrombocytopenia thrombosis prevention|thrombosis prevention in heparin-induced thrombocytopenia|0|07.453909|1
00001695|hip surgery deep vein thrombosis prevention|hip surgery deep vein thrombosis prevention|0|07.453910|2
00001696|knee replacement deep vein thrombosis prevention|knee replacement deep vein thrombosis prevention|0|07.453911|2
00001697|abdominal surgery deep vein thrombosis prevention|abdominal surgery deep vein thrombosis prevention|0|07.453912|2
00001698|venous thrombosis|venous thrombosis|0|07.453913|1
00001699|stasis ulcer|stasis ulcer|0|07.454000|2
00001700|varicose veins|varicose veins|0|07.454900|2
00001701|hemorrhoids|hemorrhoids|0|07.455600|3
00001702|bleeding hemorrhoids|bleeding hemorrhoids|0|07.455800|1
00001703|bleeding esophageal varices|bleeding esophageal varices|0|07.456000|1
00001704|esophageal varices|esophageal varices|0|07.456100|2
00001705|lymphocele|lymphocele|0|07.457800|1
00001706|orthostatic hypotension|orthostatic hypotension|0|07.458000|3
00001707|symptomatic orthostatic hypotension|symptomatic orthostatic hypotension|0|07.458001|3
00001708|idiopathic orthostatic hypotension|idiopathic orthostatic hypotension|0|07.458100|2
00001709|hypotension|hypotension|0|07.458900|3
00001710|acute hypotension|acute hypotension|0|07.458901|1
00001711|controlled hypotension|controlled hypotension|0|07.458902|1
00001712|mild to moderate hypotension|mild to moderate hypotension|0|07.458903|3
00001713|severe hypotension|severe hypotension|0|07.458904|3
00001714|hemorrhage|hemorrhage|0|07.459000|1
00001715|acute hemorrhage|acute hemorrhage|0|07.459001|1
00001716|arterial hemorrhage|arterial hemorrhage|0|07.459002|1
00001717|Significant Bleeding|Significant Bleeding|2|07.459003|1
00001718|hemorrhage during ocular surgery|hemorrhage during ocular surgery|0|07.459004|1
00001719|hyperfibrinolysis-induced hemorrhage|hyperfibrinolysis-induced hemorrhage|0|07.459005|1
00001720|superficial bleeding|superficial bleeding|0|07.459006|1
00001721|collateral circulation|collateral circulation|0|07.459890|2
00001722|ecchymosis|ecchymosis|0|07.459891|1
00001723|phlebosclerosis|phlebosclerosis|0|07.459892|1
00001724|vasodilation of blood vessels|vasodilation of blood vessels|0|07.459893|1
00001725|Circulatory System Disorders|Circulatory System Disorders|1|07.459900|3
00001726|occlusive vascular disease|occlusive vascular disease|0|07.459901|2
00001727|circulatory depression|circulatory depression|2|07.459902|3
00001728|ischemia|ischemia|0|07.459903|3
00001729|peripheral ischemia|peripheral ischemia|0|07.459904|3
00001730|thoracic surgery|thoracic surgery|0|08. 40690|1
00001731|bone marrow transplant|bone marrow transplant|0|08. 41000|1
00001732|myeloid engraftment enhancement|myeloid engraftment enhancement|0|08. 41001|1
00001733|progenitor cell enhancement|progenitor cell enhancement|0|08. 41002|1
00001734|delay or failure of autologous bone marrow transplant|delay or failure of autologous bone marrow transplant|0|08. 41003|1
00001735|delay or failure of allogenic bone marrow transplant|delay or failure of allogenic bone marrow transplant|0|08. 41004|1
00001736|myeloid engraftment enhancement post aut PBPC transplant|myeloid engraftment enhancement after autologous peripheral blood progenitor cell transplant|0|08. 41005|1
00001737|history of splenectomy|history of splenectomy|0|08. 41501|2
00001738|cold symptoms|cold symptoms|0|08.460000|1
00001739|acute bacterial maxillary sinusitis|acute bacterial maxillary sinusitis|0|08.461000|1
00001740|acute maxillary Streptococcus pneumoniae sinusitis|acute maxillary Streptococcus pneumoniae sinusitis|0|08.461001|1
00001741|acute maxillary Haemophilus influenzae sinusitis|acute maxillary Haemophilus influenzae sinusitis|0|08.461002|1
00001742|acute maxillary Moraxella catarrhalis sinusitis|acute maxillary Moraxella catarrhalis sinusitis|0|08.461003|1
00001743|acute bacterial sinusitis|acute bacterial sinusitis|0|08.461900|1
00001744|acute Streptococcus pneumoniae bacterial sinusitis|acute Streptococcus pneumoniae bacterial sinusitis|0|08.461901|1
00001745|acute Haemophilus influenzae bacterial sinusitis|acute Haemophilus influenzae bacterial sinusitis|0|08.461902|1
00001746|acute Moraxella catarrhalis bacterial sinusitis|acute Moraxella catarrhalis bacterial sinusitis|0|08.461903|1
00001747|acute Haemophilus parahaemolyticus bacterial sinusitis|acute Haemophilus parahaemolyticus bacterial sinusitis|0|08.461904|1
00001748|acute E. coli bacterial sinusitis|acute E. coli bacterial sinusitis|0|08.461905|1
00001749|acute Haemophilus parainfluenzae bacterial sinusitis|acute Haemophilus parainfluenzae bacterial sinusitis|0|08.461906|1
00001750|pharyngitis|pharyngitis|0|08.462000|1
00001751|Haemophilus influenzae pharyngitis|Haemophilus influenzae pharyngitis|0|08.462001|1
00001752|sore throat|sore throat|0|08.462002|1
00001753|tonsillitis|tonsillitis|0|08.463000|1
00001754|laryngitis|laryngitis|0|08.464000|1
00001755|tracheitis|tracheitis|0|08.464100|1
00001756|croup|croup|0|08.464400|1
00001757|upper respiratory infection|upper respiratory infection|0|08.465900|1
00001758|upper respiratory pneumococcal infection|upper respiratory pneumococcal infection|0|08.465901|1
00001759|upper respiratory streptococcal infection|upper respiratory streptococcal infection|0|08.465902|1
00001760|bacterial exacerbation of acute bronchitis|bacterial exacerbation of acute bronchitis|0|08.466000|1
00001761|bronchiolitis|bronchiolitis|0|08.466100|1
00001762|bronchiolitis obliterans|bronchiolitis obliterans|0|08.466101|2
00001763|nasal polyp|nasal polyp|0|08.471900|2
00001764|Nasal Polyps with Asthma|Nasal Polyps with Asthma|2|08.471901|2
00001766|rhinitis|rhinitis|0|08.472000|1
00001767|chronic non-allergic rhinitis|chronic non-allergic rhinitis|0|08.472001|2
00001768|sinusitis|sinusitis|0|08.473900|1
00001769|acute Staph. aureus sinusitis|acute Staph. aureus sinusitis|0|08.473901|1
00001770|allergic rhinitis|allergic rhinitis|0|08.477900|3
00001771|severe allergic rhinitis|severe allergic rhinitis|0|08.477901|1
00001772|vasomotor rhinitis|vasomotor rhinitis|0|08.477902|1
00001773|perennial allergic rhinitis|perennial allergic rhinitis|0|08.477903|1
00001774|allergic rhinitis prevention|allergic rhinitis prevention|0|08.477904|2
00001775|nasal congestion|nasal congestion|0|08.478100|1
00001776|eustachian tube congestion|eustachian tube congestion|0|08.478101|1
00001777|nasal septal ulcers|nasal septal ulcers|0|08.478102|1
00001778|dry nose|dry nose|0|08.478104|1
00001779|nasal passage irritation|nasal passage irritation|0|08.478105|1
00001780|crusted nasal mucosa|crusted nasal mucosa|0|08.478106|1
00001781|lesion of nasal mucosa|lesion of nasal mucosa|0|08.478108|1
00001782|nasal pain|nasal pain|0|08.478109|3
00001783|nasal septal perforation|nasal septal perforation|0|08.47810A|2
00001784|nasal turbinate hypertrophy|nasal turbinate hypertrophy|0|08.478110|3
00001786|pharyngeal edema|pharyngeal edema|0|08.478250|1
00001787|Impaired Gag Reflex|Impaired Gag Reflex|1|08.478290|1
00001788|suppression of the gag reflex|suppression of the gag reflex|0|08.478291|1
00001789|throat ulceration|throat ulceration|0|08.478292|1
00001790|throat constriction|throat constriction|0|08.478293|1
00001791|laryngeal edema|laryngeal edema|0|08.478600|1
00001792|laryngismus|laryngismus|0|08.478750|2
00001793|upper respiratory hypersensitivity reaction|upper respiratory hypersensitivity reaction|0|08.478800|1
00001795|respiratory syncytial virus pneumonia prevention|respiratory syncytial virus pneumonia prevention|0|08.480101|1
00001796|pneumococcal pneumonia|pneumococcal pneumonia|0|08.481000|1
00001797|Klebsiella pneumonia|Klebsiella pneumonia|0|08.482000|1
00001798|Pseudomonas aeruginosa pneumonia|Pseudomonas aeruginosa pneumonia|0|08.482100|1
00001799|acute P. aeruginosa pneumonia in cystic fibrosis|acute Pseudomonas aeruginosa pneumonia associated with cystic fibrosis|0|08.482101|1
00001801|Haemophilus influenzae pneumonia|Haemophilus influenzae pneumonia|0|08.482200|1
00001802|Haemophilus parainfluenza pneumonia|Haemophilus parainfluenza pneumonia|0|08.482201|1
00001803|Haemophilus parahaemolyticus pneumonia|Haemophilus parahaemolyticus pneumonia|0|08.482202|1
00001804|streptococcal pneumonia|streptococcal pneumonia|0|08.482300|1
00001805|Enterococcus pneumonia|Enterococcus pneumonia|0|08.482390|1
00001806|staphylococcal pneumonia|staphylococcal pneumonia|0|08.482400|1
00001807|anaerobic pneumonia|anaerobic pneumonia|0|08.482810|1
00001808|Bacteroides pneumonia|Bacteroides pneumonia|0|08.482811|1
00001809|Escherichia coli pneumonia|Escherichia coli pneumonia|0|08.482820|1
00001810|gram-negative aerobic bacillary pneumonia|gram-negative aerobic bacillary pneumonia|0|08.482830|1
00001811|Legionnaires' disease|Legionnaires' disease|0|08.482831|1
00001812|Serratia pneumonia|Serratia pneumonia|0|08.482832|1
00001813|Enterobacter pneumonia|Enterobacter pneumonia|0|08.482833|1
00001815|Legionella pneumophila pneumonia|Legionella pneumophila pneumonia|0|08.482835|1
00001816|Moraxella catarrhalis pneumonia|Moraxella catarrhalis pneumonia|0|08.482836|1
00001817|Proteus pneumonia|Proteus pneumonia|0|08.482837|1
00001818|Citrobacter pneumonia|Citrobacter pneumonia|0|08.482838|1
00001819|bacterial pneumonia|bacterial pneumonia|0|08.482900|1
00001820|mycoplasmal pneumonia|mycoplasmal pneumonia|0|08.483000|1
00001821|chlamydial pneumonia|chlamydial pneumonia|0|08.483800|1
00001822|fungal infection of lung|fungal infection of lung|0|08.484700|1
00001823|pneumonia|pneumonia|0|08.486000|1
00001824|nosocomial bacterial pneumonia|nosocomial bacterial pneumonia|0|08.486001|1
00001825|nosocomial pneumonia due to Haemophilus influenzae|nosocomial pneumonia due to Haemophilus influenzae|0|08.486002|1
00001826|Klebsiella nosocomial pneumonia|Klebsiella nosocomial pneumonia|0|08.486003|1
00001827|Staphylococcus nosocomial pneumonia|Staphylococcus nosocomial pneumonia|0|08.486004|1
00001828|influenza|influenza|0|08.487100|1
00001829|influenza due to influenza virus type A|influenza due to influenza virus type A|0|08.487101|1
00001830|influenza due to influenza virus type B|influenza due to influenza virus type B|0|08.487102|1
00001831|influenza A prevention|influenza A prevention|0|08.487103|1
00001832|influenza prevention|influenza prevention|0|08.487104|1
00001833|bronchitis|bronchitis|0|08.490000|3
00001834|bronchitis with bacterial exacerbation|bronchitis with bacterial exacerbation|0|08.490001|1
00001835|bronchial irritation|bronchial irritation|0|08.490002|1
00001836|increased bronchial secretions|increased bronchial secretions|0|08.490003|1
00001837|thick bronchial secretions|thick bronchial secretions|0|08.490004|1
00001838|Staphylococcus aureus bronchitis|Staphylococcus aureus bronchitis|0|08.490005|1
00001839|Streptococcus pneumoniae bronchitis|Streptococcus pneumoniae bronchitis|0|08.490006|1
00001840|Haemophilus influenzae bronchitis|Haemophilus influenzae bronchitis|0|08.490007|1
00001841|Haemophilus parainfluenzae bronchitis|Haemophilus parainfluenzae bronchitis|0|08.490008|1
00001842|Moraxella catarrhalis bronchitis|Moraxella catarrhalis bronchitis|0|08.490009|1
00001843|Enterobacter cloacae bronchitis|Enterobacter cloacae bronchitis|0|08.490010|1
00001844|Chlamydia pneumoniae bronchitis|Chlamydia pneumoniae bronchitis|0|08.490011|1
00001845|Klebsiella pneumoniae bronchitis|Klebsiella pneumoniae bronchitis|0|08.490012|1
00001846|chronic bronchitis with bacterial exacerbation|chronic bronchitis with bacterial exacerbation|0|08.491000|2
00001847|chronic bronchitis|chronic bronchitis|0|08.491001|2
00001848|Streptococcus pneumoniae chronic bronchitis|Streptococcus pneumoniae chronic bronchitis|0|08.491100|2
00001849|Haemophilus influenzae chronic bronchitis|Haemophilus influenzae chronic bronchitis|0|08.491101|2
00001850|Haemophilus parainfluenzae chronic bronchitis|Haemophilus parainfluenzae chronic bronchitis|0|08.491102|2
00001851|Klebsiella pneumoniae chronic bronchitis|Klebsiella pneumoniae chronic bronchitis|0|08.491103|2
00001852|Staphylococcus chronic bronchitis|Staphylococcus chronic bronchitis|0|08.491104|2
00001853|Moraxella catarrhalis chronic bronchitis|Moraxella catarrhalis chronic bronchitis|0|08.491105|2
00001854|Bronchiolitis Obliterans|Bronchiolitis Obliterans|1|08.491800|2
00001855|pulmonary emphysema|pulmonary emphysema|0|08.492800|2
00001857|prevention of bronchospasms with emphysema|prevention of bronchospasms with emphysema|0|08.492802|2
00001858|extrinsic asthma|extrinsic asthma|0|08.493000|2
00001860|status asthmaticus|status asthmaticus|0|08.493010|1
00001861|extrinsic asthma with status asthmaticus|extrinsic asthma with status asthmaticus|0|08.493011|1
00001862|intrinsic asthma|intrinsic asthma|0|08.493100|2
00001864|intrinsic asthma with status asthmaticus|intrinsic asthma with status asthmaticus|0|08.493112|1
00001865|chronic obstructive asthma|chronic obstructive asthma|0|08.493200|2
00001866|asthma|asthma|0|08.493900|3
00001867|diagnostic test for asthma|diagnostic test for asthma|0|08.493901|1
00001868|acute asthma attack|acute asthma attack|0|08.493902|1
00001869|asthma prevention|asthma prevention|0|08.493905|2
00001870|nocturnal asthma|nocturnal asthma|0|08.493906|2
00001871|asthma exacerbation|asthma exacerbation|0|08.493907|1
00001872|bronchiectasis|bronchiectasis|0|08.494000|3
00001874|hypersensitivity pneumonitis|hypersensitivity pneumonitis|0|08.495901|3
00001875|obstructive pulmonary disease|obstructive pulmonary disease|0|08.496000|2
00001876|severe chronic obstructive pulmonary disease|severe chronic obstructive pulmonary disease|0|08.496001|2
00001877|chronic obstructive pulmonary disease with bronchospasms|chronic obstructive pulmonary disease with bronchospasms|0|08.496002|2
00001878|bronchospasm prevention with COPD|bronchospasm prevention with COPD|0|08.496003|2
00001879|berylliosis|berylliosis|0|08.503000|1
00001880|aspiration pneumonia|aspiration pneumonia|0|08.507000|1
00001881|aspiration pneumonia prevention|aspiration pneumonia prevention|0|08.507001|3
00001882|aspiration pneumonitis|aspiration pneumonitis|0|08.507002|1
00001883|Streptococcus empyema|Streptococcus empyema|0|08.510900|1
00001884|Bacteroides empyema|Bacteroides empyema|0|08.510901|1
00001885|pleural empyema|pleural empyema|0|08.510902|1
00001886|pleuritis|pleuritis|0|08.511000|1
00001887|pleural effusions|pleural effusions|0|08.511900|3
00001888|pleural malignant effusion|pleural malignant effusion|0|08.511901|1
00001889|pneumothorax|pneumothorax|0|08.512800|1
00001890|lung abscess|lung abscess|0|08.513000|1
00001891|necrotizing pneumonia|necrotizing pneumonia|0|08.513001|1
00001892|Streptococcus lung abscess|Streptococcus lung abscess|0|08.513002|1
00001893|enterococcus lung abscess|enterococcus lung abscess|0|08.513003|1
00001894|Staphylococcus lung abscess|Staphylococcus lung abscess|0|08.513004|1
00001895|E. coli lung abscess|E. coli lung abscess|0|08.513005|1
00001896|Klebsiella lung abscess|Klebsiella lung abscess|0|08.513006|1
00001897|Haemophilus influenzae lung abscess|Haemophilus influenzae lung abscess|0|08.513007|1
00001898|Bacteroides lung abscess|Bacteroides lung abscess|0|08.513008|1
00001899|anaerobic lung abscess|anaerobic lung abscess|0|08.513009|1
00001900|pulmonary edema|pulmonary edema|0|08.514000|3
00001901|pulmonary congestion|pulmonary congestion|0|08.514001|3
00001902|interstitial pneumonitis|interstitial pneumonitis|0|08.515000|1
00001903|pulmonary fibrosis|pulmonary fibrosis|0|08.515001|2
00001904|alveolitis|alveolitis|0|08.516300|1
00001905|atelectasis|atelectasis|0|08.518000|1
00001906|atelectasis due to mucous obstruction|atelectasis due to mucous obstruction|0|08.518001|1
00001907|Loffler syndrome|Loffler syndrome|0|08.518300|3
00001908|pulmonary infiltrates|pulmonary infiltrates|0|08.518301|3
00001909|eosinophilic pneumonia|eosinophilic pneumonia|0|08.518302|1
00001910|acute pulmonary edema|acute pulmonary edema|0|08.518400|1
00001911|pulmonary insufficiency following trauma or surgery|pulmonary insufficiency following trauma or surgery|0|08.518500|1
00001912|allergic bronchopulmonary aspergillosis|allergic bronchopulmonary aspergillosis|0|08.518600|1
00001913|acute respiratory failure|acute respiratory failure|0|08.518810|1
00001914|respiratory depression|respiratory depression|0|08.518820|3
00001915|acute respiratory distress syndrome|acute respiratory distress syndrome|0|08.518822|1
00001916|pulmonary disease|pulmonary disease|0|08.518890|2
00001917|Active Pulmonary Disease|Active Pulmonary Disease|1|08.518891|1
00001918|chronic pulmonary disease|chronic pulmonary disease|0|08.518892|2
00001919|bronchospastic pulmonary disease|bronchospastic pulmonary disease|0|08.519100|2
00001920|bronchospasm prevention|bronchospasm prevention|0|08.519101|3
00001921|exercise-induced bronchospasm|exercise-induced bronchospasm|0|08.519102|1
00001922|exercise-induced bronchospasm prevention|exercise-induced bronchospasm prevention|0|08.519103|1
00001923|bronchospasm during anesthesia|bronchospasm during anesthesia|0|08.519104|1
00001924|lower respiratory infection|lower respiratory infection|0|08.519800|3
00001925|chronic disease of respiratory system|chronic disease of respiratory system|0|08.519900|2
00001926|gastroscopy adjunct|gastroscopy adjunct|0|09. 44130|1
00001928|ileojejunal bypass|ileojejunal bypass|0|09. 45910|1
00001929|ileocolic anastomosis|ileocolic anastomosis|0|09. 45930|3
00001930|ileostomy|ileostomy|0|09. 46200|2
00001931|diagnostic aid for biliary tract|diagnostic aid for biliary tract|0|09. 51190|1
00001932|diagnostic test for pancreas function|diagnostic test for pancreas function|0|09. 52190|1
00001933|gastrointestinal tract surgery|gastrointestinal tract surgery|0|09. 54990|1
00001934|preoperative bowel preparation|preoperative bowel preparation|0|09. 54992|1
00001935|bowel evacuation|bowel evacuation|0|09. 54993|1
00001936|infection prevention for GI surgery|infection prevention for GI surgery|0|09. 54994|1
00001937|dental caries|dental caries|0|09.521000|3
00001938|dental plaque prevention|dental plaque prevention|0|09.521001|3
00001939|dental fluorosis|dental fluorosis|0|09.521003|2
00001940|dental discoloration|dental discoloration|0|09.521700|2
00001941|increased tartar formation|increased tartar formation|0|09.521701|3
00001942|tooth disorder|tooth disorder|0|09.521900|1
00001943|pulpal hemorrhage|pulpal hemorrhage|0|09.522900|1
00001944|acute gingivitis|acute gingivitis|0|09.523000|1
00001945|gingivitis|gingivitis|0|09.523001|3
00001947|gingivostomatitis|gingivostomatitis|0|09.523102|1
00001948|periodontal infection|periodontal infection|0|09.523300|1
00001949|periodontitis|periodontitis|0|09.523400|2
00001950|periodontitis adjunct therapy|periodontitis adjunct therapy|0|09.523401|1
00001951|gingival hyperplasia|gingival hyperplasia|0|09.523800|3
00001952|gingival bleeding|gingival bleeding|0|09.523801|3
00001953|gingival disorders|gingival disorders|0|09.523900|3
00001955|Mouth Inflammation|Mouth Inflammation|1|09.523902|1
00001957|gingival pain|gingival pain|0|09.523904|3
00001958|temporomandibular joint disorder|temporomandibular joint disorder|0|09.524600|2
00001959|oral cavity disorders|oral cavity disorders|0|09.525900|3
00001960|toothache|toothache|0|09.525901|1
00001961|jaw pain|jaw pain|0|09.526900|3
00001962|jaw protrusion|jaw protrusion|0|09.526901|2
00001963|parotitis|parotitis|0|09.527200|1
00001965|sialoadenitis|sialoadenitis|0|09.527202|1
00001966|salivary secretion disorder|salivary secretion disorder|0|09.527700|3
00001967|sialorrhea|sialorrhea|0|09.527701|3
00001968|xerostomia|xerostomia|0|09.527702|1
00001969|saliva discoloration|saliva discoloration|0|09.527703|1
00001970|xerostomia secondary to Sjogren's syndrome|xerostomia secondary to Sjogren's syndrome|0|09.527704|2
00001971|xerostomia secondary to radiation therapy|xerostomia secondary to radiation therapy|0|09.527705|2
00001972|stomatitis|stomatitis|0|09.528000|3
00001973|aphthous stomatitis|aphthous stomatitis|0|09.528200|1
00001974|recurrent aphthous stomatitis|recurrent aphthous stomatitis|0|09.528201|1
00001975|prevention of recurrent aphthous stomatitis|prevention of recurrent aphthous stomatitis|0|09.528202|1
00001976|mouth infection prevention|mouth infection prevention|0|09.528300|1
00001977|cheilitis|cheilitis|0|09.528500|1
00001978|cheilosis|cheilosis|0|09.528501|1
00001979|cheilodynia|cheilodynia|0|09.528502|3
00001980|lip hypertrophy|lip hypertrophy|0|09.528503|3
00001981|leucoplakia of oral mucosa|leucoplakia of oral mucosa|0|09.528600|3
00001982|mouth irritation|mouth irritation|0|09.528900|3
00001983|denture stomatitis|denture stomatitis|0|09.528901|1
00001984|mouth discoloration|mouth discoloration|0|09.528902|3
00001985|glossitis|glossitis|0|09.529000|1
00001986|atrophic glossitis|atrophic glossitis|0|09.529400|1
00001987|sore tongue|sore tongue|0|09.529600|1
00001988|tongue discoloration|tongue discoloration|0|09.529901|3
00001990|achalasia of esophagus|achalasia of esophagus|0|09.530000|2
00001991|esophagitis|esophagitis|0|09.530100|3
00001992|reflux esophagitis|reflux esophagitis|0|09.530110|3
00001993|erosive esophagitis|erosive esophagitis|0|09.530190|2
00001994|maintenance of healing erosive esophagitis|maintenance of healing erosive esophagitis|0|09.530191|2
00001995|esophageal ulcer|esophageal ulcer|0|09.530200|1
00001996|esophageal compression|esophageal compression|0|09.530300|2
00001997|esophageal obstruction|esophageal obstruction|0|09.530301|1
00001998|esophageal perforation|esophageal perforation|0|09.530400|1
00001999|gastroesophageal reflux disease|gastroesophageal reflux disease|0|09.530810|2
00002000|maintenance of healing gastroesophageal reflux|maintenance of healing gastroesophageal reflux|0|09.530811|3
00002001|tracheoesophageal fistula|tracheoesophageal fistula|0|09.530840|2
00002002|bronchoesophageal fistula|bronchoesophageal fistula|0|09.530890|2
00002003|esophageal pain|esophageal pain|0|09.530891|1
00002004|esophageal edema|esophageal edema|0|09.530892|1
00002005|acute gastric ulcer with hemorrhage|acute gastric ulcer with hemorrhage|0|09.531000|1
00002006|acute gastric ulcer with perforation|acute gastric ulcer with perforation|0|09.531100|1
00002007|acute gastric ulcer with hemorrhage and perforation|acute gastric ulcer with hemorrhage and perforation|0|09.531200|1
00002008|acute gastric ulcer|acute gastric ulcer|0|09.531300|1
00002009|chronic gastric ulcer with hemorrhage|chronic gastric ulcer with hemorrhage|0|09.531400|2
00002010|chronic gastric ulcer with perforation|chronic gastric ulcer with perforation|0|09.531500|2
00002011|chronic gastric ulcer with hemorrhage and perforation|chronic gastric ulcer with hemorrhage and perforation|0|09.531600|2
00002012|chronic gastric ulcer|chronic gastric ulcer|0|09.531700|2
00002013|gastric ulcer|gastric ulcer|0|09.531900|1
00002014|gastric ulcer due to H. pylori|gastric ulcer due to H. pylori|0|09.531901|1
00002015|maintenance of healing gastric ulcer|maintenance of healing gastric ulcer|0|09.531902|1
00002016|acute duodenal ulcer with hemorrhage|acute duodenal ulcer with hemorrhage|0|09.532000|1
00002017|acute duodenal ulcer with perforation|acute duodenal ulcer with perforation|0|09.532100|1
00002018|acute duodenal ulcer with hemorrhage and perforation|acute duodenal ulcer with hemorrhage and perforation|0|09.532200|1
00002019|acute duodenal ulcer|acute duodenal ulcer|0|09.532300|1
00002020|chronic duodenal ulcer with hemorrhage|chronic duodenal ulcer with hemorrhage|0|09.532400|2
00002021|chronic duodenal ulcer with perforation|chronic duodenal ulcer with perforation|0|09.532500|2
00002022|chronic duodenal ulcer with hemorrhage and perforation|chronic duodenal ulcer with hemorrhage and perforation|0|09.532600|2
00002023|chronic duodenal ulcer|chronic duodenal ulcer|0|09.532700|2
00002024|duodenal ulcer|duodenal ulcer|0|09.532900|1
00002025|duodenal ulcer due to H. pylori|duodenal ulcer due to H. pylori|0|09.532901|1
00002026|maintenance of healing duodenal ulcer|maintenance of healing duodenal ulcer|0|09.532902|1
00002027|acute peptic ulcer with hemorrhage|acute peptic ulcer with hemorrhage|0|09.533000|1
00002028|acute peptic ulcer with perforation|acute peptic ulcer with perforation|0|09.533100|1
00002029|acute peptic ulcer with hemorrhage and perforation|acute peptic ulcer with hemorrhage and perforation|0|09.533200|1
00002030|acute peptic ulcer|acute peptic ulcer|0|09.533300|1
00002031|chronic peptic ulcer with hemorrhage|chronic peptic ulcer with hemorrhage|0|09.533400|2
00002032|chronic peptic ulcer with perforation|chronic peptic ulcer with perforation|0|09.533500|2
00002033|chronic peptic ulcer with hemorrhage and perforation|chronic peptic ulcer with hemorrhage and perforation|0|09.533600|2
00002034|chronic peptic ulcer|chronic peptic ulcer|0|09.533700|2
00002035|peptic ulcer|peptic ulcer|0|09.533900|1
00002036|H. pylori gastrointestinal tract infection|H. pylori gastrointestinal tract infection|0|09.533901|1
00002037|stenosing peptic ulcer|stenosing peptic ulcer|0|09.533903|2
00002038|exacerbation of peptic ulcer|exacerbation of peptic ulcer|0|09.533904|1
00002039|maintenance of healing peptic ulcer|maintenance of healing peptic ulcer|0|09.533905|1
00002040|acute gastrointestinal ulcer with hemorrhage|acute gastrointestinal ulcer with hemorrhage|0|09.534000|1
00002041|acute gastrointestinal ulcer with perforation|acute gastrointestinal ulcer with perforation|0|09.534100|1
00002042|acute GI ulcer with hemorrhage and perforation|acute gastrointestinal ulcer with hemorrhage and perforation|0|09.534200|1
00002043|acute gastrointestinal ulcer|acute gastrointestinal ulcer|0|09.534300|1
00002044|chronic gastrointestinal ulcer with hemorrhage|chronic gastrointestinal ulcer with hemorrhage|0|09.534400|2
00002045|chronic gastrointestinal ulcer with perforation|chronic gastrointestinal ulcer with perforation|0|09.534500|2
00002046|chronic GI ulcer with hemorrhage and perforation|chronic gastrointestinal ulcer with hemorrhage and perforation|0|09.534600|2
00002047|chronic gastrointestinal ulcer|chronic gastrointestinal ulcer|0|09.534700|2
00002048|gastrointestinal ulcer|gastrointestinal ulcer|0|09.534900|1
00002049|gastrointestinal ulcer due to H. pylori|gastrointestinal ulcer due to H. pylori|0|09.534901|1
00002050|erosive gastritis|erosive gastritis|0|09.535400|3
00002051|gastritis|gastritis|0|09.535500|3
00002052|Helicobacter pylori gastritis|Helicobacter pylori gastritis|0|09.535501|2
00002053|achlorhydria|achlorhydria|0|09.536000|2
00002054|gastroparesis|gastroparesis|0|09.536300|2
00002055|gastric acid hypersecretory conditions|gastric acid hypersecretory conditions|0|09.536800|3
00002056|intestinal hypermotility|intestinal hypermotility|0|09.536802|3
00002057|pathological gastric acid hypersecretory condition|pathological gastric acid hypersecretory condition|0|09.536803|3
00002058|hypochlorhydria|hypochlorhydria|0|09.536805|2
00002059|dyspepsia|dyspepsia|0|09.536806|1
00002060|disorder of the digestive system|disorder of the digestive system|0|09.536900|3
00002061|acute severe gastrointestinal disorder|acute severe gastrointestinal disorder|0|09.536901|1
00002062|upper digestive tract disorder|upper digestive tract disorder|0|09.536906|3
00002063|gastrointestinal irritation|gastrointestinal irritation|0|09.536908|1
00002064|Gastric Outlet Obstruction|Gastric Outlet Obstruction|1|09.537000|3
00002066|duodenal obstruction|duodenal obstruction|0|09.537300|3
00002067|pyloroduodenal obstruction|pyloroduodenal obstruction|0|09.537800|3
00002068|E. coli appendicitis|E. coli appendicitis|0|09.540000|1
00002069|Bacteroides appendicitis|Bacteroides appendicitis|0|09.540001|1
00002070|complicated appendicitis|complicated appendicitis|0|09.540002|1
00002071|Streptococcus complicated appendicitis|Streptococcus complicated appendicitis|0|09.540003|1
00002072|E. coli complicated appendicitis|E. coli complicated appendicitis|0|09.540004|1
00002073|Klebsiella complicated appendicitis|Klebsiella complicated appendicitis|0|09.540005|1
00002074|Pseudomonas aeruginosa complicated appendicitis|Pseudomonas aeruginosa complicated appendicitis|0|09.540006|1
00002075|Bacteroides complicated appendicitis|Bacteroides complicated appendicitis|0|09.540007|1
00002076|Peptostreptococcus complicated appendicitis|Peptostreptococcus complicated appendicitis|0|09.540008|1
00002077|appendicitis|appendicitis|0|09.541000|1
00002078|Symptoms of Appendicitis|Symptoms of Appendicitis|2|09.541001|1
00002079|diarrhea secondary to inflammatory bowel disease|diarrhea secondary to inflammatory bowel disease|0|09.552903|3
00002080|hiatal hernia|hiatal hernia|0|09.553300|2
00002081|hiatal hernia with reflux esophagitis|hiatal hernia with reflux esophagitis|0|09.553301|3
00002082|abdominal herniation|abdominal herniation|0|09.553900|3
00002083|Crohn's ileitis|Crohn's ileitis|0|09.555000|2
00002084|Crohn's disease|Crohn's disease|0|09.555900|3
00002085|fistulizing Crohn's disease|fistulizing Crohn's disease|0|09.555901|3
00002086|severe Crohn's disease|severe Crohn's disease|0|09.555902|3
00002087|ulcerative enterocolitis|ulcerative enterocolitis|0|09.556000|3
00002088|ulcerative proctitis|ulcerative proctitis|0|09.556200|3
00002089|ulcerative colitis|ulcerative colitis|0|09.556900|2
00002090|severe ulcerative colitis|severe ulcerative colitis|0|09.556901|2
00002091|toxic megacolon|toxic megacolon|0|09.556902|1
00002092|ulcerative colitis remission|ulcerative colitis remission|0|09.556903|2
00002093|intestinal ischemic necrosis|intestinal ischemic necrosis|0|09.557000|1
00002094|necrotizing enterocolitis|necrotizing enterocolitis|0|09.557001|1
00002095|ischemic bowel disease|ischemic bowel disease|0|09.557100|2
00002096|ischemic colitis|ischemic colitis|0|09.557900|3
00002097|toxic colitis|toxic colitis|0|09.558200|1
00002098|inflammatory bowel disease|inflammatory bowel disease|0|09.558900|3
00002099|colitis|colitis|0|09.558901|3
00002100|gastroenteritis|gastroenteritis|0|09.558902|3
00002101|hemorrhagic colitis|hemorrhagic colitis|0|09.558903|3
00002102|enterocolitis|enterocolitis|0|09.558904|3
00002103|intussusception of intestine|intussusception of intestine|0|09.560000|3
00002104|paralytic ileus|paralytic ileus|0|09.560100|1
00002105|ileus|ileus|0|09.560101|1
00002106|paralytic ileus prevention|paralytic ileus prevention|0|09.560102|1
00002107|intestinal impaction|intestinal impaction|0|09.560300|3
00002108|fecal impaction|fecal impaction|0|09.560390|1
00002109|gastrointestinal obstruction|gastrointestinal obstruction|0|09.560900|1
00002110|mechanical intestinal obstruction|mechanical intestinal obstruction|0|09.560901|1
00002111|Intestinal Obstruction|Intestinal Obstruction|1|09.560902|1
00002112|intestinal stenosis|intestinal stenosis|0|09.560903|2
00002113|diverticulitis of gastrointestinal tract|diverticulitis of gastrointestinal tract|0|09.562110|3
00002114|constipation|constipation|0|09.564000|3
00002116|irritable bowel syndrome|irritable bowel syndrome|0|09.564100|3
00002117|diarrhea predominant irritable bowel syndrome|diarrhea predominant irritable bowel syndrome|0|09.564101|3
00002118|dumping syndrome|dumping syndrome|0|09.564200|3
00002119|atony of colon|atony of colon|0|09.564900|3
00002120|rectal fistula|rectal fistula|0|09.565100|2
00002122|E. coli peritonitis|E. coli peritonitis|0|09.567001|1
00002123|Klebsiella pneumoniae peritonitis|Klebsiella pneumoniae peritonitis|0|09.567002|1
00002124|Bacteroides peritonitis|Bacteroides peritonitis|0|09.567003|1
00002125|Clostridium peritonitis|Clostridium peritonitis|0|09.567004|1
00002126|Peptococcus peritonitis|Peptococcus peritonitis|0|09.567005|1
00002127|Peptostreptococcus peritonitis|Peptostreptococcus peritonitis|0|09.567006|1
00002128|Eubacterium peritonitis|Eubacterium peritonitis|0|09.567007|1
00002129|Enterobacter peritonitis|Enterobacter peritonitis|0|09.567008|1
00002130|streptococcal peritonitis|streptococcal peritonitis|0|09.567009|1
00002131|Proteus peritonitis|Proteus peritonitis|0|09.567010|1
00002132|Pseudomonas aeruginosa peritonitis|Pseudomonas aeruginosa peritonitis|0|09.567011|1
00002133|Staphylococcus peritonitis|Staphylococcus peritonitis|0|09.567012|1
00002134|Enterococcus peritonitis|Enterococcus peritonitis|0|09.567013|1
00002135|complicated E. coli peritonitis|complicated E. coli peritonitis|0|09.567014|1
00002136|complicated Pseudomonas aeruginosa peritonitis|complicated Pseudomonas aeruginosa peritonitis|0|09.567015|1
00002137|complicated Proteus peritonitis|complicated Proteus peritonitis|0|09.567016|1
00002138|complicated Klebsiella peritonitis|complicated Klebsiella peritonitis|0|09.567017|1
00002139|complicated Bacteroides peritonitis|complicated Bacteroides peritonitis|0|09.567018|1
00002140|complicated Streptococcus peritonitis|complicated Streptococcus peritonitis|0|09.567019|1
00002141|complicated Enterobacter peritonitis|complicated Enterobacter peritonitis|0|09.567020|1
00002142|complicated Peptostreptococcus peritonitis|complicated Peptostreptococcus peritonitis|0|09.567021|1
00002143|complicated Prevotella peritonitis|complicated Prevotella peritonitis|0|09.567022|1
00002144|anaerobic peritonitis|anaerobic peritonitis|0|09.567023|1
00002145|intra-abdominal abscess|intra-abdominal abscess|0|09.567200|1
00002146|intra-abdominal Bacteroides abscess|intra-abdominal Bacteroides abscess|0|09.567201|1
00002147|intra-abdominal Clostridium abscess|intra-abdominal Clostridium abscess|0|09.567202|1
00002148|intra-abdominal Eubacterium abscess|intra-abdominal Eubacterium abscess|0|09.567203|1
00002149|intra-abdominal Peptococcus abscess|intra-abdominal Peptococcus abscess|0|09.567204|1
00002150|intra-abdominal Peptostreptococcus abscess|intra-abdominal Peptostreptococcus abscess|0|09.567205|1
00002151|intra-abdominal E. coli abscess|intra-abdominal E. coli abscess|0|09.567206|1
00002152|intra-abdominal Klebsiella abscess|intra-abdominal Klebsiella abscess|0|09.567207|1
00002153|intra-abdominal anaerobic abscess|intra-abdominal anaerobic abscess|0|09.567208|1
00002154|peritonitis|peritonitis|0|09.567900|1
00002155|complicated bacterial peritonitis|complicated bacterial peritonitis|0|09.567901|1
00002156|adhesion of gastrointestinal tract|adhesion of gastrointestinal tract|0|09.568000|1
00002157|peritoneal effusion|peritoneal effusion|1|09.568820|1
00002158|malignant ascites|malignant ascites|0|09.568821|1
00002159|infectious disease of abdomen|infectious disease of abdomen|0|09.568900|1
00002160|intra-abdominal infection adjunct treatment|intra-abdominal infection adjunct treatment|0|09.568901|1
00002161|rectal bleeding|rectal bleeding|0|09.569300|1
00002162|Undiagnosed Rectal Bleeding|Undiagnosed Rectal Bleeding|1|09.569301|1
00002163|rectal disorder|rectal disorder|0|09.569400|3
00002164|anorectal disorders|anorectal disorders|0|09.569401|3
00002165|rectal pain|rectal pain|0|09.569420|1
00002166|proctitis|proctitis|0|09.569490|3
00002167|rectal irritation|rectal irritation|0|09.569491|1
00002168|perianal irritation|perianal irritation|0|09.569492|1
00002169|gastrointestinal fistula|gastrointestinal fistula|0|09.569810|3
00002170|ulceration of intestine|ulceration of intestine|0|09.569820|1
00002171|intestinal perforation|intestinal perforation|0|09.569830|1
00002172|intestinal anastomosis|intestinal anastomosis|0|09.569890|2
00002173|melanosis of colon|melanosis of colon|0|09.569892|2
00002174|hepatic necrosis|hepatic necrosis|0|09.570000|1
00002175|acute hepatic failure|acute hepatic failure|0|09.570001|1
00002176|alcoholic fatty liver|alcoholic fatty liver|0|09.571000|2
00002177|alcoholic liver damage|alcoholic liver damage|0|09.571200|2
00002178|chronic hepatitis|chronic hepatitis|0|09.571400|2
00002179|autoimmune hepatitis|autoimmune hepatitis|0|09.571490|2
00002180|hepatic cirrhosis|hepatic cirrhosis|0|09.571500|2
00002181|periportal fibrosis|periportal fibrosis|0|09.571501|2
00002182|edema due to hepatic cirrhosis|edema due to hepatic cirrhosis|0|09.571502|2
00002183|hepatic fibrosis|hepatic fibrosis|0|09.571503|2
00002184|biliary cirrhosis|biliary cirrhosis|0|09.571600|2
00002185|biliary sclerosis|biliary sclerosis|0|09.571601|1
00002186|steatosis of liver|steatosis of liver|0|09.571800|3
00002187|chronic hepatic disease|chronic hepatic disease|0|09.571900|2
00002188|hepatocellular damage|hepatocellular damage|0|09.571901|3
00002189|liver abscess|liver abscess|0|09.572000|1
00002190|Bacteroides liver abscess|Bacteroides liver abscess|0|09.572001|1
00002191|Clostridium liver abscess|Clostridium liver abscess|0|09.572002|1
00002192|Eubacterium liver abscess|Eubacterium liver abscess|0|09.572003|1
00002193|Peptococcus liver abscess|Peptococcus liver abscess|0|09.572004|1
00002194|Peptostreptococcus liver abscess|Peptostreptococcus liver abscess|0|09.572005|1
00002195|hepatic coma|hepatic coma|0|09.572200|1
00002196|hepatic failure|hepatic failure|0|09.572800|1
00002197|hepatitis|hepatitis|0|09.573300|3
00002198|acute hepatitis|acute hepatitis|0|09.573301|1
00002199|drug-induced hepatitis|drug-induced hepatitis|0|09.573304|3
00002200|hepatic hepatoptosis|hepatic hepatoptosis|0|09.573800|2
00002201|peliosis hepatis|peliosis hepatis|0|09.573801|1
00002202|disease of liver|disease of liver|0|09.573900|2
00002203|severe hepatic disease|severe hepatic disease|0|09.573903|2
00002204|hepatorenal syndrome|hepatorenal syndrome|0|09.573904|2
00002205|reduced hepatic blood flow|reduced hepatic blood flow|0|09.573906|2
00002207|cholelithiasis prevention|cholelithiasis prevention|0|09.574101|3
00002208|biliary calculus|biliary calculus|0|09.574200|1
00002209|gallstone complications|gallstone complications|0|09.574201|3
00002210|choledocholithiasis|choledocholithiasis|0|09.574500|1
00002211|cholecystitis|cholecystitis|0|09.575000|1
00002212|gallbladder obstruction|gallbladder obstruction|0|09.575200|1
00002213|gallbladder disease|gallbladder disease|0|09.575900|3
00002214|sclerosing cholangitis|sclerosing cholangitis|0|09.576100|1
00002215|cholangitis|cholangitis|0|09.576101|1
00002216|biliary obstruction|biliary obstruction|0|09.576200|3
00002217|complete biliary obstruction|complete biliary obstruction|0|09.576201|1
00002218|biliary obstruction with pruritus|biliary obstruction with pruritus|0|09.576202|1
00002219|obstructive hyperbilirubinemia|obstructive hyperbilirubinemia|0|09.576800|1
00002220|cholestasis|cholestasis|0|09.576801|1
00002221|biliary spasm|biliary spasm|0|09.576802|1
00002222|biliary tract infection|biliary tract infection|0|09.576900|1
00002223|biliary tract disorder|biliary tract disorder|0|09.576901|2
00002224|severe biliary tract infections|severe biliary tract infections|0|09.576902|1
00002225|acute pancreatitis|acute pancreatitis|0|09.577000|1
00002226|chronic pancreatitis|chronic pancreatitis|0|09.577100|2
00002227|exocrine pancreatic insufficiency|exocrine pancreatic insufficiency|0|09.577800|3
00002228|pancreatic fistula|pancreatic fistula|0|09.577801|3
00002229|bloody stools|bloody stools|0|09.578100|1
00002230|black tarry stools|black tarry stools|0|09.578101|1
00002231|gastrointestinal hemorrhage|gastrointestinal hemorrhage|0|09.578900|1
00002232|upper GI bleed|upper GI bleed|0|09.578901|1
00002233|predisposition to GI hemorrhage|predisposition to GI hemorrhage|0|09.578902|2
00002234|Undiagnosed GI Bleeding|Undiagnosed GI Bleeding|1|09.578903|1
00002235|severe GI bleeding within last 10 days|severe GI bleeding within last 10 days|0|09.578904|1
00002236|Prevent Stress-Related GI Mucosal Bleeding|Stress-Related GI Mucosal Bleeding Prevention|2|09.578905|3
00002237|upper GI bleed prevention|upper GI bleed prevention|0|09.578906|3
00002238|celiac disease|celiac disease|0|09.579000|1
00002239|short bowel syndrome|short bowel syndrome|0|09.579300|2
00002240|steatorrhea|steatorrhea|0|09.579800|1
00002241|malabsorption states|malabsorption states|0|09.579900|3
00002242|calcium intestinal malabsorption|calcium intestinal malabsorption|0|09.579901|2
00002243|Malabsorption Syndrome|Malabsorption Syndrome|1|09.579902|2
00002244|renal transplant|renal transplant|0|10. 55690|2
00002245|bladder surgery|bladder surgery|0|10. 57000|1
00002246|procedure on urinary system|procedure on urinary system|0|10. 59990|1
00002247|nephrotic syndrome|nephrotic syndrome|0|10.581900|2
00002248|renal disease with edema|renal disease with edema|0|10.581901|3
00002249|edema due to nephrotic syndrome|edema due to nephrotic syndrome|0|10.581902|1
00002250|chronic nephritis|chronic nephritis|0|10.582900|2
00002251|end-stage renal disease|end-stage renal disease|0|10.582901|2
00002252|interstitial nephritis|interstitial nephritis|0|10.583890|1
00002253|glomerulonephritis|glomerulonephritis|0|10.583900|1
00002254|nephritis|nephritis|0|10.583901|1
00002255|nephrotoxicity|nephrotoxicity|0|10.583902|3
00002256|acute renal failure|acute renal failure|0|10.584001|1
00002257|renal tubular necrosis|renal tubular necrosis|0|10.584500|1
00002259|chronic kidney disease|chronic kidney disease|0|10.585000|2
00002260|Chronic Renal Failure and Nitrogen Retention|Chronic Renal Failure with Nitrogen Retention|1|10.585001|2
00002261|renal failure|renal failure|0|10.586000|3
00002262|uremia|uremia|0|10.586001|3
00002263|renal osteodystrophy|renal osteodystrophy|0|10.588000|2
00002264|renal osteodystrophy with hyperphosphatemia|renal osteodystrophy with hyperphosphatemia|0|10.588001|1
00002267|renal tubular acidosis|renal tubular acidosis|0|10.588802|1
00002268|growth failure secondary to chronic renal failure|growth failure secondary to chronic renal failure|0|10.588803|2
00002269|hyperparathyroidism secondary to chronic renal failure|hyperparathyroidism secondary to chronic renal failure|0|10.588804|2
00002271|chronic pyelonephritis|chronic pyelonephritis|0|10.590000|2
00002272|pyelonephritis|pyelonephritis|0|10.590800|1
00002273|renal papillary necrosis|renal papillary necrosis|0|10.590801|1
00002274|E. coli pyelonephritis|E. coli pyelonephritis|0|10.590802|1
00002275|Klebsiella pyelonephritis|Klebsiella pyelonephritis|0|10.590803|1
00002276|Proteus pyelonephritis|Proteus pyelonephritis|0|10.590804|1
00002278|urate renal calculi|urate renal calculi|0|10.592001|1
00002279|kidney stone|kidney stone|0|10.592900|3
00002280|cystine renal calculi|cystine renal calculi|0|10.592902|3
00002281|calcium renal calculi prevention|calcium renal calculi prevention|0|10.592903|3
00002282|recurrent calcium renal calculi|recurrent calcium renal calculi|0|10.592904|3
00002283|struvite renal calculi|struvite renal calculi|0|10.592905|3
00002284|calcium oxalate renal calculi|calcium oxalate renal calculi|0|10.592907|3
00002285|calcium phosphate renal calculi|calcium phosphate renal calculi|0|10.592908|3
00002286|infected urolithiasis|infected urolithiasis|0|10.592909|1
00002287|retroperitoneal fibrosis|retroperitoneal fibrosis|0|10.593400|2
00002288|renal artery thrombosis|renal artery thrombosis|0|10.593810|1
00002289|renal infarction|renal infarction|0|10.593811|3
00002291|ureteral spasm with pain|ureteral spasm with pain|0|10.593891|1
00002292|kidney disease with reduction in GFR|kidney disease with reduction in glomerular filtration rate (GFR)|0|10.593900|3
00002293|severe renal impairment|severe renal impairment|0|10.593901|3
00002295|hypercalcemia associated with renal insufficiency|hypercalcemia associated with renal insufficiency|0|10.593904|3
00002296|renal disease with mild to moderate impairment|renal disease with mild to moderate renal function impairment|0|10.593905|3
00002297|prevention of chemotherapy-induced renal impairment|prevention of cancer chemotherapy-induced renal impairment|0|10.593906|1
00002298|Citrobacter cystitis|Citrobacter cystitis|0|10.595000|1
00002299|Enterobacter cystitis|Enterobacter cystitis|0|10.595001|1
00002300|E. coli cystitis|E. coli cystitis|0|10.595002|1
00002301|Klebsiella cystitis|Klebsiella cystitis|0|10.595003|1
00002302|Proteus cystitis|Proteus cystitis|0|10.595004|1
00002303|Pseudomonas aeruginosa cystitis|Pseudomonas aeruginosa cystitis|0|10.595005|1
00002304|Staphylococcus cystitis|Staphylococcus cystitis|0|10.595006|1
00002305|interstitial cystitis|interstitial cystitis|0|10.595100|1
00002306|cystitis|cystitis|0|10.595900|1
00002307|hemorrhagic cystitis|hemorrhagic cystitis|0|10.595901|1
00002308|bladder infection|bladder infection|0|10.595902|1
00002309|chemotherapy-induced hemorrhagic cystitis|chemotherapy-induced hemorrhagic cystitis|0|10.595903|1
00002310|bladder outflow obstruction|bladder outflow obstruction|0|10.596000|3
00002311|bladder hyperactivity|bladder hyperactivity|0|10.596510|1
00002312|paralytic bladder|paralytic bladder|0|10.596530|3
00002313|rupture of bladder|rupture of bladder|0|10.596600|1
00002314|fungal bladder infections|fungal bladder infections|0|10.596800|1
00002315|bladder irritability|bladder irritability|0|10.596801|1
00002316|small capacity bladder|small capacity bladder|0|10.596900|2
00002317|urethritis|urethritis|0|10.597800|1
00002318|female urethral syndrome|female urethral syndrome|0|10.597810|1
00002319|urethral stricture|urethral stricture|0|10.598900|1
00002320|urinary tract infection|urinary tract infection|0|10.599000|3
00002321|genitourinary tract infections|genitourinary tract infections|0|10.599001|1
00002322|complicated bacterial infection of urinary tract|complicated bacterial infection of urinary tract|0|10.599002|1
00002323|fungal urinary tract infection|fungal urinary tract infection|0|10.599003|1
00002324|male genital tract infection|male genital tract infection|0|10.599005|1
00002325|Enterococcus urinary tract infection|Enterococcus urinary tract infection|0|10.599006|1
00002326|Enterobacter cloacae urinary tract infection|Enterobacter cloacae urinary tract infection|0|10.599007|1
00002327|E. coli urinary tract infection|E. coli urinary tract infection|0|10.599008|1
00002328|Klebsiella urinary tract infection|Klebsiella urinary tract infection|0|10.599009|1
00002329|Proteus urinary tract infection|Proteus urinary tract infection|0|10.599010|1
00002330|Pseudomonas aeruginosa urinary tract infection|Pseudomonas aeruginosa urinary tract infection|0|10.599011|1
00002331|Providencia urinary tract infection|Providencia urinary tract infection|0|10.599012|1
00002332|Staphylococcus aureus urinary tract infection|Staphylococcus aureus urinary tract infection|0|10.599014|1
00002333|E. coli genitourinary tract infection|E. coli genitourinary tract infection|0|10.599015|1
00002335|complicated UTI with Pseudomonas aeruginosa|complicated UTI with Pseudomonas aeruginosa|0|10.599017|1
00002336|complicated Proteus UTI|complicated Proteus UTI|0|10.599018|1
00002337|complicated E. coli UTI|complicated E. coli UTI|0|10.599019|1
00002338|Klebsiella complicated UTI|Klebsiella complicated UTI|0|10.599020|1
00002339|Enterobacter complicated UTI|Enterobacter complicated UTI|0|10.599021|1
00002340|Serratia complicated UTI|Serratia complicated UTI|0|10.599022|1
00002341|Staphylococcus aureus complicated UTI|Staphylococcus aureus complicated UTI|0|10.599023|1
00002342|Providencia complicated UTI|Providencia complicated UTI|0|10.599024|1
00002343|Citrobacter complicated UTI|Citrobacter complicated UTI|0|10.599025|1
00002344|Citrobacter urinary tract infection|Citrobacter urinary tract infection|0|10.599026|1
00002345|Morganella morganii urinary tract infection|Morganella morganii urinary tract infection|0|10.599027|1
00002346|Serratia urinary tract infection|Serratia urinary tract infection|0|10.599028|1
00002347|Enterococcus complicated UTI|Enterococcus complicated UTI|0|10.599029|1
00002348|Staphylococcus epidermidis urinary tract infection|Staphylococcus epidermidis urinary tract infection|0|10.599030|1
00002349|Staphylococcus saprophyticus urinary tract infection|Staphylococcus saprophyticus urinary tract infection|0|10.599031|1
00002350|prevention of bacterial urinary tract infection|prevention of bacterial urinary tract infection|0|10.599032|3
00002351|complicated genitourinary tract infection|complicated genitourinary tract infection|0|10.599033|1
00002352|urinary tract obstructive uropathy|urinary tract obstructive uropathy|0|10.599600|3
00002353|hematuria|hematuria|0|10.599700|1
00002354|hematuria of upper urinary tract origin|hematuria of upper urinary tract origin|0|10.599701|1
00002355|ureteral spasm|ureteral spasm|0|10.599840|1
00002356|genitourinary tract hemorrhage|genitourinary tract hemorrhage|0|10.599890|1
00002357|disorder of the urinary system|disorder of the urinary system|0|10.599900|3
00002359|sterile pyuria|sterile pyuria|0|10.599902|1
00002361|benign prostatic hyperplasia|benign prostatic hyperplasia|0|10.600000|2
00002362|benign prostatic hyperplasia with lower urinary tract sx|benign prostatic hyperplasia with lower urinary tract symptom|0|10.600001|2
00002363|nonobstructive prostatic hypertrophy|nonobstructive prostatic hypertrophy|0|10.600002|3
00002364|E. coli prostatitis|E. coli prostatitis|0|10.601000|1
00002365|Proteus prostatitis|Proteus prostatitis|0|10.601001|1
00002366|Klebsiella prostatitis|Klebsiella prostatitis|0|10.601002|1
00002367|Enterococcus prostatitis|Enterococcus prostatitis|0|10.601003|1
00002368|Enterobacter prostatitis|Enterobacter prostatitis|0|10.601004|1
00002369|chronic bacterial prostatitis|chronic bacterial prostatitis|0|10.601100|2
00002370|granulomatous prostatitis|granulomatous prostatitis|0|10.601800|1
00002372|epididymitis|epididymitis|0|10.604900|1
00002373|orchitis|orchitis|0|10.604901|1
00002374|Chlamydial epididymitis|Chlamydial epididymitis|0|10.604902|1
00002375|orchitis with bilateral torsion|orchitis with bilateral torsion|0|10.604990|1
00002376|sexually transmitted epididymo-orchitis|sexually transmitted epididymo-orchitis|0|10.604991|1
00002377|oligospermia|oligospermia|0|10.606100|3
00002378|male infertility|male infertility|0|10.606900|2
00002379|balanitis|balanitis|0|10.607100|1
00002380|priapism|priapism|0|10.607300|1
00002381|painful erection|painful erection|0|10.607303|1
00002382|recurrent priapism|recurrent priapism|0|10.607304|3
00002383|erectile dysfunction|erectile dysfunction|0|10.607840|3
00002384|Peyronie's disease|Peyronie's disease|0|10.607890|3
00002386|penile ulcerations|penile ulcerations|0|10.607892|1
00002387|frequent erections|frequent erections|0|10.607893|2
00002388|penile angulation|penile angulation|0|10.607894|2
00002389|fibrosis of corpus cavernosum|fibrosis of corpus cavernosum|0|10.607895|2
00002390|testicular atrophy|testicular atrophy|0|10.608300|3
00002391|testicular swelling|testicular swelling|0|10.608860|1
00002392|fibrocystic breast disease|fibrocystic breast disease|0|10.610100|3
00002393|breast fibroadenosis|breast fibroadenosis|0|10.610200|2
00002394|gynecomastia|gynecomastia|0|10.611100|3
00002395|breast size decreased|breast size decreased|0|10.611400|1
00002396|galactorrhea not associated with childbirth|galactorrhea not associated with childbirth|0|10.611600|3
00002397|mastalgia|mastalgia|0|10.611710|3
00002398|unspecified lump in breast|unspecified lump in breast|0|10.611720|2
00002399|breast engorgement|breast engorgement|0|10.611790|1
00002400|nipple discharge|nipple discharge|0|10.611791|1
00002401|tubo-ovarian abscess|tubo-ovarian abscess|0|10.614200|1
00002402|Bacteroides tubo-ovarian abscess|Bacteroides tubo-ovarian abscess|0|10.614201|1
00002403|Clostridium tubo-ovarian abscess|Clostridium tubo-ovarian abscess|0|10.614202|1
00002404|Peptococcus tubo-ovarian abscess|Peptococcus tubo-ovarian abscess|0|10.614203|1
00002405|Peptostreptococcus tubo-ovarian abscess|Peptostreptococcus tubo-ovarian abscess|0|10.614204|1
00002406|anaerobic tubo-ovarian abscess|anaerobic tubo-ovarian abscess|0|10.614205|1
00002407|salpingitis|salpingitis|0|10.614206|1
00002408|pelvic cellulitis|pelvic cellulitis|0|10.614300|1
00002409|E. coli pelvic cellulitis|E. coli pelvic cellulitis|0|10.614301|1
00002410|Bacteroides pelvic cellulitis|Bacteroides pelvic cellulitis|0|10.614302|1
00002411|Enterococcus pelvic cellulitis|Enterococcus pelvic cellulitis|0|10.614303|1
00002412|Neisseria gonorrhea pelvic cellulitis|Neisseria gonorrhea pelvic cellulitis|0|10.614304|1
00002413|Clostridium pelvic cellulitis|Clostridium pelvic cellulitis|0|10.614305|1
00002414|Peptococcus pelvic cellulitis|Peptococcus pelvic cellulitis|0|10.614306|1
00002415|Peptostreptococcus pelvic cellulitis|Peptostreptococcus pelvic cellulitis|0|10.614307|1
00002416|streptococcal pelvic cellulitis|streptococcal pelvic cellulitis|0|10.614308|1
00002417|Prevotella pelvic cellulitis|Prevotella pelvic cellulitis|0|10.614309|1
00002418|Gardnerella pelvic cellulitis|Gardnerella pelvic cellulitis|0|10.614310|1
00002419|anaerobic pelvic cellulitis|anaerobic pelvic cellulitis|0|10.614311|1
00002420|pelvic abscess|pelvic abscess|0|10.614312|1
00002421|E. coli pelvic inflammatory disease|E. coli pelvic inflammatory disease|0|10.614800|1
00002422|Bacteroides pelvic inflammatory disease|Bacteroides pelvic inflammatory disease|0|10.614801|1
00002423|Clostridium pelvic inflammatory disease|Clostridium pelvic inflammatory disease|0|10.614802|1
00002424|Peptococcus pelvic inflammatory disease|Peptococcus pelvic inflammatory disease|0|10.614803|1
00002425|Peptostreptococcus pelvic inflammatory disease|Peptostreptococcus pelvic inflammatory disease|0|10.614804|1
00002426|group B Streptococcus pelvic inflammatory disease|group B Streptococcus pelvic inflammatory disease|0|10.614805|1
00002427|Staphylococcus pelvic inflammatory disease|Staphylococcus pelvic inflammatory disease|0|10.614806|1
00002428|streptococcal pelvic inflammatory disease|streptococcal pelvic inflammatory disease|0|10.614807|1
00002429|Enterobacter pelvic inflammatory disease|Enterobacter pelvic inflammatory disease|0|10.614808|1
00002430|Klebsiella pelvic inflammatory disease|Klebsiella pelvic inflammatory disease|0|10.614809|1
00002431|Proteus pelvic inflammatory disease|Proteus pelvic inflammatory disease|0|10.614810|1
00002432|Fusobacterium pelvic inflammatory disease|Fusobacterium pelvic inflammatory disease|0|10.614811|1
00002433|Enterococcus pelvic inflammatory disease|Enterococcus pelvic inflammatory disease|0|10.614812|1
00002434|inflammatory disease of female pelvic organs|inflammatory disease of female pelvic organs|0|10.614900|1
00002435|pelvic inflammatory disease prevention|pelvic inflammatory disease prevention|0|10.614901|3
00002436|female genital tract infection|female genital tract infection|0|10.614902|1
00002437|Chlamydia trachomatis pelvic inflammatory disease|Chlamydia trachomatis pelvic inflammatory disease|0|10.614903|1
00002438|pelvic inflammatory disease with Neisseria gonorrhea|pelvic inflammatory disease with Neisseria gonorrhea|0|10.614904|1
00002439|Mycoplasma hominis pelvic inflammatory disease|Mycoplasma hominis pelvic inflammatory disease|0|10.614905|1
00002440|endometritis|endometritis|0|10.615900|1
00002441|Clostridium endometritis|Clostridium endometritis|0|10.615902|1
00002442|Peptococcus endometritis|Peptococcus endometritis|0|10.615903|1
00002443|Peptostreptococcus endometritis|Peptostreptococcus endometritis|0|10.615904|1
00002444|endomyometritis|endomyometritis|0|10.615905|1
00002445|Bacteroides endometritis|Bacteroides endometritis|0|10.615906|1
00002446|Bacteroides endomyometritis|Bacteroides endomyometritis|0|10.615907|1
00002447|Clostridium endomyometritis|Clostridium endomyometritis|0|10.615908|1
00002448|Peptococcus endomyometritis|Peptococcus endomyometritis|0|10.615909|1
00002449|Peptostreptococcus endomyometritis|Peptostreptococcus endomyometritis|0|10.615910|1
00002450|Staphylococcus endometritis|Staphylococcus endometritis|0|10.615911|1
00002451|streptococcal endometritis|streptococcal endometritis|0|10.615912|1
00002452|Enterococcus endometritis|Enterococcus endometritis|0|10.615913|1
00002453|Enterobacter endometritis|Enterobacter endometritis|0|10.615914|1
00002454|Klebsiella endometritis|Klebsiella endometritis|0|10.615915|1
00002455|E. coli endometritis|E. coli endometritis|0|10.615916|1
00002456|Proteus endometritis|Proteus endometritis|0|10.615917|1
00002457|Fusobacterium endometritis|Fusobacterium endometritis|0|10.615918|1
00002458|streptococcal endomyometritis|streptococcal endomyometritis|0|10.615919|1
00002459|Enterococcus endomyometritis|Enterococcus endomyometritis|0|10.615920|1
00002460|Prevotella endomyometritis|Prevotella endomyometritis|0|10.615921|1
00002461|Gardnerella endomyometritis|Gardnerella endomyometritis|0|10.615922|1
00002462|E. coli endomyometritis|E. coli endomyometritis|0|10.615923|1
00002463|anaerobic endometritis|anaerobic endometritis|0|10.615924|1
00002464|cervicitis|cervicitis|0|10.616000|1
00002465|endocervical lesions|endocervical lesions|0|10.616001|1
00002466|Staphylococcus cervicitis|Staphylococcus cervicitis|0|10.616002|1
00002467|Streptococcus cervicitis|Streptococcus cervicitis|0|10.616003|1
00002468|Clostridium cervicitis|Clostridium cervicitis|0|10.616004|1
00002469|Bacteroides cervicitis|Bacteroides cervicitis|0|10.616005|1
00002470|E. coli cervicitis|E. coli cervicitis|0|10.616006|1
00002471|vaginitis|vaginitis|0|10.616100|1
00002472|ulceration of vulva|ulceration of vulva|0|10.616800|1
00002473|bacterial vaginosis|bacterial vaginosis|0|10.616900|1
00002474|Gardnerella vaginalis bacterial vaginosis|Gardnerella vaginalis bacterial vaginosis|0|10.616901|1
00002475|endometriosis|endometriosis|0|10.617900|2
00002476|ovarian cyst|ovarian cyst|0|10.620200|3
00002477|ovarian hyperstimulation syndrome|ovarian hyperstimulation syndrome|0|10.620800|3
00002478|ovarian enlargement|ovarian enlargement|0|10.620801|1
00002479|endometrial polyps|endometrial polyps|0|10.621000|3
00002480|endometrial hyperplasia|endometrial hyperplasia|0|10.621300|2
00002481|endometrial hyperplasia prevention|endometrial hyperplasia prevention|0|10.621301|2
00002482|uterine contractions|uterine contractions|0|10.621800|1
00002483|stenosis of cervix|stenosis of cervix|0|10.622400|3
00002484|vaginal discharge|vaginal discharge|0|10.623500|1
00002485|vaginal irritation|vaginal irritation|0|10.623900|1
00002486|vaginal dryness|vaginal dryness|0|10.623901|1
00002487|atrophy of vulva|atrophy of vulva|0|10.624100|2
00002488|clitoral hypertrophy|clitoral hypertrophy|0|10.624200|2
00002489|vulvar squamous hyperplasia|vulvar squamous hyperplasia|0|10.624300|2
00002490|vulvar edema|vulvar edema|0|10.624800|1
00002491|dysmenorrhea|dysmenorrhea|0|10.625300|3
00002492|premenstrual syndrome|premenstrual syndrome|0|10.625400|3
00002493|premenstrual dysphoric disorder|premenstrual dysphoric disorder|0|10.625401|3
00002495|uterine cramps|uterine cramps|0|10.625800|3
00002496|undiagnosed mass of uterine adnexa|undiagnosed mass of uterine adnexa|0|10.625801|3
00002497|vaginal burning|vaginal burning|0|10.625900|1
00002498|vulvodynia|vulvodynia|0|10.625901|3
00002499|amenorrhea|amenorrhea|0|10.626000|3
00002501|secondary amenorrhea|secondary amenorrhea|0|10.626002|2
00002502|menorrhagia|menorrhagia|0|10.626200|1
00002503|irregular menstrual periods|irregular menstrual periods|0|10.626400|2
00002504|abnormal vaginal bleeding|abnormal vaginal bleeding|0|10.626600|1
00002505|abnormal uterine bleeding due to hormonal imbalance|abnormal uterine bleeding due to hormonal imbalance|0|10.626800|1
00002506|abnormal uterine bleeding|abnormal uterine bleeding|0|10.626801|1
00002507|menstrual disorder|menstrual disorder|0|10.626900|1
00002508|vasomotor symptoms associated with menopause|vasomotor symptoms associated with menopause|0|10.627200|1
00002509|anxiety associated with menopause|anxiety associated with menopause|0|10.627201|2
00002510|atrophic vaginitis associated with menopause|atrophic vaginitis associated with menopause|0|10.627300|3
00002511|post-menopausal symptoms|post-menopausal symptoms|0|10.627800|2
00002512|infertility associated with anovulation|infertility associated with anovulation|0|10.628000|2
00002513|female infertility|female infertility|0|10.628900|2
00002514|ovarian function studies|ovarian function studies|0|10.628901|1
00002516|prevention of infection in transrectal prostate biopsy|prevention of infection in transrectal prostate biopsy|0|11. 60111|1
00002518|transurethral prostatectomy infection prevention|transurethral prostatectomy infection prevention|0|11. 60201|1
00002519|prevention of infection from transurethral surgery|prevention of infection from transurethral surgery|0|11. 60990|1
00002520|bilateral orchiectomy|bilateral orchiectomy|0|11. 62410|1
00002521|penile prosthesis|penile prosthesis|0|11. 64970|2
00002522|benign hydatidiform mole|benign hydatidiform mole|0|11.630000|2
00002524|ectopic pregnancy|ectopic pregnancy|0|11.633900|1
00002525|abortion with sepsis|abortion with sepsis|0|11.637020|1
00002526|E. coli septic abortion|E. coli septic abortion|0|11.637021|1
00002527|Bacteroides septic abortion|Bacteroides septic abortion|0|11.637022|1
00002528|Enterococcus septic abortion|Enterococcus septic abortion|0|11.637023|1
00002529|streptococcal septic abortion|streptococcal septic abortion|0|11.637024|1
00002530|Peptostreptococcus septic abortion|Peptostreptococcus septic abortion|0|11.637025|1
00002531|Prevotella septic abortion|Prevotella septic abortion|0|11.637026|1
00002532|Gardnerella septic abortion|Gardnerella septic abortion|0|11.637027|1
00002533|postabortal hemorrhage|postabortal hemorrhage|0|11.637100|1
00002534|incomplete abortion|incomplete abortion|0|11.637700|1
00002535|abortion|abortion|0|11.637900|1
00002536|threatened abortion|threatened abortion|0|11.637901|1
00002538|amniotic membrane rupture|amniotic membrane rupture|0|11.641200|1
00002539|antepartum hemorrhage|antepartum hemorrhage|0|11.641800|1
00002540|pregnancy-induced hypertension|pregnancy-induced hypertension|0|11.642400|1
00002541|mild pre-eclampsia|mild pre-eclampsia|0|11.642401|1
00002542|severe pre-eclampsia|severe pre-eclampsia|0|11.642500|1
00002543|eclampsia of pregnancy|eclampsia of pregnancy|0|11.642600|1
00002544|premature labor|premature labor|0|11.644200|1
00002545|postpartum infection|postpartum infection|0|11.646640|1
00002546|E. coli postpartum infection|E. coli postpartum infection|0|11.646641|1
00002547|Bacteroides postpartum infection|Bacteroides postpartum infection|0|11.646642|1
00002548|Enterococcus postpartum infection|Enterococcus postpartum infection|0|11.646643|1
00002549|streptococcal postpartum infection|streptococcal postpartum infection|0|11.646644|1
00002550|Peptostreptococcus postpartum infection|Peptostreptococcus postpartum infection|0|11.646645|1
00002551|Prevotella postpartum infection|Prevotella postpartum infection|0|11.646646|1
00002552|Gardnerella postpartum infection|Gardnerella postpartum infection|0|11.646647|1
00002553|gestational diabetes mellitus|gestational diabetes mellitus|0|11.648000|1
00002554|prevention of Rh incompatibility reaction|prevention of Rh incompatibility reaction|0|11.656100|2
00002556|contraction stress test|contraction stress test|0|11.656901|1
00002557|chorioamnionitis|chorioamnionitis|0|11.658400|1
00002560|uterine hypertonic patterns|uterine hypertonic patterns|0|11.661400|2
00002562|uterine rupture in pregnancy|uterine rupture in pregnancy|0|11.665100|1
00002563|postpartum hemorrhage|postpartum hemorrhage|0|11.666100|1
00002565|lactation deficiency|lactation deficiency|0|11.676400|1
00002566|breast milk flow decreased|breast milk flow decreased|0|11.676500|1
00002567|galactorrhea associated with childbirth|galactorrhea associated with childbirth|0|11.676600|1
00002568|treatment for suppression of lactation|treatment for suppression of lactation|0|11.676900|3
00002570|endometrial ablation adjunct|endometrial ablation adjunct|0|12. 68231|1
00002572|abdominal hysterectomy infection prevention|abdominal hysterectomy infection prevention|0|12. 68401|1
00002574|vaginal hysterectomy infection prevention|vaginal hysterectomy infection prevention|0|12. 68501|1
00002575|in vitro fertilization|in vitro fertilization|0|12. 69920|1
00002576|gynecological surgery|gynecological surgery|0|12. 69990|1
00002579|vaginal cuff surgery post-op infection|vaginal cuff surgery post-op infection|0|12. 70142|1
00002580|vaginal cuff surgery post-op Bacteroides infection|vaginal cuff surgery post-op Bacteroides infection|0|12. 70143|1
00002581|vaginal cuff surgery post-op Clostridium infection|vaginal cuff surgery post-op Clostridium infection|0|12. 70144|1
00002582|vaginal cuff surgery post-op Peptococcus infection|vaginal cuff surgery post-op Peptococcus infection|0|12. 70145|1
00002583|post-operative vaginal cuff Peptostreptococcus infection|post-operative vaginal cuff Peptostreptococcus infection|0|12. 70146|1
00002584|postsurgical vaginal cuff anaerobic infections|postsurgical vaginal cuff anaerobic infections|0|12. 70147|1
00002585|furunculosis|furunculosis|0|12.680900|1
00002586|paronychia|paronychia|0|12.681900|3
00002587|impetigo|impetigo|0|12.684000|1
00002588|pyoderma gangrenosum|pyoderma gangrenosum|0|12.686010|1
00002589|pyogenic granuloma|pyogenic granuloma|0|12.686100|1
00002590|ecthyma|ecthyma|0|12.686800|3
00002591|skin and skin structure infection|skin and skin structure infection|0|12.686900|3
00002592|skin inflammation|skin inflammation|0|12.686901|1
00002593|bacterial skin and skin structure infection|bacterial skin and skin structure infection|0|12.686902|1
00002594|minor bacterial skin infections|minor bacterial skin infections|0|12.686903|1
00002595|pustular skin infection|pustular skin infection|0|12.686904|1
00002596|acute eruptions of skin|acute eruptions of skin|0|12.686905|1
00002597|Staphylococcus aureus skin and skin structure infection|Staphylococcus aureus skin and skin structure infection|0|12.686906|1
00002598|skin and skin structure Strep. pyogenes infection|skin and skin structure Streptococcus pyogenes infection|0|12.686907|1
00002599|Staph epidermidis skin and skin structure infection|Staphylococcus epidermidis skin and skin structure infection|0|12.686908|1
00002600|skin and skin structure E. coli infection|skin and skin structure E. coli infection|0|12.686909|1
00002601|skin and skin structure Proteus infection|skin and skin structure Proteus infection|0|12.686910|1
00002602|skin and skin structure Klebsiella infection|skin and skin structure Klebsiella infection|0|12.686911|1
00002603|skin and skin structure Bacteroides fragilis infection|skin and skin structure Bacteroides fragilis infection|0|12.686912|1
00002604|skin and skin structure Clostridium infection|skin and skin structure Clostridium infection|0|12.686913|1
00002605|skin and skin structure Peptostreptococcus infection|skin and skin structure Peptostreptococcus infection|0|12.686914|1
00002606|skin and skin structure Peptococcus infection|skin and skin structure Peptococcus infection|0|12.686915|1
00002607|complicated skin and skin structure S. aureus infection|complicated skin and skin structure Staphylococcus aureus infection|0|12.686916|1
00002608|skin and skin structure Strep agalactiae infection|skin and skin structure Streptococcus agalactiae infection|0|12.686917|1
00002609|complicated skin structure S. agalactiae infection|complicated skin and skin structure Streptococcus agalactiae infection|0|12.686918|1
00002610|complicated skin structure P. aeruginosa infection|complicated skin and skin structure Pseudomonas aeruginosa infection|0|12.686919|1
00002611|complicated skin structure E. faecalis infection|complicated skin and skin structure Enterococcus faecalis infection|0|12.686920|1
00002612|complicated skin and skin structure E. coli infection|complicated skin and skin structure E. coli infection|0|12.686921|1
00002613|complicated skin and skin structure Proteus infection|complicated skin and skin structure Proteus infection|0|12.686922|1
00002614|skin and skin structure Fusobacterium infection|skin and skin structure Fusobacterium infection|0|12.686923|1
00002615|skin and skin structure Enterobacter infection|skin and skin structure Enterobacter infection|0|12.686924|1
00002616|skin and skin structure Acinetobacter infection|skin and skin structure Acinetobacter infection|0|12.686925|1
00002617|skin and skin structure P. aeruginosa infection|skin and skin structure Pseudomonas aeruginosa infection|0|12.686926|1
00002618|skin and skin structure Enterococcus infection|skin and skin structure Enterococcus infection|0|12.686927|1
00002619|skin and skin structure Citrobacter infection|skin and skin structure Citrobacter infection|0|12.686928|1
00002620|skin and skin structure Providencia infection|skin and skin structure Providencia infection|0|12.686929|1
00002621|skin and skin structure Serratia infection|skin and skin structure Serratia infection|0|12.686930|1
00002622|complicated skin structure S. pyogenes infection|complicated skin and skin structure Streptococcus pyogenes infection|0|12.686931|1
00002623|complicated skin and skin structure infection|complicated skin and skin structure infection|0|12.686932|1
00002624|skin and skin structure Haemophilus infection|skin and skin structure Haemophilus infection|0|12.686933|1
00002625|skin and skin structure Morganella morganii infection|skin and skin structure Morganella morganii infection|0|12.686934|1
00002626|skin and skin structure anaerobic infection|skin and skin structure anaerobic infection|0|12.686935|1
00002627|seborrheic dermatitis|seborrheic dermatitis|0|12.690100|3
00002628|dandruff|dandruff|0|12.690180|3
00002629|diaper rash|diaper rash|0|12.691000|1
00002630|atopic dermatitis|atopic dermatitis|0|12.691800|1
00002631|dermatitis due to topical drug|dermatitis due to topical drug|0|12.692300|1
00002632|poison ivy|poison ivy|0|12.692600|1
00002633|poison oak|poison oak|0|12.692601|1
00002634|sunburn|sunburn|0|12.692710|1
00002635|polymorphous light eruption|polymorphous light eruption|0|12.692720|1
00002636|skin photosensitivity|skin photosensitivity|0|12.692721|3
00002638|phototoxicity|phototoxicity|0|12.692723|1
00002639|Hydroa vacciniforme|Hydroa vacciniforme|0|12.692724|2
00002640|dermatitis due to sunlight|dermatitis due to sunlight|0|12.692790|2
00002641|radiodermatitis|radiodermatitis|0|12.692820|1
00002642|contact dermatitis|contact dermatitis|0|12.692900|3
00002643|eczema|eczema|0|12.692901|3
00002644|allergic dermatitis|allergic dermatitis|0|12.693000|1
00002646|Allergy to Papaya|Allergy to Papaya|2|12.693102|2
00002647|Allergy to Pork|Allergy to Pork|2|12.693103|2
00002648|Allergy to Beef|Allergy to Beef|2|12.693104|2
00002649|Allergy to Yeast|Allergy to Yeast|2|12.693105|2
00002650|Allergy to Eggs|Allergy to Eggs|2|12.693106|2
00002651|Allergy to Chicken Proteins|Allergy to Chicken Proteins|2|12.693107|2
00002652|Allergy to Proteins|Allergy to Proteins|2|12.693108|2
00002653|Allergy due to Substance Taken Internally|Allergy due to Substance Taken Internally|1|12.693800|2
00002654|Allergy due to Hamster Protein|Allergy due to Hamster Protein|2|12.693801|2
00002655|dermatitis herpetiformis|dermatitis herpetiformis|0|12.694000|1
00002657|subcorneal pustular dermatosis|subcorneal pustular dermatosis|0|12.694100|1
00002658|pemphigus|pemphigus|0|12.694400|3
00002659|pemphigoid|pemphigoid|0|12.694500|3
00002660|bullous pemphigoid|bullous pemphigoid|0|12.694501|3
00002661|cicatricial pemphigoid|cicatricial pemphigoid|0|12.694600|3
00002662|bullous dermatitis|bullous dermatitis|0|12.694900|1
00002663|erythema multiforme|erythema multiforme|0|12.695100|3
00002664|toxic epidermal necrolysis|toxic epidermal necrolysis|0|12.695101|3
00002665|Stevens-Johnson syndrome|Stevens-Johnson syndrome|0|12.695102|3
00002667|erythema nodosum|erythema nodosum|0|12.695200|3
00002670|acne rosacea|acne rosacea|0|12.695302|1
00002671|discoid lupus erythematosus|discoid lupus erythematosus|0|12.695400|3
00002672|subacute cutaneous lupus erythematosus|subacute cutaneous lupus erythematosus|0|12.695401|3
00002673|exfoliative dermatitis|exfoliative dermatitis|0|12.695890|1
00002674|intertrigo|intertrigo|0|12.695891|3
00002675|Sweet's syndrome|Sweet's syndrome|0|12.695892|3
00002676|abnormal desquamation|abnormal desquamation|0|12.695893|3
00002677|granuloma annulare|granuloma annulare|0|12.695894|2
00002679|erythema|erythema|0|12.695900|3
00002680|postirradiation erythema|postirradiation erythema|0|12.695901|1
00002681|severe erythema|severe erythema|0|12.695902|3
00002682|psoriatic arthritis|psoriatic arthritis|0|12.696000|2
00002683|psoriasis|psoriasis|0|12.696100|2
00002684|psoriasiform eruption|psoriasiform eruption|0|12.696101|1
00002685|severe recalcitrant psoriasis|severe recalcitrant psoriasis|0|12.696102|2
00002686|plaque psoriasis|plaque psoriasis|0|12.696103|3
00002687|lichen planus|lichen planus|0|12.697000|1
00002688|oral lichen planus|oral lichen planus|0|12.697001|1
00002689|erosive lichen planus|erosive lichen planus|0|12.697002|1
00002690|pruritus ani|pruritus ani|0|12.698000|1
00002691|genital organ pruritus|genital organ pruritus|0|12.698100|1
00002692|lichen simplex chronicus|lichen simplex chronicus|0|12.698300|2
00002693|prurigo nodularis|prurigo nodularis|0|12.698301|1
00002694|pruritus of skin|pruritus of skin|0|12.698900|3
00002695|severe pruritus|severe pruritus|0|12.698901|1
00002697|palmar pruritus|palmar pruritus|0|12.698903|1
00002698|calluses and corns|calluses and corns|0|12.700000|3
00002699|morphea|morphea|0|12.701000|3
00002700|elastosis perforans serpiginosa|elastosis perforans serpiginosa|0|12.701101|1
00002701|congenital ichthyosis|congenital ichthyosis|0|12.701102|1
00002702|hyperkeratosis|hyperkeratosis|0|12.701103|2
00002703|keratoderma|keratoderma|0|12.701104|2
00002704|skin striae|skin striae|0|12.701300|3
00002705|keloid|keloid|0|12.701400|2
00002706|skin atrophy|skin atrophy|0|12.701800|2
00002707|fine wrinkling|fine wrinkling|0|12.701801|2
00002708|actinic keratosis|actinic keratosis|0|12.702000|1
00002709|non-hyperkeratotic actinic keratosis|non-hyperkeratotic actinic keratosis|0|12.702001|1
00002710|onycholysis|onycholysis|0|12.703800|3
00002712|nail disorders|nail disorders|0|12.703900|3
00002713|nail discoloration|nail discoloration|0|12.703901|3
00002714|alopecia|alopecia|0|12.704000|1
00002715|alopecia areata|alopecia areata|0|12.704010|1
00002716|male patterned baldness|male patterned baldness|0|12.704090|2
00002717|hirsutism|hirsutism|0|12.704100|3
00002718|female hirsutism|female hirsutism|0|12.704101|2
00002719|increased facial hair|increased facial hair|0|12.704102|3
00002720|increased pubic hair|increased pubic hair|0|12.704103|3
00002721|female facial hirsutism|female facial hirsutism|0|12.704104|2
00002722|hair bleaching|hair bleaching|0|12.704300|3
00002723|hair discoloration|hair discoloration|0|12.704301|3
00002724|folliculitis|folliculitis|0|12.704800|1
00002725|gram-negative folliculitis|gram-negative folliculitis|0|12.704801|1
00002726|pilomotor abnormalities|pilomotor abnormalities|0|12.704900|3
00002727|decreased sweating|decreased sweating|0|12.705000|3
00002729|hidradenitis suppurativa|hidradenitis suppurativa|0|12.705830|1
00002730|discoloration of sweat|discoloration of sweat|0|12.705890|1
00002731|acne vulgaris|acne vulgaris|0|12.706100|3
00002732|acneiform eruption|acneiform eruption|0|12.706101|3
00002733|Adolescent Acne|Adolescent Acne|1|12.706102|2
00002734|worsening acne|worsening acne|0|12.706103|3
00002735|seborrhea|seborrhea|0|12.706300|3
00002736|dry skin|dry skin|0|12.706800|3
00002738|oily skin|oily skin|0|12.706900|3
00002739|decubital ulcer|decubital ulcer|0|12.707000|1
00002740|lower extremity ulcer|lower extremity ulcer|0|12.707100|3
00002741|ulcerative lesion of face|ulcerative lesion of face|0|12.707800|3
00002742|skin ulcer|skin ulcer|0|12.707900|1
00002743|chronic idiopathic urticaria|chronic idiopathic urticaria|0|12.708100|2
00002744|dermatographic urticaria|dermatographic urticaria|0|12.708300|2
00002745|urticaria|urticaria|0|12.708900|1
00002746|urticaria treatment adjunct|urticaria treatment adjunct|0|12.708902|1
00002747|transfusion reaction urticaria|transfusion reaction urticaria|0|12.708903|1
00002748|dyschromia|dyschromia|0|12.709000|3
00002749|skin hypopigmentation|skin hypopigmentation|0|12.709001|3
00002750|vitiligo|vitiligo|0|12.709010|3
00002751|Leukoderma|Leukoderma|1|12.709090|1
00002753|chloasma|chloasma|0|12.709092|3
00002754|melanosis|melanosis|0|12.709093|1
00002755|mottle hyperpigmentation|mottle hyperpigmentation|0|12.709094|2
00002756|superficial skin ulcer|superficial skin ulcer|0|12.709300|1
00002757|necrobiosis lipoidica diabeticorum|necrobiosis lipoidica diabeticorum|0|12.709301|2
00002758|blistering skin|blistering skin|0|12.709800|1
00002760|skin pigmentation enhancement|skin pigmentation enhancement|0|12.709802|1
00002761|skin fissure|skin fissure|0|12.709803|1
00002762|chafing|chafing|0|12.709804|1
00002763|disorder of skin|disorder of skin|0|12.709900|3
00002764|Skin Lesion|Skin Lesion|1|12.709901|1
00002766|raw skin|raw skin|0|12.709903|3
00002769|dermatosis of the scalp|dermatosis of the scalp|0|12.709906|1
00002770|induction of labor|induction of labor|0|13. 73400|1
00002771|cervical ripening procedure|cervical ripening procedure|0|13. 73990|1
00002773|cesarean section infection prevention|cesarean section infection prevention|0|13. 74001|1
00002775|systemic lupus erythematosus|systemic lupus erythematosus|0|13.710000|2
00002776|acute lupus erythematosus|acute lupus erythematosus|0|13.710001|1
00002777|lupus-like syndrome|lupus-like syndrome|0|13.710003|3
00002778|scleroderma|scleroderma|0|13.710100|2
00002779|scleroderma renal crisis|scleroderma renal crisis|0|13.710101|1
00002780|scleroderma thyroiditis|scleroderma thyroiditis|0|13.710102|1
00002781|keratoconjunctivitis sicca|keratoconjunctivitis sicca|0|13.710200|2
00002782|dermatomyositis|dermatomyositis|0|13.710300|1
00002783|systemic dermatomyositis|systemic dermatomyositis|0|13.710301|1
00002784|collagen vascular disease|collagen vascular disease|0|13.710900|2
00002785|septic arthritis|septic arthritis|0|13.711000|1
00002786|Staphylococcus septic arthritis|Staphylococcus septic arthritis|0|13.711001|1
00002787|Streptococcus Spp. Septic Arthritis|Streptococcus Spp. Septic Arthritis|1|13.711002|1
00002788|E. coli septic arthritis|E. coli septic arthritis|0|13.711003|1
00002789|Haemophilus septic arthritis|Haemophilus septic arthritis|0|13.711004|1
00002790|Klebsiella Spp. Septic Arthritis|Klebsiella Spp. Septic Arthritis|1|13.711005|1
00002791|Staphylococcus aureus joint infection|Staphylococcus aureus joint infection|0|13.711400|1
00002792|Bacteroides joint infection|Bacteroides joint infection|0|13.711401|1
00002793|Pseudomonas aeruginosa joint infection|Pseudomonas aeruginosa joint infection|0|13.711402|1
00002794|Klebsiella joint infection|Klebsiella joint infection|0|13.711403|1
00002795|Enterobacter joint infection|Enterobacter joint infection|0|13.711404|1
00002796|Enterococcus joint infection|Enterococcus joint infection|0|13.711405|1
00002797|Serratia joint infection|Serratia joint infection|0|13.711406|1
00002798|streptococcal joint infection|streptococcal joint infection|0|13.711407|1
00002799|E. coli joint infection|E. coli joint infection|0|13.711408|1
00002800|Proteus joint infection|Proteus joint infection|0|13.711409|1
00002801|Peptococcus joint infection|Peptococcus joint infection|0|13.711410|1
00002802|Peptostreptococcus joint infection|Peptostreptococcus joint infection|0|13.711411|1
00002803|anaerobic joint infection|anaerobic joint infection|0|13.711412|1
00002804|infectious disorder of joint|infectious disorder of joint|0|13.711900|1
00002805|rheumatoid arthritis|rheumatoid arthritis|0|13.714000|2
00002806|rheumatoid arthritis in pt at high gastric ulcer risk|rheumatoid arthritis in patient at high gastric ulcer risk|0|13.714001|2
00002807|Felty's syndrome|Felty's syndrome|0|13.714100|3
00002808|juvenile idiopathic arthritis|juvenile idiopathic arthritis|0|13.714300|2
00002809|Arthrosis|Arthrosis|1|13.715000|2
00002810|osteoarthritis of the knee|osteoarthritis of the knee|0|13.715360|2
00002811|osteoarthritis|osteoarthritis|0|13.715900|2
00002812|post traumatic osteoarthritis|post traumatic osteoarthritis|0|13.715901|2
00002813|synovitis due to osteoarthritis|synovitis due to osteoarthritis|0|13.715902|2
00002814|osteoarthritis in patient at high gastric ulcer risk|osteoarthritis in patient at high gastric ulcer risk|0|13.715903|2
00002816|arthritis|arthritis|0|13.716900|3
00002817|knee inflammation|knee inflammation|0|13.716960|3
00002818|neck hyperextension|neck hyperextension|0|13.718880|1
00002819|swelling of ankles or feet|swelling of ankles or feet|0|13.719070|3
00002820|arthralgia|arthralgia|0|13.719400|3
00002821|arthritic pain|arthritic pain|0|13.719401|3
00002822|mild arthritic pain|mild arthritic pain|2|13.719402|3
00002823|shoulder pain|shoulder pain|0|13.719410|3
00002824|joint stiffness|joint stiffness|0|13.719500|3
00002827|ankylosing spondylitis|ankylosing spondylitis|0|13.720000|2
00002828|spinal hyperostosis|spinal hyperostosis|0|13.721800|1
00002829|herniated lumbar disc|herniated lumbar disc|0|13.722100|1
00002830|discitis|discitis|0|13.722900|1
00002831|bacterial discitis|bacterial discitis|0|13.722901|1
00002832|neck pain|neck pain|0|13.723100|3
00002833|neck stiffness|neck stiffness|0|13.723500|3
00002834|spinal stenosis|spinal stenosis|0|13.724000|2
00002835|lower back pain|lower back pain|0|13.724200|3
00002836|back pain|back pain|0|13.724500|3
00002837|back stiffness|back stiffness|0|13.724800|3
00002838|back tenderness|back tenderness|0|13.724801|3
00002839|polymyalgia rheumatica|polymyalgia rheumatica|0|13.725000|2
00002840|acute shoulder pain due to tendonitis|acute shoulder pain due to tendonitis|0|13.726000|1
00002841|acute shoulder pain due to bursitis|acute shoulder pain due to bursitis|0|13.726100|1
00002842|epicondylitis|epicondylitis|0|13.726320|1
00002843|achilles tendinitis|achilles tendinitis|0|13.726710|1
00002844|tendonitis|tendonitis|0|13.726901|3
00002845|tenosynovitis|tenosynovitis|0|13.727000|1
00002846|bursitis|bursitis|0|13.727300|1
00002847|tendon rupture|tendon rupture|0|13.727600|1
00002848|rotator cuff tendon rupture|rotator cuff tendon rupture|0|13.727610|1
00002849|tendon rupture extensor of hand and wrist|tendon rupture extensor of hand and wrist|0|13.727630|1
00002850|tendon rupture flexor of hand and wrist|tendon rupture flexor of hand and wrist|0|13.727640|1
00002851|non-traumatic rupture of achilles tendon|non-traumatic rupture of achilles tendon|0|13.727670|1
00002852|Streptococcus myositis|Streptococcus myositis|0|13.728000|1
00002853|heterotopic ossification|heterotopic ossification|0|13.728120|2
00002855|muscle spasm|muscle spasm|0|13.728850|1
00002856|muscle spasm with pain|muscle spasm with pain|0|13.728851|3
00002857|hypertonia|hypertonia|0|13.728853|1
00002858|necrotizing fasciitis Streptococcus infection|necrotizing fasciitis Streptococcus infection|0|13.728860|1
00002859|rhabdomyolysis|rhabdomyolysis|0|13.728890|1
00002860|muscle weakness|muscle weakness|0|13.728900|3
00002861|muscle rigidity|muscle rigidity|0|13.728901|3
00002863|myalgia|myalgia|0|13.729100|3
00002864|myositis|myositis|0|13.729101|1
00002865|fibromyalgia|fibromyalgia|0|13.729102|2
00002866|neuralgia|neuralgia|0|13.729200|3
00002867|pain in extremities|pain in extremities|0|13.729500|3
00002868|calf pain|calf pain|0|13.729501|3
00002869|foot pain|foot pain|0|13.729502|3
00002870|finger pain|finger pain|0|13.729503|3
00002871|cramps|cramps|0|13.729820|3
00002872|cramps in legs|cramps in legs|0|13.729821|3
00002873|muscle weakness in limbs|muscle weakness in limbs|0|13.729890|3
00002874|muscle weakness in lower extremities|muscle weakness in lower extremities|0|13.729893|3
00002875|acute osteomyelitis|acute osteomyelitis|0|13.730000|1
00002876|continuation tx. for acute osteomyelitis|continuation therapy for acute osteomyelitis|0|13.730001|1
00002877|Klebsiella pneumoniae osteomyelitis|Klebsiella pneumoniae osteomyelitis|0|13.730002|1
00002878|Proteus mirabilis osteomyelitis|Proteus mirabilis osteomyelitis|0|13.730003|1
00002879|Streptococcus osteomyelitis|Streptococcus osteomyelitis|0|13.730004|1
00002880|Staphylococcus aureus osteomyelitis|Staphylococcus aureus osteomyelitis|0|13.730005|1
00002881|Pseudomonas aeruginosa osteomyelitis|Pseudomonas aeruginosa osteomyelitis|0|13.730006|1
00002882|E. coli osteomyelitis|E. coli osteomyelitis|0|13.730007|1
00002883|Enterobacter osteomyelitis|Enterobacter osteomyelitis|0|13.730008|1
00002884|Bacteroides osteomyelitis|Bacteroides osteomyelitis|0|13.730009|1
00002885|Enterococcus osteomyelitis|Enterococcus osteomyelitis|0|13.730010|1
00002886|Serratia osteomyelitis|Serratia osteomyelitis|0|13.730011|1
00002887|Haemophilus osteomyelitis|Haemophilus osteomyelitis|0|13.730012|1
00002888|Peptococcus osteomyelitis|Peptococcus osteomyelitis|0|13.730013|1
00002889|Peptostreptococcus osteomyelitis|Peptostreptococcus osteomyelitis|0|13.730014|1
00002891|continuation tx. for chronic osteomyelitis|continuation therapy for chronic osteomyelitis|0|13.730101|2
00002892|osteomyelitis|osteomyelitis|0|13.730200|3
00002894|bone infection|bone infection|0|13.730900|3
00002895|Paget's disease of bone|Paget's disease of bone|0|13.731000|2
00002896|osteoporosis|osteoporosis|0|13.733000|2
00002897|secondary osteoporosis|secondary osteoporosis|0|13.733001|2
00002898|pre-menopausal osteoporosis|pre-menopausal osteoporosis|0|13.733002|2
00002899|postmenopausal osteoporosis|postmenopausal osteoporosis|0|13.733010|2
00002900|post-menopausal osteoporosis prevention|post-menopausal osteoporosis prevention|0|13.733011|2
00002901|glucocorticoid-induced osteoporosis|glucocorticoid-induced osteoporosis|0|13.733090|2
00002902|prevention of glucocorticoid-induced osteoporosis|prevention of glucocorticoid-induced osteoporosis|0|13.733091|2
00002903|cortical hyperostosis|cortical hyperostosis|2|13.733300|1
00002905|bone disease|bone disease|0|13.733900|2
00002906|hypercalcemia associated with metabolic bone disease|hypercalcemia associated with metabolic bone disease|0|13.733901|2
00002907|bone pain|bone pain|0|13.733902|3
00002908|osteopenia|osteopenia|0|13.733903|2
00002910|bone pain flare reaction|bone pain flare reaction|0|13.733905|1
00002911|premature epiphyseal closure|premature epiphyseal closure|0|13.733910|2
00002912|relapsing polychondritis|relapsing polychondritis|0|13.733990|2
00002913|bone tenderness|bone tenderness|0|13.733992|3
00002914|skeletal hyperostosis|skeletal hyperostosis|0|13.733993|2
00002915|prosthetic arthroplasty infection prevention|prosthetic arthroplasty infection prevention|0|14. 81960|1
00002917|myelodysplastic syndrome|myelodysplastic syndrome|0|14.742590|3
00002918|change in corneal curvature|change in corneal curvature|0|14.743410|1
00002919|blue sclera|blue sclera|0|14.743470|3
00002921|congenital subaortic stenosis|congenital subaortic stenosis|0|14.746810|2
00002923|spasm of the right ventricle infundibulum|spasm of the right ventricle infundibulum|0|14.746831|3
00002924|congenital heart disease|congenital heart disease|0|14.746900|2
00002925|patent ductus arteriosus|patent ductus arteriosus|0|14.747000|2
00002926|arteriovenous malformation|arteriovenous malformation|0|14.747900|3
00002927|Hirschsprung disease|Hirschsprung disease|0|14.751300|2
00002928|biliary atresia|biliary atresia|0|14.751610|3
00002929|congenital abnormality of uterus|congenital abnormality of uterus|0|14.752300|2
00002930|cryptorchidism|cryptorchidism|0|14.752500|2
00002931|hypospadia|hypospadia|0|14.752600|2
00002932|bilateral anorchia|bilateral anorchia|0|14.752800|3
00002933|spondylolisthesis|spondylolisthesis|0|14.756120|2
00002935|osteopetrosis|osteopetrosis|0|14.756520|2
00002936|lamellar ichthyosis|lamellar ichthyosis|0|14.757100|2
00002937|ichthyosiform erythroderma|ichthyosiform erythroderma|0|14.757101|2
00002939|Netherton's syndrome|Netherton's syndrome|0|14.757103|2
00002941|xeroderma pigmentosum|xeroderma pigmentosum|0|14.757331|2
00002942|epidermolysis bullosa|epidermolysis bullosa|0|14.757390|1
00002943|Down's syndrome|Down's syndrome|0|14.758000|2
00002944|Turner syndrome|Turner syndrome|0|14.758600|3
00002945|Klinefelter's syndrome|Klinefelter's syndrome|0|14.758700|3
00002946|Prader-Willi syndrome|Prader-Willi syndrome|0|14.759810|2
00002947|Noonan's syndrome|Noonan's syndrome|0|14.759890|3
00002950|prevention of maternal-fetal transmission of HIV|prevention of maternal-fetal transmission of HIV|0|15.760201|1
00002954|Fetal Distress|Fetal Distress|2|15.768400|1
00002955|respiratory distress syndrome in the newborn|respiratory distress syndrome in the newborn|0|15.769000|1
00002956|prevention of respiratory distress in the newborn|prevention of respiratory distress syndrome in the newborn|0|15.769001|1
00002957|neonatal apnea|neonatal apnea|0|15.770800|1
00002958|granulomatosis infantiseptica|granulomatosis infantiseptica|0|15.771200|1
00002959|ophthalmia neonatorum|ophthalmia neonatorum|0|15.771600|1
00002960|prevention of neonatal ophthalmia|prevention of neonatal ophthalmia|0|15.771601|3
00002961|neonate at high risk of infection|neonate at high risk of infection|0|15.771800|1
00002962|neonatal hyperbilirubinemia|neonatal hyperbilirubinemia|0|15.774600|1
00002963|neonatal thyrotoxicosis|neonatal thyrotoxicosis|0|15.775300|1
00002964|neonatal hypocalcemic tetany|neonatal hypocalcemic tetany|0|15.775400|1
00002965|hemorrhagic disease of newborn due to vitamin K def|hemorrhagic disease of newborn due to vitamin K deficiency|0|15.776000|3
00002968|gray syndrome from chloramphenicol administration|gray syndrome from chloramphenicol administration|0|15.779400|3
00002969|intrauterine fetal death|intrauterine fetal death|0|15.779900|1
00002970|colorectal surgery|colorectal surgery|0|16. 48990|1
00002971|colorectal surgery infection prevention|colorectal surgery infection prevention|0|16. 48991|1
00002972|cisternography|cisternography|0|16. 87020|1
00002973|CT scan of brain|CT scan of brain|0|16. 87030|1
00002974|myelography|myelography|0|16. 87210|1
00002975|gastrointestinal radiography adjunct|gastrointestinal radiography adjunct|0|16. 87690|1
00002976|endoscopic retrograde cholangiopancreatography|endoscopic retrograde cholangiopancreatography|0|16. 87691|1
00002977|digestive system radiography|digestive system radiography|0|16. 87692|1
00002978|urography|urography|0|16. 87730|1
00002979|pyelography retrograde|pyelography retrograde|0|16. 87740|1
00002980|retrograde cystourethrography|retrograde cystourethrography|0|16. 87760|1
00002981|retrograde cystography|retrograde cystography|0|16. 87770|1
00002982|cholangiogram|cholangiogram|0|16. 87810|1
00002983|hysterosalpingography|hysterosalpingography|0|16. 87830|1
00002984|arthrography|arthrography|0|16. 88320|1
00002985|diagnostic imaging|diagnostic imaging|0|16. 88391|1
00002986|arteriography|arteriography|0|16. 88400|1
00002987|angiography|angiography|0|16. 88402|1
00002988|cerebral arteriography|cerebral arteriography|0|16. 88410|1
00002989|aortography|aortography|0|16. 88420|1
00002990|renal arteriography|renal arteriography|0|16. 88450|1
00002991|peripheral arteriography|peripheral arteriography|0|16. 88480|1
00002992|angiocardiography|angiocardiography|0|16. 88500|1
00002993|cardiac ventriculography|cardiac ventriculography|0|16. 88540|1
00002994|venography|venography|0|16. 88600|1
00002995|splenoportography|splenoportography|0|16. 88640|1
00002996|peripheral venography|peripheral venography|0|16. 88660|1
00002997|intraosseous venography|intraosseous venography|0|16. 88670|1
00002998|brain imaging|brain imaging|0|16. 88910|1
00002999|spinal lesion imaging|spinal lesion imaging|0|16. 88930|1
00003000|head and neck imaging|head and neck imaging|0|16. 88970|1
00003001|endogenous estrogen production test|endogenous estrogen production test|0|16. 89290|1
00003002|pituitary function studies|pituitary function studies|0|16. 89390|1
00003003|diagnostic test for thyroid dysfunction|diagnostic test for thyroid dysfunction|0|16. 89391|1
00003004|T3 suppression for thyroid function test|T3 suppression for thyroid function test|0|16. 92010|1
00003006|magnetic resonance imaging of liver|magnetic resonance imaging of liver|0|16. 92021|1
00003007|renal function study|renal function study|0|16. 92032|1
00003008|prostatic cancer metastases imaging|prostatic cancer metastases imaging|0|16. 92090|1
00003009|radiation therapy|radiation therapy|0|16. 92290|1
00003010|narcoanalysis|narcoanalysis|0|16. 94210|1
00003011|electroconvulsive therapy|electroconvulsive therapy|0|16. 94240|1
00003013|Contact Lens Intolerance|Contact Lens Intolerance|2|16. 95321|1
00003014|intubation of gastrointestinal tract|intubation of gastrointestinal tract|0|16. 96080|1
00003015|repeated blood transfusions|repeated blood transfusions|0|16. 99031|3
00003016|diagnostic test for growth hormone secretion|diagnostic test for growth hormone secretion|0|16. 99241|1
00003017|sedation as adjunct to anesthesia|sedation as adjunct to anesthesia|0|16. 99260|1
00003018|cardioversion of atrial fibrillation|cardioversion of atrial fibrillation|0|16. 99610|1
00003019|cardioversion of atrial flutter|cardioversion of atrial flutter|0|16. 99611|1
00003020|cardioversion of ventricular fibrillation|cardioversion of ventricular fibrillation|0|16. 99620|1
00003022|internal injury due to CPR|internal injury due to CPR|0|16. 99631|1
00003023|invasive surgical procedure|invasive surgical procedure|0|16. 99991|1
00003024|administration of general anesthesia|administration of general anesthesia|0|16. 99994|1
00003025|general anesthesia adjunct|general anesthesia adjunct|0|16. 99995|1
00003026|administration of local anesthesia|administration of local anesthesia|0|16. 99996|1
00003027|local anesthesia adjunct|local anesthesia adjunct|0|16. 99997|1
00003028|Organ Biopsy within Last 10 Days|Organ Biopsy within Last 10 Days|2|16. 99999|1
00003029|postoperative care|postoperative care|0|16. 9999A|1
00003030|reversal of benzodiazepine-maintained anesthesia|reversal of benzodiazepine-maintained anesthesia|0|16. 9999C|1
00003031|foot abscess|foot abscess|0|16.682700|3
00003032|abscess|abscess|0|16.682900|1
00003033|coma|coma|0|16.780010|3
00003034|drug-induced coma|drug-induced coma|0|16.780011|1
00003035|altered consciousness|altered consciousness|0|16.780020|3
00003036|drowsy|drowsy|0|16.780090|3
00003037|unconsciousness|unconsciousness|0|16.780091|3
00003038|sedation|sedation|0|16.780092|1
00003039|sedation in pediatric patients|sedation in pediatric patients|0|16.780094|1
00003040|conscious sedation|conscious sedation|0|16.780095|1
00003041|sedation hangover effect|sedation hangover effect|0|16.780096|1
00003042|sedation in intubated patient|sedation in intubated patient|0|16.780097|1
00003043|concentration difficulty|concentration difficulty|0|16.780098|3
00003044|delirium|delirium|0|16.780099|3
00003045|memory impairment|memory impairment|0|16.78009A|3
00003046|stupor|stupor|0|16.78009B|3
00003047|altered mental status|altered mental status|0|16.78009C|1
00003048|sedation in obstetrics|sedation in obstetrics|0|16.78009D|1
00003049|reversal of benzodiazepine-induced sedation|reversal of benzodiazepine-induced sedation|0|16.78009E|1
00003050|hallucinations|hallucinations|0|16.780100|3
00003051|syncope|syncope|0|16.780200|1
00003052|abnormal vasomotor function|abnormal vasomotor function|0|16.780201|3
00003053|seizure disorder|seizure disorder|0|16.780300|3
00003054|febrile convulsions|febrile convulsions|0|16.780310|1
00003055|tonic clonic seizure|tonic clonic seizure|0|16.780390|1
00003056|vertigo|vertigo|0|16.780400|3
00003059|dizziness|dizziness|0|16.780403|3
00003061|sleep disorder|sleep disorder|0|16.780501|3
00003063|insomnia|insomnia|0|16.780520|3
00003064|severe insomnia|severe insomnia|0|16.780521|1
00003067|irregular sleep-wake rhythm|irregular sleep-wake rhythm|0|16.780550|1
00003068|sleep apnea|sleep apnea|0|16.780570|2
00003069|fever|fever|0|16.780600|1
00003070|continuous fever|continuous fever|0|16.780601|1
00003071|high fever >101 degrees fahrenheit|high fever >101 degrees fahrenheit|0|16.780602|1
00003072|drug fever|drug fever|0|16.780604|1
00003073|fever due to malignancy|fever due to malignancy|0|16.780605|1
00003075|fatigue|fatigue|0|16.780700|3
00003076|flu-like symptoms|flu-like symptoms|0|16.780701|1
00003077|hyperhidrosis|hyperhidrosis|0|16.780800|1
00003078|body odor|body odor|0|16.780801|3
00003079|pain|pain|0|16.780900|3
00003080|Hyperemia|Hyperemia|1|16.780901|1
00003081|postoperative acute pain|postoperative acute pain|0|16.780902|1
00003082|pain treatment adjunct|pain treatment adjunct|0|16.780903|3
00003083|chills|chills|0|16.780905|3
00003084|severe pain|severe pain|0|16.780906|3
00003085|advanced hormone refractory prostate cancer pain|advanced hormone refractory prostate cancer pain|0|16.780907|1
00003086|labor pain|labor pain|0|16.780908|1
00003087|hypokinesia|hypokinesia|0|16.780909|1
00003088|pain due to osteoblastic bone metastasis|pain due to osteoblastic bone metastasis|0|16.780910|2
00003089|breakthrough cancer pain|breakthrough cancer pain|0|16.780911|3
00003090|chronic pain|chronic pain|0|16.780912|2
00003091|chronic pain with opioid tolerance|chronic pain with opioid tolerance|0|16.780913|2
00003092|tremor|tremor|0|16.781000|3
00003093|excessive tremors|excessive tremors|0|16.781001|3
00003094|episodic dyscontrol|episodic dyscontrol|0|16.781002|2
00003095|opisthotonus|opisthotonus|0|16.781003|3
00003096|trismus|trismus|0|16.781004|2
00003097|athetoid movements|athetoid movements|0|16.781006|3
00003098|muscle fasciculation|muscle fasciculation|0|16.781007|3
00003099|akathisia|akathisia|0|16.781008|3
00003100|dysgeusia|dysgeusia|0|16.781100|3
00003101|parosmia|parosmia|0|16.781101|3
00003102|gait abnormality|gait abnormality|0|16.781200|3
00003103|ataxia|ataxia|0|16.781300|3
00003104|dyskinesia|dyskinesia|0|16.781301|3
00003105|hypotonia|hypotonia|0|16.781302|3
00003106|tetany|tetany|0|16.781700|3
00003108|muscle relaxation|muscle relaxation|0|16.781900|1
00003110|skeletal muscle relaxation for endotracheal intubation|skeletal muscle relaxation for endotracheal intubation|0|16.781902|1
00003111|skeletal muscle relaxation for intubation in C-section|skeletal muscle relaxation for endotracheal intubation in C-section|0|16.781904|1
00003112|hypoesthesia|hypoesthesia|0|16.782000|3
00003113|head sensation disturbance|head sensation disturbance|0|16.782001|3
00003114|trunk sensation disturbance|trunk sensation disturbance|0|16.782002|3
00003115|sensation disturbance of limbs|sensation disturbance of limbs|2|16.782003|3
00003116|sensation disturbance of genitals|sensation disturbance of genitals|0|16.782004|3
00003117|tingling sensation of hands or feet|tingling sensation of hands or feet|0|16.782005|3
00003118|skin rash|skin rash|0|16.782100|3
00003119|skin irritation|skin irritation|0|16.782101|1
00003120|palmar rash|palmar rash|0|16.782102|1
00003121|skin nodules|skin nodules|0|16.782200|3
00003123|skin swelling|skin swelling|0|16.782202|1
00003124|subcutaneous nodules|subcutaneous nodules|0|16.782203|3
00003125|edema|edema|0|16.782300|3
00003126|peripheral edema|peripheral edema|0|16.782301|3
00003127|localized edema|localized edema|0|16.782302|3
00003128|facial edema|facial edema|0|16.782303|3
00003129|circumoral edema|circumoral edema|0|16.782304|3
00003130|hyperbilirubinemia|hyperbilirubinemia|0|16.782400|3
00003131|cholestasis of pregnancy|cholestasis of pregnancy|0|16.782402|2
00003132|cyanosis|cyanosis|0|16.782500|1
00003133|pallor|pallor|0|16.782610|3
00003134|livedo reticularis|livedo reticularis|0|16.782611|3
00003135|flushing|flushing|0|16.782620|1
00003136|petechiae|petechiae|0|16.782700|1
00003137|skin crusting|skin crusting|0|16.782800|1
00003138|skin thickening|skin thickening|0|16.782801|1
00003140|skin scaling|skin scaling|0|16.782803|1
00003141|skin scaling of hands|skin scaling of hands|0|16.782804|1
00003142|skin scaling of feet|skin scaling of feet|0|16.782805|1
00003143|palmar-plantar erythrodysesthesia|palmar-plantar erythrodysesthesia|0|16.782806|1
00003144|Skin Blemishes|Skin Blemishes|1|16.782900|1
00003145|anorexia|anorexia|0|16.783000|2
00003146|weight gain|weight gain|0|16.783100|1
00003147|weight loss|weight loss|0|16.783200|1
00003148|growth failure|growth failure|0|16.783400|1
00003149|polydipsia|polydipsia|0|16.783500|1
00003150|increased appetite|increased appetite|0|16.783601|3
00003151|appetite changes|appetite changes|0|16.783900|3
00003152|decreased thirst|decreased thirst|0|16.783901|3
00003153|headache disorder|headache disorder|0|16.784000|3
00003154|severe headache disorder|severe headache disorder|0|16.784001|3
00003155|frequent headache disorder|frequent headache disorder|0|16.784002|2
00003156|sinus headache|sinus headache|0|16.784003|3
00003157|vascular headache|vascular headache|0|16.784004|3
00003158|Vascular Headache Prevention|Vascular Headache Prevention|1|16.784005|3
00003159|dry throat|dry throat|0|16.784100|1
00003160|intracranial lesion|intracranial lesion|0|16.784200|2
00003161|tongue swelling|tongue swelling|0|16.784201|1
00003162|aphasia|aphasia|0|16.784300|3
00003163|voice change|voice change|0|16.784490|3
00003164|deepening voice in females|deepening voice in females|2|16.784491|3
00003165|hoarseness|hoarseness|0|16.784492|1
00003166|vocalization|vocalization|0|16.784493|1
00003167|slurred speech|slurred speech|0|16.784500|1
00003168|dysarthria|dysarthria|0|16.784501|3
00003169|dysphasia|dysphasia|0|16.784502|3
00003170|Incoherent Speech|Incoherent Speech|1|16.784503|3
00003171|apraxia|apraxia|0|16.784690|3
00003172|agnosia|agnosia|0|16.784691|3
00003173|epistaxis|epistaxis|0|16.784700|3
00003174|sneezing|sneezing|0|16.784900|1
00003175|halitosis|halitosis|0|16.784901|1
00003176|Tachyarrhythmia|Tachyarrhythmia|1|16.785000|3
00003177|perioperative tachycardia|perioperative tachycardia|0|16.785001|1
00003178|intraoperative tachycardia|intraoperative tachycardia|0|16.785002|1
00003179|palpitations|palpitations|0|16.785100|1
00003180|dermal necrosis|dermal necrosis|0|16.785400|1
00003181|shock|shock|0|16.785500|1
00003182|Circulatory Collapse|Circulatory Collapse|1|16.785502|1
00003183|incipient shock|incipient shock|0|16.785503|1
00003184|cardiogenic shock|cardiogenic shock|0|16.785510|1
00003185|septic shock|septic shock|0|16.785590|1
00003186|hypovolemic shock|hypovolemic shock|0|16.785591|1
00003187|lymphadenopathy|lymphadenopathy|0|16.785600|2
00003189|pulse changes|pulse changes|0|16.785900|1
00003191|respiration changes|respiration changes|0|16.786000|1
00003192|deep breath urge|deep breath urge|0|16.786001|1
00003193|hyperventilation|hyperventilation|0|16.786010|1
00003194|apnea|apnea|0|16.786030|3
00003195|Cheyne-Stokes respiration|Cheyne-Stokes respiration|0|16.786040|1
00003196|Shortness of Breath|Shortness of Breath|1|16.786050|1
00003197|tachypnea|tachypnea|0|16.786060|3
00003198|wheezing|wheezing|0|16.786070|3
00003199|dyspnea|dyspnea|0|16.786090|1
00003200|hypercapnia|hypercapnia|0|16.786092|1
00003201|bradypnea|bradypnea|0|16.786094|1
00003202|severe dyspnea|severe dyspnea|0|16.786099|1
00003203|yawning|yawning|0|16.78609A|1
00003204|stridor|stridor|0|16.786100|3
00003205|cough|cough|0|16.786200|3
00003206|hemoptysis|hemoptysis|0|16.786300|3
00003207|respiratory tract hemorrhage|respiratory tract hemorrhage|0|16.786301|1
00003208|sputum discoloration|sputum discoloration|0|16.786400|1
00003209|increased sputum|increased sputum|0|16.786401|1
00003211|chest pain|chest pain|0|16.786500|3
00003212|rib pain|rib pain|0|16.786501|3
00003213|chest tightness|chest tightness|0|16.786590|1
00003214|rales|rales|0|16.786700|1
00003215|hiccups|hiccups|0|16.786800|3
00003217|nausea and vomiting|nausea and vomiting|0|16.787010|1
00003218|prolonged-severe nausea and vomiting|prolonged-severe nausea and vomiting|0|16.787011|1
00003219|predisposition to nausea and vomiting|predisposition to nausea and vomiting|0|16.787012|2
00003220|prevention of post-operative nausea and vomiting|prevention of post-operative nausea and vomiting|0|16.787013|1
00003221|post-operative nausea and vomiting|post-operative nausea and vomiting|0|16.787014|1
00003222|prevention of nausea and vomiting|prevention of nausea and vomiting|0|16.787015|1
00003223|nausea|nausea|0|16.787020|1
00003225|severe nausea|severe nausea|0|16.787022|1
00003226|vomiting|vomiting|0|16.787030|1
00003227|severe vomiting|severe vomiting|0|16.787031|1
00003228|persistent vomiting|persistent vomiting|0|16.787032|1
00003229|bloody vomit|bloody vomit|0|16.787033|1
00003230|heartburn|heartburn|0|16.787100|3
00003231|dysphagia|dysphagia|0|16.787200|3
00003232|flatulence|flatulence|0|16.787300|1
00003233|Bloating|Bloating|1|16.787301|1
00003234|flatulence with discharge|flatulence with discharge|0|16.787302|3
00003235|eructation|eructation|0|16.787303|1
00003236|absence of bowel sounds|absence of bowel sounds|0|16.787500|1
00003237|fecal incontinence|fecal incontinence|0|16.787600|2
00003239|oily rectal leakage|oily rectal leakage|0|16.787602|3
00003240|fecal urgency|fecal urgency|0|16.787603|3
00003241|discolored feces|discolored feces|0|16.787700|1
00003242|oily rectal discharge|oily rectal discharge|0|16.787701|3
00003243|loose stools|loose stools|0|16.787702|3
00003245|tenesmus|tenesmus|0|16.787901|3
00003246|diarrhea|diarrhea|0|16.787910|1
00003247|severe diarrhea|severe diarrhea|0|16.787911|3
00003248|severe and chronic diarrhea|severe and chronic diarrhea|0|16.787912|2
00003249|increased defecation frequency|increased defecation frequency|0|16.787990|3
00003250|renal colic|renal colic|0|16.788000|1
00003251|dysuria|dysuria|0|16.788100|1
00003252|urinary burning sensation|urinary burning sensation|0|16.788101|1
00003253|urinary retention|urinary retention|0|16.788200|3
00003254|urinary incontinence|urinary incontinence|0|16.788300|2
00003255|urinary urge incontinence|urinary urge incontinence|0|16.788310|2
00003257|nocturnal enuresis|nocturnal enuresis|0|16.788360|3
00003258|increased urinary frequency|increased urinary frequency|0|16.788400|1
00003260|polyuria|polyuria|0|16.788420|1
00003261|nocturia|nocturia|0|16.788430|1
00003262|oliguria|oliguria|0|16.788500|1
00003263|urinary tract irritation|urinary tract irritation|0|16.788900|1
00003264|bladder pain|bladder pain|0|16.788901|1
00003265|abdominal pain with cramps|abdominal pain with cramps|0|16.789000|3
00003266|hepatomegaly|hepatomegaly|0|16.789100|3
00003267|splenomegaly|splenomegaly|0|16.789200|3
00003268|abdominal distension|abdominal distension|0|16.789300|3
00003269|ascites|ascites|0|16.789500|1
00003270|Abdominal Tenderness Upper Right Quadrant|Abdominal Tenderness Upper Right Quadrant|2|16.789610|1
00003271|generalized abdominal tenderness|generalized abdominal tenderness|0|16.789670|3
00003273|pelvic pain|pelvic pain|0|16.789901|3
00003274|erythrocyte abnormality|erythrocyte abnormality|0|16.790000|3
00003275|abnormal glucose tolerance|abnormal glucose tolerance|0|16.790200|3
00003276|hyperuricemia|hyperuricemia|0|16.790600|3
00003277|azotemia|azotemia|0|16.790601|3
00003278|hyperglycemia|hyperglycemia|0|16.790602|3
00003279|bacteremia|bacteremia|0|16.790700|1
00003280|vancomycin resistant Enterococcus faecium bacteremia|vancomycin resistant Enterococcus faecium bacteremia|0|16.790701|1
00003281|aerobic gram-negative bacteremia|aerobic gram-negative bacteremia|0|16.790702|1
00003282|proteinuria|proteinuria|0|16.791000|1
00003283|myoglobinuria|myoglobinuria|0|16.791300|1
00003284|glycosuria|glycosuria|0|16.791500|1
00003285|diagnostic test for glycosuria|diagnostic test for glycosuria|0|16.791501|1
00003286|diagnostic test for ketonuria|diagnostic test for ketonuria|0|16.791601|1
00003287|Aciduria|Aciduria|1|16.791900|1
00003288|crystalluria|crystalluria|0|16.791901|1
00003289|urine discoloration|urine discoloration|0|16.791902|1
00003290|pyuria|pyuria|0|16.791903|1
00003291|abnormal electroencephalogram|abnormal electroencephalogram|0|16.794020|1
00003292|abnormal hepatic function tests|abnormal hepatic function tests|0|16.794800|1
00003293|nonspecific abnormal papanicolaou smear of cervix|nonspecific abnormal papanicolaou smear of cervix|0|16.795000|1
00003295|hyporeflexia|hyporeflexia|0|16.796101|3
00003296|hyperreflexia|hyperreflexia|0|16.796102|3
00003297|Abnormal Clinical Findings|Abnormal Clinical Findings|2|16.796400|3
00003298|blood pressure abnormal|blood pressure abnormal|0|16.796401|3
00003299|breath test for abnormal urease|breath test for abnormal urease|0|16.796402|2
00003300|hypoxia|hypoxia|0|16.799000|3
00003301|severe hypoxemia|severe hypoxemia|0|16.799001|1
00003302|CNS depression|CNS depression|0|16.799100|3
00003304|drug-induced CNS depression|drug-induced CNS depression|0|16.799102|3
00003305|nervousness|nervousness|0|16.799200|3
00003306|tension|tension|0|16.799201|1
00003307|debilitation|debilitation|0|16.799300|3
00003308|severe debilitation|severe debilitation|0|16.799301|2
00003309|catabolic process|catabolic process|0|16.799400|3
00003310|cachexia|cachexia|0|16.799401|2
00003311|Toxemia|Toxemia|2|16.799800|1
00003313|bed-ridden|bed-ridden|0|16.799802|2
00003314|flail chest|flail chest|0|17.807400|1
00003315|fracture|fracture|0|17.829000|1
00003316|head injury|head injury|0|17.854000|1
00003317|wound|wound|0|17.879800|1
00003318|lacerations|lacerations|0|17.879801|1
00003319|bleeding from wound|bleeding from wound|0|17.879802|1
00003320|impaired wound healing|impaired wound healing|0|17.879803|1
00003321|large open wound|large open wound|0|17.879804|1
00003322|corneal abrasion|corneal abrasion|0|17.918100|1
00003323|arthropod bite wound|arthropod bite wound|0|17.919400|1
00003324|ocular injury|ocular injury|0|17.921900|1
00003325|ocular open globe injury|ocular open globe injury|0|17.921901|1
00003326|bruising|bruising|0|17.924900|3
00003327|Airway Obstruction Secondary to Medications|Airway Obstruction Secondary to Medications|2|17.934900|1
00003328|burns|burns|0|17.949000|1
00003329|severe burns|severe burns|0|17.949001|1
00003330|spinal cord injury|spinal cord injury|0|17.952900|3
00003331|neurologic injury|neurologic injury|0|17.957900|3
00003332|post traumatic wound infection|post traumatic wound infection|0|17.958300|1
00003333|infection of burn wound|infection of burn wound|0|17.958301|1
00003334|Staph aureus traumatic skin lesion infection|Staph aureus traumatic skin lesion infection|0|17.958303|1
00003335|traumatic skin lesion Strep pyogenes infection|traumatic skin lesion Streptococcus pyogenes infection|0|17.958304|1
00003336|nasal trauma|nasal trauma|0|17.959000|1
00003337|disorder of mucous membrane|disorder of mucous membrane|0|17.959800|1
00003338|major traumatic injury|major traumatic injury|0|17.959900|1
00003339|pyrimethamine toxicity|pyrimethamine toxicity|0|17.961400|1
00003340|trimethoprim toxicity|trimethoprim toxicity|0|17.961900|1
00003341|iodine poisoning|iodine poisoning|0|17.962800|1
00003342|methotrexate toxicity|methotrexate toxicity|0|17.963100|1
00003343|iron toxicity|iron toxicity|0|17.964000|1
00003344|heparin toxicity|heparin toxicity|0|17.964200|1
00003345|opioid overdose|opioid overdose|0|17.965000|1
00003346|acetaminophen overdose|acetaminophen overdose|0|17.965400|1
00003347|gold toxicity|gold toxicity|0|17.965600|1
00003348|cholinesterase inhibitors toxicity|cholinesterase inhibitors toxicity|0|17.971000|1
00003349|muscarine toxicity|muscarine toxicity|0|17.971001|1
00003350|toxic quinidine serum level|toxic quinidine serum level|0|17.972000|1
00003351|digitalis toxicity|digitalis toxicity|0|17.972100|1
00003352|tachycardia due to digitalis toxicity|tachycardia due to digitalis toxicity|0|17.972101|1
00003353|digitalis toxicity with AV conduction defects|digitalis toxicity with AV conduction defects|0|17.972102|1
00003354|aluminum toxicity|aluminum toxicity|0|17.974600|1
00003355|ergot alkaloid toxicity|ergot alkaloid toxicity|0|17.975000|1
00003356|ethylene glycol toxicity|ethylene glycol toxicity|0|17.980800|1
00003357|lead toxicity|lead toxicity|0|17.984900|1
00003358|mercury toxicity|mercury toxicity|0|17.985000|1
00003359|arsenic toxicity|arsenic toxicity|0|17.985100|1
00003360|cadmium toxicity|cadmium toxicity|0|17.985500|1
00003361|heavy metal toxicity|heavy metal toxicity|0|17.985900|1
00003362|silver toxicity|silver toxicity|0|17.985901|1
00003363|uranium toxicity|uranium toxicity|0|17.985902|1
00003364|toxic selenium level|toxic selenium level|0|17.985903|1
00003365|cyanide toxicity|cyanide toxicity|0|17.989000|1
00003366|allergic reaction to insect venom|allergic reaction to insect venom|0|17.989501|1
00003367|unknown oral substance toxicity|unknown oral substance toxicity|0|17.989900|1
00003368|toxin-mediated diarrhea|toxin-mediated diarrhea|0|17.989901|1
00003371|prevention of radiation-induced nausea and vomiting|prevention of radiation-induced nausea and vomiting|0|17.990002|1
00003372|hypothermia|hypothermia|0|17.991600|1
00003373|heat stroke|heat stroke|0|17.992000|1
00003374|anoxia due to high altitude|anoxia due to high altitude|0|17.993200|1
00003375|motion sickness|motion sickness|0|17.994600|1
00003376|anaphylaxis|anaphylaxis|0|17.995000|1
00003377|anaphylaxis adjunct|anaphylaxis adjunct|0|17.995001|1
00003378|angioedema|angioedema|0|17.995100|1
00003380|Allergy to E. Coli Derived Proteins|Allergy to E. Coli Derived Proteins|2|17.995201|2
00003381|Sensitivity to Iodine|Sensitivity to Iodine|2|17.995202|2
00003382|Sensitivity to Iodinated Contrast Media|Sensitivity to Iodinated Contrast Media|2|17.995203|2
00003383|Sensitivity to Cholinergics|Sensitivity to Cholinergics|2|17.995205|2
00003384|Sensitivity to Ergot Alkaloids|Sensitivity to Ergot Alkaloids|2|17.995206|2
00003385|hypersensitivity drug reaction|hypersensitivity drug reaction|0|17.995207|1
00003386|bovine allergy testing|bovine allergy testing|0|17.995208|1
00003387|allergic reaction|allergic reaction|0|17.995300|3
00003388|Allergic Reaction|Allergic Reaction|1|17.995301|2
00003389|human seminal plasma allergy|human seminal plasma allergy|0|17.995302|2
00003390|gastrointestinal food allergy|gastrointestinal food allergy|0|17.995303|2
00003391|malignant hyperthermia|malignant hyperthermia|0|17.995860|1
00003392|malignant hyperthermia prevention|malignant hyperthermia prevention|0|17.995861|1
00003393|organ transplant rejection|organ transplant rejection|0|17.996800|1
00003394|prevention of transplant rejection|prevention of transplant rejection|0|17.996801|3
00003396|solid organ transplant recipient on immunosuppressive tx|solid organ transplant recipient on immunosuppressive therapy|0|17.996806|2
00003397|recipient of organ transplant|recipient of organ transplant|0|17.996807|2
00003398|post-transplant lymphoproliferative disease|post-transplant lymphoproliferative disease|0|17.996808|1
00003399|kidney transplant rejection|kidney transplant rejection|0|17.996810|1
00003400|prevention of kidney transplant rejection|prevention of kidney transplant rejection|0|17.996811|2
00003401|liver transplant rejection|liver transplant rejection|0|17.996820|1
00003402|prevention of liver transplant rejection|prevention of liver transplant rejection|0|17.996821|2
00003404|prevention of cardiac transplant rejection|prevention of cardiac transplant rejection|0|17.996831|2
00003405|graft-versus-host disease|graft-versus-host disease|0|17.996850|3
00003406|prevention of graft-versus-host disease|prevention of graft-versus-host disease|0|17.996851|2
00003407|predisposition to aspiration|predisposition to aspiration|0|17.997301|2
00003408|postsurgical hemorrhage|postsurgical hemorrhage|0|17.998100|1
00003409|postsurgical complications|postsurgical complications|0|17.998900|3
00003410|serum sickness|serum sickness|0|17.999500|1
00003411|injection site sequelae|injection site sequelae|0|17.999900|1
00003412|treatment site sequelae|treatment site sequelae|0|17.999901|1
00003413|prevention of HIV infection after exposure|prevention of HIV infection after exposure|0|18.V01700|1
00003414|meningococcal carrier|meningococcal carrier|0|18.V02500|2
00003415|cholera vaccination|cholera vaccination|0|18.V03000|1
00003416|typhoid-paratyphoid prevention|typhoid-paratyphoid prevention|0|18.V03100|1
00003418|tetanus prevention|tetanus prevention|0|18.V03700|1
00003419|prevention of Haemophilus influenzae type b|prevention of Haemophilus influenzae type b|0|18.V03810|1
00003420|prevention of Streptococcus pneumoniae infection|prevention of Streptococcus pneumoniae infection|0|18.V03820|1
00003421|lyme disease prevention|lyme disease prevention|0|18.V03900|1
00003422|poliomyelitis vaccination|poliomyelitis vaccination|0|18.V04000|1
00003423|measles vaccination|measles vaccination|0|18.V04200|1
00003424|rubella vaccination|rubella vaccination|0|18.V04300|1
00003425|yellow fever vaccination|yellow fever vaccination|0|18.V04400|1
00003426|mumps vaccination|mumps vaccination|0|18.V04600|1
00003428|hepatitis B prevention|hepatitis B prevention|0|18.V05301|1
00003429|viral hepatitis A prevention|viral hepatitis A prevention|0|18.V05302|1
00003430|diphtheria-pertussis-tetanus combined vaccination|diphtheria-pertussis-tetanus combined vaccination|0|18.V06100|1
00003431|measles-mumps-rubella vaccination|measles-mumps-rubella vaccination|0|18.V06400|1
00003432|tetanus-diphtheria prevention|tetanus-diphtheria prevention|0|18.V06500|1
00003433|measles-rubella vaccination|measles-rubella vaccination|0|18.V06801|1
00003434|Rubella and Mumps Prevention|Rubella and Mumps Prevention|1|18.V06802|1
00003435|diphtheria-pertussis-tetanus-Haemophilus B vaccination|diphtheria-pertussis-tetanus-Haemophilus B vaccination|0|18.V06803|1
00003436|Haemophilus B-Tetanus Toxoid Prevention|Haemophilus B-Tetanus Toxoid Prevention|2|18.V06804|1
00003437|desensitization to allergen|desensitization to allergen|0|18.V07100|1
00003438|prevention of perioperative infection|prevention of perioperative infection|0|18.V07300|3
00003440|Penicillin Allergy|Penicillin Allergy|2|18.V14000|2
00003441|familial history of ischemic heart disease|familial history of ischemic heart disease|0|18.V17300|2
00003442|familial history of cardiovascular disease|familial history of cardiovascular disease|0|18.V17400|2
00003444|Familial History of Diabetes Mellitus|Familial History of Diabetes Mellitus|2|18.V18000|2
00003446|pregnancy|pregnancy|0|18.V22200|1
00003447|pregnancy detection|pregnancy detection|0|18.V22201|1
00003449|first and second trimester pregnancy|first and second trimester pregnancy|1|18.V22203|1
00003450|childbirth|childbirth|0|18.V24000|1
00003451|childbirth within last 10 days|childbirth within last 10 days|0|18.V24001|1
00003452|lactation|lactation|0|18.V24100|1
00003453|Female Sterilization|Female Sterilization|2|18.V25200|1
00003454|pregnancy contraception|pregnancy contraception|0|18.V25900|1
00003455|postcoital contraception|postcoital contraception|0|18.V25901|1
00003456|prevention of sexually transmitted disease|prevention of sexually transmitted disease|0|18.V25902|3
00003457|Cervical Neoplasia Prevention|Cervical Neoplasia Prevention|2|18.V25903|3
00003458|ovulation stimulation|ovulation stimulation|0|18.V26800|1
00003459|follicle stimulation|follicle stimulation|0|18.V26801|1
00003460|premature luteinizing hormone surges|premature luteinizing hormone surges|0|18.V26802|1
00003461|infertility|infertility|0|18.V26803|1
00003462|early induction luteinization|early induction luteinization|0|18.V26804|1
00003463|ovarian follicle maturation induction|ovarian follicle maturation induction|0|18.V26805|1
00003464|renal impairment in patient undergoing kidney transplant|renal impairment in patient undergoing kidney transplant|0|18.V42001|1
00003465|hepatic impairment in pt undergoing liver transplant|hepatic impairment in patient undergoing liver transplant|0|18.V42701|1
00003466|cardiopulmonary arteriovenous fistula|cardiopulmonary arteriovenous fistula|0|18.V45100|1
00003467|multiparity|multiparity|0|18.V61500|1
00003468|Dietary Restriction|Dietary Restriction|2|18.V65300|2
00003470|front tooth fillings|front tooth fillings|0|18.V72201|1
00003471|ingestion of petroleum distillates|ingestion of petroleum distillates|0|19.E86200|1
00003472|radiation-induced mucositis|radiation-induced mucositis|0|19.E87920|1
00003473|radiation-induced esophageal ulcer|radiation-induced esophageal ulcer|0|19.E87921|1
00003474|sclerotherapy-induced mucositis|sclerotherapy-induced mucositis|0|19.E87980|1
00003475|sclerotherapy-induced esophageal ulcer|sclerotherapy-induced esophageal ulcer|0|19.E87981|1
00003483|Hypersensitivity to Rifampin|Hypersensitivity to Rifampin|2|19.E93061|2
00003487|Prevention of Antineoplastic-Induced N&V|Prevention of Antineoplastic-Induced Nausea and Vomiting|1|19.E93073|1
00003489|antibiotic-induced hypoprothrombinemia|antibiotic-induced hypoprothrombinemia|0|19.E93091|1
00003511|cancer chemotherapy-induced nausea and vomiting|cancer chemotherapy-induced nausea and vomiting|0|19.E93311|1
00003512|differentiation syndrome in acute promyelocytic leukemia|differentiation syndrome in acute promyelocytic leukemia|0|19.E93312|1
00003513|Retinoid Toxicity|Retinoid Toxicity|1|19.E93313|1
00003514|chemotherapy-induced diarrhea|chemotherapy-induced diarrhea|0|19.E93314|1
00003515|prevention of chemotherapy-induced nausea and vomiting|prevention of cancer chemotherapy-induced nausea and vomiting|0|19.E93315|1
00003516|chemotherapy-induced hypogonadism|chemotherapy-induced hypogonadism|0|19.E93316|1
00003517|chemotherapy-induced mucositis|chemotherapy-induced mucositis|0|19.E93317|1
00003518|chemotherapy-induced esophageal ulcer|chemotherapy-induced esophageal ulcer|0|19.E93318|1
00003521|Chymopapain Therapy|Chymopapain Therapy|2|19.E93340|1
00003527|anticoagulant-induced prothrombin deficiency|anticoagulant-induced prothrombin deficiency|0|19.E93421|1
00003529|antibody response to previous streptokinase therapy|antibody response to previous streptokinase therapy|0|19.E93440|1
00003530|thrombolytic drug-induced cholesterol embolism|thrombolytic drug-induced cholesterol embolism|0|19.E93441|1
00003531|Protamine Therapy|Protamine Therapy|2|19.E93450|1
00003534|allergic reaction from blood products|allergic reaction from blood products|0|19.E93471|1
00003539|opioid-induced respiratory depression|opioid-induced respiratory depression|0|19.E93521|1
00003541|Aspirin Allergy|Aspirin Allergy|2|19.E93531|2
00003544|Gold Compound Therapy|Gold Compound Therapy|2|19.E93560|1
00003545|NSAID-induced gastric ulcer|NSAID-induced gastric ulcer|0|19.E93561|2
00003546|NSAID-induced duodenal ulcer|NSAID-induced duodenal ulcer|0|19.E93562|1
00003569|hypotension secondary to spinal anesthesia|hypotension secondary to spinal anesthesia|0|19.E93871|1
00003570|prevention of hypotension during spinal anesthesia|prevention of hypotension during spinal anesthesia|0|19.E93872|1
00003578|benzodiazepine overdose|benzodiazepine overdose|0|19.E93940|1
00003586|organophosphorous overdose|organophosphorous overdose|0|19.E94100|1
00003590|propranolol overdose|propranolol overdose|0|19.E94200|1
00003592|digitalis toxicity by EKG|digitalis toxicity by EKG|0|19.E94211|1
00003619|curare overdose|curare overdose|0|19.E94520|1
00003656|sexual transmitted disease exposure from sexual assault|sexual transmitted disease exposure from sexual assault|0|19.E96010|1
00003657|Not Applicable|Not Applicable|0|999999999|3
00004032|pneumococcal pharyngitis|pneumococcal pharyngitis|0|01.034002|1
00004033|rhinocerebral phycomycosis|rhinocerebral phycomycosis|0|01.117701|1
00004034|nonpsychotic anxiety|nonpsychotic anxiety|0|05.300003|3
00004035|preoperative anxiety|preoperative anxiety|0|05.300004|3
00004036|pre-op apprehension|pre-op apprehension|0|05.300005|3
00004037|cryptococcal meningitis in HIV|cryptococcal meningitis in HIV|0|06.321001|1
00004038|Meniere's disease|Meniere's disease|0|06.386000|2
00004039|acute streptococcal pyogenes bacterial sinusitis|acute streptococcal pyogenes bacterial sinusitis|0|08.461907|1
00004040|mixed gonococcal and chlamydia infection of the urethra|mixed gonococcal and chlamydia infection of the urethra|0|10.616007|1
00004041|skin and skin structure strep. pneumoniae infection|skin and skin structure Streptococcus pneumoniae infection|0|12.686936|1
00004042|muscle spasticity of cerebral origin|muscle spasticity of cerebral origin|0|13.728854|3
00004043|spinal anesthesia|spinal anesthesia|0|16. 9999D|1
00004065|paucibacillary leprosy|paucibacillary leprosy|0|01.030803|2
00004066|single lesion paucibacillary leprosy|single lesion paucibacillary leprosy|0|01.030804|2
00004068|secondary angle-closure glaucoma|secondary angle-closure glaucoma|0|06.365601|2
00004069|acquired arteriovenous pulmonary shunt|acquired arteriovenous pulmonary shunt|0|07.417000|2
00004070|dyspepsia prevention|dyspepsia prevention|0|09.536807|1
00004071|chronic urticaria|chronic urticaria|0|12.708904|2
00004072|congenital arteriovenous pulmonary shunt|congenital arteriovenous pulmonary shunt|0|14.747300|2
00004073|heartburn prevention|heartburn prevention|0|16.787101|1
00004074|bloody diarrhea|bloody diarrhea|0|16.787913|1
00004116|acute hepatitis C|acute hepatitis C|0|01.070510|1
00004117|color blindness|color blindness|0|06.368591|3
00004118|coronary artery spasm|coronary artery spasm|0|07.413909|3
00004119|paresthesia|paresthesia|0|16.782006|3
00004137|CNS pleocytosis|CNS pleocytosis|0|06.349908|1
00004138|severe constipation|severe constipation|0|09.564002|1
00004139|urolithiasis|urolithiasis|0|10.592910|3
00004140|urinary urgency|urinary urgency|0|16.788690|1
00004184|candidal urinary tract infection|candidal urinary tract infection|0|01.112200|2
00004185|candidal endocarditis|candidal endocarditis|0|01.112810|1
00004186|candidal meningitis|candidal meningitis|0|01.112830|1
00004187|candidal septicemia|candidal septicemia|0|01.112892|1
00004188|pulmonary cryptococcosis|pulmonary cryptococcosis|0|01.117501|1
00004189|cryptococcal septicemia|cryptococcal septicemia|0|01.117502|1
00004190|cryptococcal urinary tract infection|cryptococcal urinary tract infection|0|01.117503|1
00004191|refractory malignant tumor of testis|refractory malignant tumor of testis|0|02.239501|2
00004192|chronic iron overload|chronic iron overload|0|03.275002|2
00004193|increased intraocular pressure after ocular procedure|increased intraocular pressure after ocular procedure|0|06.365041|1
00004194|peripheral venous insufficiency|peripheral venous insufficiency|0|07.459810|3
00004195|prevention of stress ulcer|prevention of stress ulcer|0|09.533906|1
00004196|duodenitis|duodenitis|0|09.535600|1
00004197|cholestatic hepatitis|cholestatic hepatitis|0|09.573802|1
00004198|neurogenic bladder|neurogenic bladder|0|10.596540|2
00004199|nongonococcal urethritis|nongonococcal urethritis|0|10.597801|1
00004200|recurrent persistent urethritis|recurrent persistent urethritis|0|10.597802|1
00004201|E. coli gynecological infections|E. coli gynecological infections|0|10.615925|1
00004202|Bacteroides gynecological infections|Bacteroides gynecological infections|0|10.615926|1
00004203|pelvic hematoma|pelvic hematoma|0|10.629800|3
00004204|disorder of musculoskeletal system|disorder of musculoskeletal system|0|13.728902|3
00004205|hand pain|hand pain|0|13.729504|3
00004206|lethargy|lethargy|0|16.780702|3
00004207|intracranial hypertension|intracranial hypertension|0|16.781990|3
00004208|dysesthesia|dysesthesia|0|16.782007|3
00004209|flank pain|flank pain|0|16.789001|3
00004210|decrease ejaculate volume|decrease ejaculate volume|0|16.792200|3
00004211|hematoma|hematoma|0|17.924901|1
00004212|prevent subacute thromb after coronary stent|subacute thrombosis prevention after coronary stent implantation|2|17.996740|1
00004222|reactivated tuberculosis|reactivated tuberculosis|0|01.011907|1
00004223|staphylococcal pharyngitis|staphylococcal pharyngitis|0|08.462003|1
00004224|upper respiratory infection from Haemophilus influenzae|upper respiratory infection due to Haemophilus influenzae|0|08.465903|1
00004225|upper respiratory infection due to Staphylococcus|upper respiratory infection due to Staphylococcus|0|08.465904|1
00004226|E. coli bronchitis|E. coli bronchitis|0|08.490013|1
00004227|Pseudomonas aeruginosa bronchitis|Pseudomonas aeruginosa bronchitis|0|08.490014|1
00004228|Proteus bronchitis|Proteus bronchitis|0|08.490015|1
00004229|Serratia bronchitis|Serratia bronchitis|0|08.490016|1
00004230|Citrobacter peritonitis|Citrobacter peritonitis|0|09.567024|1
00004231|Serratia peritonitis|Serratia peritonitis|0|09.567025|1
00004232|genitourinary tract infection due to Proteus|genitourinary tract infection due to Proteus|0|10.599034|1
00004233|Enterococcus genitourinary tract infection|Enterococcus genitourinary tract infection|0|10.599035|1
00004234|muscle spasticity of spinal origin|muscle spasticity of spinal origin|0|13.728855|3
00004235|Shivering|Shivering|1|16.781009|1
00004236|intractable hiccups|intractable hiccups|0|16.786801|3
00004237|intra-operative nausea and vomiting|intra-operative nausea and vomiting|0|16.787016|1
00004247|cerebrovascular insufficiency|cerebrovascular insufficiency|0|07.437903|2
00004248|phlebitis|phlebitis|0|07.451906|1
00004249|rhinorrhea|rhinorrhea|0|08.478112|1
00004293|herpes simplex keratoconjunctivitis|herpes simplex keratoconjunctivitis|0|01.054490|2
00004294|ocular histoplasmosis|ocular histoplasmosis|0|01.115991|1
00004295|pathologic myopia|pathologic myopia|0|06.367101|3
00004296|Sinus Pain|Sinus Pain|1|08.478113|1
00004297|rebound nasal congestion|rebound nasal congestion|0|08.478114|1
00004298|suprapubic pain|suprapubic pain|0|16.789090|3
00004346|cutaneous anthrax|cutaneous anthrax|0|01.022000|1
00004347|ocular stromal edema|ocular stromal edema|0|06.364802|1
00004377|hypovolemia|hypovolemia|0|03.276504|1
00004378|hypervolemia|hypervolemia|0|03.276604|1
00004379|hypoplastic anemia|hypoplastic anemia|0|04.284902|3
00004380|cardiac conduction delay|cardiac conduction delay|0|07.426907|3
00004381|Throat Inflammation|Throat Inflammation|1|08.478294|1
00004382|primary biliary cholangitis|primary biliary cholangitis|0|09.571602|2
00004383|mixed gonococcal and chlamydia infection of the cervix|mixed gonococcal and chlamydia infection of the cervix|0|10.616008|1
00004384|vulvovaginitis|vulvovaginitis|0|10.616101|1
00004385|actinic cheilitis|actinic cheilitis|0|12.692725|2
00004386|Sjogren's syndrome|Sjogren's syndrome|0|13.710201|2
00004387|synovitis|synovitis|0|13.727001|1
00004388|keratosis follicularis|keratosis follicularis|0|14.757391|1
00004389|general weakness|general weakness|0|16.780703|3
00004390|malaise|malaise|0|16.780704|3
00004391|involuntary muscle movement|involuntary muscle movement|0|16.781010|1
00004392|clammy skin|clammy skin|0|16.782901|1
00004393|gangrene|gangrene|0|16.785401|1
00004394|tissue necrosis|tissue necrosis|0|16.785402|1
00004395|hypoventilation|hypoventilation|0|16.786095|1
00004396|irritability|irritability|0|16.799202|1
00004397|diagnostic test for ovulation|diagnostic test for ovulation|0|18.V26290|1
00004398|accidental fall|accidental fall|0|19.E88890|1
00004428|Sepsis Syndrome|Sepsis Syndrome|2|01.038902|1
00004429|mucocutaneous candidiasis|mucocutaneous candidiasis|0|01.112301|1
00004430|night terror|night terror|0|05.307460|3
00004431|prevention of ischemic complications of non-Q wave MI|prevention of ischemic complications of non-Q wave MI|0|07.410911|1
00004432|prevention of cardiac ischemia in unstable angina|prevention of cardiac ischemia in unstable angina|0|07.413910|1
00004452|acute cerebellar syndrome|acute cerebellar syndrome|0|06.348803|1
00004453|Granulomatous Colitis|Granulomatous Colitis|1|09.555100|2
00004454|collagenous colitis|collagenous colitis|0|09.558905|2
00004455|chronic ulcerative rectosigmoiditis|chronic ulcerative rectosigmoiditis|0|09.569893|3
00004491|gastroenteritis due to Salmonella|gastroenteritis due to Salmonella|0|01.003000|1
00004493|Listeria monocytogenes septicemia|Listeria monocytogenes septicemia|0|01.027003|1
00004494|cutaneous listeriosis|cutaneous listeriosis|0|01.027004|1
00004495|acute epiglottitis|acute epiglottitis|0|08.464300|1
00004496|Listeria septic arthritis|Listeria septic arthritis|0|13.711006|1
00004497|Listeria osteomyelitis|Listeria osteomyelitis|0|13.730015|1
00004500|acute staphylococcal bacterial sinusitis|acute staphylococcal bacterial sinusitis|0|08.461908|1
00004566|infant botulism|infant botulism|0|01.005101|1
00004567|Jakob-Creutzfeldt disease|Jakob-Creutzfeldt disease|0|01.046100|1
00004568|basal cell carcinoma of skin|basal cell carcinoma of skin|0|02.173905|2
00004569|malignant lymphoma|malignant lymphoma|0|02.202802|1
00004570|Wernicke-Korsakoff syndrome|Wernicke-Korsakoff syndrome|0|05.291101|1
00004571|reversal of neuromuscular blockade|reversal of neuromuscular blockade|0|06.358904|1
00004572|acne rosacea keratitis|acne rosacea keratitis|0|12.695303|1
00004615|Yersinia pseudotuberculosis infection|Yersinia pseudotuberculosis infection|0|01.027802|1
00004616|herpes simplex hepatitis|herpes simplex hepatitis|0|01.070590|2
00004617|herpes zoster hepatitis|herpes zoster hepatitis|0|01.070591|2
00004618|hypocalcemia prevention|hypocalcemia prevention|0|03.275411|3
00004619|hydrocephalus due to intraventricular hemorrhage|hydrocephalus due to intraventricular hemorrhage|0|06.331300|2
00004620|infantile spasms|infantile spasms|0|06.345600|2
00004621|urinary tract obstruction|urinary tract obstruction|0|10.599601|3
00004622|viral skin infection|viral skin infection|0|12.686937|1
00004623|infected atopic dermatitis|infected atopic dermatitis|0|12.691801|1
00004624|aorta dextratransposition with intact ventricular septum|aorta dextratransposition with intact ventricular septum|0|14.745110|2
00004625|tetralogy of fallot|tetralogy of fallot|0|14.745200|2
00004626|congenital atresia of pulmonary valve|congenital atresia of pulmonary valve|0|14.746010|2
00004627|tricuspid valve atresia|tricuspid valve atresia|0|14.746100|2
00004628|Ebstein's anomaly of the tricuspid valve|Ebstein's anomaly of the tricuspid valve|0|14.746200|2
00004629|coarctation of aorta|coarctation of aorta|0|14.747100|2
00004630|pulmonary artery stenosis|pulmonary artery stenosis|0|14.747301|2
00004631|prevention of neonatal group B streptococcal infection|prevention of neonatal group B streptococcal infection|0|14.771800|2
00004632|neonatal group B streptococcal septicemia|neonatal group B streptococcal septicemia|0|14.771801|1
00004633|neonatal meningitis|neonatal meningitis|0|14.771802|1
00004634|neonatal pneumonia|neonatal pneumonia|0|14.771803|1
00004635|sepsis of newborn|sepsis of newborn|0|14.771804|1
00004636|neonatal herpes meningoencephalitis|neonatal herpes meningoencephalitis|0|15.771201|1
00004637|meconium ileus|meconium ileus|0|15.777100|3
00004638|prevention of NSAID-induced gastric ulcer|prevention of NSAID-induced gastric ulcer|0|19.E93563|1
00004654|seizure due to abrupt benzodiazepine withdrawal|seizure due to abrupt benzodiazepine withdrawal|0|19.E93941|1
00004655|seizure due to alcohol withdrawal|seizure due to alcohol withdrawal|0|19.E98090|1
00004670|Wenckebach's block|Wenckebach's block|0|07.426132|3
00004671|hemarthrosis|hemarthrosis|0|13.719100|1
00004672|chronic diarrhea|chronic diarrhea|0|16.787914|2
00004731|ocular infection|ocular infection|0|06.360000|2
00004732|infection by Yersinia enterocolitica|infection by Yersinia enterocolitica|0|01.008440|1
00004733|gastrointestinal stromal tumor|gastrointestinal stromal tumor|0|02.239001|1
00004734|21-hydroxylase deficiency|21-hydroxylase deficiency|0|03.255202|3
00004735|Wernicke's encephalopathy|Wernicke's encephalopathy|0|03.265101|3
00004736|homocystinuria type III|homocystinuria type III|0|03.270401|2
00004737|homocysteinemia|homocysteinemia|0|03.270402|2
00004738|Ureaplasma meningitis|Ureaplasma meningitis|0|06.320824|1
00004739|moderate hypertension|moderate hypertension|0|07.401915|2
00004740|Ureaplasma pneumonia|Ureaplasma pneumonia|0|08.482839|1
00004741|bronchoedema|bronchoedema|0|08.519801|3
00004742|complicated peritonitis due to Clostridium|complicated peritonitis due to Clostridium|0|09.567026|1
00004743|complicated peritonitis due to Eubacterium|complicated peritonitis due to Eubacterium|0|09.567027|1
00004744|nephrogenic diabetes insipidus|nephrogenic diabetes insipidus|0|10.588100|1
00004746|septic abortion due to Porphyromonas|septic abortion due to Porphyromonas|0|11.637029|1
00004747|postpartum endomyometritis due to Streptococcus|postpartum endomyometritis due to Streptococcus|0|11.670040|1
00004748|postpartum endomyometritis due to E. coli|postpartum endomyometritis due to E. coli|0|11.670041|1
00004749|postpartum endomyometritis due to Bacteroides|postpartum endomyometritis due to Bacteroides|0|11.670042|1
00004750|postpartum endomyometritis due to Porphyromonas|postpartum endomyometritis due to Porphyromonas|0|11.670043|1
00004751|postpartum endomyometritis due to Peptostreptococcus|postpartum endomyometritis due to Peptostreptococcus|0|11.670044|1
00004752|postpartum endomyometritis due to Prevotella|postpartum endomyometritis due to Prevotella|0|11.670045|1
00004753|ecthyma gangrenosum|ecthyma gangrenosum|0|12.686090|1
00004754|complicated skin structure Peptostreptococcus infection|complicated skin and skin structure Peptostreptococcus infection|0|12.686938|1
00004755|twin reversal arterial perfusion syndrome|twin reversal arterial perfusion syndrome|0|15.762300|2
00004756|neonatal bronchopulmonary dysplasia|neonatal bronchopulmonary dysplasia|0|15.770700|1
00004757|congenital toxoplasmosis|congenital toxoplasmosis|0|15.771202|1
00004758|anemia of prematurity|anemia of prematurity|0|15.776600|3
00004759|post-op gynecologic infection due to Streptococcus|post-op gynecologic infection due to Streptococcus|0|17.998590|1
00004760|post-op gynecological infection due to E. coli|post-op gynecological infection due to E. coli|0|17.998591|1
00004761|post-op gynecologic infection due to Bacteroides|post-op gynecologic infection due to Bacteroides|0|17.998592|1
00004762|post-op gynecologic infection due to Porphyromonas|post-op gynecologic infection due to Porphyromonas|0|17.998593|1
00004763|post-op gynecological Peptostreptococcus infection|post-op gynecological Peptostreptococcus infection|0|17.998594|1
00004764|post-op gynecologic infection due to Prevotella|post-op gynecologic infection due to Prevotella|0|17.998595|1
00004839|AIDS with Kaposi's sarcoma|AIDS with Kaposi's sarcoma|0|02.176901|2
00004840|nesidioblastosis|nesidioblastosis|0|02.211701|2
00004841|congenital adrenal hyperplasia|congenital adrenal hyperplasia|0|03.255203|2
00004842|hereditary tyrosinemia type I|hereditary tyrosinemia type I|0|03.270201|2
00004843|hypertyrosinemia|hypertyrosinemia|0|03.270202|2
00004844|homocystinuria type I|homocystinuria type I|0|03.270403|2
00004845|homocystinuria type II|homocystinuria type II|0|03.270404|2
00004846|cystathioninuria|cystathioninuria|0|03.270405|2
00004847|GABA transaminase deficiency|GABA transaminase deficiency|0|03.270801|2
00004848|abetalipoproteinemia|abetalipoproteinemia|0|03.272501|2
00004849|Crigler-Najjar syndrome|Crigler-Najjar syndrome|0|03.277400|2
00004850|disruptive behavior disorder|disruptive behavior disorder|0|05.301302|3
00004851|restless leg syndrome|restless leg syndrome|0|06.333992|1
00004852|x-linked adrenoleukodystrophy|x-linked adrenoleukodystrophy|0|03.27786A|2
00004853|retinopathy of prematurity|retinopathy of prematurity|0|06.362210|1
00004854|acute streptococcal epiglottitis|acute streptococcal epiglottitis|0|08.464301|1
00004855|congenital pituitary hypoplasia|congenital pituitary hypoplasia|0|14.759200|2
00004856|omphalitis of newborn|omphalitis of newborn|0|14.771400|1
00004857|intraventricular hemorrhage in newborn|intraventricular hemorrhage in newborn|0|14.772100|1
00004858|neonatal mixed apnea|neonatal mixed apnea|0|15.770801|1
00004859|kernicterus|kernicterus|0|15.774700|1
00004860|neonatal hyperthyroidism|neonatal hyperthyroidism|0|15.775301|1
00004861|osteopenia of prematurity|osteopenia of prematurity|0|15.775401|1
00004862|Neonatal Hypomagnesemia|Neonatal Hypomagnesemia|1|15.775402|1
00004863|prevention of hemorrhagic disease of newborn|prevention of hemorrhagic disease of newborn due to vitamin K deficiency|0|15.776001|1
00004864|neonatal abstinence syndrome|neonatal abstinence syndrome|0|15.779500|1
00004865|extravasation injury|extravasation injury|0|17.999902|1
00004866|nontraumatic splenic rupture|nontraumatic splenic rupture|0|04.289591|1
00004882|symptomatic gastroesophageal reflux disease|symptomatic gastroesophageal reflux disease|0|09.530812|3
00004892|Default Screening Record|Default Screening Record|0|999|3
00004905|bone metastases of solid tumors|bone metastases of solid tumors|0|02.198504|2
00004907|recurrent malignant glioma|recurrent malignant glioma|0|02.191902|2
00004908|Crigler-Najjar syndrome, type II|Crigler-Najjar syndrome, type II|0|03.277401|2
00004910|methanol poisoning|methanol poisoning|0|17.980100|1
00004912|hypertensive crisis in pregnancy|hypertensive crisis in pregnancy|0|11.642901|1
00004913|bone marrow suppression due to folic acid antagonism|bone marrow suppression due to folic acid antagonism|0|04.289905|1
00004915|Enterocolitis due to Salmonella|Enterocolitis due to Salmonella|1|01.003001|1
00004920|pharyngitis due to Haemophilus parainfluenzae|pharyngitis due to Haemophilus parainfluenzae|0|08.462004|1
00004929|Haemophilus parainfluenzae acute otitis media|Haemophilus parainfluenzae acute otitis media|0|06.382905|1
00005181|esophageal dysmotility|esophageal dysmotility|0|09.530900|2
00005265|scoliosis|scoliosis|0|13.737300|2
00005266|bacteremia due to Leuconostoc|bacteremia due to Leuconostoc|0|16.790703|1
00005267|neonatal Leuconostoc meningitis|neonatal Leuconostoc meningitis|0|14.771805|1
00005273|toxocariasis due to Toxocara cati|toxocariasis due to Toxocara cati|0|01.128001|1
00005277|toxocariasis due to Toxocara canis|toxocariasis due to Toxocara canis|0|01.128002|1
00005281|multifocal atrial tachycardia|multifocal atrial tachycardia|0|07.427894|1
00005288|ectopic atrial tachycardia|ectopic atrial tachycardia|0|07.427899|1
00005289|Hashimoto thyroiditis|Hashimoto thyroiditis|0|03.245200|1
00005291|congenital sucrase-isomaltase deficiency|congenital sucrase-isomaltase deficiency|0|03.271301|2
00005295|mansonellosis due to Mansonella perstans|mansonellosis due to Mansonella perstans|0|01.125500|1
00005297|eosinophilic enterocolitis due to Ancylostoma caninum|eosinophilic enterocolitis due to Ancylostoma caninum|0|09.558906|1
00005299|microsporidiosis|microsporidiosis|0|01.136801|1
00005414|vascular access hemorrhage|vascular access hemorrhage|0|17.996741|1
00005415|vascular access thrombosis|vascular access thrombosis|0|17.996742|1
00005418|scalp psoriasis|scalp psoriasis|0|12.696104|3
00005419|hyperuricemia due to cancer therapy|hyperuricemia due to cancer therapy|0|16.790603|1
00005420|adenine phosphoribosyltransferase deficiency|adenine phosphoribosyltransferase deficiency|0|03.277200|1
00005421|deficiency of ribose-phosphate pyrophosphokinase|deficiency of ribose-phosphate pyrophosphokinase|0|03.277201|1
00005422|NB phosphoribosylpyrophosphate synthetase superactivity|neonatal phosphoribosylpyrophosphate synthetase superactivity|0|03.277202|1
00005425|neurogenic pain|neurogenic pain|0|13.729201|3
00005429|seasonal allergic rhinitis|seasonal allergic rhinitis|0|08.477905|2
00005459|Citrobacter septicemia|Citrobacter septicemia|0|01.038494|1
00005460|Klebsiella septicemia|Klebsiella septicemia|0|01.038495|1
00005468|Citrobacter biliary tract infection|Citrobacter biliary tract infection|0|09.576803|1
00005469|Enterobacter biliary tract infection|Enterobacter biliary tract infection|0|09.576804|1
00005470|Escherichia coli biliary tract infection|Escherichia coli biliary tract infection|0|09.576805|1
00005471|Klebsiella biliary tract infection|Klebsiella biliary tract infection|0|09.576806|1
00005473|Proteus biliary tract infection|Proteus biliary tract infection|0|09.576807|1
00005475|Pseudomonas aeruginosa biliary tract infection|Pseudomonas aeruginosa biliary tract infection|0|09.576808|1
00005479|Serratia biliary tract infection|Serratia biliary tract infection|0|09.576809|1
00005480|Staphylococcus biliary tract infection|Staphylococcus biliary tract infection|0|09.576810|1
00005481|Citrobacter osteomyelitis|Citrobacter osteomyelitis|0|13.730201|1
00005482|Klebsiella osteomyelitis|Klebsiella osteomyelitis|0|13.730202|1
00005486|Proteus osteomyelitis|Proteus osteomyelitis|0|13.730203|1
00005488|Staphylococcus osteomyelitis|Staphylococcus osteomyelitis|0|13.730204|1
00005490|Citrobacter joint infection|Citrobacter joint infection|0|13.711007|1
00005491|Staphylococcus joint infection|Staphylococcus joint infection|0|13.711008|1
00005492|Citrobacter meningitis|Citrobacter meningitis|0|06.320825|1
00005493|Enterobacter meningitis|Enterobacter meningitis|0|06.320826|1
00005494|Proteus meningitis|Proteus meningitis|0|06.320827|1
00005495|Serratia meningitis|Serratia meningitis|0|06.320828|1
00005496|skin and skin structure Staph. infection|skin and skin structure Staphylococcus infection|0|12.686939|1
00005659|decrease in forced vital capacity|decrease in forced vital capacity|0|16.786900|1
00005660|disseminated coccidioidomycosis|disseminated coccidioidomycosis|0|01.114300|1
00005661|onychomycosis due to Trichophyton|onychomycosis due to Trichophyton|0|01.110103|1
00005663|onychomycosis due to Candida|onychomycosis due to Candida|0|01.112302|1
00005665|Aspergillus pneumonia|Aspergillus pneumonia|0|01.117305|1
00005666|pulmonary coccidioidomycosis|pulmonary coccidioidomycosis|0|01.114500|1
00005668|thrombosis w/heparin-induced thrombocytopenia during PCI|thrombosis with heparin-induced thrombocytopenia during percutaneous coronary intervention|0|17.997790|1
00005671|asymptomatic left ventricular dysfunction|asymptomatic left ventricular dysfunction|0|07.42990B|2
00005672|thromboembolism due to prosthetic heart valves|thromboembolism due to prosthetic heart valves|0|17.996710|2
00005673|prevent thromboembolism in chronic atrial fibrillation|prevention of thromboembolism in chronic atrial fibrillation|0|07.444909|2
00005675|Cystic Aponeurosis Tumor|Cystic Aponeurosis Tumor|1|02.239202|3
00005677|subacute bursitis|subacute bursitis|0|13.727301|1
00005678|staphylococcal tonsillitis|staphylococcal tonsillitis|0|08.463001|1
00005679|tonsillitis due to Haemophilus influenzae|tonsillitis due to Haemophilus influenzae|0|08.463002|1
00005680|skin and skin structure Streptococcus infection|skin and skin structure Streptococcus infection|0|12.686940|1
00005735|synergy for staphylococcal septicemia|synergy for staphylococcal septicemia|0|01.038101|1
00005736|synergy for enterococcal infection|synergy for enterococcal infection|0|01.041041|1
00005737|synergy for staphylococcal biliary tract infection|synergy for staphylococcal biliary tract infection|0|09.576811|1
00005738|synergy for staphylococcal osteomyelitis|synergy for staphylococcal osteomyelitis|0|13.730205|1
00005739|synergy for staphylococcal joint infection|synergy for staphylococcal joint infection|0|13.711009|1
00005742|synergy for streptococcal endocarditis|synergy for streptococcal endocarditis|0|07.421008|1
00005743|synergy for staphylococcal endocarditis|synergy for staphylococcal endocarditis|0|07.421009|1
00005744|synergy for staphylococcal meningitis|synergy for staphylococcal meningitis|0|06.320301|1
00005745|synergy for staphylococcal peritonitis|synergy for staphylococcal peritonitis|0|09.567209|1
00005777|hypocalcemic tetany|hypocalcemic tetany|0|16.781701|1
00005779|diffuse proliferative lupus nephritis|diffuse proliferative lupus nephritis|0|13.710004|2
00005857|acute abdominal pain|acute abdominal pain|0|16.789002|1
00005879|enanthema|enanthema|0|16.782902|1
00005890|hypoxanthine-guanine phosphoribosyltransferase deficienc|hypoxanthine-guanine phosphoribosyltransferase deficiency|0|03.277203|1
00005925|Metastatic Breast Cancer Progress Post-Antiestrogen Tx|Metastatic Breast Cancer Progression Post-Antiestrogen Therapy|0|02.174900|2
00005926|slipped capital epiphyses|slipped capital epiphyses|0|13.732200|1
00005930|progression of nevus|progression of nevus|0|02.216900|1
00005937|glabellar lines|glabellar lines|0|12.709805|2
00005986|Acinetobacter pneumonia|Acinetobacter pneumonia|0|08.48283A|1
00005989|Acinetobacter osteomyelitis|Acinetobacter osteomyelitis|0|13.730206|1
00005993|Acinetobacter joint infection|Acinetobacter joint infection|0|13.71100A|1
00005995|complicated urinary tract infection due to Acinetobacter|complicated urinary tract infection due to Acinetobacter|0|10.599036|1
00005998|Acinetobacter meningitis|Acinetobacter meningitis|0|06.320829|1
00006004|Acinetobacter biliary tract infection|Acinetobacter biliary tract infection|0|09.576812|1
00006006|argininosuccinate lyase deficiency|argininosuccinate lyase deficiency|0|03.270601|1
00006007|carbamoyl phosphate synthetase deficiency|carbamoyl phosphate synthetase deficiency|0|03.270602|1
00006011|citrullinemia|citrullinemia|0|03.270603|1
00006012|isovaleric acidemia|isovaleric acidemia|0|03.270301|1
00006013|metabolic alkalosis|metabolic alkalosis|0|03.276303|1
00006014|advanced breast cancer progress post-antiestrogen tx|advanced breast cancer progress post-antiestrogen therapy|0|02.174901|2
00006016|locally advanced breast carcinoma|locally advanced breast carcinoma|0|02.174902|2
00006056|synergy for candida infection|synergy for candida infection|0|01.112901|3
00006058|synergy for cryptococcal infection|synergy for cryptococcal infection|0|01.117504|1
00006059|synergy for Aspergillus infection|synergy for Aspergillus infection|0|01.117306|3
00006060|synergy for Sporothrix infection|synergy for Sporothrix infection|0|01.117102|3
00006062|abrupt drug withdrawal causing life-threatening sequelae|abrupt drug withdrawal causing life-threatening sequelae|0|05.292003|1
00006068|synergy for group B streptococcal septicemia|synergy for group B streptococcal septicemia|0|14.771806|1
00006069|synergy for Pseudomonas aeruginosa meningitis|synergy for Pseudomonas aeruginosa meningitis|0|06.320822|1
00006070|synergy for Pseudomonas aeruginosa osteomyelitis|synergy for Pseudomonas aeruginosa osteomyelitis|0|13.730017|3
00006071|synergy for Pseudomonas aeruginosa pneumonia|synergy for Pseudomonas aeruginosa pneumonia|0|08.482102|1
00006072|synergy for Staphylococcus aureus pneumonia|synergy for Staphylococcus aureus pneumonia|0|08.482401|1
00006073|Synergy for Staphylococcus Aureus Osteomyelitis|Synergy for Staphylococcus Aureus Osteomyelitis|0|13.730016|3
00006074|synergy for S. aureus skin and skin structure infection|synergy for Staphylococcus aureus skin and skin structure infection|0|12.686941|3
00006075|synergy for staphylococcal infection|synergy for staphylococcal infection|0|01.041102|3
00006076|synergy for Listeria monocytogenes septicemia|synergy for Listeria monocytogenes septicemia|0|01.027005|1
00006077|synergy for Listeria monocytogenes meningitis|synergy for Listeria monocytogenes meningitis|0|01.027006|1
00006078|synergy for anthrax infection|synergy for anthrax infection|0|01.022902|1
00006184|local anesthesia for endotracheal intubation|local anesthesia for endotracheal intubation|0|16. 9999E|1
00006185|local anesthesia for urethral pain|local anesthesia for urethral pain|0|16. 9999F|1
00006187|High Altitude Pulmonary Edema Prevention|High Altitude Pulmonary Edema Prevention|0|17.993201|1
00006208|foreign body sensation of eye|foreign body sensation of eye|0|06.379804|1
00006209|ocular warming sensation|ocular warming sensation|0|06.379803|1
00006210|sticky sensation of eye|sticky sensation of eye|0|06.379805|1
00006211|Transient Tyrosinemia of the Newborn|Transient Tyrosinemia of the Newborn|0|15.775800|1
00006212|Hawkinsinuria|Hawkinsinuria|0|03.270203|1
00006213|Alcaptonuria|Alcaptonuria|0|03.270204|1
00006266|varicella zoster virus infection|varicella zoster virus infection|0|01.052901|1
00006272|measles|measles|0|01.055900|1
00006276|Untreated Bacterial Infection|Untreated Bacterial Infection|0|01.041905|1
00006277|untreated fungal infection|untreated fungal infection|0|01.117901|1
00006438|Beta-Ketothiolase Deficiency|Beta-Ketothiolase Deficiency|0|03.277608|1
00006439|ornithine carbamoyltransferase deficiency|ornithine carbamoyltransferase deficiency|0|03.270604|1
00006440|biotinidase deficiency|biotinidase deficiency|0|03.277609|1
00006441|Holocarboxylase Deficiency|Holocarboxylase Deficiency|0|03.277610|1
00006442|Lysinuric Protein Intolerance|Lysinuric Protein Intolerance|0|03.270700|1
00006443|glutaric aciduria type I|glutaric aciduria type I|0|03.277611|1
00006444|propionic acidemia|propionic acidemia|0|03.270302|1
00006445|3-Methylcrotonyl-CoA Carboxylase Deficiency|3-Methylcrotonyl-CoA Carboxylase Deficiency|0|03.277612|1
00006447|3-Hydroxy 3-Methylglutaric Aciduria|3-Hydroxy 3-Methylglutaric Aciduria|0|03.270303|1
00006448|glutaric aciduria type II|glutaric aciduria type II|0|03.277613|1
00006449|Congenital Lactic Acidosis|Congenital Lactic Acidosis|0|03.276206|2
00006450|Acrodermatitis Enteropathica|Acrodermatitis Enteropathica|0|12.686801|1
00006451|hemangiomata of infancy|hemangiomata of infancy|0|02.228001|2
00006452|arginase deficiency|arginase deficiency|0|03.270605|1
00006489|prevention of transient ischemic attack|prevention of transient ischemic attack|0|07.435903|3
00006498|contrast media-induced nephrotoxicity prevention|contrast media-induced nephrotoxicity prevention|0|10.584501|1
00006500|Tyrosinemia Type III|Tyrosinemia Type III|0|03.270205|2
00006572|acute H. flu exacerbation of obstructive chr. bronchitis|acute exacerbation of obstructive chronic bronchitis due to H. flu|0|08.491200|1
00006573|acute exacerbation obst chr bronchitis by M. catarrhalis|acute exacerbation of obstructive chronic bronchitis by M. catarrhalis|0|08.491201|1
00006574|acute exacerbation obstr chr bronchitis S. pneumoniae|acute exacerbation of obstructive chronic bronchitis by Streptococcus pneumoniae|0|08.491202|1
00006595|fungal infection due to Scedosporium apiospermum|fungal infection due to Scedosporium apiospermum|0|01.117601|1
00006596|Fusarium infection|Fusarium infection|0|01.118001|1
00006597|fungal infection due to Fusarium solani|fungal infection due to Fusarium solani|0|01.118002|1
00006763|vitamin deficiency prevention|vitamin deficiency prevention|0|03.269201|3
00006765|ocular surface squamous neoplasia|ocular surface squamous neoplasia|0|02.234000|2
00006768|constipation predominant irritable bowel syndrome|constipation predominant irritable bowel syndrome|0|09.564102|2
00006769|synergy for Staphylococcus aureus endocarditis|synergy for Staphylococcus aureus endocarditis|0|07.421010|1
00006924|Substance Overdose|Substance Overdose|0|17.977900|1
00006925|urine alkalinization|urine alkalinization|0|16.791904|1
00006934|debridement of wound of skin|debridement of wound of skin|0|15. 86280|1
00007034|hemolytic anemia from pyruvate kinase and G6PD deficienc|hemolytic anemia from pyruvate kinase and G6PD deficiencies|0|04.282301|1
00007036|tetanus adjunct treatment|tetanus adjunct treatment|0|01.037001|1
00007085|galactose intolerance|galactose intolerance|2|03.271302|2
00007142|diarrhea due to E. coli|diarrhea due to E. coli|0|01.008000|1
00007234|sensation of cold|sensation of cold|0|16.782008|1
00007235|sensation of warmth|sensation of warmth|0|16.782009|1
00007238|CMV retinitis in AIDS patient|CMV retinitis in AIDS patient|0|06.363202|1
00007239|CMV retinitis in immunocompromised patient|CMV retinitis in immunocompromised patient|0|06.363203|1
00007242|acyclovir-resistant HSV infection|acyclovir-resistant HSV infection|0|01.054905|1
00007243|acyclovir-resist. mucocutaneous HSV in immunocompromised|acyclovir-resistant mucocutaneous HSV in immunocompromised patient|0|01.054792|1
00007244|CMV-related polyradiculopathy in AIDS patient|CMV-related polyradiculopathy in AIDS patient|0|06.357001|1
00007245|prevention of CMV disease in advanced HIV patient|prevention of CMV disease in advanced HIV patient|0|01.078504|1
00007278|AIDS with acyclovir-resistant varicella zoster virus|AIDS with acyclovir-resistant varicella zoster virus infection|0|01.052902|1
00007570|central nervous system infection|central nervous system infection|0|06.349892|1
00007610|cataplexy with associated narcolepsy|cataplexy with associated narcolepsy|0|06.347002|2
00007614|pyridoxine-dependent seizure|pyridoxine-dependent seizure|0|15.779000|2
00007624|Fatty Stool as Cystic Fibrosis Intestinal Manifestation|Fatty Stool as Cystic Fibrosis Intestinal Manifestation|0|09.579400|1
00007631|Asthma Related to Salicylate Allergy|Asthma Related to Salicylate Allergy|2|08.493908|1
00007636|gastrointestinal perforation|gastrointestinal perforation|0|09.534501|1
00007662|diabetic peripheral neuropathy|diabetic peripheral neuropathy|0|03.250600|2
00007836|pregnancy- third trimester|pregnancy- third trimester|0|18.V22204|2
00007941|stimulant drug dependence|stimulant drug dependence|0|05.304400|1
00007942|sedative drug dependence|sedative drug dependence|0|05.304100|1
00007943|Cannabis Dependence|Cannabis Dependence|0|05.304300|1
00008225|pneumonia due to Klebsiella pneumoniae|pneumonia due to Klebsiella pneumoniae|0|08.482001|1
00008226|pneumonia due to Staphylococcus aureus|pneumonia due to Staphylococcus aureus|0|08.482410|1
00008228|Chlamydia Coinfection with Rectal Gonorrhea|Chlamydia Coinfection with Rectal Gonorrhea|0|01.098701|1
00008229|Chlamydia Coinfection with Pharyngeal Gonorrhea|Chlamydia Coinfection with Pharyngeal Gonorrhea|0|01.098601|1
00008236|acute sinusitis due to Klebsiella pneumoniae|acute sinusitis due to Klebsiella pneumoniae|0|08.473902|1
00008269|No Disease Contraindications|No Disease Contraindications|0|999999991|3
00008270|No Side Effects|No Side Effects|0|999999992|3
00008271|No Indications|No Indications|0|999999993|3
00008306|Calcium Channel Blocker Overdose|Calcium Channel Blocker Overdose|0|17.972900|1
00008311|renal disease with moderate to severe impairment|renal disease with moderate to severe function impairment|0|10.593907|1
00008349|Provision of Therapeutic Radionuclide|Provision of Therapeutic Radionuclide|2|16. 88900|1
00008387|severe neutropenic disorder|severe neutropenic disorder|0|04.288016|1
00008438|Athletic Performance|Athletic Performance|2|18.V70300|1
00008439|Bell's palsy|Bell's palsy|0|06.351000|2
00008440|Birth Defects Prevention|Birth Defects Prevention|2|14.759900|1
00008441|onychia sicca|onychia sicca|0|12.703801|2
00008442|capillary fragility|capillary fragility|0|04.287800|1
00008443|Childhood Infectious Diseases|Childhood Infectious Diseases|0|16.799803|1
00008444|chronic fatigue syndrome|chronic fatigue syndrome|0|16.780710|2
00008446|abdominal colic|abdominal colic|0|16.789003|1
00008447|Dupuytren's contracture|Dupuytren's contracture|0|13.728600|2
00008450|Recurrent Ear Infections|Recurrent Ear Infections|0|06.382906|2
00008453|Insulin Resistance Syndrome|Insulin Resistance Syndrome|1|03.259800|2
00008454|Jet Lag|Jet Lag|0|16.780790|1
00008455|lactose intolerance|lactose intolerance|0|03.271303|2
00008457|Menkes Disease|Menkes Disease|0|14.759891|2
00008460|Minor Injuries|Minor Injuries|0|17.959901|1
00008461|nausea gravidarum|nausea gravidarum|0|11.643000|2
00008462|Monosodium Glutamate Sensitivity|Monosodium Glutamate Sensitivity|2|17.995304|2
00008463|Osgood-Schlatter disease|Osgood-Schlatter disease|0|13.732400|2
00008464|seasonal affective disorder|seasonal affective disorder|0|05.298001|2
00008465|snoring|snoring|0|16.78609B|2
00008466|sprains and strains|sprains and strains|0|17.848900|1
00008467|Pre-Surgery or Post-Surgery Health Examination|Pre-Surgery or Post-Surgery Health Examination|0|18.V72840|1
00008468|Yellow Nail Syndrome|Yellow Nail Syndrome|0|12.703802|2
00008477|Radiography with IV Iodinated Contrast Agent|Radiography with IV Iodinated Contrast Agent|0|16. 88392|1
00008491|Beta-Blocker Overdose|Beta-Blocker Overdose|0|17.972901|1
00008512|malignant neoplasm of bone marrow|malignant neoplasm of bone marrow|0|02.202803|2
00008593|heterozygous familial hypercholesterolemia|heterozygous familial hypercholesterolemia|0|03.272002|2
00008594|sitosterolemia|sitosterolemia|0|09.579801|2
00008595|primary prevention of coronary heart disease|primary prevention of coronary heart disease|0|07.414900|2
00008610|severe autonomic insufficiency|severe autonomic insufficiency|0|06.337901|1
00008641|lipodystrophy|lipodystrophy|0|03.272600|2
00008680|Whipple's disease|Whipple's disease|0|01.040200|2
00008760|left bundle branch block|left bundle branch block|0|07.426300|1
00008761|familial dysautonomia|familial dysautonomia|0|14.742800|2
00008762|pleural fibrosis|pleural fibrosis|0|08.511001|3
00008766|intraventricular conduction delay|intraventricular conduction delay|0|07.426908|1
00008789|valvular sclerosis|valvular sclerosis|0|07.424907|1
00008820|postexposure plague prophylaxis|postexposure plague prophylaxis|0|18.V01890|1
00008821|administration of regional anesthesia|administration of regional anesthesia|0|16. 9999G|1
00008822|Psychosis associated with Alzheimer's Disease|Psychosis associated with Alzheimer's Disease|0|06.331001|1
00008923|Philadelphia chromosome positive CML|Philadelphia chromosome positive chronic myelocytic leukemia|0|02.205104|2
00008925|pulmonary capillary hemangiomatosis|pulmonary capillary hemangiomatosis|0|02.228090|2
00008933|encephalitis due to toxoplasmosis|encephalitis due to toxoplasmosis|0|01.130000|1
00008952|hepatic encephalopathy|hepatic encephalopathy|0|09.572201|3
00008953|ductal carcinoma in situ of breast|ductal carcinoma in situ of breast|0|02.233005|2
00009017|prior radiation therapy involving bone|prior radiation therapy involving bone|0|16. 92291|1
00009022|Malignant Bone Disease|Malignant Bone Disease|0|02.170902|2
00009027|Hypogonadal Osteoporosis in Male Patient|Hypogonadal Osteoporosis in Male Patient|0|13.733092|2
00009032|nosocomial pneumonia D/T methicillin-sensitive S. aureus|nosocomial pneumonia due to methicillin-sensitive Staphylococcus aureus|0|08.482411|1
00009033|synergy for nosocomial pneumonia due to P. aeruginosa|synergy for nosocomial pneumonia due to Pseudomonas aeruginosa|0|08.482103|1
00009038|nosocomial pneumonia due to Serratia marcescens|nosocomial pneumonia due to Serratia marcescens|0|08.48283B|1
00009041|nosocomial pneumonia due to Escherichia coli|nosocomial pneumonia due to Escherichia coli|0|08.482821|1
00009042|nosocomial pneumonia due to Klebsiella pneumoniae|nosocomial pneumonia due to Klebsiella pneumoniae|0|08.482002|1
00009059|nosocomial pneumonia due to Streptococcus pneumoniae|nosocomial pneumonia due to Streptococcus pneumoniae|0|08.481001|1
00009101|Hyperparathyroid Bone Disease|Hyperparathyroid Bone Disease|0|13.733994|2
00009102|Hepatic Osteodystrophy|Hepatic Osteodystrophy|0|13.733995|2
00009135|synergy for Citrobacter meningitis|synergy for Citrobacter meningitis|0|06.32082A|1
00009138|synergy for enterococcal endocarditis|synergy for enterococcal endocarditis|0|07.421011|1
00009139|synergy for Enterobacter meningitis|synergy for Enterobacter meningitis|0|06.32082B|1
00009142|synergy for Escherichia coli meningitis|synergy for Escherichia coli meningitis|0|06.32082C|1
00009143|synergy for Klebsiella meningitis|synergy for Klebsiella meningitis|0|06.32082D|1
00009146|synergy for neonatal meningitis|synergy for neonatal meningitis|0|15.771890|1
00009152|synergy for Proteus meningitis|synergy for Proteus meningitis|0|06.32082E|1
00009161|synergy for P. aeruginosa biliary tract infection|synergy for Pseudomonas aeruginosa biliary tract infection|0|09.576813|1
00009163|synergy for Pseudomonas aeruginosa joint infection|synergy for Pseudomonas aeruginosa joint infection|0|13.71100B|1
00009194|synergy for Pseudomonas aeruginosa peritonitis|synergy for Pseudomonas aeruginosa peritonitis|0|09.567210|1
00009195|synergy for Pseudomonas aeruginosa septicemia|synergy for Pseudomonas aeruginosa septicemia|0|01.038431|1
00009196|synergy for Serratia meningitis|synergy for Serratia meningitis|0|06.32082F|1
00009199|synergy for skin structure P. aeruginosa infection|synergy for skin and skin structure Pseudomonas aeruginosa infection|0|12.686942|1
00009201|synergy for Staphylococcus skin structure infection|synergy for Staphylococcus skin and skin structure infection|0|12.686943|1
00009232|ehrlichiosis|ehrlichiosis|0|01.082400|1
00009234|Pseudomonas respiratory tract infxn in cystic fibrosis|Pseudomonas respiratory tract infection in cystic fibrosis|0|08.490017|3
00009236|facial fine wrinkling|facial fine wrinkling|0|12.701802|1
00009238|facial hyperpigmentation|facial hyperpigmentation|0|12.709095|1
00009239|facial hypopigmentation|facial hypopigmentation|0|12.709096|1
00009240|facial lentigo|facial lentigo|0|12.709097|2
00009299|leptospirosis|leptospirosis|0|01.100900|1
00009300|Postmenopausal Advanced Breast CA Post-Antiestrogen Tx|Postmenopausal Advanced Breast Cancer Post-Antiestrogen Therapy|0|02.174903|2
00009302|early breast cancer HR positive and postmenopausal|early breast cancer hormone receptor positive and postmenopausal|0|02.174904|2
00009326|immunoglobulin deficiency|immunoglobulin deficiency|0|03.279001|1
00009328|prevention of rubella after exposure|prevention of rubella after exposure|0|18.V01400|1
00009331|measles contact|measles contact|0|18.V01701|1
00009332|varicella contact|varicella contact|0|18.V01702|1
00009350|prev Rh isoimmuniz 1st trimester pregnancy termination|prevention of Rh isoimmunization at first-trimester pregnancy termination|0|11.656101|1
00009351|prevention of Rh isoimmunization after blood transfusion|prevention of Rh isoimmunization after blood transfusion|0|17.999700|1
00009352|prevention of rhesus isoimmunization affecting pregnancy|prevention of rhesus isoimmunization affecting pregnancy|0|15.773000|1
00009353|Bleeding due to Clotting Factor Inhibition|Bleeding due to Clotting Factor Inhibition|0|04.286908|1
00009355|Prevent Surgery-Induced Bleed from Factor Inhibition|Prevention of Surgery-Induced Bleeding due to Factor Inhibition|0|04.286909|1
00009387|Proteus mirabilis urinary tract infection|Proteus mirabilis urinary tract infection|0|10.599037|1
00009388|Enterococcus faecalis urinary tract infection|Enterococcus faecalis urinary tract infection|0|10.599038|1
00009390|hemodialysis with high-flux membrane|hemodialysis with high-flux membrane|0|07. 39951|2
00009453|DPT, hepatitis B and polio vaccination|diphtheria, pertussis, tetanus, hepatitis B and polio vaccination|0|18.V07390|1
00009498|solar lentigines|solar lentigines|0|12.709098|2
00009520|osteogenesis imperfecta|osteogenesis imperfecta|0|14.756510|2
00009521|Hyporetinemia|Hyporetinemia|1|03.264800|1
00009529|Vitamin A Deficiency with Xerophthalmia|Vitamin A Deficiency with Xerophthalmia|0|03.264700|1
00009587|TPMT poor metabolizer|TPMT poor metabolizer|0|03.277204|2
00009669|angiostrongyliasis due to Angiostrongylus cantonensis|angiostrongyliasis due to Angiostrongylus cantonensis|0|01.127701|3
00009677|angiostrongyliasis due to Angiostrongylus costaricensis|angiostrongyliasis due to Angiostrongylus costaricensis|0|01.127702|3
00009772|hemorrhagic shock|hemorrhagic shock|0|07.459008|1
00009798|myopathy with CK elevation|myopathy with CK elevation|0|13.729103|1
00009799|kyphoscoliosis with respiratory compromise|kyphoscoliosis with respiratory compromise|0|13.737301|2
00009800|opioid use last 4 hours in narcotic-dependent patient|opioid use last 4 hours in narcotic-dependent patient|0|05.304901|1
00009877|Trematodiasis|Trematodiasis|0|01.121900|1
00009884|Cestodiasis|Cestodiasis|0|01.123900|1
00009892|Fasciolopsiasis due to Fasciolopsis Buski|Fasciolopsiasis due to Fasciolopsis Buski|0|01.121400|1
00009893|Heterophyiasis due to Heterophyes Heterophyes|Heterophyiasis due to Heterophyes Heterophyes|0|01.121600|1
00009894|metorchiasis due to Metorchis conjunctus|metorchiasis due to Metorchis conjunctus|0|01.121300|1
00009897|Nanophyetiasis due to Nanophyetus Salmincola|Nanophyetiasis due to Nanophyetus Salmincola|0|01.121800|1
00009925|infection by Cryptosporidium|infection by Cryptosporidium|0|01.007400|1
00010011|prevention of skin allograft rejection|prevention of skin allograft rejection|0|17.996520|1
00010013|Langerhans cell histiocytosis|Langerhans cell histiocytosis|0|03.277800|3
00010134|prevention of chemotherapy-induced hemorrhagic cystitis|prevention of chemotherapy-induced hemorrhagic cystitis|0|10.595904|1
00010165|dilated cardiomyopathy|dilated cardiomyopathy|0|07.425404|1
00010167|nonmetastatic osteosarcoma of bone|nonmetastatic osteosarcoma of bone|0|02.170903|2
00010168|polymyositis|polymyositis|0|13.710400|2
00010176|vaccination to prevent OM due to S. pneumoniae|vaccination to prevent otitis media due to Streptococcus pneumoniae|0|06.382907|1
00010355|prevention of nerve agent poisoning|prevention of nerve agent poisoning|0|19.E99720|1
00010365|liver transplantation|liver transplantation|0|09. 50500|2
00010367|lung transplantation|lung transplantation|0|06. 33500|2
00010374|hepatic artery thrombosis in liver transplant|hepatic artery thrombosis in liver transplant|0|17.996822|1
00010377|bronchial anastomotic dehiscence in lung transplant|bronchial anastomotic dehiscence in lung transplant|0|17.996840|1
00010422|malignant glioma|malignant glioma|0|02.191903|2
00010499|prevention of paroxysmal supraventricular tachycardia|prevention of paroxysmal supraventricular tachycardia|0|07.427005|3
00010526|Atrophic Urethritis|Atrophic Urethritis|0|10.597803|1
00010527|portal hypertension|portal hypertension|0|09.572300|1
00010583|prevent fetal neural tube defect|prevention of fetal neural tube defect during pregnancy|0|11.655000|2
00010667|secretin stimulation testing|secretin stimulation testing|0|09. 52191|1
00010686|molluscum contagiosum infection|molluscum contagiosum infection|0|01.078000|1
00010690|reverse mydriasis from opht adrenergic or anticholin agt|treatment to reverse mydriasis caused by ophthalmic adrenergic or anticholinergic agent|0|03. 16290|1
00010715|Pyridoxine Dependency Syndrome|Pyridoxine Dependency Syndrome|0|03.266101|2
00010719|drug-induced pyridoxine deficiency|drug-induced pyridoxine deficiency|0|03.266102|3
00010722|Neurotoxicity due to Isoniazid Poisoning|Neurotoxicity due to Isoniazid Poisoning|2|17.961800|1
00010729|Neurotoxicity due to Gyromitra Mushroom|Neurotoxicity due to Gyromitra Mushroom Poisoning|2|17.988100|1
00010730|Neurotoxicity due to Cycloserine Poisoning|Neurotoxicity due to Cycloserine Poisoning|2|17.960600|1
00010732|Neurotoxicity due to Hydrazine Poisoning|Neurotoxicity due to Hydrazine Poisoning|2|17.983900|1
00010752|increased creatine kinase level|increased creatine kinase level|0|16.790604|1
00010769|jaundice|jaundice|0|16.782403|1
00010800|No Known Medical Problem|No Known Medical Problem|0|18.V70000|3
00010835|maculopapular rash|maculopapular rash|0|12.709806|1
00010838|anuria|anuria|0|16.788501|1
00010866|administration of corneal anesthesia|administration of corneal anesthesia|0|16. 9999H|1
00010870|nummular dermatitis|nummular dermatitis|0|12.692902|3
00010871|Stasis Dermatitis|Stasis Dermatitis|0|07.459811|2
00010892|Growth Hormone-Secreting Pituitary Adenomas|Growth Hormone-Secreting Pituitary Adenomas|0|02.227301|2
00010902|suicidal behavior in schizophrenia|suicidal behavior in schizophrenia|0|05.300909|3
00010904|suicidal behavior in schizoaffective disorder|suicidal behavior in schizoaffective disorder|0|05.300910|3
00010918|hypertension with left ventricular hypertrophy|hypertension with left ventricular hypertrophy|0|07.402901|2
00011006|tobacco use|tobacco use|0|05.305102|2
00011007|tobacco smoker|tobacco smoker|0|05.305103|2
00011008|smoking cessation|smoking cessation|0|05.305104|2
00011060|Lhermitte's sign|Lhermitte's sign|0|16.781991|1
00011074|thrombosis prevention after PCI|thrombosis prevention after percutaneous coronary intervention|0|07.453914|3
00011098|varicella vaccination|varicella vaccination|0|18.V05401|1
00011104|maintain patency of indwelling intravenous catheter|maintain patency of indwelling intravenous catheter|0|07. 38992|3
00011128|fructose intolerance|fructose intolerance|0|03.271201|2
00011150|delayed hypersensitivity skin test for tuberculin PPD|delayed hypersensitivity skin test for tuberculin purified protein derivative- PPD|0|18.V74100|1
00011179|diagnostic test for Histoplasma capsulatum exposure|diagnostic test for Histoplasma capsulatum exposure|0|18.V75400|1
00011181|envenomation by black widow spider|envenomation by black widow spider|0|17.989502|1
00011182|envenomation by coral snake (Micrurus fulvius)|envenomation by coral snake (Micrurus fulvius)|0|17.989503|1
00011183|envenomation by pit viper snake (Crotalidae)|envenomation by pit viper snake (Crotalidae)|0|17.989504|1
00011189|prevention of cramps associated with heat exhaustion|prevention of muscle cramps associated with heat exhaustion|0|17.992200|1
00011191|prevention of heat exhaustion|prevention of heat exhaustion|0|17.992500|1
00011209|scleral icterus|scleral icterus|0|06.379190|1
00011214|Cow Milk Intolerance|Cow Milk Intolerance|0|09.579802|2
00011215|chronic obstructive pulmonary disease|chronic obstructive pulmonary disease|0|08.496004|2
00011230|wound irrigation|wound irrigation|0|16. 96590|1
00011231|skin disinfection|skin disinfection|0|16. 9999I|1
00011259|Nondiabetic Proteinuric Nephropathy|Nondiabetic Proteinuric Nephropathy|0|10.588805|2
00011261|prevention of LH surge in ovarian hyperstimulation|prevention of luteinizing hormone surge when undergoing controlled ovarian hyperstimulation|0|18.V26806|1
00011289|rabies vaccination|rabies vaccination|0|01.071000|1
00011291|rabies postexposure prophylaxis|rabies postexposure prophylaxis|0|01.071001|1
00011303|left ventricular dysfunction following MI|left ventricular dysfunction following myocardial infarction|0|07.42990C|1
00011307|Fabry disease|Fabry disease|0|03.272701|2
00011316|mucopolysaccharidosis type I|mucopolysaccharidosis type I|0|03.277500|2
00011370|intra-abdominal Candida abscess|intra-abdominal Candida abscess|0|09.567211|1
00011371|Candida peritonitis|Candida peritonitis|0|09.567902|1
00011373|Candida pleural space infection|Candida pleural space infection|0|08.511002|1
00011376|candidemia|candidemia|0|01.112502|1
00011412|regional anesthesia for C-section|regional anesthesia for cesarean section|0|16. 9999J|1
00011415|regional anesthesia for surgery|regional anesthesia for surgery|0|16. 9999K|1
00011417|major nerve block for surgery|major nerve block for surgery|0|16. 9999L|1
00011418|regional anesthesia for labor pain|regional anesthesia for labor pain|0|16. 9999M|1
00011419|regional anesthesia for postoperative pain|regional anesthesia for postoperative pain|0|16. 9999N|1
00011420|local anesthesia for procedure|local anesthesia for procedure|0|16. 9999O|1
00011482|immunosuppression therapy for lung transplant|immunosuppression therapy for lung transplant|0|17.996841|2
00011486|Dopa-Responsive Dystonia|Dopa-Responsive Dystonia|0|06.333600|2
00011491|acute repetitive seizures|acute repetitive seizures|0|06.345901|1
00011544|transient testosterone increase in male|transient testosterone increase in male|0|03.257000|1
00011546|cancer-related spinal cord compression|cancer-related spinal cord compression|0|06.336900|2
00011549|coronary artery dissection|coronary artery dissection|0|07.414120|1
00011574|chronic E. coli prostatitis|chronic Escherichia coli prostatitis|0|10.601101|2
00011575|chronic Enterococcus faecalis prostatitis|chronic Enterococcus faecalis prostatitis|0|10.601102|2
00011577|chronic S. epidermidis prostatitis|chronic Staphylococcus epidermidis prostatitis|0|10.601103|2
00011655|recurrent herpes simplex labialis|recurrent herpes simplex labialis|0|01.054903|3
00011657|pellagra|pellagra|0|03.265201|3
00011693|morbid obesity|morbid obesity|0|03.278010|2
00011701|orgasm disorder|orgasm disorder|0|05.302730|3
00011703|choking sensation|choking sensation|0|16.784902|3
00011705|skin hypertrophy|skin hypertrophy|0|12.701900|3
00011710|regional anesthesia for ophthalmologic surgery|regional anesthesia for ophthalmologic surgery|0|16. 9999P|1
00011711|local anesthesia for ophthalmologic procedure|local anesthesia for ophthalmologic procedure|0|16. 9999Q|1
00011792|TPN-associated Cholestasis|TPN-associated Cholestasis|0|09.576814|1
00011810|cardiopulmonary bypass for CABG|cardiopulmonary bypass for CABG|0|07. 39610|1
00011841|diabetic foot infection due to gram-positive bacteria|diabetic foot infection due to gram-positive bacteria|0|12.686944|3
00011845|salicylate intoxication|salicylate intoxication|0|17.965100|1
00011856|human bite wound|human bite wound|0|19.E92830|1
00011857|dog bite wound|dog bite wound|0|19.E90600|1
00011858|cat bite wound|cat bite wound|0|19.E90630|1
00011867|CD20 positive non-Hodgkin's lymphoma|CD20 positive non-Hodgkin's lymphoma|0|02.202804|3
00011884|human anti-mouse antibody (HAMA) positive|human anti-mouse antibody (HAMA) positive|0|16.795790|2
00011988|dihydropyrimidine dehydrogenase deficiency|dihydropyrimidine dehydrogenase deficiency|0|03.277205|2
00011994|alpha-1-proteinase inhibitor deficiency emphysema|pulmonary emphysema associated with alpha-1-proteinase inhibitor deficiency|0|03.277604|2
00012000|high grade dysplasia associated with Barrett's esophagus|high grade dysplasia associated with Barrett's esophagus|0|02.230101|3
00012052|magnetic resonance imaging|magnetic resonance imaging|0|16. 88971|1
00012103|acutely deteriorating asthma|acutely deteriorating asthma|0|08.493903|1
00012136|Latex Allergy|Latex Allergy|2|18.V15070|2
00012149|mineral deficiency|mineral deficiency|0|03.269303|3
00012151|mineral deficiency prevention|mineral deficiency prevention|0|03.269304|3
00012155|magnetic resonance imaging of gastrointestinal tract|magnetic resonance imaging of gastrointestinal tract|0|16. 88972|1
00012203|toxic amikacin serum level|toxic amikacin serum level|0|17.960800|1
00012204|toxic carbamazepine serum level|toxic carbamazepine serum level|0|17.966300|1
00012207|toxic cyclosporine serum level|toxic cyclosporine serum level|0|17.963101|1
00012208|toxic gentamicin serum level|toxic gentamicin serum level|0|17.960801|1
00012209|systemic lidocaine toxicity|systemic lidocaine toxicity|0|17.968500|1
00012210|toxic lithium serum level|toxic lithium serum level|0|17.969800|1
00012211|toxic phenobarbital serum level|toxic phenobarbital serum level|0|17.967000|1
00012212|toxic primidone serum level|toxic primidone serum level|0|17.966301|1
00012213|toxic procainamide plasma level|toxic procainamide plasma level|0|17.972001|1
00012214|toxic sirolimus whole blood level|toxic sirolimus whole blood level|0|17.963102|1
00012215|toxic tacrolimus whole blood level|toxic tacrolimus whole blood level|0|17.963103|1
00012216|toxic theophylline serum level|toxic theophylline serum level|0|17.975700|1
00012217|toxic tobramycin serum level|toxic tobramycin serum level|0|17.960802|1
00012218|toxic valproic acid plasma level|toxic valproic acid plasma level|0|17.966302|1
00012219|toxic vancomycin serum level|toxic vancomycin serum level|0|17.960803|1
00012284|complicated skin structure Strep dysgalactiae infection|complicated skin and skin structure Streptococcus dysgalactiae infection|0|12.686945|1
00012293|hypoproteinemia|hypoproteinemia|0|03.273801|3
00012297|autoimmune thrombocytopenia|autoimmune thrombocytopenia|0|04.287404|3
00012327|hypersomnia|hypersomnia|0|16.780540|3
00012328|supraventricular premature beats|supraventricular premature beats|0|07.427611|3
00012339|hormone receptor + postmenopausal advanced breast cancer|hormone receptor positive postmenopausal advanced breast cancer|0|02.174905|2
00012340|ER+ postmenopausal early breast cancer post-tamoxifen|hormone receptor positive postmenopausal early breast cancer after adjuvant tamoxifen|0|02.174906|2
00012350|cardiac transplantation|cardiac transplantation|0|07. 37510|2
00012352|prevention of CMV disease after kidney transplantation|prevention of CMV disease after kidney transplantation|0|17.996812|2
00012354|prevention of CMV disease after cardiac transplantation|prevention of CMV disease after cardiac transplantation|0|17.996832|2
00012355|prevention of CMV disease in kidney-pancreas transplant|prevention of cytomegalovirus disease after kidney-pancreas transplantation|0|17.996860|2
00012388|anterior ischemic optic neuropathy|anterior ischemic optic neuropathy|0|06.377410|3
00012391|Pleural Fibrosis|Pleural Fibrosis|1|08.511003|3
00012458|mild to moderate Alzheimer's type dementia|mild to moderate Alzheimer's type dementia|0|06.331002|2
00012460|moderate to severe Alzheimer's type dementia|moderate to severe Alzheimer's type dementia|0|06.331003|2
00012480|intestinal angioedema|intestinal angioedema|0|17.995101|1
00012484|hypoestrogenism due to bilateral oophorectomy|hypoestrogenism due to bilateral oophorectomy|0|03.256303|2
00012545|idiopathic short stature|idiopathic short stature|0|16.783430|2
00012550|severe recalcitrant nodular acne|severe recalcitrant nodular acne|0|12.706105|3
00012554|COPD Associated with Chronic Bronchitis|COPD Associated with Chronic Bronchitis|0|08.496005|2
00012862|depression associated with bipolar disorder|depression associated with bipolar disorder|0|05.296500|2
00013390|prevention of recurrent atrial fibrillation|prevention of recurrent atrial fibrillation|0|07.427313|2
00013391|sleepiness due to obstructive sleep apnea|sleepiness due to obstructive sleep apnea|0|16.780530|2
00013392|sleepiness due to shift work sleep disorder|sleepiness due to shift work sleep disorder|0|05.307450|3
00013393|head and neck angioedema|head and neck angioedema|0|17.995102|1
00013394|malignant mesothelioma of pleura|malignant mesothelioma of pleura|0|02.163100|2
00013395|Colorectal Carcinoma with EGFR Expression|Colorectal Carcinoma with Epidermal Growth Factor Receptor Expression|0|02.230904|2
00013396|sudden onset of sleep|sudden onset of sleep|0|16.78009F|3
00013397|surgical wound dehiscence|surgical wound dehiscence|0|17.998310|1
00013398|parathyroid carcinoma with hypercalcemia|parathyroid carcinoma with hypercalcemia|0|02.194100|3
00013399|metabolic syndrome x|metabolic syndrome x|0|03.277700|2
00013400|Agitation associated with Schizophrenia|agitation associated with schizophrenia|0|05.295901|3
00013401|agitation associated with bipolar mania|agitation associated with bipolar mania|0|05.296401|3
00013402|Anaphylaxis from Desensitization to Allergen|Anaphylaxis Occurring from Desensitization to Allergens|2|18.V07101|1
00013403|follicular lymphoma|follicular lymphoma|0|02.202000|2
00013404|Prevention of Ventilator-Associated Pneumonia|Prevention of Ventilator-Associated Pneumonia|0|08.486005|3
00013405|progressive chronic lymphocytic leukemia|progressive chronic lymphocytic leukemia|0|02.204102|2
00013406|prevention of bacterial infection in CLL|prevention of bacterial infection in chronic lymphocytic leukemia|0|01.041902|1
00013407|prevention of herpes zoster in immunocompromised patient|prevention of herpes zoster in immunocompromised patient|0|01.053901|1
00013408|pure red cell aplasia associated with CLL|pure red cell aplasia associated with chronic lymphocytic leukemia|0|02.204103|3
00013409|diffuse large B-cell lymphoma|diffuse large B-cell lymphoma|0|02.202805|2
00013410|progressive diffuse large B-cell lymphoma|progressive diffuse large B-cell lymphoma|0|02.202806|2
00013411|pediatric fever without a source|pediatric fever without a source|0|16.780606|1
00013412|viral gastroenteritis|viral gastroenteritis|0|01.008600|1
00013413|selective decontamination of the digestive tract|selective decontamination of the digestive tract|0|09. 54995|1
00013414|anticholinergic toxicity|anticholinergic toxicity|0|17.971100|1
00013415|hypopyon|hypopyon|0|06.364050|1
00013416|Ear Finding|Ear Finding|0|06.388904|3
00013417|prevention of cytarabine-induced keratoconjunctivitis|prevention of cytarabine-induced keratoconjunctivitis|0|06.370402|1
00013418|CNS disease prevention in non-Hodgkin's lymphoma|adjunct for CNS disease prevention in non-Hodgkin's lymphoma|0|02.202807|1
00013419|advanced malignant neoplasm of liver|advanced malignant neoplasm of liver|0|02.230802|3
00013420|corneal limbitis|corneal limbitis|0|06.370905|3
00013421|pulmonary hemorrhage|pulmonary hemorrhage|0|16.786302|1
00013422|interstitial lung disease|interstitial lung disease|0|08.519901|3
00013423|congenital defect requiring patency of ductus arteriosus|congenital heart defect requiring patency of ductus arteriosus|0|14.747001|1
00013424|Prevention of Oliguria|Prevention of Oliguria|0|16.788502|1
00013425|loss of bone density due to androgen deprivation therapy|loss of bone mineral density (BMD) due to androgen deprivation therapy|0|13.733093|3
00013426|gastric retention|gastric retention|0|09.536902|3
00013427|furred tongue|furred tongue|0|09.529300|1
00013428|scleritis|scleritis|0|06.379000|3
00013429|hyperparathyroidism secondary to CRF with dialysis|hyperparathyroidism secondary to chronic renal failure with dialysis|0|10.588806|2
00013430|bipolar disorder in remission|bipolar disorder in remission|0|05.296660|3
00013431|mania associated with bipolar disorder, adjunct|mania associated with bipolar disorder, adjunct treatment|0|05.296402|3
00013432|bacterial meningitis|bacterial meningitis|0|06.320900|1
00013433|bacterial urinary tract infection|bacterial urinary tract infection|0|10.599004|3
00013434|Waldenstrom's macroglobulinemia|Waldenstrom's macroglobulinemia|0|02.273300|3
00013435|hepatitis B immune due to latent hepatitis B infection|hepatitis B immune due to latent hepatitis B infection|0|01.070301|2
00013436|synergy for bacterial meningitis|synergy for bacterial meningitis|0|06.320901|1
00013440|synergy for prevention of enterococcal endocarditis|synergy for prevention of enterococcal endocarditis|0|07.421012|1
00013441|odynophagia|odynophagia|0|16.787201|3
00013442|chronic idiopathic constipation|chronic idiopathic constipation|0|09.564001|2
00013443|prevention of xerostomia secondary to radiation therapy|prevention of xerostomia secondary to radiation therapy|0|09.527706|1
00013444|prevention of neutropenia from cancer chemotherapy|prevention of neutropenia from cancer chemotherapy|0|04.288017|1
00013445|conditioning prior to allogeneic stem cell transplant|conditioning prior to allogeneic hematopoietic stem cell transplant|0|08. 41006|1
00013446|prevention of chemotherapy-induced mucositis|prevention of chemotherapy-induced mucositis|0|19.E93319|1
00013447|prevention of radiation therapy-induced mucositis|prevention of radiation therapy-induced mucositis|0|19.E87922|1
00013448|high density lipoprotein deficiency|high density lipoprotein deficiency|0|03.272502|2
00013449|meconium aspiration syndrome|meconium aspiration syndrome|0|15.770100|1
00013450|prevention of chemotherapy-induced neurotoxicity|prevention of chemotherapy-induced neurotoxicity|0|19.E93310|1
00013451|reactivation of hepatitis B|reactivation of hepatitis B|0|01.070302|1
00013452|aseptic necrosis of jaw bone|aseptic necrosis of jaw bone|0|09.526400|3
00013453|invasive dental procedure|invasive dental procedure|0|05. 23000|1
00013454|pathological fracture|pathological fracture|0|13.733190|3
00013455|prevention of ocular surgery-induced miosis|prevention of ocular surgery-induced miosis|0|06.379490|1
00013456|radiation therapy involving the lungs|radiation therapy involving the lungs|0|16. 92292|1
00013457|prevent seizures after head trauma or surgery|prevention of seizures following cranial trauma or surgery|0|06.345907|3
00013458|cognitive impairment following traumatic brain injury|cognitive impairment following traumatic brain injury|0|16.78009G|3
00013459|depressive disorder following traumatic brain injury|depressive disorder following traumatic brain injury|0|05.311002|3
00013460|follicle stimulation for assisted fertilization|follicle stimulation for assisted fertilization procedure|0|18.V26807|3
00013461|hepatic blood flow clearance study|hepatic blood flow clearance study|0|16.794801|1
00013462|post-anesthesia respiratory depression|post-anesthesia respiratory depression|0|08.518823|1
00013463|drug-exacerbated psoriasis|drug-exacerbated psoriasis|0|12.696105|1
00013464|lymph node positive colorectal carcinoma|lymph node positive colorectal carcinoma|0|02.230905|3
00013465|preoperative pain management|preoperative pain management|0|16.780990|1
00013466|Intraoperative Pain Management|Intraoperative Pain Management|0|16.780991|1
00013467|exposure to plutonium radiation|exposure to plutonium radiation|0|19.E92650|1
00013468|exposure to americium radiation|exposure to americium radiation|0|19.E92651|1
00013469|exposure to curium radiation|exposure to curium radiation|0|19.E92652|1
00013474|Reproductive System Disorder|Reproductive System Disorder|0|10.626901|3
00013475|severe recalcitrant nodular rosacea|severe recalcitrant nodular rosacea|0|12.695304|3
00013476|postoperative pain from cesarean section|postoperative pain from cesarean section|0|16.780916|1
00013477|postoperative pain from lower abdominal procedure|postoperative pain from lower abdominal procedure|0|16.780915|1
00013478|postoperative pain from lower extremity ortho procedure|postoperative pain from lower extremity orthopedic procedures|0|16.780914|1
00013479|Lown-Ganong-Levine syndrome|Lown-Ganong-Levine syndrome|0|07.426811|3
00013480|renal fibrosis|renal fibrosis|0|10.587000|3
00013481|Pervasive Developmental Disorder|Pervasive Developmental Disorder|0|05.299900|2
00013482|perioperative care|perioperative care|0|16. 9999R|1
00013483|thrombophlebitis migrans|thrombophlebitis migrans|0|07.451907|3
00013484|increased cardiovascular event risk|increased cardiovascular event risk|0|07.42990D|3
00013485|alcohol intolerance|alcohol intolerance|0|03.277901|3
00013486|minor skin wound pain|minor skin wound pain|0|16.782010|1
00013487|paradoxical bronchospasm|paradoxical bronchospasm|0|08.519105|1
00013488|structural disorder of heart|structural disorder of heart|0|07.42990E|2
00013489|administration of local anesthesia by infiltration|administration of local anesthesia by infiltration|0|16. 9999S|1
00013490|administration of local anesthetic nerve block|administration of local anesthetic nerve block|0|16. 9999T|1
00013491|meningococcal vaccination|meningococcal vaccination|0|01.036201|1
00013492|verruca plantaris|verruca plantaris|0|01.078191|3
00013493|major depressive disorder treatment adjunct|major depressive disorder treatment adjunct|0|05.311003|3
00013494|intractable eczema|intractable eczema|0|12.692903|3
00013495|AIDS with toxoplasmosis|acquired immunodeficiency syndrome with toxoplasmosis|0|01.130903|3
00013496|tuberculosis meningitis treatment adjunct|tuberculosis meningitis treatment adjunct|0|01.013001|1
00013497|type 2 diabetes mellitus treatment adjunct|type 2 diabetes mellitus treatment adjunct|0|03.250001|2
00013498|type 1 diabetes mellitus treatment adjunct|type 1 diabetes mellitus treatment adjunct|0|03.250011|2
00013499|lamivudine-refractory chronic hepatitis B|lamivudine-refractory chronic hepatitis B|0|01.070303|2
00013500|senile dementia|senile dementia|0|05.290000|2
00013501|non-cardiac chest pain|non-cardiac chest pain|0|16.786599|3
00013502|adynamic bone disease|adynamic bone disease|0|13.733906|2
00013503|anal fissure|anal fissure|0|09.565000|3
00013504|dysgammaglobulinemia|dysgammaglobulinemia|0|03.279060|3
00013505|Asymptomatic Pediatric HIV Infection|Asymptomatic Pediatric HIV Infection|0|01.042009|2
00013506|Maroteaux-Lamy syndrome|Maroteaux-Lamy syndrome|0|03.277501|2
00013507|Accelerated Atrioventricular Conduction|Accelerated Atrioventricular Conduction|0|07.426888|3
00013508|partial epilepsy treatment adjunct|partial epilepsy treatment adjunct|0|06.345504|2
00013509|tonic-clonic epilepsy treatment adjunct|tonic-clonic epilepsy treatment adjunct|0|06.345103|2
00013510|subacute sclerosing panencephalitis|subacute sclerosing panencephalitis|0|01.046200|2
00013511|envenomation by elapid snake (Elapidae)|envenomation by elapid snake (Elapidae)|0|17.989505|1
00013512|postpartum depression|postpartum depression|0|11.648440|1
00013513|thallium poisoning|thallium poisoning|0|17.985904|1
00013514|exposure to cesium radiation|exposure to cesium radiation|0|19.E92653|1
00013515|succinate-semialdehyde dehydrogenase deficiency|succinate-semialdehyde dehydrogenase deficiency|0|03.277870|2
00013516|coronary artery bypass graft procedure|coronary artery bypass graft procedure|0|07. 39611|1
00013517|Superinfection|Superinfection|0|01.139800|3
00013518|perforation of cornea|perforation of cornea|0|06.371402|1
00013519|corneal epithelial degeneration|corneal epithelial degeneration|0|06.371403|1
00013520|corneal dystrophy|corneal dystrophy|0|06.371500|1
00013521|tear film insufficiency|tear film insufficiency|0|06.375151|3
00013522|indifference|indifference|0|05.296991|3
00013523|toxic shock syndrome|toxic shock syndrome|0|01.040820|1
00013524|Worsening Headache Disorder|Worsening Headache Disorder|0|16.784006|3
00013525|prolonged post-op immobilization after major surgery|major surgery with prolonged post-operative immobilization|0|16.799804|1
00013526|Diabetes with Vascular Disease Complication|Diabetes with Vascular Disease Complication|0|03.250903|2
00013527|primary insulin-like growth factor-1 deficiency|primary insulin-like growth factor-1 deficiency|0|03.253302|2
00013528|hypertrophy of tonsils|hypertrophy of tonsils|0|08.474100|2
00013529|Chronic Serous Otitis Media|Chronic Serous Otitis Media|0|06.381100|2
00013530|primary immune deficiency disorder|primary immune deficiency disorder|0|03.279061|2
00013531|hypogammaglobulinemia|hypogammaglobulinemia|0|03.279002|3
00013532|secondary malignant neoplasm of bone marrow|secondary malignant neoplasm of bone marrow|0|02.198505|3
00013533|secondary malignant neoplasm of lymph nodes|secondary malignant neoplasm of lymph nodes|0|02.202900|3
00013534|operation on lens|operation on lens|0|03. 13900|1
00013535|disorder of pleura|disorder of pleura|0|08.511004|3
00013536|diabetic foot infection|diabetic foot infection|0|12.686946|3
00013537|T-cell acute lymphoblastic leukemia|T-cell acute lymphoblastic leukemia|0|02.204001|1
00013538|T-cell lymphoblastic lymphoma|T-cell lymphoblastic lymphoma|0|02.202808|3
00013539|intrathecal injection of chemotherapeutic agent|intrathecal injection of chemotherapeutic agent|0|02.239703|3
00013540|radiation therapy of cranium|radiation therapy of cranium|0|16. 92293|1
00013541|radiation therapy of vertebral column|radiation therapy of vertebral column|0|16. 92294|1
00013542|perioral dermatitis|perioral dermatitis|0|12.695305|3
00013543|Heart Failure with Preserved Ejection Fraction|Heart Failure with Preserved Ejection Fraction|0|07.428300|3
00013544|Disorder of Breast|Disorder of Breast|0|10.611900|3
00013545|mammography abnormal|mammography abnormal|0|10.611700|3
00013546|otosclerosis|otosclerosis|0|06.387000|2
00013547|pancreatitis|pancreatitis|0|09.577001|3
00013548|Metastatic Calcification|Metastatic Calcification|0|03.275406|3
00013549|Syphilitic Skin Disorder|Syphilitic Skin Disorder|0|01.091301|3
00013550|placenta previa|placenta previa|0|11.641000|1
00013551|operation on nose|operation on nose|0|05. 21000|1
00013552|neoplasm of female genital organ|neoplasm of female genital organ|0|02.239502|3
00013553|oligomenorrhea|oligomenorrhea|0|10.626100|3
00013554|nephrocalcinosis|nephrocalcinosis|0|03.275490|3
00013555|multiple pregnancy|multiple pregnancy|0|11.651000|1
00013556|disorder of prostate|disorder of prostate|0|10.602900|3
00013557|macular retinal edema|macular retinal edema|0|06.362900|3
00013558|contrast ventriculography of brain|contrast ventriculography of brain|0|16. 87021|1
00013559|pituitary apoplexy|pituitary apoplexy|0|03.253801|3
00013560|viral hepatitis C|viral hepatitis C|0|01.070700|2
00013561|viral hepatitis B|viral hepatitis B|0|01.070304|3
00013562|gastrointestinal hypomotility|gastrointestinal hypomotility|0|09.536801|3
00013563|tricyclic antidepressant overdose|tricyclic antidepressant overdose|0|17.969000|1
00013564|atrophic gastritis|atrophic gastritis|0|09.535100|2
00013565|Acute Poliomyelitis|Acute Poliomyelitis|0|01.045000|1
00013566|previous cesarean section|previous cesarean section|0|11.654200|2
00013567|envenomation by stonefish spine|envenomation by stonefish spine|0|17.989506|1
00013568|grand multiparity|grand multiparity|0|11.659400|2
00013569|tumor of hypothalamus|tumor of hypothalamus|0|02.191000|3
00013570|hemoglobinopathy|hemoglobinopathy|0|02.282700|3
00013571|Operation on Stomach|Operation on Stomach|0|09. 43000|1
00013572|Injury of Ear|Injury of Ear|0|17.925100|3
00013573|procedure on ear|procedure on ear|0|04. 20990|1
00013574|infection by Baylisascaris|infection by Baylisascaris|0|01.128800|3
00013575|psychogenic polydipsia|psychogenic polydipsia|0|16.783501|3
00013576|Ophthalmoplegic Migraine|Ophthalmoplegic Migraine|0|06.346801|3
00013577|erythrocytosis|erythrocytosis|0|04.289001|3
00013578|fallopian tube disorder|fallopian tube disorder|0|10.620900|3
00013579|bacterial eye infection|bacterial eye infection|0|06.360001|3
00013580|amebic infection of the eye|amebic infection of the eye|0|01.006901|3
00013581|unsteady gait|unsteady gait|0|16.781201|3
00013582|malposition or malpresentation of fetus|malposition or malpresentation of fetus|0|11.652000|1
00013583|lichen sclerosus|lichen sclerosus|0|12.701001|3
00013584|ultraviolet light therapy|ultraviolet light therapy|0|16. 99820|1
00013585|Graves' disease|Graves' disease|0|03.242000|3
00013586|Colostomy|Colostomy|0|09. 46100|3
00013587|Small Intestine Excision|Small Intestine Excision|0|09. 45600|1
00013588|Kock pouch|Kock pouch|0|09. 46220|2
00013589|aldosteronism|aldosteronism|0|03.255102|3
00013590|Activated Protein C Resistance|Activated Protein C Resistance|0|04.289810|3
00013591|right ventricular failure|right ventricular failure|0|07.428008|3
00013592|pseudophakia|pseudophakia|0|18.V43100|2
00013593|autonomic dysreflexia|autonomic dysreflexia|0|06.337300|3
00013594|transsphenoidal hypophysectomy|transsphenoidal hypophysectomy|0|02. 07620|1
00013595|Disorder of Parathyroid Gland|Disorder of Parathyroid Gland|0|03.252900|3
00013596|pulmonary veno-occlusive disease|pulmonary veno-occlusive disease|0|07.416001|3
00013597|mural thrombus of heart|mural thrombus of heart|0|07.429892|1
00013598|prevention of uterine inertia|prevention of uterine inertia|0|11.661200|1
00013599|Perianal Infection|Perianal Infection|0|09.566000|3
00013600|otitis|otitis|0|06.382908|3
00013601|CD4 T lymphocyte deficiency|CD4 T lymphocyte deficiency|0|01.042010|3
00013602|shallow anterior chamber of eye|shallow anterior chamber of eye|0|06.365000|3
00013603|fetal distress|fetal distress|0|15.768401|1
00013604|tropical sprue|tropical sprue|0|09.579100|3
00013605|Upper Gastrointestinal Surgery|Upper Gastrointestinal Surgery|0|09. 42990|1
00013606|megacolon|megacolon|0|09.564700|3
00013607|Tetramine Rodenticide Toxicity|Tetramine Rodenticide Toxicity|0|19.E86370|1
00013608|Neural Tube Defect|Neural Tube Defect|0|14.741000|2
00013609|sheep liver fluke infection|sheep liver fluke infection|0|01.121301|3
00013610|Burkitt's lymphoma|Burkitt's lymphoma|0|02.200200|3
00013611|dysplasia of cervix|dysplasia of cervix|0|10.622100|3
00013612|procedure by transurethral approach|procedure by transurethral approach|0|10. 58000|1
00013613|burning caused by hydrofluoric acid|burning caused by hydrofluoric acid|0|19.E92400|1
00013614|Chylothorax|Chylothorax|0|07.457801|3
00013615|lithotripsy|lithotripsy|0|16. 98500|1
00013616|kidney excision|kidney excision|0|10. 55500|2
00013617|Cholecystectomy|Cholecystectomy|0|09. 51200|2
00013618|Exercise-Induced Angina|Exercise-Induced Angina|0|07.413911|3
00013619|fetal growth retardation|fetal growth retardation|0|15.764900|1
00013620|envenomation by sea snake (Hydrophiinae)|envenomation by sea snake (Hydrophiinae)|0|17.989507|1
00013621|uremic bleeding tendency|uremic bleeding tendency|0|04.287104|3
00013622|hyporeninemic hypoaldosteronism|hyporeninemic hypoaldosteronism|0|10.588807|3
00013623|Upper Limb Spasticity associated with Stroke|Upper Limb Spasticity associated with Stroke|0|16.781905|3
00013624|Facial Spasm|Facial Spasm|0|06.351800|3
00013625|adjuvant to increase absorption-dispersion of drugs|adjunct treatment to increase absorption and dispersion of other injected drugs|0|16. 99290|1
00013626|hypodermoclysis|hypodermoclysis|0|16. 99291|1
00013627|cluster headache prevention|cluster headache prevention|0|06.346202|3
00013628|Raised Intraocular Pressure|Raised Intraocular Pressure|1|06.365001|3
00013629|anterior chamber inflammation|anterior chamber inflammation|0|06.379990|3
00013630|vitreous floater|vitreous floater|0|06.379240|3
00013631|periorbital hematoma|periorbital hematoma|0|06.379995|1
00013632|retinal edema|retinal edema|0|06.362831|1
00013633|carotid artery occlusion|carotid artery occlusion|0|07.433100|3
00013634|stricture of esophagus|stricture of esophagus|0|09.530302|3
00013635|eosinophilia myalgia syndrome|eosinophilia myalgia syndrome|0|13.710500|1
00013636|Lower Abdominal Procedure|Lower Abdominal Procedure|0|09. 54991|1
00013637|trimetrexate toxicity|trimetrexate toxicity|0|17.963104|1
00013638|sulfadiazine toxicity|sulfadiazine toxicity|0|17.961000|3
00013639|lysosomal alpha-1,4-glucosidase deficiency|lysosomal alpha-1,4-glucosidase deficiency|0|03.271001|2
00013640|Crohn's disease in remission|Crohn's disease in remission|0|09.555903|2
00013641|Barbiturate Withdrawal|Barbiturate Withdrawal|0|05.292004|1
00013642|progressive multifocal leukoencephalopathy|progressive multifocal leukoencephalopathy|0|01.463000|3
00013643|disease due to West Nile virus|disease due to West Nile virus|0|01.066400|1
00013644|parvovirus infection|parvovirus infection|0|01.057000|1
00013645|prevention of dental caries|prevention of dental caries|0|09.521002|2
00013646|carcinoid crisis|carcinoid crisis|0|03.259201|1
00013647|shingles vaccination|shingles vaccination|0|01.053903|1
00013648|infection due to Penicillium marneffei|infection due to Penicillium marneffei|0|01.118003|3
00013649|right-sided S. aureus endocarditis|right-sided Staphylococcus aureus endocarditis|0|07.421013|1
00013650|EGFR positive non-small cell lung cancer|epidermal growth factor receptor positive non-small cell lung cancer|0|02.235700|2
00013651|EGFR negative non-small cell lung cancer|epidermal growth factor receptor negative non-small cell lung cancer|0|02.235701|2
00013652|vaccination to prevent genital warts due to HPV|vaccination to prevent genital warts due to human papillomavirus|0|01.078110|3
00013653|vaccination to prevent cervical cancer due to HPV|vaccination to prevent cervical cancer due to human papillomavirus|0|02.233101|1
00013654|meningoencephalitis due to Naegleria|meningoencephalitis due to Naegleria|0|01.136201|1
00013655|nephrogenic systemic fibrosis|nephrogenic systemic fibrosis|0|12.709907|3
00013656|premature menopause|premature menopause|0|03.256310|2
00013657|chromium deficiency|chromium deficiency|0|03.269305|3
00013658|diffuse Lewy body disease|diffuse Lewy body disease|0|06.331820|2
00013659|muscular dystrophy|muscular dystrophy|0|06.369100|2
00013660|dementia associated with Parkinson's disease|dementia associated with Parkinson's disease|0|06.332005|2
00013661|Philadelphia chromosome positive ALL|Philadelphia chromosome positive acute lymphoblastic leukemia|0|02.204002|2
00013662|Severe Venous Varices|Severe Venous Varices|0|07.454901|2
00013663|Severe Acquired Atrophy of Uterus|Severe Acquired Atrophy of Uterus|0|10.621801|2
00013664|Cervical Spine Fracture|Cervical Spine Fracture|0|17.805000|3
00013665|Peritoneal Dialysis|Peritoneal Dialysis|0|09. 54900|3
00013666|hepatosplenic T-cell lymphoma|hepatosplenic T-cell lymphoma|0|02.202809|3
00013667|mucopolysaccharidosis type II|mucopolysaccharidosis type II|0|03.277502|2
00013668|recurrent mucocutaneous herpes simplex in HIV patient|recurrent mucocutaneous herpes simplex in human immunodeficiency virus infected patient|0|01.054906|2
00013669|systemic sclerosis-associated interstitial lung disease|systemic sclerosis-associated interstitial lung disease|0|13.710103|3
00013670|Open Fracture of Shaft of Tibia|Open Fracture of Shaft of Tibia|0|17.823000|1
00013671|ventricular rate control in atrial fibrillation|ventricular rate control in atrial fibrillation|0|07.427314|3
00013672|prevention of a. fib post cardio-thoracic surgery|prevention of post cardio-thoracic surgery atrial fibrillation|0|07.427315|1
00013673|Paracervical Block for Labor Pain|Paracervical Block for Labor Pain|0|16. 9999U|1
00013674|Exudative Dermatosis|Exudative Dermatosis|0|12.709908|3
00013676|excessive vomiting in pregnancy|excessive vomiting in pregnancy|0|11.643001|3
00013677|stinging of skin|stinging of skin|0|16.782103|3
00013678|prevention of invasive pulmonary aspergillosis|prevention of invasive pulmonary aspergillosis|0|01.117307|3
00013679|posterior reversible encephalopathy syndrome|posterior reversible encephalopathy syndrome|0|06.348302|1
00013680|exacerbation of Gilles de la Tourette's syndrome|exacerbation of Gilles de la Tourette's syndrome|0|05.307231|1
00013682|placental abruption|placental abruption|0|11.641201|1
00013683|bronchial erosion due to malignant esophagus neoplasm|bronchial erosion due to malignant esophagus neoplasm|0|08.519190|3
00013684|tracheal erosion due to malignant esophagus neoplasm|tracheal erosion due to malignant esophagus neoplasm|0|08.519191|3
00013685|refractive keratoplasty by laser surgery|refractive keratoplasty by laser surgery|0|03. 11700|1
00013686|dermatofibrosarcoma protuberans|dermatofibrosarcoma protuberans|0|02.173000|3
00013687|chronic eosinophilic leukemia|chronic eosinophilic leukemia|0|02.205105|3
00013688|hypereosinophilic syndrome|hypereosinophilic syndrome|0|02.205106|3
00013689|cephalopelvic disproportion|cephalopelvic disproportion|0|11.653400|1
00013690|multiple organ failure|multiple organ failure|0|17.995949|1
00013691|imperforate anus|imperforate anus|0|14.751200|2
00013692|mixed bipolar I disorder|mixed bipolar I disorder|0|05.296600|3
00013693|abdominal pain of unknown cause|abdominal pain of unknown cause|0|16.789004|3
00013694|Hypertrophic Solar Keratosis|Hypertrophic Solar Keratosis|0|12.702002|3
00013695|post-operative from CABG surgery|post-operative from CABG surgery|0|07. 39612|1
00013696|refractory oropharyngeal candidiasis|refractory oropharyngeal candidiasis|0|01.112003|3
00013697|HER2-positive carcinoma of breast|HER2-positive carcinoma of breast|0|02.233006|2
00013698|tumor hemorrhage|tumor hemorrhage|0|02.239906|1
00013699|mantle cell lymphoma|mantle cell lymphoma|0|02.202810|3
00013700|lymphedema|lymphedema|0|07.457100|3
00013701|prevent hemorrhage & CV instability from bypass - CABG|prevention of hemorrhage with cardiovascular instability from cardiopulmonary bypass - CABG|0|07. 39613|1
00013702|prevention of peri-operative hemorrhage|prevention of peri-operative hemorrhage|0|17.998110|1
00013703|black stools|black stools|0|16.792100|3
00013704|avascular necrosis of bone|avascular necrosis of bone|0|13.733400|3
00013705|prevention of acute gastrointestinal ulcer re-bleed|prevention of acute gastrointestinal ulcer re-bleed|0|09.534001|1
00013706|dysglycemia|dysglycemia|0|16.790290|1
00013707|severe combined immunodeficiency disease|severe combined immunodeficiency disease|0|03.279201|2
00013708|common variable agammaglobulinemia|common variable agammaglobulinemia|0|03.279062|2
00013709|x-linked agammaglobulinemia|x-linked agammaglobulinemia|0|03.279040|2
00013710|Wiskott-Aldrich syndrome|Wiskott-Aldrich syndrome|0|03.279120|2
00013711|hypogammaglobulinemia with recurrent bacterial infection|hypogammaglobulinemia associated with recurrent bacterial infection|0|03.279003|3
00013712|chronic inflammatory demyelinating polyneuropathy|chronic inflammatory demyelinating polyneuropathy|0|06.357890|2
00013713|inclusion body myositis|inclusion body myositis|0|13.729104|3
00013714|multifocal motor neuropathy|multifocal motor neuropathy|0|06.357891|3
00013715|neonatal alloimmune thrombocytopenia|neonatal alloimmune thrombocytopenia|0|15.776100|1
00013716|thyroid eye disease|thyroid eye disease|0|03.242001|3
00013717|posttransfusion purpura|posttransfusion purpura|0|04.287405|1
00013718|stiff-man syndrome|stiff-man syndrome|0|06.333910|2
00013719|prevention of relapse to opioid dependence|prevention of relapse to opioid dependence|0|05.304002|3
00013720|Chronic PTSD with Trauma Nightmares|Chronic Post Traumatic Stress Disorder with Trauma-related Nightmares|0|05.309811|2
00013721|exacerbation of ulcerative colitis|exacerbation of ulcerative colitis|0|09.556904|1
00013722|cataract surgery|cataract surgery|0|03. 13190|1
00013723|prevention of motion sickness|prevention of motion sickness|0|17.994601|1
00013724|fungal infection of nose|fungal infection of nose|0|01.117902|3
00013725|intraoperative floppy iris syndrome|intraoperative floppy iris syndrome|0|06.364900|1
00013726|drug resistance to anti-retroviral therapy|drug resistance to anti-retroviral therapy|0|01.042011|2
00013727|complex sleep behavior|complex sleep behavior|0|16.780502|3
00013728|paroxysmal nocturnal hemoglobinuria|paroxysmal nocturnal hemoglobinuria|0|04.283203|2
00013729|Surgical Adjunct for Bone Augmentation in Oral Surgery|Surgical Adjunct for Bone Augmentation associated with Oral Surgery|0|05. 23001|1
00013730|Surgical Adjunct for Fusion of Lumbar Spine Spondylosis|Surgical Adjunct for Fusion Procedure of Lumbar Spondylosis|0|14. 84520|1
00013731|persistent pulmonary hypertension of the newborn|persistent pulmonary hypertension of the newborn|0|14.747830|1
00013732|Inflammatory Disorder of Genitourinary System|Inflammatory Disorder of Genitourinary System|0|10.599800|3
00013733|neoplasm of liver|neoplasm of liver|0|02.239000|3
00013734|Inborn Error of Amino Acid Metabolism|Inborn Error of Amino Acid Metabolism|0|03.270002|2
00013735|functional disorder of bladder neck and sphincter|functional disorder of bladder neck and sphincter mechanism|0|10.596001|3
00013736|Nonfunctioning Gallbladder|Nonfunctioning Gallbladder|0|09.575901|3
00013737|peripheral arterial occlusive disease|peripheral arterial occlusive disease|0|07.447903|3
00013739|acute oral cavity infection|acute oral cavity infection|0|09.525902|1
00013740|hemothorax|hemothorax|0|16.786303|3
00013741|protein C deficiency disease|protein C deficiency disease|0|04.289811|2
00013742|dissection of aorta|dissection of aorta|0|07.441901|3
00013743|carcinomatosis|carcinomatosis|0|02.199000|3
00013744|ulceration of colon|ulceration of colon|0|09.569821|3
00013745|Fanconi's anemia|Fanconi's anemia|0|04.824000|2
00013746|Herpes Gestationis|Herpes Gestationis|2|12.694800|1
00013747|Incomplete Testicular Development|Incomplete Testicular Development|0|03.257204|2
00013748|lupus anticoagulant disorder|lupus anticoagulant disorder|0|04.289812|2
00013749|puerperal endometritis|puerperal endometritis|0|11.670400|1
00013750|High-Renin Essential Hypertension|High-Renin Essential Hypertension|0|07.401916|2
00013757|N-acetyltransferase slow acetylator|slow acetylator due to N-acetyltransferase enzyme variant|0|03.277614|2
00013758|compression of umbilical cord|compression of umbilical cord|0|15.762500|1
00013759|Hereditary Von Willebrand Disease Type 2B|Hereditary Von Willebrand Disease Type 2B|0|04.286401|2
00013760|Guttate Psoriasis|Guttate Psoriasis|0|12.696106|3
00013761|pustular psoriasis|pustular psoriasis|0|12.696107|3
00013762|infection of ear|infection of ear|0|06.388905|3
00013763|prevention of post-extubation laryngeal edema|prevention of post-extubation laryngeal edema|0|16. 96700|1
00013764|avian influenza (H5N1) vaccination|avian influenza (H5N1) vaccination|0|08.487105|1
00013765|cryoglobulinemia|cryoglobulinemia|0|03.273200|3
00013766|Disorder of Colon|Disorder of Colon|0|09.536909|3
00013767|organophos insecticide poisoning|organophos insecticide poisoning|0|19.E86310|1
00013768|poisoning due to nerve agent|poisoning due to nerve agent|0|19.E99721|1
00013769|prevention of recurrent venous thrombosis in malignancy|prevention of recurrent venous thrombosis associated with malignancy|0|07.453915|3
00013770|bacterial mastitis|bacterial mastitis|0|10.610400|1
00013771|myelodysplastic, myeloproliferative diseases with PDGFR|myelodysplastic, myeloproliferative diseases associated with platelet-derived growth factor receptor|0|02.238701|3
00013772|melioidosis|melioidosis|0|01.025000|3
00013773|syncope due to bradycardia|syncope due to bradycardia|0|16.780202|3
00013774|diverticular disease|diverticular disease|0|09.562000|3
00013775|ectropion of cervix|ectropion of cervix|0|10.622000|3
00013776|cervical discharge|cervical discharge|0|10.622800|3
00013778|high output heart failure|high output heart failure|0|07.428902|3
00013779|Gestational Trophoblastic Disease|Gestational Trophoblastic Disease|0|18.V13100|1
00013780|nontraumatic hemoperitoneum|nontraumatic hemoperitoneum|0|09.568810|1
00013781|transfusion related acute lung injury|transfusion related acute lung injury|0|08.518700|1
00013782|severe myopia|severe myopia|0|06.367102|3
00013783|Krukenberg spindle|Krukenberg spindle|0|06.371130|2
00013784|pulmonary arterial hypertension|pulmonary arterial hypertension|0|07.416002|3
00013785|adrenal hemorrhage|adrenal hemorrhage|0|03.255406|1
00013786|lyme disease of the central nervous system|lyme disease of the central nervous system|0|01.088814|3
00013787|refractory extrinsic asthma|refractory extrinsic asthma|0|08.493001|3
00013788|disorder of thymus gland|disorder of thymus gland|0|03.254900|3
00013789|intestinal abscess|intestinal abscess|0|09.569500|3
00013790|bacterial otitis externa|bacterial otitis externa|0|06.382909|3
00013791|Air Embolism|Air Embolism|0|17.999100|1
00013792|Decompression Sickness|Decompression Sickness|0|17.993300|1
00013793|maxillofacial injury|maxillofacial injury|0|17.959001|3
00013794|vitamin B deficiency|vitamin B deficiency|0|03.266900|3
00013795|neuropathic pain|neuropathic pain|0|13.729202|3
00013796|pupillary block glaucoma|pupillary block glaucoma|0|06.365610|3
00013797|limb lymphedema|limb lymphedema|0|07.457101|3
00013798|uterine scar present|uterine scar present|0|10.621802|3
00013799|minimal change glomerulonephritis|minimal change glomerulonephritis|0|10.581300|3
00013800|Bladder Disorder|Bladder Disorder|0|10.596901|3
00013801|Leukemia in Remission|Leukemia in Remission|0|02.208910|3
00013802|glucagonoma|glucagonoma|0|02.157400|3
00013803|cerebral malaria|cerebral malaria|0|01.084900|3
00013804|spinal cord compression|spinal cord compression|0|06.336901|3
00013805|prevention of vitamin B12 deficiency|prevention of vitamin B12 deficiency|0|03.266204|3
00013806|Atypical Pneumonia|Atypical Pneumonia|0|08.486006|3
00013807|sickle cell trait|sickle cell trait|0|04.282500|3
00013808|Metabolic Bone Disease|Metabolic Bone Disease|0|13.731001|3
00013809|left main coronary artery disease|left main coronary artery disease|0|07.414004|3
00013810|invasive bladder cancer|invasive bladder cancer|0|02.188000|3
00013811|anterior uveitis|anterior uveitis|0|06.364306|3
00013812|CCR5 tropic HIV infection|CCR5 tropic HIV infection|0|01.042020|3
00013813|hepatic metastases|hepatic metastases|0|02.197700|3
00013814|intestinal hernia|intestinal hernia|0|09.553950|1
00013815|zidovudine-induced anemia|zidovudine-induced anemia|0|04.281908|3
00013816|bleeding risk from vitamin K epoxide reductase gene|bleeding risk associated with vitamin K epoxide reductase (warfarin-sensitive) gene|0|03.277801|1
00013817|CYP2C9 poor metabolizer|CYP2C9 poor metabolizer|0|03.277802|2
00013818|CYP2D6 ultrarapid metabolizer|CYP2D6 ultrarapid metabolizer|0|03.277803|2
00013819|treatment-resistant schizophrenia|treatment-resistant schizophrenia|0|05.295800|2
00013820|severe pain with opioid tolerance|severe pain with opioid tolerance|0|16.780917|2
00013821|reduction of allogeneic blood transfusion in surgery|reduction of allogeneic blood transfusion in surgery|0|17.998111|2
00013822|Congenital Glaucoma|Congenital Glaucoma|0|14.743200|3
00013823|Neovascular Glaucoma|Neovascular Glaucoma|0|06.365630|3
00013824|Pigmentary Glaucoma|Pigmentary Glaucoma|0|06.365130|3
00013825|worsening of chronic heart failure|worsening of chronic heart failure|0|07.428009|3
00013826|Cellulitis of the Lower Extremity|Cellulitis of the Lower Extremity|0|12.682000|3
00013827|Alcohol-Induced Psychosis|Alcohol-Induced Psychosis|0|05.291001|3
00013828|first degree atrioventricular heart block|first degree atrioventricular heart block|0|07.426110|3
00013829|Postpartum Psychosis|Postpartum Psychosis|0|11.648441|1
00013830|phlebitis of the lower extremity|phlebitis of the lower extremity|0|07.451200|3
00013831|hypertensive retinopathy|hypertensive retinopathy|0|06.362110|2
00013832|hyperchloremic acidosis|hyperchloremic acidosis|0|03.276906|1
00013833|hereditary retinal dystrophy|hereditary retinal dystrophy|0|06.362700|2
00013834|hemodynamic instability|hemodynamic instability|0|16.796403|3
00013835|history of total gastrectomy|history of total gastrectomy|0|09. 43990|2
00013836|crushing injury|crushing injury|0|17.929900|1
00013837|lymphoid leukemia|lymphoid leukemia|0|02.204003|3
00013838|osteolytic neoplasm|osteolytic neoplasm|0|02.198506|3
00013839|pre-malignant skin lesion|pre-malignant skin lesion|0|02.238200|2
00013840|micturition syncope|micturition syncope|0|16.780203|1
00013841|respiratory obstruction|respiratory obstruction|0|19.E91200|1
00013842|Autoimmune Neutropenia|Autoimmune Neutropenia|0|04.288090|2
00013843|tooth enamel hypoplasia|tooth enamel hypoplasia|0|09.520400|3
00013844|hypofibrinogenemia|hypofibrinogenemia|0|04.286910|3
00013845|Refractory Anemia|Refractory Anemia|2|04.285902|2
00013846|hyperlipoproteinemia|hyperlipoproteinemia|0|03.272401|2
00013847|left-to-right cardiovascular shunt|left-to-right cardiovascular shunt|0|07.417001|3
00013848|malignant neoplasm of skin|malignant neoplasm of skin|0|02.173906|2
00013849|acute ST elevation myocardial infarction|acute ST elevation myocardial infarction|0|07.410912|1
00013850|left ventricular outflow obstruction|left ventricular outflow obstruction|0|07.425405|3
00013851|acquired factor VIII deficiency disease|acquired factor VIII deficiency disease|0|04.286702|3
00013852|bleeding in acquired factor VIII deficiency disease|bleeding episode in acquired factor VIII deficiency disease|0|04.286703|1
00013853|prevent surg.-induced bleed in Von Willebrand's disease|prevention of surgery-induced bleed in Von Willebrand's disease|0|04.286402|1
00013854|deformity of erection of the penis|deformity of erection of the penis|0|10.607900|2
00013855|Secondary Uterine Inertia|Secondary Uterine Inertia|0|11.661100|1
00013856|atrial arrhythmia|atrial arrhythmia|0|07.427906|3
00013857|choroidal detachment|choroidal detachment|0|06.363700|1
00013858|mechanical ventilation|mechanical ventilation|0|16. 96701|1
00013859|internal hemorrhage|internal hemorrhage|0|07.459009|1
00013860|Breakthrough Pain in Opioid-Tolerant Patients|Breakthrough Pain in Opioid-Tolerant Patients|0|16.780918|3
00013861|Pain in Opioid Naive Patients|Pain in Opioid Naive Patients|0|16.780919|3
00013862|upper abdominal pain|upper abdominal pain|0|16.789005|3
00013863|extravasation injury from anthracycline injection|extravasation injury from anthracycline injection|0|17.999903|1
00013864|acute thromboembolic stroke|acute thromboembolic stroke|0|07.434903|1
00013865|surgical hemostasis adjunct|surgical hemostasis adjunct|0|16. 99200|1
00013866|cellulitis|cellulitis|0|12.682900|3
00013867|Peri-operative Acute Renal Failure in Liver Transplant|Acute Renal Insufficiency During Peri-operative Liver Transplant Period|0|09. 50501|1
00013868|echocardiography imaging adjunct|echocardiography imaging adjunct|0|07. 37292|1
00013869|right-to-left cardiovascular shunt|right-to-left cardiovascular shunt|0|07.447000|2
00013870|bidirectional cardiovascular shunt|bidirectional cardiovascular shunt|0|07.447001|3
00013871|hereditary complement deficiency|hereditary complement deficiency|0|03.279800|2
00013872|essential tremor|essential tremor|0|06.333100|2
00013873|new fistula formation involving an internal organ|new fistula formation involving an internal organ|0|08.510903|3
00013874|liver cell carcinoma|liver cell carcinoma|0|02.155000|3
00013875|ophthalmic angiography|ophthalmic angiography|0|16. 95120|1
00013876|Radioisotope Scan of Bone|Radioisotope Scan of Bone|0|16. 92140|1
00013877|brachial plexus disorder|brachial plexus disorder|0|13.723400|3
00013878|Senile Purpura|Senile Purpura|0|04.287201|2
00013879|Central Diabetes Insipidus|Central Diabetes Insipidus|0|03.253502|3
00013880|HLA-B *57:01 positive|HLA-B *57:01 positive|0|17.995209|2
00013881|HLA-B *15:02 positive|HLA-B *15:02 positive|0|17.995210|2
00013882|borderline personality disorder|borderline personality disorder|0|05.301830|2
00013883|acquired phimosis|acquired phimosis|0|10.605000|3
00013884|induration of skin|induration of skin|0|16.782802|3
00013885|Headache especially in pt w/out Opiate Toler|Headache Pain especially in Patients who are not Opiate Tolerant|2|16.784007|3
00013886|shortened time to tumor progression|shortened time to tumor progression|0|02.239907|3
00013887|prevent ventricular arrhythmia due to congenital long QT|prevention of ventricular arrhythmia due to congenital long QT syndrome|0|07.426820|3
00013888|systemic cryptococcosis treatment adjunct|systemic cryptococcosis treatment adjunct|0|01.117505|3
00013889|systemic candidiasis treatment adjunct|systemic candidiasis treatment adjunct|0|01.112503|3
00013890|hyperesthesia|hyperesthesia|0|16.782012|3
00013891|UGT1A1*28 polymorphism|UGT1A1*28 polymorphism|0|03.277402|2
00013892|hypochloremic alkalosis|hypochloremic alkalosis|0|03.276304|1
00013893|azoospermia|azoospermia|0|10.606000|3
00013894|familial Mediterranean fever|familial Mediterranean fever|0|03.277310|2
00013895|cerebral palsy-associated limb spasticity|cerebral palsy-associated limb spasticity|0|06.343000|2
00013896|cutaneous pseudolymphoma|cutaneous pseudolymphoma|0|02.216901|3
00013897|facial nerve disorder|facial nerve disorder|0|06.351900|3
00013898|Cryopyrin-Associated Periodic Syndrome|Cryopyrin-Associated Periodic Syndrome|0|03.279401|2
00013899|CYP2D6 poor metabolizer|CYP2D6 poor metabolizer|0|03.277804|2
00013900|dream disorder|dream disorder|0|16.780503|3
00013901|testicular pain|testicular pain|0|10.608800|1
00013902|muscle atrophy|muscle atrophy|0|13.728200|3
00013903|adjunct to fluorouracil treatment of colorectal cancer|adjunct to fluorouracil treatment of colorectal cancer|0|02.230906|1
00013904|focal segmental glomerulosclerosis|focal segmental glomerulosclerosis|0|10.582800|2
00013905|prevent hepatitis B reactivation in immunocompromised|prevention of hepatitis B reactivation in immunocompromised patient|0|01.070305|3
00013906|vulvar intraepithelial neoplasia|vulvar intraepithelial neoplasia|0|10.624090|3
00013907|acquired dystonia|acquired dystonia|0|06.333720|3
00013908|opioid-induced constipation|opioid-induced constipation|0|09.564003|3
00013909|dysphoric mood|dysphoric mood|0|05.296992|3
00013910|vitrectomy adjunct to enhance visualization|vitrectomy adjunct to enhance visualization|0|03. 14790|1
00013911|Cocaine-Associated Acute Ischemic Heart Disease|Cocaine-Associated Acute Ischemic Heart Disease|0|07.414801|1
00013912|postoperative ileus|postoperative ileus|0|09.560103|1
00013913|chest discomfort|chest discomfort|0|16.786591|1
00013914|carotid artery stenosis|carotid artery stenosis|0|07.433101|3
00013916|hyperinsulinism|hyperinsulinism|0|02.211702|3
00013917|prevention of vitamin D deficiency|prevention of vitamin D deficiency|0|03.268902|3
00013918|anticonvulsant-induced osteomalacia|anticonvulsant-induced osteomalacia|0|03.268201|2
00013919|boutonneuse fever|boutonneuse fever|0|01.082100|3
00013920|hereditary factor VII deficiency disease|hereditary factor VII deficiency disease|0|04.286304|2
00013921|transient global amnesia|transient global amnesia|0|07.437700|1
00013922|necrotizing pancreatitis|necrotizing pancreatitis|0|09.577002|1
00013923|increased reticulin bone marrow deposition|increased reticulin bone marrow deposition|0|04.284200|3
00013924|severe thrombocytopenia in refractory chronic ITP|severe thrombocytopenia in refractory chronic immune thrombocytopenia purpura|0|04.287310|3
00013925|purple glove syndrome|purple glove syndrome|0|19.E93610|1
00013926|prevention of bleeding esophageal varices|prevention of bleeding esophageal varices|0|07.456001|1
00013927|vaccination to prevent vulvar cancer due to HPV|vaccination to prevent vulvar cancer due to human papillomavirus|0|02.233304|2
00013928|vaccination to prevent vaginal cancer due to HPV|vaccination to prevent vaginal cancer due to human papillomavirus|0|02.233305|2
00013929|focal nodular hyperplasia of liver|focal nodular hyperplasia of liver|0|09.573803|3
00013930|skin grafting adjunct|skin grafting adjunct|0|15. 86600|1
00013931|hyperproteinemia|hyperproteinemia|0|03.273802|3
00013932|pseudohyponatremia|pseudohyponatremia|0|03.276101|1
00013934|complicated skin structure K. pneumoniae infection|complicated skin and skin structure Klebsiella pneumoniae infection|0|12.686947|1
00013935|complicated skin and skin structure E. cloacae infection|complicated skin infection from Enterobacter cloacae bacteria|0|12.686948|1
00013936|ophthalmoplegia|ophthalmoplegia|0|06.378500|3
00013937|reversible ischemic neurological defect|reversible ischemic neurological defect|0|18.V12540|1
00013938|sleep-onset insomnia|sleep-onset insomnia|0|16.780590|3
00013939|indolent B-cell non-Hodgkin lymphoma|indolent B-cell non-Hodgkin lymphoma|0|02.202811|2
00013940|renal pain|renal pain|0|16.788902|3
00013941|fat hypertrophy|fat hypertrophy|0|02.214100|2
00013942|dyspareunia due to menopausal vulvovaginal atrophy|dyspareunia due to menopause-associated vulvovaginal atrophy|0|10.625000|3
00013943|shortened QT interval|shortened QT interval|0|07.42789A|3
00013944|actinic prurigo|actinic prurigo|0|12.692726|3
00013945|peripheral mobilization of hematopoietic stem cells|peripheral mobilization of hematopoietic stem cells|0|08. 41007|1
00013946|chronic phase chronic myeloid leukemia|chronic phase chronic myeloid leukemia|0|02.205107|2
00013947|facial palsy|facial palsy|0|06.351001|3
00013948|severe malaria|severe malaria|0|01.084602|1
00013949|wild-type KRAS colorectal cancer|wild-type KRAS colorectal cancer|0|02.230907|3
00013950|oral hemorrhage|oral hemorrhage|0|09.578907|3
00013951|CYP2C19 poor metabolizer|CYP2C19 poor metabolizer|0|03.277805|2
00013952|Friedreich's ataxia|Friedreich's ataxia|0|06.334000|2
00013953|impulse control disorder|impulse control disorder|0|05.312300|3
00013954|acquired coagulation factor inhibitor disorder|acquired coagulation factor inhibitor disorder|0|04.286501|3
00013955|Evans syndrome|Evans syndrome|0|04.287320|3
00013956|moderate to severe plaque psoriasis|moderate to severe plaque psoriasis|0|12.696108|2
00013957|diabetic gastroparesis|diabetic gastroparesis|0|03.250601|3
00013958|night sweats|night sweats|0|12.705891|3
00013959|Photodynamic Ablation Adjunct for Cancer|Endoscopic Photodynamic Ablation Adjunct for Cancer or High Grade Dysplasia|0|02.199101|1
00013960|ANCA-positive vasculitis|ANCA-positive vasculitis|0|07.446201|3
00013961|esophagogastrostomy|esophagogastrostomy|0|09. 44390|3
00013963|stapling of stomach|stapling of stomach|0|09. 44900|3
00013964|hypocomplementemic urticarial vasculitis|hypocomplementemic urticarial vasculitis|0|07.446202|3
00013965|short stature in child born small for gestational age|short stature in child born small for gestational age|0|16.783431|2
00013966|Q fever endocarditis|Q fever endocarditis|0|01.083001|2
00013967|trigger finger|trigger finger|0|13.727030|3
00013968|osmotic central pontine myelinolysis|osmotic central pontine myelinolysis|0|06.341901|3
00013969|hypermethioninemia|hypermethioninemia|0|03.270406|2
00013970|suppression of recurrent Herpes simplex infection in HIV|suppression of recurrent Herpes simplex infection in HIV|0|01.054907|3
00013973|fibrosing colonopathy|fibrosing colonopathy|0|09.564901|3
00013974|hormone receptor positive breast cancer|hormone receptor positive breast cancer|0|02.174907|2
00013975|BK polyomavirus reactivation nephropathy|BK polyomavirus reactivation nephropathy|0|10.590900|2
00013976|urinary hesitancy|urinary hesitancy|0|16.788640|3
00013977|Oncology Dosing Limit|Oncology Dosing Limit|2|99.999994|3
00013978|Japanese encephalitis vaccination|Japanese encephalitis vaccination|0|01.062000|1
00013979|schizoaffective disorder|schizoaffective disorder|0|05.295700|3
00013980|peripheral neuritis|peripheral neuritis|0|06.356903|3
00013981|oral hypoesthesia|oral hypoesthesia|0|09.528903|3
00013982|branch retinal vein occlusion with macular edema|branch retinal vein occlusion with macular edema|0|06.362302|3
00013983|central retinal vein occlusion with macular edema|central retinal vein occlusion with macular edema|0|06.362303|3
00013984|influenza A (H1N1 subtype) vaccination|influenza A (H1N1 subtype) vaccination|0|08.488100|1
00013985|peripheral T-cell lymphoma|peripheral T-cell lymphoma|0|02.202700|2
00013990|sleep walking disorder|sleep walking disorder|0|05.307461|3
00013991|foamy urine|foamy urine|0|16.791905|1
00013992|gastrointestinal concretion|gastrointestinal concretion|0|09.560904|1
00013994|colonic necrosis|colonic necrosis|0|09.557002|1
00013995|chondrolysis of articular cartilage|chondrolysis of articular cartilage|0|13.733996|1
00013996|prevention of recurrent bladder carcinoma|prevention of recurrent bladder carcinoma|0|02.188900|3
00013997|metastatic gastric cancer|metastatic gastric cancer|0|02.230908|2
00013998|peripheral demyelinating neuropathy|peripheral demyelinating neuropathy|0|06.356904|3
00013999|uncontrolled hypertension|uncontrolled hypertension|2|07.401909|3
00014000|prevention of inhalation anthrax|prevention of inhalation anthrax|0|01.022903|1
00014001|intravascular hemolysis|intravascular hemolysis|0|04.283204|1
00014002|medullary thyroid carcinoma|medullary thyroid carcinoma|0|02.231003|3
00014003|multiple endocrine neoplasia type 2|multiple endocrine neoplasia type 2|0|02.237401|3
00014004|C-cell hyperplasia of thyroid|C-cell hyperplasia of thyroid|0|03.246000|3
00014005|neuroendocrine prostate carcinoma|neuroendocrine prostate carcinoma|0|02.233403|2
00014006|adjunct maintenance tx for asthma|adjunct maintenance tx for asthma|0|08.493909|2
00014007|respiratory cystic fibrosis P. aeruginosa colonization|respiratory cystic fibrosis with Pseudomonas aeruginosa colonization|0|03.277020|2
00014008|prolonged PR interval|prolonged PR interval|0|07.426111|3
00014009|upper limb spasticity|upper limb spasticity|0|13.728856|3
00014010|metastatic carcinoma of cervix|metastatic carcinoma of cervix|0|02.233102|2
00014011|localized malignant tumor of anus|localized malignant tumor of anus|0|02.154300|2
00014012|metastatic malignant tumor of anus|metastatic malignant tumor of anus|0|02.154301|2
00014013|antiphospholipid syndrome|antiphospholipid syndrome|0|03.279801|3
00014014|restrictive cardiomyopathy|restrictive cardiomyopathy|0|07.425406|3
00014015|amyloid heart muscle disease|amyloid heart muscle disease|0|03.277301|2
00014016|refractory osteosarcoma|refractory osteosarcoma|0|02.170904|3
00014017|refractory Ewing's sarcoma|refractory Ewing's sarcoma|0|02.170905|3
00014018|neutropenic colitis|neutropenic colitis|0|09.558907|1
00014019|post kidney transplant renal thrombosis|post kidney transplant renal thrombosis|0|10. 55691|1
00014020|placement of indwelling epidural catheter|placement of indwelling epidural catheter|0|01. 03900|1
00014021|spinal epidural hematoma|spinal epidural hematoma|0|17.999812|1
00014022|acute postoperative pain without opiate tolerance|acute postoperative pain in patient without opiate tolerance|0|16.780920|1
00014023|fluid retention associated with menses|fluid retention associated with menses|0|03.276605|3
00014024|cerebral vasculitis|cerebral vasculitis|0|07.437401|3
00014025|pseudoscleroderma|pseudoscleroderma|0|16.782305|1
00014026|spinal osteoarthritis|spinal osteoarthritis|0|13.721900|2
00014027|sciatica|sciatica|0|13.724300|3
00014028|spasm of bladder|spasm of bladder|0|10.596902|1
00014029|uterine perforation by intrauterine contraceptive device|uterine perforation by intrauterine contraceptive device|0|17.996320|1
00014030|septicemia due to Streptococcus group A|septicemia due to Streptococcus group A|0|01.038001|1
00014031|elevated serum lipase|elevated serum lipase|0|16.790500|3
00014032|pseudoporphyria|pseudoporphyria|0|12.692727|1
00014033|prevent minor bacterial skin infection|prevent minor bacterial skin infection|0|12.686949|1
00014034|secondary acute myeloid leukemia|secondary acute myeloid leukemia|0|02.208001|3
00014035|rapid cycling bipolar disorder|rapid cycling bipolar disorder|0|05.296800|3
00014036|Heart Failure with Paroxysmal Atrial Fibrillation|Heart Failure with Paroxysmal Atrial Fibrillation|0|07.427006|2
00014037|ovarian hemorrhage|ovarian hemorrhage|0|10.620100|1
00014038|benign fundic gland polyposis of stomach|benign fundic gland polyposis of stomach|0|09.537890|1
00014039|Treatment-Refractory Type 2 Diabetes Mellitus|Treatment-Refractory Type 2 Diabetes Mellitus|0|03.250002|2
00014040|acute decompensated HF requiring IV inotropic therapy|acutely decompensated HF requiring parenteral inotropic therapy|0|07.428903|1
00014041|prevention of type 2 diabetes mellitus|prevention of type 2 diabetes mellitus|0|03.250003|2
00014042|Fracture of Femur|Fracture of Femur|0|13.733150|1
00014043|diabetes mellitus with severe insulin resistance|diabetes mellitus with severe insulin resistance|0|03.250904|3
00014044|non-infectious uveitis affecting the posterior segment|non-infectious uveitis affecting the posterior segment of eye|0|06.363204|3
00014045|SEGA associated with tuberous sclerosis|subependymal giant cell astrocytoma associated with tuberous sclerosis|0|14.759500|3
00014046|HER2-positive gastric carcinoma|HER2-positive gastric carcinoma|0|02.230909|2
00014047|chronic musculoskeletal pain|chronic musculoskeletal pain|0|13.729105|2
00014048|hyperammonemia in N-acetylglutamate synthase deficiency|hyperammonemia associated with N-acetylglutamate synthase deficiency|0|03.270606|2
00014049|lipodystrophy associated with HIV|lipodystrophy associated with human immunodeficiency virus infection|0|01.042012|2
00014050|pseudobulbar affect|pseudobulbar affect|0|05.310800|3
00014051|vaccination to prevent anal cancer due to HPV|vaccination to prevent anal cancer due to human papillomavirus|0|16.796700|1
00014052|paraneoplastic pemphigus|paraneoplastic pemphigus|0|12.694401|1
00014053|elevated serum amylase|elevated serum amylase|0|16.790501|3
00014054|risk reduction for recurrent preterm birth|risk reduction for recurrent preterm birth|0|11.644201|1
00014055|diagnostic cystoscopy aid for bladder cancer detection|diagnostic cystoscopy aid for bladder cancer detection|0|10. 57320|1
00014056|hypercalcemia due to primary hyperparathyroidism|hypercalcemia due to primary hyperparathyroidism|0|03.252002|1
00014057|retroperitoneal hemorrhage|retroperitoneal hemorrhage|0|07.459010|1
00014059|pneumatosis cystoides intestinalis|pneumatosis cystoides intestinalis|0|09.569894|1
00014060|adjuvant treatment of melanoma|adjuvant treatment of melanoma|0|02.172904|1
00014061|metastatic thyroid carcinoma|metastatic thyroid carcinoma|0|02.193000|1
00014062|inflammation of orbit|inflammation of orbit|0|06.376000|1
00014063|ligneous conjunctivitis|ligneous conjunctivitis|0|06.372100|2
00014064|microscopic polyangiitis|microscopic polyangiitis|0|07.446001|1
00014065|ruptured ovarian cyst|ruptured ovarian cyst|0|10.620201|1
00014066|metastatic castration-resistant prostate cancer|metastatic castration-resistant prostate cancer|0|02.233404|2
00014067|pancreatic neuroendocrine tumor|pancreatic neuroendocrine tumor|0|02.230910|1
00014068|glossopharyngeal neuralgia|glossopharyngeal neuralgia|0|06.352100|3
00014069|intrauterine device insertion with acute vaginitis|intrauterine device insertion with acute vaginitis|0|12. 69700|1
00014070|myopathy related to drug and SLCO1B1 gene variant|myopathy related to drug and SLCO1B1 gene variant|0|06.359400|1
00014071|SLCO1B1 polymorphism affecting OATP1B1 transporter funct|SLCO1B1 polymorphism affecting OATP1B1 transporter function|0|06.359401|2
00014072|high-grade prostate cancer|high-grade prostate cancer|0|02.233405|3
00014073|disturbance of attention|disturbance of attention|0|05.314000|3
00014074|methylmalonic acidemia|methylmalonic acidemia|0|03.270304|2
00014075|Epstein-Barr virus seronegative|Epstein-Barr virus seronegative|0|18.V72610|0
00014076|Severe Left Ventricular Failure|Severe Left Ventricular Failure|2|07.428103|3
00014077|endotracheal tube blockage|endotracheal tube blockage|0|19.E91390|3
00014078|prevention of bronchospasm with chronic bronchitis|prevention of bronchospasm with chronic bronchitis|0|08.491206|2
00014079|COPD exacerbation|exacerbation of chronic obstructive pulmonary disease|0|08.496006|3
00014080|hereditary factor XIII deficiency disease|hereditary factor XIII deficiency disease|0|04.286305|2
00014081|poisoning due to scorpion venom|poisoning due to scorpion venom|0|17.989508|1
00014082|Juvenile Idiopathic Arthritis|Juvenile Idiopathic Arthritis|1|13.714301|2
00014083|malignant melanoma with BRAF V600E mutation|malignant melanoma with BRAF V600E mutation|0|02.172905|2
00014084|fibrosis of pericardium|fibrosis of pericardium|0|07.423100|3
00014085|cranial nerve disorder|cranial nerve disorder|0|06.352900|3
00014086|systemic anaplastic large cell lymphoma|systemic anaplastic large cell lymphoma|0|02.200600|3
00014087|urinary incontinence due to detrusor overactivity|urinary incontinence due to detrusor overactivity|0|10.596590|3
00014088|photopsia|photopsia|0|06.368152|1
00014089|ALK positive non-small cell lung cancer|anaplastic lymphoma kinase positive non-small cell lung cancer|0|02.231204|2
00014090|neuroretinitis|neuroretinitis|0|06.363050|3
00014091|atypical hemolytic uremic syndrome|atypical hemolytic uremic syndrome|0|04.283111|3
00014092|breakthrough cancer pain in opioid-tolerant patient|breakthrough cancer pain in opioid-tolerant patient|0|16.780921|2
00014093|loss of bone density due to aromatase inhibitor therapy|loss of bone mineral density (BMD) due to aromatase inhibitor therapy|0|13.733003|3
00014094|parathyroid hyperactivity localization|parathyroid hyperactivity localization|0|16. 88901|1
00014095|secondary ovarian failure|secondary ovarian failure|0|03.256390|3
00014096|Brugada syndrome|Brugada syndrome|0|07.426402|2
00014098|Lennox-Gastaut syndrome treatment adjunct|Lennox-Gastaut syndrome treatment adjunct|0|06.345005|2
00014099|myelofibrosis|myelofibrosis|0|04.289830|3
00014100|untreated systemic fungal infection|untreated systemic fungal infection|0|01.118004|1
00014101|skeletal fluorosis|skeletal fluorosis|0|13.733997|2
00014102|periostitis|periostitis|0|13.730300|3
00014103|Perinatal Periventricular Hemorrhage|Perinatal Periventricular Hemorrhage|0|15.772100|1
00014104|vaccine adjunct in immunocompromised|vaccine adjunct in immunocompromised patient|0|03.279304|1
00014105|edema due to chronic venous insufficiency|edema due to chronic venous insufficiency|0|16.782306|3
00014106|edema due to sclerotherapy|edema due to sclerotherapy|0|16.782307|1
00014107|edema due to muscle sprain or strain|edema due to muscle sprain or strain|0|16.782308|1
00014108|splenic peliosis|splenic peliosis|0|04.289592|3
00014109|coarsening of facial features|coarsening of facial features|0|19.E93611|3
00014110|anti-JCV antibody positive|anti-JCV antibody positive|0|01.463010|3
00014111|ocular myasthenia|ocular myasthenia|0|06.358002|3
00014112|Adjunct Treatment of Obesity|Adjunct Treatment of Obesity in a Comprehensive Weight Reduction Regimen|0|03.278011|1
00014113|Cystic Fibrosis with G551D Mutation in CFTR Gene|Cystic Fibrosis with G551D Mutation in CFTR Gene|0|03.277008|2
00014114|loss of taste|loss of taste|0|16.781102|3
00014115|actinic keratosis on the trunk or extremities|actinic keratosis on the trunk or extremities|0|12.702003|1
00014116|actinic keratosis on the face or scalp|actinic keratosis on the face or scalp|0|12.702004|1
00014117|hypertrichosis of eyelid vellus hair|hypertrichosis of eyelid vellus hair|0|06.374541|1
00014118|CYP3A4 poor metabolizer|CYP3A4 poor metabolizer|0|03.277806|2
00014119|reduced activity of cytochrome p450 CYP1A2|reduced activity of cytochrome p450 CYP1A2|0|03.277807|2
00014120|type 2 diabetes adjunct in Cushing's syndrome|type 2 diabetes adjunct in Cushing's syndrome|0|03.250004|3
00014121|increased libido|increased libido|0|05.302702|3
00014122|acute gastroenteritis-related vomiting in pediatrics|acute gastroenteritis-related vomiting in pediatrics|0|16.787034|1
00014123|envenomation by snake|envenomation by snake|0|17.989509|1
00014124|logorrhea|logorrhea|0|16.784494|3
00014125|B-cell acute lymphoblastic leukemia|B-cell acute lymphoblastic leukemia|0|02.202812|1
00014127|renal angiomyolipoma with tuberous sclerosis complex|renal angiomyolipoma with tuberous sclerosis complex|0|14.759501|2
00014128|perforation of gallbladder|perforation of gallbladder|0|09.576903|1
00014129|prostatitis|prostatitis|0|10.601900|3
00014130|neuropathic pain associated with spinal cord injury|neuropathic pain associated with spinal cord injury|0|17.952901|2
00014131|adjunct to ab externo glaucoma surgery|adjunct to ab externo glaucoma surgery|0|03. 12540|1
00014132|abnormal hair texture|abnormal hair texture|0|12.404201|2
00014133|HIV infection pre-exposure prophylaxis|HIV infection pre-exposure prophylaxis|0|18.V01790|0
00014134|envenomation by red back spider (Latrodectus hasseltii)|envenomation by red back spider (Latrodectus hasseltii)|0|17.989510|1
00014135|asthenozoospermia|asthenozoospermia|0|16.792201|3
00014136|bronchial congestion|bronchial congestion|0|08.490018|3
00014137|hysterosalpingo contrast sonography|hysterosalpingo contrast sonography|0|16. 88790|0
00014138|gastric hypersecretion with systemic mastocytosis|gastric hypersecretion with systemic mastocytosis|0|02.202601|3
00014139|tear of retinal pigment epithelium|tear of retinal pigment epithelium|0|06.362800|1
00014140|myelodysplastic syndrome with 5q deletion|myelodysplastic syndrome with 5q deletion|0|14.742591|2
00014141|necrotizing fasciitis|necrotizing fasciitis|0|13.728861|1
00014142|hypotrichosis of eyelid lashes|hypotrichosis of eyelid lashes|0|06.374550|3
00014143|nonsquamous non-small cell lung cancer|nonsquamous non-small cell lung cancer|0|02.231205|2
00014144|vitreomacular adhesion|vitreomacular adhesion|0|06.379270|1
00014145|sleep maintenance insomnia|sleep maintenance insomnia|0|16.780522|3
00014146|thrombocytopenia associated with chronic hepatitis C|thrombocytopenia associated with chronic hepatitis C|0|04.287330|3
00014147|immune-mediated necrotizing myopathy|immune-mediated necrotizing myopathy|0|06.359700|3
00014148|transitional cell carcinoma of the urinary tract|transitional cell carcinoma of the urinary tract|0|02.189003|3
00014149|erythromelalgia|erythromelalgia|0|07.443820|2
00014150|macrophage activation syndrome|macrophage activation syndrome|0|04.288400|1
00014151|hereditary coproporphyria|hereditary coproporphyria|0|03.277106|2
00014152|adjunct to surgery or radiotherapy for thyroid carcinoma|adjunct to surgery or radiotherapy for thyroid carcinoma|0|02.193001|3
00014153|Dravet syndrome|Dravet syndrome|0|06.345104|2
00014154|colorectal polyp|colorectal polyp|0|02.211200|3
00014155|pulmonary multi-drug resistant M. tuberculosis|pulmonary multi-drug resistant Mycobacterium tuberculosis|0|01.010900|3
00014156|prenatal treatment of methylmalonic acidemia|prenatal treatment of methylmalonic acidemia|0|03.270305|2
00014157|anemia due to chemotherapy and radiotherapy combination|anemia due to chemotherapy and radiotherapy combination|0|04.281903|3
00014158|obstructive sleep apnea syndrome|obstructive sleep apnea syndrome|0|06.327230|2
00014159|erythema of mouth mucous membrane|erythema of mouth mucous membrane|0|09.528790|3
00014160|Female|Female|0|15.779901|2
00014161|Male|Male|0|15.779902|2
00014162|urine acidification UTI treatment adjunct|urine acidification UTI treatment adjunct|0|10.595890|3
00014163|cystinosis with corneal cystine crystal accumulation|benign cystinosis with corneal cystine crystal accumulation|0|03.270003|2
00014164|adjunct to leukopheresis procedure|adjunct to leukopheresis procedure|0|16. 99720|1
00014165|localized blue skin pigmentation|localized blue skin pigmentation|0|12.709099|3
00014166|erythrodermic psoriasis|erythrodermic psoriasis|0|12.696109|3
00014170|factor V leiden mutation|factor V leiden mutation|0|04.289813|2
00014171|antithrombin III deficiency due to SERPINC1 mutation|antithrombin III deficiency due to SERPINC1 mutation|0|04.289814|2
00014172|malignant melanoma with BRAF V600K mutation|malignant melanoma with BRAF V600K mutation|0|02.172906|3
00014173|lichenoid dermatitis drug eruption|lichenoid dermatitis drug eruption|0|12.692904|3
00014174|cutaneous papilloma|cutaneous papilloma|0|02.216000|3
00014175|keratoacanthoma|keratoacanthoma|0|02.238201|3
00014176|blebitis|blebitis|0|06.379600|1
00014177|giant cell tumor of bone|giant cell tumor of bone|0|02.170906|3
00014178|thrombosis of retinal vein|thrombosis of retinal vein|0|06.362304|1
00014179|hormone receptor positive, HER2-positive breast cancer|hormone receptor positive, HER2-positive metastatic breast cancer|0|02.174908|2
00014180|diarrhea with villous atrophy of the intestine|diarrhea with villous atrophy of the intestine|0|09.579803|3
00014181|adenovirus types 4, 7 vaccination|adenovirus types 4, 7 vaccination|0|18.V04890|0
00014182|progression of malignancy associated with RAS mutation|progression of malignancy associated with RAS mutation|0|02.199102|3
00014183|squamous cell carcinoma of head and neck|squamous cell carcinoma of head and neck|0|02.173920|2
00014184|acute generalized exanthematous pustulosis|acute generalized exanthematous pustulosis|0|12.693001|1
00014185|lateral canthal lines|lateral canthal lines|0|12.701803|2
00014186|malignant tumor of oral cavity|malignant tumor of oral cavity|0|02.145900|2
00014187|hyperprolinemia|hyperprolinemia|0|03.270802|2
00014188|chronic thromboembolic pulmonary hypertension|chronic thromboembolic pulmonary hypertension|0|07.416003|2
00014193|increased surgical wound drainage|increased surgical wound drainage|0|17.998901|3
00014194|chronic hepatitis C - genotype 1|chronic hepatitis C - genotype 1|0|01.070541|2
00014195|rupture of corpus cavernosum of penis|rupture of corpus cavernosum of penis|0|17.959130|1
00014196|penile hematoma|penile hematoma|0|10.607820|1
00014197|sinus tachycardia secondary to antipsychotic medication|sinus tachycardia secondary to antipsychotic medication|0|16.785003|2
00014198|hereditary factor XIII a subunit deficiency|hereditary factor XIII a subunit deficiency|0|04.286306|2
00014199|candidal balanitis|candidal balanitis|0|01.112201|1
00014200|herpes zoster encephalitis|herpes zoster encephalitis|0|01.053191|1
00014201|herpes zoster meningitis|herpes zoster meningitis|0|01.053000|1
00014202|herpes simplex meningitis|herpes simplex meningitis|0|01.054720|1
00014203|vitamin D deficiency (high dose therapy)|vitamin D deficiency (high dose therapy)|0|03.268903|3
00014204|non-24 hour sleep-wake cycle disorder|non-24 hour sleep-wake cycle disorder|0|06.327340|2
00014205|calcification of trachea|calcification of trachea|0|08.519192|2
00014206|calcification of bronchus|calcification of bronchus|0|08.519193|2
00014207|mucopolysaccharidosis type IV-A|mucopolysaccharidosis type IV-A|0|03.277503|2
00014208|torsion of ovary|torsion of ovary|0|10.620500|1
00014209|cystic fibrosis with class III CFTR mutation|cystic fibrosis with class III CFTR mutation|0|03.277009|2
00014210|generalized lipodystrophy|generalized lipodystrophy|0|03.272601|2
00014211|Aciduria|Aciduria|0|16.791906|1
00014212|pulmonary oil microembolism|pulmonary oil microembolism|0|07.415190|1
00014213|Sjogren-Larsson syndrome|Sjogren-Larsson syndrome|0|14.757104|2
00014214|body weight greater than 74 kg (164 lbs)|body weight greater than 74 kg (164 lbs)|0|03.278001|2
00014215|allergic rhinitis due to grass pollen|allergic rhinitis due to grass pollen|0|08.477906|2
00014216|oral pruritus|oral pruritus|0|09.528904|1
00014236|edema of the oral soft tissue|edema of the oral soft tissue|0|09.528905|1
00014256|candidiasis of the lung|candidiasis of the lung|0|01.112400|1
00014276|hereditary syndromes due to POLG gene mutations|hereditary neurometabolic syndromes due to POLG gene mutations|0|06.330801|2
00014296|allergic rhinitis due to ragweed pollen|allergic rhinitis due to ragweed pollen|0|08.477907|2
00014297|eosinophilic esophagitis|eosinophilic esophagitis|0|09.530130|1
00014298|multicentric Castleman's disease|multicentric Castleman's disease|0|02.229000|2
00014299|induction of intraoperative hypotension|induction of intraoperative hypotension|0|07.458905|1
00014300|cerebrovascular anomaly associated with PHACE syndrome|cerebrovascular anomaly associated with PHACE syndrome|0|02.228020|2
00014301|family history of medullary thyroid carcinoma|family history of medullary thyroid carcinoma|0|02.231206|2
00014302|ingrown fingernail or toenail|ingrown fingernail or toenail|0|12.703000|1
00014303|teething pain|teething pain|0|09.520700|1
00014304|muscle spasticity due to multiple sclerosis|muscle spasticity due to multiple sclerosis|0|06.340003|2
00014305|adenoidectomy in pediatric patient|adenoidectomy in pediatric patient|0|05. 28600|1
00014306|tonsillectomy in pediatric patient|tonsillectomy in pediatric patient|0|05. 28200|1
00014308|chronic lymphocytic leukemia with 17p deletion|chronic lymphocytic leukemia with 17p deletion|0|02.204104|2
00014309|small lymphocytic lymphoma|small lymphocytic lymphoma|0|02.204105|2
00014310|sinoatrial block|sinoatrial block|0|07.426602|3
00014311|migraine with aura|migraine with aura|0|06.346000|3
00014312|thrombosis of aorta|thrombosis of aorta|0|07.444000|1
00014313|risk of angle-closure glaucoma due to narrow angle|risk of angle-closure glaucoma due to narrow angle of anterior chamber of eye|0|06.365020|2
00014314|lipoma|lipoma|0|02.214101|2
00014315|ganglion cyst|ganglion cyst|0|13.727430|3
00014316|hypophysitis|hypophysitis|0|03.253900|3
00014317|diabetic macular edema|diabetic macular edema|0|03.250502|2
00014318|neuropsychiatric disorder|neuropsychiatric disorder|0|05.300901|3
00014319|neurocognitive disorder|neurocognitive disorder|0|06.331004|3
00014320|HLA-A *31:01 positive|HLA-A *31:01 positive|0|17.995211|2
00014321|Neurodevelopmental Disorder|Neurodevelopmental Disorder|0|05.300902|2
00014322|penalization therapy for unilateral amblyopia|penalization therapy for unilateral amblyopia|0|06.368001|2
00014323|bleeding episode in Glanzmann's thrombasthenia|bleeding episode in Glanzmann's thrombasthenia|0|04.287105|1
00014324|prevent surgery-ind bleed in Glanzmann's thrombasthenia|prevention of surgery-induced bleeding in Glanzmann's thrombasthenia|0|04.287106|1
00014326|reactivation of Epstein-Barr virus infection|reactivation of Epstein-Barr virus infection|0|01.075001|1
00014327|pain in penis|pain in penis|0|10.607901|3
00014328|edema of penis|edema of penis|0|10.607830|1
00014329|bleeding prevention in hereditary factor VIII deficiency|bleeding prevention in hereditary factor VIII deficiency|0|04.286004|1
00014330|chronic hepatitis C - genotype 2|chronic hepatitis C - genotype 2|0|01.070542|2
00014331|chronic hepatitis C - genotype 3|chronic hepatitis C - genotype 3|0|01.070543|2
00014332|chronic hepatitis C - genotype 4|chronic hepatitis C - genotype 4|0|01.070544|2
00014333|chronic hepatitis C - genotype 5|chronic hepatitis C - genotype 5|0|01.070545|2
00014334|chronic hepatitis C - genotype 6|chronic hepatitis C - genotype 6|0|01.070546|2
00014335|malignant neoplasm of fallopian tube|malignant neoplasm of fallopian tube|0|02.183200|2
00014336|primary malignant neoplasm of peritoneum|primary malignant neoplasm of peritoneum|0|02.158000|2
00014337|epithelial ovarian cancer|epithelial ovarian cancer|0|02.183001|2
00014338|sleep paralysis|sleep paralysis|0|06.327490|1
00014339|Philadelphia chromosome-negative B-cell ALL|Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia|0|02.204004|2
00014340|Merkel cell carcinoma|Merkel cell carcinoma|0|02.209310|2
00014341|panniculitis|panniculitis|0|13.729300|3
00014342|malignant gastroenteropancreatic neuroendocrine tumor|malignant gastroenteropancreatic neuroendocrine tumor|0|02.209000|2
00014343|prevent thrombosis in PCI in HIT|thrombosis prevention during percutaneous coronary intervention in heparin-induced thrombocytopenia|0|17.997791|1
00014344|malignant neoplasm of ovary with germline BRCA mutation|malignant neoplasm of ovary associated with germline BRCA mutation|0|02.183002|2
00014345|cystic fibrosis with R117H mutation in CFTR gene|cystic fibrosis with R117H mutation in CFTR gene|0|03.277010|2
00014346|weight loss management for obese patient (bmi >= 30)|weight loss management for obese patient (body mass index 30 or greater)|0|03.278002|3
00014347|wt loss mgmt, pt with bmi 27-29 & wt-related comorbidity|weight loss management for overweight patient with bmi 27 to 29 and weight-related comorbidity|0|03.278003|3
00014348|weight loss management for patient with bmi >=27|weight loss management for overweight or obese patient (body mass index 27 or greater)|0|03.278004|3
00014349|acrocyanosis|acrocyanosis|0|07.443890|1
00014350|Muckle-Wells syndrome|Muckle-Wells syndrome|0|14.759892|2
00014351|familial cold autoinflammatory syndrome|familial cold autoinflammatory syndrome|0|14.759893|2
00014352|CINCA syndrome|CINCA syndrome|0|14.759894|2
00014353|polyarticular juvenile idiopathic arthritis|polyarticular juvenile idiopathic arthritis|0|13.714302|2
00014354|systemic-onset juvenile idiopathic arthritis|systemic-onset juvenile idiopathic arthritis|0|13.714303|2
00014355|binge eating disorder|binge eating disorder|0|05.307590|2
00014356|ER(+), HER2(-) postmenopausal advanced breast cancer|estrogen receptor (ER)-positive, HER2-negative postmenopausal advanced breast cancer|0|02.174909|2
00014357|excoriation disorder|excoriation disorder|0|05.306300|2
00014359|differentiated thyroid carcinoma|differentiated thyroid carcinoma|0|02.193002|2
00014360|Pediatric Patient|Pediatric Patient|0|18.V00000|0
00014361|Adult Patient|Adult Patient|0|18.V00001|0
00014362|Geriatric Patient|Geriatric Patient|0|18.V00002|0
00014363|Patient Demographics|Patient Demographics|0|18.V00003|0
00014364|high-risk neuroblastoma|high-risk neuroblastoma|0|02.194001|2
00014365|squamous cell carcinoma of lung|squamous cell carcinoma of lung|0|02.231207|2
00014366|pre-exertional prophylaxis of anginal pain|pre-exertional prophylaxis of anginal pain|0|07.413912|1
00014367|Acute Relief of Angina Pectoris|Acute Relief of Angina Pectoris|2|07.413913|1
00014368|prevent extracorporeal clotting during hemodialysis|prevent extracorporeal clotting during hemodialysis|0|07. 39952|1
00014369|Barrett's esophagus|Barrett's esophagus|0|09.530850|2
00014370|increased hemoglobin|increased hemoglobin|0|16.790605|3
00014371|growth failure associated with Turner's syndrome|growth failure associated with Turner's syndrome|0|16.783432|2
00014372|growth failure due to Prader-Willi syndrome|growth failure due to Prader-Willi syndrome|0|16.783433|2
00014373|short stature associated with Noonan syndrome|short stature associated with Noonan syndrome|0|16.783434|2
00014374|growth failure in child with SHOX deficiency|growth failure in child with short stature homeobox-containing gene (SHOX) deficiency|0|16.783435|2
00014375|chronic cannabis smoker|chronic cannabis smoker|0|05.304301|2
00014376|Peroxisomal Disorder|Peroxisomal Disorder|0|03.277860|2
00014377|deficiency of bile acids due to peroxisomal disorder|deficiency of bile acids due to peroxisomal disorder|0|03.277861|2
00014378|bile acid synthesis disorder due to single enzyme defect|bile acid synthesis disorder due to single enzyme defect|0|03.272800|2
00014379|deficiency of bile acids in bile acid synthesis disorder|deficiency of bile acids in bile acid synthesis disorder|0|03.272801|2
00014380|polyp of intestine|polyp of intestine|0|02.211201|3
00014381|renal cyst|renal cyst|0|10.593200|2
00014382|posterior capsule opacification|posterior capsule opacification|0|06.366500|2
00014383|hypocalcemia associated with hypoparathyroidism|hypocalcemia associated with hypoparathyroidism|0|03.275412|2
00014384|hematopoietic syndrome of acute radiation syndrome|hematopoietic syndrome of acute radiation syndrome|0|17.990003|1
00014385|edema of male genital organs|edema of male genital organs|0|10.608861|1
00014386|minor musculoskeletal injury|minor musculoskeletal injury|0|17.848901|1
00014387|bradykinesia|bradykinesia|0|16.799540|3
00014388|extensive limb swelling after injection|extensive limb swelling after injection|0|13.729810|1
00014389|diarrhea associated with VIP-secreting tumor|diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor|0|02.157902|2
00014390|cloudy urine|cloudy urine|0|16.791907|1
00014391|phosphene|phosphene|0|06.368801|1
00014392|primary focal hyperhidrosis of axilla|primary focal hyperhidrosis of axilla|0|12.705210|2
00014393|squamous cell carcinoma of mouth|squamous cell carcinoma of mouth|0|02.145901|2
00014394|chronic idiopathic thrombocytopenic purpura|chronic idiopathic thrombocytopenic purpura|0|04.287311|2
00014395|acute exacerbation of multiple sclerosis|acute exacerbation of multiple sclerosis|0|06.340004|1
00014396|walking impairment due to multiple sclerosis|walking impairment due to multiple sclerosis|0|06.340005|2
00014397|relapsing form of multiple sclerosis|relapsing form of multiple sclerosis|0|06.340006|2
00014398|acute pain|acute pain|0|16.780922|1
00014399|envenomation by tiger snake (Notechis scutatus)|envenomation by tiger snake (Notechis scutatus)|0|17.989500|1
00014400|envenomation by copperhead snake (Austrelaps spp.)|envenomation by copperhead snake (Austrelaps spp.)|0|17.989511|1
00014401|envenomation by black snake (Pseudechis spp.)|envenomation by black snake (Pseudechis spp.)|0|17.989512|1
00014402|prophylaxis of anaphylactic rxn due to dextran 40 or 70|prophylaxis of anaphylactic reaction due to dextran 40 or dextran 70 infusion|0|17.995002|1
00014403|secondary progressive multiple sclerosis|secondary progressive multiple sclerosis|0|06.340007|2
00014404|luteinizing hormone hypersecretion|luteinizing hormone hypersecretion|0|03.253101|3
00014405|follicle-stimulating hormone hypersecretion|follicle-stimulating hormone hypersecretion|0|03.253102|3
00014406|non-radiographic axial spondyloarthritis|non-radiographic axial spondyloarthritis|0|13.720900|2
00014407|envenomation by eastern brown snake, Pseudonaja textilis|envenomation by eastern brown snake (Pseudonaja textilis)|0|17.989513|1
00014408|ocular symptom associated with allergic rhinitis|ocular symptom associated with allergic rhinitis|0|08.477908|3
00014409|Normal Serum Potassium Level|Normal Serum Potassium Level|0|03.276703|0
00014410|Normal Electrocardiogram|Normal Electrocardiogram|0|07.426909|0
00014411|lymphangioleiomyomatosis|lymphangioleiomyomatosis|0|08.516400|2
00014412|traveler's diarrhea due to noninvasive Escherichia coli|traveler's diarrhea due to noninvasive strain of Escherichia coli|0|01.009202|1
00014413|Macular Edema following Retinal Vein Occlusion|Macular Edema following Retinal Vein Occlusion|0|06.362305|3
00014414|nasal scabbing|nasal scabbing|0|08.478111|1
00014415|raised prostate specific antigen|raised prostate specific antigen|0|16.790930|3
00014416|polyserositis|polyserositis|0|09.568822|3
00014417|chemical leukoderma|chemical leukoderma|0|12.709002|2
00014418|hyperbilirubinemia due to hemolytic disease of newborn|hyperbilirubinemia due to hemolytic disease of newborn|0|15.773001|1
00014419|typhoid vaccination|typhoid vaccination|0|18.V03101|1
00014420|fat embolism|fat embolism|0|17.958100|1
00014421|cystic fibrosis with homozyg F508del mutation in CFTR|cystic fibrosis with homozygous F508del mutation in CFTR gene|0|03.277011|2
00014422|postmenopausal urethral atrophy|postmenopausal urethral atrophy|0|10.597804|1
00014423|prevention of poliomyelitis after exposure to poliovirus|prevention of poliomyelitis after exposure to poliovirus|0|18.V01200|1
00014424|occlusion of ureter due to calculus|occlusion of ureter due to calculus|0|10.592100|1
00014425|prevention of pulmonary thromboembolism recurrence|prevention of pulmonary thromboembolism recurrence|0|07.415103|3
00014426|prevention of deep vein thrombosis recurrence|prevention of deep vein thrombosis recurrence|0|07.453916|3
00014427|hemorrhage of muscle|hemorrhage of muscle|0|13.728891|3
00014428|excess submental fat|excess submental fat|0|03.278005|2
00014429|ankylosing spondylitis in pt at high gastric ulcer risk|ankylosing spondylitis in patient at high gastric ulcer risk|0|13.720001|2
00014430|paresis from marginal mandibular branch of facial nerve|paresis from marginal mandibular branch of facial nerve|0|06.351901|3
00014431|musculoskeletal pain|musculoskeletal pain|0|13.729106|3
00014432|familial hypokalemic periodic paralysis|familial hypokalemic periodic paralysis|0|03.276803|2
00014433|sepsis|sepsis|0|01.038903|1
00014434|premenopausal acquired hypoactive sexual desire disorder|premenopausal acquired hypoactive sexual desire disorder|0|03.302710|2
00014435|macrocytosis|macrocytosis|0|04.289890|3
00014436|severe chronic pain in opioid-tolerant pedi pt (+11 yrs)|severe chronic pain in opioid-tolerant pediatric patient (11 years of age and older)|0|16.780923|2
00014437|osteoporosis in male patient|osteoporosis in male patient|0|13.733094|2
00014438|anemia in chronic kidney disease|anemia in chronic kidney disease|0|04.281904|2
00014439|depression associated with bipolar disorder, adjunct|depression associated with bipolar disorder, adjunct treatment|0|05.296501|2
00014440|anemia in hemodialysis-dependent chronic kidney disease|anemia in hemodialysis-dependent chronic kidney disease|0|04.281905|2
00014441|lymphoid blast phase Philadelphia chromosome (+) CML|lymphoid blast phase Philadelphia chromosome positive chronic myelocytic leukemia|0|02.205108|2
00014442|myeloid blast phase Philadelphia chromosome (+) CML|myeloid blast phase Philadelphia chromosome positive chronic myelocytic leukemia|0|02.205109|2
00014443|chronic phase Philadelphia chromosome (+) CML|chronic phase Philadelphia chromosome positive chronic myelocytic leukemia|0|02.205110|2
00014444|accelerated phase Philadelphia chromosome (+) CML|accelerated phase Philadelphia chromosome positive chronic myelocytic leukemia|0|02.205111|2
00014445|hereditary orotic aciduria, type I|hereditary orotic aciduria, type I|0|03.277206|2
00014446|infantile malignant osteopetrosis|infantile malignant osteopetrosis|0|14.756521|2
00014447|hyperpigmentation of oral mucosa|hyperpigmentation of oral mucosa|0|09.528906|3
00014449|PD-L1 positive non-small cell lung cancer|PD-L1 positive non-small cell lung cancer|0|02.231208|2
00014450|drug-metabolizing enzymes|drug-metabolizing enzymes|0|03.277808|0
00014451|membrane transporters|membrane transporters|0|03.277809|0
00014452|cytochrome p450 CYP2C9|cytochrome p450 CYP2C9|0|03.277810|0
00014453|cytochrome p450 CYP2C19|cytochrome p450 CYP2C19|0|03.277811|0
00014454|cytochrome p450 CYP2D6|cytochrome p450 CYP2D6|0|03.277812|0
00014455|thiopurine S-methyltransferase|thiopurine S-methyltransferase|0|03.277207|0
00014456|drug targets|drug targets|0|03.277813|0
00014457|VKORC1|VKORC1|0|03.277814|0
00014458|CYP2C19 intermediate metabolizer|CYP2C19 intermediate metabolizer|0|03.277815|2
00014459|CYP2C19 normal metabolizer|CYP2C19 normal metabolizer|0|03.277816|2
00014460|CYP2C19 ultrarapid metabolizer|CYP2C19 ultrarapid metabolizer|0|03.277817|2
00014461|CYP2C9 intermediate metabolizer|CYP2C9 intermediate metabolizer|0|03.277818|0
00014462|CYP2C9 normal metabolizer|CYP2C9 normal metabolizer|0|03.277819|2
00014463|CYP2D6 intermediate metabolizer|CYP2D6 intermediate metabolizer|0|03.277820|2
00014464|CYP2D6 normal metabolizer|CYP2D6 normal metabolizer|0|03.277821|2
00014465|TPMT intermediate metabolizer|TPMT intermediate metabolizer|0|03.277208|2
00014467|TPMT normal metabolizer|TPMT normal metabolizer|0|03.277209|2
00014469|SLCO1B1 low function|SLCO1B1 low function|0|03.277822|2
00014470|SLCO1B1 intermediate function|SLCO1B1 intermediate function|0|03.277823|2
00014471|SLCO1B1 normal function|SLCO1B1 normal function|0|03.277824|2
00014472|reversal of dabigatran-induced anticoagulation|reversal of dabigatran-induced anticoagulation|0|17.964201|1
00014473|childhood hypophosphatasia|childhood hypophosphatasia|0|03.275303|2
00014474|infantile hypophosphatasia|infantile hypophosphatasia|0|03.275304|2
00014475|leiomyosarcoma|leiomyosarcoma|0|02.171904|2
00014476|liposarcoma|liposarcoma|0|02.171905|2
00014477|anemia in non-dialysis-dependent chronic kidney disease|anemia in non-dialysis-dependent chronic kidney disease|0|04.281906|2
00014478|vaginal ulcer|vaginal ulcer|0|10.616801|1
00014479|hyperandrogenism|hyperandrogenism|0|03.256101|2
00014480|aphonia|aphonia|0|16.784410|2
00014481|abnormal spermatozoa morphology|abnormal spermatozoa morphology|0|10.606901|3
00014482|corneal burn|corneal burn|0|17.940400|1
00014483|acute chemical conjunctivitis|acute chemical conjunctivitis|0|06.372060|1
00014484|retrograde ejaculation|retrograde ejaculation|0|10.608870|1
00014485|autosomal dominant polycystic kidney disease|autosomal dominant polycystic kidney disease|0|14.753130|2
00014486|hereditary factor X deficiency disease|hereditary factor X deficiency disease|0|04.286307|2
00014487|calcification of cornea|calcification of cornea|0|06.371430|1
00014488|idiopathic gynecomastia|idiopathic gynecomastia|0|10.611101|3
00014489|plasmacytoma|plasmacytoma|0|02.238600|2
00014490|maintenance therapy for asthma|maintenance therapy for asthma|0|08.493910|2
00014491|EGFR T790M mutation-positive non-small cell lung cancer|EGFR T790M mutation-positive non-small cell lung cancer|0|02.231209|2
00014492|cataract surgery adjunct to enhance visualization|cataract surgery adjunct to enhance visualization|0|03. 13191|1
00014493|lip swelling|lip swelling|0|09.528505|1
00014494|Disorder of Lip|Disorder of Lip|0|09.528504|3
00014495|subcutaneous urography adjunct for contrast resorption|subcutaneous urography adjunct for contrast resorption|0|16. 87731|1
00014496|radiation sickness|radiation sickness|0|17.990004|3
00014497|iododerma|iododerma|0|17.962801|1
00014498|radiation pneumonitis|radiation pneumonitis|0|08.508000|1
00014499|spasm of sphincter of Oddi|spasm of sphincter of Oddi|0|09.576500|1
00014500|second primary melanoma|second primary melanoma|0|02.172907|2
00014501|cholesteatoma of external ear|cholesteatoma of external ear|0|06.380210|2
00014502|lysosomal acid lipase deficiency|lysosomal acid lipase deficiency|0|03.272702|2
00014503|localized cutaneous amyloidosis|localized cutaneous amyloidosis|0|03.277390|3
00014504|emergency treatment of fluorouracil overdose|emergency treatment of fluorouracil overdose|0|17.963105|1
00014505|emergency treatment of severe fluorouracil toxicity|emergency treatment of severe fluorouracil toxicity|0|17.963106|1
00014506|emergency treatment of capecitabine overdose|emergency treatment of capecitabine overdose|0|17.963107|1
00014507|emergency treatment of severe capecitabine toxicity|emergency treatment of severe capecitabine toxicity|0|17.963108|1
00014508|reversal of neuromuscular blockade induced by rocuronium|reversal of neuromuscular blockade induced by rocuronium|0|06.358905|1
00014509|reversal of neuromuscular blockade induced by vecuronium|reversal of neuromuscular blockade induced by vecuronium|0|06.358906|1
00014510|swelling of pinna|swelling of pinna|0|06.380391|1
00014511|otorrhea|otorrhea|0|06.388600|1
00014512|skin metastasis of breast carcinoma|skin metastasis of breast carcinoma|0|02.198200|2
00014513|Staphylococcus nasal colonization|Staphylococcus nasal colonization|0|01.041103|2
00014514|nasal cavity infection due to staphylococcus|nasal cavity infection due to staphylococcus|0|08.465905|1
00014515|portal vein thrombosis|portal vein thrombosis|0|07.452000|1
00014516|conditioning prior to autologous stem cell transplant|conditioning prior to autologous hematopoietic stem cell transplant|0|08. 41090|1
00014517|lower limb spasticity|lower limb spasticity|0|13.728857|3
00014518|hypnagogic hallucination|hypnagogic hallucination|0|16.780101|1
00014519|bullous keratopathy|bullous keratopathy|0|06.371230|2
00014520|envenomation by common taipan snake (O. scutellatus)|envenomation by common taipan snake (Oxyuranus scutellatus)|0|17.989514|1
00014521|complex regional pain syndrome, type I|complex regional pain syndrome, type I|0|06.337200|2
00014522|onychoclasis|onychoclasis|0|12.703902|1
00014523|HR(+), HER2(-) advanced female breast cancer|hormone receptor (HR)-positive, HER2-negative advanced female breast cancer|0|02.174910|2
00014524|acute retinal necrosis|acute retinal necrosis|0|06.362891|1
00014525|blanching of skin|blanching of skin|0|16.782612|1
00014526|nonfunctional neuroendocrine tumor of GI origin|nonfunctional neuroendocrine tumor of gastrointestinal origin|0|02.209001|2
00014527|nonfunctional neuroendocrine tumor of lung origin|nonfunctional neuroendocrine tumor of lung origin|0|02.209210|2
00014528|ROS1 positive non-small cell lung cancer|ROS1 positive non-small cell lung cancer|0|02.231210|2
00014529|relapsed chronic lymphocytic leukemia|relapsed chronic lymphocytic leukemia|0|02.204106|2
00014530|relapsed follicular B-cell non-Hodgkin lymphoma|relapsed follicular B-cell non-Hodgkin lymphoma|0|02.202001|2
00014531|relapsed small lymphocytic lymphoma|relapsed small lymphocytic lymphoma|0|02.204107|2
00014532|bronchiolitis obliterans with organizing pneumonia|bronchiolitis obliterans with organizing pneumonia|0|08.516360|1
00014533|skin lesion|skin lesion|0|12.709902|3
00014534|skin plaque|skin plaque|0|12.709904|3
00014535|cerebral pseudoatrophy|cerebral pseudoatrophy|0|06.348804|1
00014537|disorder of sweat gland|disorder of sweat gland|0|12.705001|3
00014538|miliaria|miliaria|0|12.705100|1
00014539|ultrasonography of liver|ultrasonography of liver|0|16. 88740|0
00014540|cytochrome p450 CYP3A4|cytochrome p450 CYP3A4|0|03.277825|0
00014541|anogenital candidiasis|anogenital candidiasis|0|01.112893|1
00014542|migration of implant|migration of implant|0|17.996590|0
00014544|psychosis associated with Parkinson's disease|psychosis associated with Parkinson's disease|0|06.332006|1
00014545|expulsion of intrauterine contraceptive device|expulsion of intrauterine contraceptive device|0|17.996321|1
00014546|hemiparesis|hemiparesis|0|06.342901|2
00014547|nonconvulsive status epilepticus|nonconvulsive status epilepticus|0|06.345202|1
00014548|protrusion of implant|protrusion of implant|0|17.996591|0
00014549|CD25-positive cutaneous T-cell lymphoma|CD25-positive cutaneous T-cell lymphoma|0|02.202103|2
00014550|vitelliform macular lesion|vitelliform macular lesion|0|06.362170|3
00014551|cytochrome p450 CYP2C8|cytochrome p450 CYP2C8|0|03.277826|0
00014552|cytochrome p450 CYP1A2|cytochrome p450 CYP1A2|0|03.277827|0
00014553|cytochrome p450 CYP2B6|cytochrome p450 CYP2B6|0|03.277828|0
00014554|organic anion transporting polypeptide 1B1|organic anion transporting polypeptide 1B1 (OATP1B1)|0|03.277829|0
00014555|pain in oropharynx|pain in oropharynx|0|08.462005|1
00014556|insulin autoimmune syndrome|insulin autoimmune syndrome|0|03.279490|2
00014557|hypertrophic thickening of tongue|hypertrophic thickening of tongue|0|09.529800|1
00014558|swelling of vagina|swelling of vagina|0|10.623800|1
00014559|erythema of vagina|erythema of vagina|0|10.623801|1
00014561|cerebellar atrophy|cerebellar atrophy|0|06.334900|2
00014563|adenocarcinoma of corpus uteri|adenocarcinoma of corpus uteri|0|02.233202|2
00014564|Chronic kidney disease stage 1 GFR>90mL/min|Chronic kidney disease stage 1 (normal) GFR>90mL/min with signs of kidney damage|1|10.585002|2
00014565|chronic kidney disease stage 1 (mild) GFR >90mL/min|chronic kidney disease stage 1 (mild) GFR 90mL/min or higher with signs of kidney damage|0|10.585100|2
00014568|chronic kidney disease stage 2 (mild) GFR 60-89 mL/min|chronic kidney disease stage 2 (mild) GFR 60-89 mL/min|0|10.585200|2
00014569|chronic kidney disease stage 3A (moderate) GFR 45-59|chronic kidney disease stage 3A (moderate) GFR 45-59 mL/min|0|10.585300|2
00014570|chronic kidney disease stage 3B (moderate) GFR 30-44|chronic kidney disease stage 3B (moderate) GFR 30-44 mL/min|0|10.585301|2
00014571|chronic kidney disease stage 4 (severe) GFR 15-29 mL/min|chronic kidney disease stage 4 (severe) GFR 15-29 mL/min|0|10.585400|2
00014572|chronic kidney disease stage 5 (failure) GFR<15 mL/min|chronic kidney disease stage 5 (failure) GFR<15 mL/min|0|10.585500|2
00014573|acute angle-closure glaucoma|acute angle-closure glaucoma|0|06.365220|1
00014574|DRESS syndrome|DRESS syndrome|0|17.995212|1
00014576|calciphylaxis|calciphylaxis|0|03.275491|2
00014577|progressive keratoconus|progressive keratoconus|0|06.371601|2
00014578|corneal ectasia following refractive surgery|corneal ectasia following refractive surgery|0|06.371710|2
00014579|loss of sense of smell|loss of sense of smell|0|16.781103|3
00014580|kidney disease with likely reduction in GFR|kidney disease with likely reduction in glomerular filtration rate (GFR)|0|10.593908|3
00014581|acquired ichthyosis|acquired ichthyosis|0|12.701105|3
00014582|malignant neoplasm of cervix|malignant neoplasm of cervix|0|02.233103|2
00014583|allergic rhinitis due to house dust mite|allergic rhinitis due to house dust mite|0|08.477800|1
00014584|heavy feeling|heavy feeling|0|16.780791|1
00014585|increased rate of carcinoma tumor cell growth|increased rate of carcinoma tumor cell growth|0|02.239908|1
00014586|urosepsis|urosepsis|0|01.038904|1
00014587|cytokine release syndrome|cytokine release syndrome|0|17.995213|1
00014588|central serous chorioretinopathy|central serous chorioretinopathy|0|06.362410|1
00014589|gagging|gagging|0|16.787991|1
00014590|inappropriate sinus tachycardia|inappropriate sinus tachycardia|0|16.785004|2
00014591|Duchenne dystrophy amenable to exon 51 skipping therapy|Duchenne muscular dystrophy due to genetic mutation amenable to exon 51 skipping therapy|0|06.359101|2
00014592|augmentation of restless legs syndrome|augmentation of restless legs syndrome|0|06.333993|1
00014593|fibrotic drug-induced cardiac valvulopathy|fibrotic drug-induced cardiac valvulopathy|0|07.424908|3
00014594|prevent MI in pt with angina & risk of gastric ulcer|myocardial infarction prevention in patient with angina pectoris and with high gastric ulcer risk|0|07.410913|2
00014595|prevent myocardial reinfarction in pt w- gast ulcer risk|myocardial reinfarction prevention in patient at high risk of gastric ulcer risk|0|07.410914|3
00014596|cerebral thromboemb prevention in pt w- gast ulcer risk|cerebral thromboembolism prevention in patient at high risk of gastric ulcer|0|07.434904|2
00014597|prevent thrombosis after PCI in pt at gastric ulcer risk|thrombosis prevention after percutaneous coronary intervention in patient at high gastric ulcer risk|0|07.453917|3
00014598|TNF receptor-associated periodic fever syndrome|TNF receptor-associated periodic fever syndrome|0|03.279803|2
00014599|hereditary periodic fever|hereditary periodic fever|0|03.279802|2
00014600|hyper-IgD periodic fever syndrome|hyper-IgD periodic fever syndrome|0|03.279804|2
00014601|CKD stage 5 (failure) without dialysis GFR<15 mL/min|chronic kidney disease stage 5 (failure) without dialysis GFR<15 mL/min|0|10.585501|2
00014602|CYP2B6*6/*6 genotype|CYP2B6*6/*6 genotype|0|03.277830|0
00014603|atypical femoral fracture|atypical femoral fracture|0|13.733151|1
00014604|epidural lipomatosis|epidural lipomatosis|0|02.214800|2
00014605|hemorrhage of myocardium|hemorrhage of myocardium|0|07.429893|1
00014606|hemorrhagic cyst of ovary|hemorrhagic cyst of ovary|0|10.620202|1
00014607|vascular ectasia of gastric antrum|vascular ectasia of gastric antrum|0|09.537830|1
00014608|histiocytic necrotizing lymphadenitis|histiocytic necrotizing lymphadenitis|0|04.289300|1
00014609|metastatic NSCLC with EGFR exon 21 L858R substitution|metastatic non-small cell lung cancer with EGFR exon 21 L858R substitution mutation|0|02.231211|2
00014610|metastatic NSCLC with EGFR exon 19 deletion|metastatic non-small cell lung cancer with EGFR exon 19 deletion|0|02.231212|2
00014612|insomnia associated with depression|insomnia associated with depression|0|16.780523|3
00014613|cardiac transplant rejection|cardiac transplant rejection|0|17.996830|1
00014614|unresect or metastatic CD117+ gastrointest stromal tumor|unresectable or metastatic Kit (CD117) positive gastrointestinal stromal tumor|0|02.239002|2
00014615|adjuvant therapy of CD117+ gastrointest stromal tumor|adjuvant therapy following surgical resection of Kit (CD117) positive gastrointestinal stromal tumor|0|02.239003|2
00014616|adjunct therapy to prevent CDI recurrence|adjunct therapy to prevent Clostridioides difficile infection (CDI) recurrence|0|01.008451|0
00014618|aspirin exacerbated respiratory disease|aspirin exacerbated respiratory disease|0|08.508800|1
00014619|Jarisch-Herxheimer reaction|Jarisch-Herxheimer reaction|0|17.995214|1
00014620|convalescence following chemotherapy|convalescence following chemotherapy|0|18.V66200|1
00014621|hymenoptera venom desensitization therapy|hymenoptera venom desensitization therapy|0|18.V07102|1
00014622|Descemet's membrane fold|Descemet's membrane fold|0|06.371320|3
00014623|epithelial ovarian cancer with BRCA mutation|epithelial ovarian cancer with BRCA mutation|0|02.183003|2
00014624|community acquired bacterial pneumonia|community acquired bacterial pneumonia|0|08.486007|1
00014625|aseptic necrosis of bone in orofacial region|aseptic necrosis of bone in orofacial region|0|13.733401|3
00014626|acute pain at drug application site|acute pain at drug application site|0|16.780924|1
00014627|spinal muscular atrophy|spinal muscular atrophy|0|06.335100|2
00014628|ultrasonography of urinary tract|ultrasonography of urinary tract|0|16. 88750|0
00014629|mitral valve regurgitation|mitral valve regurgitation|0|07.424001|3
00014630|injury of meniscus of knee joint|injury of meniscus of knee joint|0|13.717500|1
00014631|full-thickness articular cartilage defect of the knee|full-thickness articular cartilage defect of the knee|0|13.717900|2
00014632|colchicine toxicity|colchicine toxicity|0|17.974700|1
00014633|hormonal contraception failure|hormonal contraception failure|0|18.V22205|0
00014634|marginal zone lymphoma|marginal zone lymphoma|0|02.200300|2
00014635|adjunct therapy for acute enterocolitis|adjunct therapy for acute enterocolitis|0|09.558908|1
00014636|adjunct therapy for peptic ulcer disease|adjunct therapy for peptic ulcer disease|0|09.533907|3
00014637|adjunct therapy for irritable bowel syndrome|adjunct therapy for irritable bowel syndrome|0|09.564103|2
00014638|history of cerebrovascular accident|history of cerebrovascular accident|0|07.436001|2
00014639|immunosuppression induction therapy for lung transplant|immunosuppression induction therapy for lung transplantation|0|17.996842|1
00014641|immunosuppression maintenance tx for lung transplant|immunosuppression maintenance therapy for lung transplantation|0|17.996843|2
00014642|catatonia|catatonia|0|05.295200|3
00014643|central obesity|central obesity|0|03.278006|2
00014644|idiopathic pulmonary fibrosis|idiopathic pulmonary fibrosis|0|08.516310|3
00014645|epigastric fullness|epigastric fullness|0|16.789360|1
00014646|opportunistic viral infection|opportunistic viral infection|0|01.079991|3
00014647|prevention of osteoporosis|prevention of osteoporosis|0|13.733095|2
00014648|prevention of thrombosis|prevention of thrombosis|0|07.453918|3
00014649|history of drug abuse|history of drug abuse|0|05.305930|2
00014650|prevention of gastrointestinal ulcer|prevention of gastrointestinal ulcer|0|09.534902|3
00014651|substance use, including abuse or dependence|substance use, including abuse or dependence|0|05.305901|3
00014652|excessive granulation tissue|excessive granulation tissue|0|12.701500|1
00014654|carcinoid syndrome diarrhea|carcinoid syndrome diarrhea|0|03.259202|3
00014660|gallbladder absent|gallbladder absent|0|09.575902|2
00014661|history of cholecystectomy|history of cholecystectomy|0|09.575903|2
00014662|congenital absence of gallbladder|congenital absence of gallbladder|0|09.575904|2
00014663|anxiety disorder|anxiety disorder|0|05.300006|2
00014664|symptoms of anxiety|symptoms of anxiety|0|05.300007|1
00014665|primary progressive multiple sclerosis|primary progressive multiple sclerosis|0|06.340008|2
00014666|hepatitis B carrier|hepatitis B carrier|0|18.V02610|2
00014669|prevention of postoperative endophthalmitis|prevention of postoperative endophthalmitis|0|06.360192|1
00014670|medication overuse headache|medication overuse headache|0|06.339300|1
00014673|mild intermittent asthma|mild intermittent asthma|0|08.493904|2
00014674|arteriosclerotic vascular disease|arteriosclerotic vascular disease|0|07.440904|2
00014675|retrobulbar hemorrhage|retrobulbar hemorrhage|0|06.376890|1
00014676|nasal mucosa edematous|nasal mucosa edematous|0|16.782309|1
00014677|increased risk of atherosclerotic cardiovascular disease|increased risk of atherosclerotic cardiovascular disease|0|07.440905|2
00014678|radiation recall syndrome|radiation recall syndrome|0|12.692821|1
00014680|transthyretin familial amyloid polyneuropathy|transthyretin familial amyloid polyneuropathy|0|03.277391|2
00014681|poisoning due to Indian cobra (Naja naja) venom|poisoning due to Indian cobra (Naja naja) venom|0|17.989515|1
00014682|poisoning due to Common krait (Bungarus caeruleus) venom|poisoning due to Common krait (Bungarus caeruleus) venom|0|17.989516|1
00014683|poisoning due to Russell's viper (Vipera russelli) venom|poisoning due to Russell's viper (Vipera russelli) venom|0|17.989517|1
00014684|poisoning from saw-scaled viper (Echis carinatus) venom|poisoning due to saw-scaled viper (Echis carinatus) venom|0|17.989518|1
00014686|treatment to slow loss of walking in late infantile CLN2|treatment to slow loss of ambulation in late infantile neuronal ceroid lipofuscinosis type 2|0|06.330100|2
00014687|acute myeloid leukemia with FLT3 mutation|acute myeloid leukemia with FMS-like tyrosine kinase-3 (FLT3) mutation|0|02.205003|2
00014688|aggressive systemic mastocytosis|aggressive systemic mastocytosis|0|02.202602|2
00014689|SM with associated hematological neoplasm|systemic mastocytosis with associated hematological neoplasm|0|02.202603|2
00014690|mast cell leukemia|mast cell leukemia|0|02.202604|2
00014691|chronic constipation|chronic constipation|0|09.564004|2
00014692|Cockayne syndrome|Cockayne syndrome|0|14.759895|2
00014693|urea cycle disorder|urea cycle disorder|0|03.270607|2
00014694|papillary thyroid carcinoma|papillary thyroid carcinoma|0|02.193003|2
00014695|history of diabetes-related lower-extremity amputation|history of diabetes-related lower-extremity amputation|0|18.V49700|2
00014696|history of bariatric surgery|history of bariatric surgery|0|18.V45860|2
00014697|elevated protein level in cerebrospinal fluid|elevated protein level in cerebrospinal fluid|0|16.792000|1
00014698|decreased protein level in cerebrospinal fluid|decreased protein level in cerebrospinal fluid|0|16.792001|1
00014699|pleocytosis of cerebrospinal fluid|pleocytosis of cerebrospinal fluid|0|16.792002|1
00014700|hyperphenylalaninemia|hyperphenylalaninemia|0|03.270101|3
00014701|history of Roux-en-Y gastric bypass|history of Roux-en-Y gastric bypass|0|18.V45861|2
00014702|microsatellite instability-high solid malignant tumor|microsatellite instability-high solid malignant tumor|0|02.199103|2
00014703|mixed connective tissue disease|mixed connective tissue disease|0|13.710901|2
00014704|disorder of kidney|disorder of kidney|0|10.593902|3
00014705|acute hemorrhagic edema of infancy|acute hemorrhagic edema of infancy|0|07.446203|1
00014706|cylindruria|cylindruria|0|16.791700|1
00014708|procedure|procedure|0|16. 99990|0
00014709|inflammatory disorder|inflammatory disorder|0|18.V00004|3
00014710|inflammatory disorder of musculoskeletal system|inflammatory disorder of musculoskeletal system|0|18.V00005|3
00014711|inflammatory disorder of digestive system|inflammatory disorder of digestive system|0|09.558909|3
00014712|inflammatory disorder of the nervous system|inflammatory disorder of the nervous system|0|18.V00006|3
00014713|inflammatory disorder of respiratory tract|inflammatory disorder of respiratory tract|0|18.V00007|3
00014714|inflammatory disorder of cardiovascular system|inflammatory disorder of cardiovascular system|0|18.V00008|3
00014715|disorder of respiratory system|disorder of respiratory system|0|08.519902|3
00014716|infectious disease of lung|infectious disease of lung|0|08.519802|3
00014717|disorder of nervous system|disorder of nervous system|0|06.349901|3
00014721|non-small cell lung cancer with BRAF V600E mutation|non-small cell lung cancer with BRAF V600E mutation|0|02.231213|2
00014724|wild-type KRAS and NRAS colorectal cancer|wild-type KRAS and NRAS colorectal cancer|0|02.230911|2
00014725|chronic iron overload due to repeated blood transfusions|chronic iron overload due to repeated blood transfusions|0|03.275003|2
00014727|chronic iron overload in NTD thalassemia|chronic iron overload in patient with non-transfusion-dependent thalassemia (NTDT)|0|03.275004|2
00014729|vulvovaginal dryness|vulvovaginal dryness|0|10.623902|3
00014731|acute myeloid leukemia with IDH2 mutation|acute myeloid leukemia with isocitrate dehydrogenase-2 (IDH2) mutation|0|02.205004|2
00014732|microsatellite instability-high colorectal cancer|microsatellite instability-high colorectal cancer|0|02.230912|2
00014738|disturbance in thinking|disturbance in thinking|0|05.293002|1
00014739|hypercupremia|hypercupremia|0|16.790606|1
00014740|scar of skin|scar of skin|0|12.709200|2
00014741|breakage of implant|breakage of implant|0|17.996592|1
00014743|cerebral herniation|cerebral herniation|0|06.348400|1
00014744|chronic diarrhea due to bile acid malabsorption|chronic diarrhea due to bile acid malabsorption|0|09.579804|2
00014745|chronic diarrhea associated with short bowel syndrome|chronic diarrhea associated with short bowel syndrome|0|09.579301|2
00014746|seizure due to isoniazid toxicity|seizure due to isoniazid toxicity|0|16.780391|1
00014747|seizure due to gyromitrin-containing mushroom poisoning|seizure due to gyromitrin-containing mushroom poisoning|0|16.780392|1
00014748|CD33 positive acute myeloid leukemia|CD33 positive acute myeloid leukemia|0|02.205005|2
00014749|chronic indeterminate Chagas disease|chronic indeterminate Chagas disease|0|01.086201|2
00014750|Chagas disease|Chagas disease|0|01.086200|3
00014751|hemophagocytic lymphohistiocytosis|hemophagocytic lymphohistiocytosis|0|04.288401|2
00014752|intracranial hematoma|intracranial hematoma|0|07.432901|1
00014753|P-glycoprotein|P-glycoprotein|0|03.277831|0
00014754|seborrheic dermatitis of scalp|seborrheic dermatitis of scalp|0|12.690110|3
00014755|PD-L1 positive adenocarcinoma of stomach|PD-L1 positive adenocarcinoma of stomach|0|02.230913|2
00014756|PD-L1 (+) adenocarcinoma of gastroesophageal junction|PD-L1 positive adenocarcinoma of gastroesophageal junction|0|02.230914|2
00014757|plantar fascial fibromatosis|plantar fascial fibromatosis|0|13.728710|2
00014758|vitamin K deficiency due to fat malabsorption|vitamin K deficiency due to fat malabsorption|0|03.269001|3
00014759|horizontal forehead lines|horizontal forehead lines|0|12.701804|2
00014760|deepening of upper eyelid sulcus|deepening of upper eyelid sulcus|0|06.376400|3
00014761|mitochondrial disease|mitochondrial disease|0|03.277871|2
00014762|paradoxical convulsion|paradoxical convulsion|0|16.780393|1
00014764|acalculia|acalculia|0|16.784692|3
00014765|respiratory depression due to CNS depression|respiratory depression due to central nervous system depression|0|08.518824|1
00014766|low serum thyroid hormone concentration and normal TSH|low serum concentrations of thyroid hormone (T4 and T3) and normal thyroid-stimulating hormone (TSH)|0|16.794500|1
00014767|Erdheim-Chester disease with BRAF V600 mutation|Erdheim-Chester disease with BRAF V600 mutation|0|03.277890|2
00014768|heat intolerance|heat intolerance|0|16.780992|3
00014774|primary cutaneous anaplastic large cell lymphoma|primary cutaneous anaplastic large cell lymphoma|0|02.200601|2
00014775|CD30-positive mycosis fungoides|CD30-positive mycosis fungoides|0|02.202104|2
00014777|multiple myeloma maintenance therapy following auto-HSCT|multiple myeloma maintenance therapy following autologous hematopoietic stem cell transplantation|0|02.203002|2
00014778|prevention of cytomegalovirus infection after allo-HSCT|prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant|0|17.996880|1
00014779|barium sulfate embolism|barium sulfate embolism|0|17.999200|1
00014780|nutritional disorder|nutritional disorder|0|03.269900|3
00014781|RCC adjuvant therapy following nephrectomy|renal cell carcinoma adjuvant therapy following nephrectomy|0|02.189004|2
00014782|mucopolysaccharidosis type VII|mucopolysaccharidosis type VII|0|03.277504|2
00014783|eosinophilic granulomatosis with polyangiitis|eosinophilic granulomatosis with polyangiitis|0|07.446401|2
00014784|abnormal saccadic eye movement|abnormal saccadic eye movement|0|06.379570|3
00014786|acute cholecystitis without calculus|acute cholecystitis without calculus|0|09.575001|1
00014787|raised seborrheic keratosis|raised seborrheic keratosis|0|12.702100|2
00014789|biallelic RPE65 mutation-associated retinal dystrophy|biallelic RPE65 mutation-associated retinal dystrophy|0|06.362760|2
00014790|macular hole|macular hole|0|06.362540|1
00014791|prevention of skeletal related event in multiple myeloma|prevention of skeletal related events in multiple myeloma|0|02.203003|0
00014792|prevention of skeletal related events in bone metastases|prevention of skeletal related events associated with bone metastases from solid tumor|0|02.198507|0
00014793|organic cation transporter 2|organic cation transporter 2 (OCT2)|0|03.277832|0
00014794|pharmacogenomics|pharmacogenomics|0|03.277833|0
00014795|germline BRCA-mutated, HER2(-) metastatic breast cancer|germline BRCA-mutated, HER2-negative metastatic breast cancer|0|02.174911|2
00014796|pure red cell aplasia|pure red cell aplasia|0|04.284810|2
00014797|acute pulpitis|acute pulpitis|0|09.522000|1
00014799|hypotension due to distributive shock|hypotension due to distributive shock|0|16.785592|1
00014800|neuroendocrine hormonal crisis|neuroendocrine hormonal crisis|0|02.209002|1
00014801|accidental injury|accidental injury|0|17.959902|1
00014802|ventilator-associated bacterial pneumonia|ventilator-associated bacterial pneumonia|0|17.997310|1
00014803|metastatic castration-sensitive prostate cancer|metastatic castration-sensitive prostate cancer|0|02.233406|2
00014804|prevention of measles after exposure|prevention of measles after exposure|0|18.V01704|1
00014805|prevention of varicella after exposure|prevention of varicella after exposure|0|18.V01703|1
00014806|dyspareunia|dyspareunia|0|10.625001|1
00014807|non-metastatic castration-resistant prostate cancer|non-metastatic castration-resistant prostate cancer|0|02.233407|2
00014808|hematospermia|hematospermia|0|10.608820|3
00014809|small lymphocytic lymphoma with 17p deletion|small lymphocytic lymphoma with 17p deletion|0|02.200301|2
00014810|B-cell chronic lymphocytic leukemia, 17p del|B-cell chronic lymphocytic leukemia with 17p deletion|2|02.204108|2
00014811|drug-induced extrapyramidal reaction|drug-induced extrapyramidal reaction|0|06.333001|3
00014812|lymphangioma|lymphangioma|0|02.228100|3
00014813|Vogt-Koyanagi-Harada disease|Vogt-Koyanagi-Harada disease|0|07.364240|2
00014814|Takotsubo cardiomyopathy|takotsubo cardiomyopathy|0|07.429830|3
00014816|short cervical length in pregnancy|short cervical length in pregnancy|0|11.649700|3
00014817|endometrial hypoplasia|endometrial hypoplasia|0|10.621803|2
00014818|hyperextension of joint|hyperextension of joint|0|13.718801|3
00014819|leg pain|leg pain|0|13.729505|3
00014820|acquired genu valgum|acquired genu valgum|0|13.736410|3
00014821|compression fracture|compression fracture|0|13.733100|3
00014822|actinic keratosis of the upper extremity|actinic keratosis of the upper extremity|0|12.702005|2
00014823|postmenopausal bleeding|postmenopausal bleeding|0|10.627100|3
00014824|erythema dyschromicum perstans|erythema dyschromicum perstans|0|12.709003|3
00014825|corneal verticillata|corneal verticillata|0|06.371102|3
00014826|adjunct therapy for partial seizure w tuberous sclerosis|adjunct therapy for partial-onset seizure associated with tuberous sclerosis|0|14.759502|3
00014827|paresthesia of plantar surface|paresthesia of plantar surface|0|16.782013|3
00014828|drug-induced hot flash|drug-induced hot flash|0|17.995215|3
00014829|dental abscess|dental abscess|0|09.522500|1
00014830|malignant neoplasm of pancreas|malignant neoplasm of pancreas|0|02.157000|3
00014831|subluxation of lens|subluxation of lens|0|06.379320|3
00014833|anaplastic thyroid carcinoma with BRAF V600E mutation|anaplastic thyroid carcinoma with BRAF V600E mutation|0|02.193004|3
00014834|reversal of rivaroxaban anticoagulation|reversal of rivaroxaban anticoagulation|0|17.964202|1
00014835|reversal of apixaban anticoagulation|reversal of apixaban anticoagulation|0|17.964203|0
00014836|postural deformity|postural deformity|0|16.781203|2
00014837|prothrombin G20210A mutation|prothrombin G20210A mutation|0|04.289815|3
00014838|retinal macroaneurysm|retinal macroaneurysm|0|06.362171|3
00014839|prophylaxis for tympanostomy tube insertion|prophylaxis for tympanostomy tube insertion|0|06.381101|3
00014840|pre-proc tx of thrombocytopenia with chronic liver dx|pre-procedure treatment of thrombocytopenia associated with chronic liver disease|0|04.287406|2
00014841|local anesthesia for procedure on or through nasal cavit|local anesthesia for procedure on or through nasal cavity|0|03. 99290|1
00014844|respiratory tract congestion|respiratory tract congestion|0|08.478295|3
00014845|viral bronchitis|viral bronchitis|0|08.466002|1
00014846|pemphigus vulgaris|pemphigus vulgaris|0|12.694402|3
00014847|concomitant hypertension and osteoarthritis|concomitant hypertension and osteoarthritis|0|13.715904|2
00014848|primary mediastinal large B-cell lymphoma|primary mediastinal large B-cell lymphoma|0|02.200770|2
00014849|acute occlusion of mesenteric vein|acute occlusion of mesenteric vein|0|09.557003|1
00014850|aortitis|aortitis|0|07.447603|3
00014852|necrolytic migratory erythema|necrolytic migratory erythema|0|12.695000|3
00014853|acquired absence of tooth|acquired absence of tooth|0|09.525100|1
00014854|oral paresthesia|oral paresthesia|0|16.782014|3
00014855|acute myeloid leukemia with IDH1 mutation|acute myeloid leukemia with isocitrate dehydrogenase-1 (IDH1) mutation|0|02.205006|1
00014856|tachycardia|tachycardia|0|16.785005|3
00014857|tachyarrhythmia|tachyarrhythmia|0|16.785006|3
00014859|linear immunoglobulin A bullous dermatosis|linear immunoglobulin A bullous dermatosis|0|12.694801|3
00014860|thrombocytopenia associated with chronic hepatitis|thrombocytopenia associated with chronic hepatitis|0|04.287502|3
00014861|paraganglioma|paraganglioma|0|02.194600|2
00014862|hydronephrosis|hydronephrosis|0|10.591000|3
00014863|alveolar hemorrhage|alveolar hemorrhage|0|15.770300|1
00014864|PD-L1 positive cervical cancer|PD-L1 positive cervical cancer|0|02.180000|3
00014865|necrotizing fasciitis of perineum or genital area|necrotizing fasciitis of perineum or genital area|0|13.728862|1
00014866|smallpox|smallpox|0|01.050000|1
00014867|NUDT15 poor metabolizer|NUDT15 poor metabolizer|0|03.277210|2
00014868|acquired communicating hydrocephalus|acquired communicating hydrocephalus|0|06.331301|3
00014869|computerized tomography of abdomen|computerized tomography of abdomen|0|16.880100|1
00014870|envenomation by common death adder (A. antarcticus)|envenomation by common death adder (A. antarcticus)|0|17.989519|1
00014871|squamous cell carcinoma of skin|squamous cell carcinoma of skin|0|02.173921|2
00014872|refractory Mycobacterium avium complex pulmonary disease|refractory Mycobacterium avium complex pulmonary disease|0|01.031002|3
00014876|adenosine deaminase severe combined immune deficiency|adenosine deaminase severe combined immune deficiency|0|03.279203|2
00014877|cervicocephalic arterial dissection|cervicocephalic arterial dissection|0|07.433210|1
00014878|malignant esophageal obstruction|malignant esophageal obstruction|0|02.150901|2
00014879|neurotrophic keratitis|neurotrophic keratitis|0|06.370351|2
00014880|enterocutaneous fistula|enterocutaneous fistula|0|09.569811|3
00014881|solid tumor with NTRK gene fusion|solid tumor with neurotrophic receptor tyrosine kinase (NTRK) gene fusion|0|02.199104|2
00014882|differentiation syndrome|differentiation syndrome|0|19.E93320|1
00014883|mucociliary clearance defect|mucociliary clearance defect|0|08.519903|3
00014884|NAT2 poor metabolizer|NAT2 poor metabolizer|0|03.277902|2
00014885|dropped head syndrome|dropped head syndrome|0|06.359402|3
00014887|asystole|asystole|0|07.427501|1
00014888|arterial dissection|arterial dissection|0|07.443200|3
00014889|aortic aneurysm|aortic aneurysm|0|07.441100|3
00014890|blastic plasmacytoid dendritic cell neoplasm|blastic plasmacytoid dendritic cell neoplasm|0|02.202813|2
00014891|pancreatic duct stenosis|pancreatic duct stenosis|0|09.577802|3
00014897|eosinophilic asthma|eosinophilic asthma|0|08.518304|2
00014898|pseudocellulitis|pseudocellulitis|0|12.682901|1
00014900|cytomegalovirus colitis|cytomegalovirus colitis|0|09.558910|1
00014901|intention tremor|intention tremor|0|06.333101|3
00014902|history of opioid overdose|history of opioid overdose|0|17.965001|2
00014907|Marfan syndrome|Marfan syndrome|0|14.759896|2
00014908|Ehlers-Danlos syndrome|Ehlers-Danlos syndrome|0|14.756830|2
00014910|Mazzotti reaction|Mazzotti reaction|0|17.995290|3
00014911|PCI adjunct for thrombosis prevention|percutaneous coronary intervention adjunct for thrombosis prevention|0|07. 36022|1
00014913|prevention of anginal pain from vasospastic angina|prevention of anginal pain associated with vasospastic angina|0|07.413101|2
00014914|prevention of anginal pain in coronary artery disease|prevention of anginal pain associated with coronary artery disease|0|07.413102|2
00014915|acute episode of anginal pain|acute episode of anginal pain|0|07.413906|1
00014916|FDA approved indication no longer recommended for use|FDA approved indication no longer recommended for use in current practice|0|99.999995|0
00014917|eosinophilic enteritis|eosinophilic enteritis|0|09.558911|3
00014918|hematoma of abdominal wall|hematoma of abdominal wall|0|17.924902|1
00014919|finding of bowel sounds|finding of bowel sounds|0|16.787501|0
00014920|bowel sounds hyperactive|bowel sounds hyperactive|0|16.787502|3
00014921|subcutaneous crepitus|subcutaneous crepitus|0|12.709909|1
00014922|discolored nasal discharge|discolored nasal discharge|0|08.478115|1
00014923|fascioliasis|fascioliasis|0|01.121302|3
00014924|acquired thrombotic thrombocytopenic purpura|acquired thrombotic thrombocytopenic purpura|0|04.287503|1
00014925|pharmacogenomic test order and result status|pharmacogenomic test order and result status|0|03.277834|0
00014926|HLA-B *57:01 ordered, result pending|HLA-B *57:01 ordered, result pending|0|03.277835|0
00014927|HLA-B *57:01 no result on file, not currently ordered|HLA-B *57:01 no result on file, not currently ordered|0|03.277836|0
00014928|TPMT ordered, result pending|TPMT ordered, result pending|0|03.277837|0
00014929|TPMT no result on file, not currently ordered|TPMT no result on file, not currently ordered|0|03.277838|0
00014930|CYP2D6 ordered, result pending|CYP2D6 ordered, result pending|0|03.277839|0
00014931|CYP2D6 no result on file, not currently ordered|CYP2D6 no result on file, not currently ordered|0|03.277840|0
00014932|pseudoaldosteronism|pseudoaldosteronism|0|03.255140|3
00014933|feeling of alcohol intoxication|feeling of alcohol intoxication|0|16.799590|1
00014934|reactivation of hepatitis C|reactivation of hepatitis C|0|01.070901|1
00014936|PD-L1 expressing triple-negative breast cancer|PD-L1 expressing triple-negative breast cancer|0|02.174912|2
00014937|decrease in lung function measured by spirometer|decrease in lung function measured by spirometer|0|16.794200|1
00014938|increased alanine transaminase|increased alanine transaminase|0|16.790400|1
00014939|increased aspartate transaminase|increased aspartate transaminase|0|16.790401|1
00014940|intestinal obstruction|intestinal obstruction|0|09.560905|3
00014941|aseptic necrosis of head of humerus|aseptic necrosis of head of humerus|0|13.733402|3
00014946|aseptic necrosis of head of femur|aseptic necrosis of head of femur|0|13.733403|3
00014947|HR-positive, HER2-negative advanced breast cancer|hormone receptor (HR)-positive, HER2-negative advanced breast cancer|0|02.174913|2
00014948|prevention of cidofovir-induced nephrotoxicity|prevention of cidofovir-induced nephrotoxicity|0|10.583891|1
00014949|advanced urothelial carcinoma with FGFR2 gene alteration|advanced urothelial carcinoma with fibroblast growth factor receptor 2 (FGFR2) genetic alteration|0|02.189005|2
00014950|advanced urothelial carcinoma with FGFR3 gene alteration|advanced urothelial carcinoma with fibroblast growth factor receptor 3 (FGFR3) genetic alteration|0|02.189006|2
00014951|yellow fever vaccine-associated viscerotropic disease|yellow fever vaccine-associated viscerotropic disease|0|17.979300|1
00014952|yellow fever vaccine-associated neurotropic disease|yellow fever vaccine-associated neurotropic disease|0|17.979301|1
00014958|polyp of gallbladder|polyp of gallbladder|0|09.575905|3
00014959|non-infectious uveitis|non-infectious uveitis|0|06.360111|3
00014960|transthyretin-related amyloid cardiomyopathy|transthyretin-related amyloid cardiomyopathy|0|03.277392|2
00014961|chronic non-infectious anterior uveitis|chronic non-infectious anterior uveitis|0|06.360112|2
00014962|prolonged activated partial thromboplastin time|prolonged activated partial thromboplastin time|0|16.790920|3
00014963|HR(+), HER2(-), PIK3CA mutated advanced breast cancer|hormone receptor (HR)-positive, HER2-negative, PIK3CA mutated advanced breast cancer|0|02.174914|2
00014964|increased troponin-I level|increased troponin-I level|0|16.790607|1
00014966|episodic cluster headache|episodic cluster headache|0|06.339010|2
00014967|exostosis|exostosis|0|13.726902|2
00014968|high output ileostomy|high output ileostomy|0|16.787915|3
00014969|kaposiform hemangioendothelioma|kaposiform hemangioendothelioma|0|02.228002|3
00014970|microcystic lymphatic malformation|microcystic lymphatic malformation|0|14.747600|2
00014971|hydantoin toxicity|hydantoin toxicity|0|17.966100|1
00014972|chronic rhinosinusitis with nasal polyposis|chronic rhinosinusitis with nasal polyposis|0|08.471902|2
00014973|neuromyelitis optica with anti-aquaporin-4 antibodies|neuromyelitis optica spectrum disorder with anti-aquaporin-4 (AQP4) antibodies|0|06.341000|2
00014974|CYP2C19 ordered, result pending|CYP2C19 ordered, result pending|0|03.277841|0
00014975|CYP2C19 no result on file, not currently ordered|CYP2C19 no result on file, not currently ordered|0|03.277842|0
00014976|combination pharmacogenomic concept|combination pharmacogenomic concept|0|00.000000|0
00014977|CYP2C19 rapid metabolizer|CYP2C19 rapid metabolizer|0|03.277843|2
00014982|oligoarticular juvenile idiopathic arthritis|oligoarticular juvenile idiopathic arthritis|0|13.714304|2
00014983|gender dysphoria adjunct therapy|gender dysphoria adjunct therapy|0|05.302510|0
00014984|prevention of thromboembolism in paroxysmal atrial fib|prevention of thromboembolism in paroxysmal atrial fibrillation|0|07.427316|3
00014985|adult-onset Still's disease|adult-onset Still's disease|0|13.714200|2
00014986|oral ulcers associated with Behcet's disease|oral ulcers associated with Behcet's disease|0|01.136101|3
00014987|lichenoid keratosis|lichenoid keratosis|0|12.701106|2
00014989|pre-existing hypertension during pregnancy|pre-existing hypertension during pregnancy|0|11.642000|2
00014992|PD-L1 positive squamous cell carcinoma of esophagus|PD-L1 positive squamous cell carcinoma of esophagus|0|02.150902|2
00014993|tenosynovial giant cell tumor|tenosynovial giant cell tumor|0|13.727020|3
00014994|vanishing bile duct syndrome|vanishing bile duct syndrome|0|09.576203|3
00014995|peripheral sensory neuropathy|peripheral sensory neuropathy|0|06.357892|2
00014996|intramyelinic edema|intramyelinic edema|0|06.348903|2
00014997|drug treatment failure|drug treatment failure|0|18.V87400|0
00014998|cancer drug treatment failure|cancer drug treatment failure|0|18.V87401|0
00015001|HLA-B *15:02 negative|HLA-B *15:02 negative|0|03.277844|0
00015002|genotypes & phenotypes with increased ADR susceptibility|genotypes and phenotypes with increased ADR susceptibility|0|18.V00009|0
00015003|PGX combination 1|PGX combination 1|0|00.000001|0
00015004|HLA-B *58:01 negative|HLA-B *58:01 negative|0|17.995216|0
00015005|HLA-B *58:01 positive|HLA-B *58:01 positive|0|17.995217|2
00015006|pleuritic chest pain|pleuritic chest pain|0|16.786520|2
00015007|CYP2D6 normal-intermediate metabolizer (AS1.5-2.0)|CYP2D6 normal-intermediate metabolizer (activity score 1.5-2.0)|0|03.277845|2
00015008|CYP2D6 intermediate metabolizer (AS=1, no *10 allele)|CYP2D6 intermediate metabolizer (activity score 1, no *10 allele present)|0|03.277846|2
00015009|CYP2D6 intermediate metabolizer (AS=1, *10 allele)|CYP2D6 intermediate metabolizer (activity score 1, *10 allele present)|0|03.277847|2
00015010|CYP2C9 *1/*2 genotype|CYP2C9 *1/*2 genotype|0|03.277848|2
00015011|CYP2C9 *1/*3 genotype|CYP2C9 *1/*3 genotype|0|03.277849|2
00015012|CYP2C9 *2/*2 genotype|CYP2C9 *2/*2 genotype|0|03.277850|2
00015013|CYP2C9 *2/*3 genotype|CYP2C9 *2/*3 genotype|0|03.277851|2
00015014|CYP2C9 *3/*3 genotype|CYP2C9 *3/*3 genotype|0|03.277852|2
00015015|VKORC1 -1639 A/A genotype|VKORC1 -1639 A/A genotype|0|03.277853|2
00015016|VKORC1 -1639 A/G genotype|VKORC1 -1639 A/G genotype|0|03.277854|2
00015017|PGX combination 2|PGX combination 2|0|00.000002|0
00015018|PGX combination 3|PGX combination 3|0|00.000003|0
00015019|PGX combination 4|PGX combination 4|0|00.000004|0
00015020|PGX combination 5|PGX combination 5|0|00.000005|0
00015021|PGX combination 6|PGX combination 6|0|00.000006|0
00015022|PGX combination 7|PGX combination 7|0|00.000007|0
00015023|PGX combination 8|PGX combination 8|0|00.000008|0
00015024|PGX combination 9|PGX combination 9|0|00.000009|0
00015025|PGX combination 10|PGX combination 10|0|00.000010|0
00015026|PGX combination 11|PGX combination 11|0|00.000011|0
00015027|pigmentary maculopathy|pigmentary maculopathy|0|06.362551|2
00015028|hemoglobin Zurich|hemoglobin Zurich|0|04.282700|3
00015029|phlebitis after infusion|phlebitis after infusion|0|07.451890|1
00015031|thrombosis of pelvic vein|thrombosis of pelvic vein|0|07.453890|3
00015032|HR+, HER2-negative advanced male breast cancer|hormone receptor (HR)-positive, HER2-negative advanced male breast cancer|0|02.179000|2
00015033|cytomegalovirus hepatitis reactivation|cytomegalovirus hepatitis reactivation|0|01.078505|1
00015035|HLA-B *58:01 ordered, result pending|HLA-B *58:01 ordered, result pending|0|03.277855|0
00015036|HLA-B *58:01 no result on file, not currently ordered|HLA-B *58:01 no result on file, not currently ordered|0|03.277856|0
00015037|HLA-B *15:02 ordered, result pending|HLA-B *15:02 ordered, result pending|0|03.277857|0
00015038|SLCO1B1 ordered, result pending|SLCO1B1 ordered, result pending|0|03.277858|0
00015039|HLA-B *15:02 no result on file, not currently ordered|HLA-B *15:02 no result on file, not currently ordered|0|03.277859|0
00015040|SLCO1B1 no result on file, not currently ordered|SLCO1B1 no result on file, not currently ordered|0|03.27780A|0
00015041|dengue vaccination|dengue vaccination|0|18.V03500|1
00015042|congenital myasthenic syndrome|congenital myasthenic syndrome|0|06.358101|2
00015043|retinal pigment epithelial detachment|retinal pigment epithelial detachment|0|06.362420|1
00015044|infantile cortical hyperostosis|infantile cortical hyperostosis|0|13.733301|1
00015045|prevention of painful phototoxic reaction in EPP|prevention of painful phototoxic reaction in erythropoietic protoporphyria|0|03.277107|2
00015048|neuraxial anesthesia|neuraxial anesthesia|0|16. 9999V|1
00015049|deep peripheral nerve block|deep peripheral nerve block|0|16. 9999W|1
00015050|deep plexus block|deep plexus block|0|16. 9999X|1
00015051|elevated C-reactive protein|elevated C-reactive protein|0|16.790950|3
00015052|CYP2B6 ultrarapid metabolizer|CYP2B6 ultrarapid metabolizer|0|03.27780B|2
00015053|CYP2B6 rapid metabolizer|CYP2B6 rapid metabolizer|0|03.27780C|2
00015054|CYP2B6 intermediate metabolizer|CYP2B6 intermediate metabolizer|0|03.27780D|2
00015055|CYP2B6 poor metabolizer|CYP2B6 poor metabolizer|0|03.27780E|2
00015056|Child-Pugh class A hepatic impairment|Child-Pugh class A hepatic impairment|0|09.573905|2
00015057|Child-Pugh class B hepatic impairment|Child-Pugh class B hepatic impairment|0|09.573907|2
00015058|Child-Pugh class C hepatic impairment|Child-Pugh class C hepatic impairment|0|09.573908|2
00015059|cystic fibrosis with heterozyg F508del mutation in CFTR|cystic fibrosis with heterozygous F508del mutation in CFTR gene|0|19.E84800|2
00015060|Bowen's disease|Bowen's disease|0|02.232900|2
00015061|tick-borne encephalitis vaccination|tick-borne encephalitis vaccination|0|01.063900|1
00015062|UDP-glucuronosyltransferase|UDP-glucuronosyltransferase|0|03.27780F|0
00015063|anemia in beta thalassemia|anemia in beta thalassemia|0|04.282401|2
00015064|CYP2B6 ordered, result pending|CYP2B6 ordered, result pending|0|03.27780G|0
00015065|CYP2B6 no result on file, not currently ordered|CYP2B6 no result on file, not currently ordered|0|03.27780H|0
00015066|postmenopausal osteoporosis and high fracture risk|osteoporosis in postmenopausal woman at high risk for fracture|0|13.733191|2
00015067|acute hepatic porphyria|acute hepatic porphyria|0|03.277108|2
00015068|application site bleeding|application site bleeding|0|17.995291|1
00015069|Duchenne dystrophy amenable to exon 53 skipping therapy|Duchenne muscular dystrophy due to genetic mutation amenable to exon 53 skipping therapy|0|06.359102|2
00015070|monoparesis|monoparesis|0|13.729891|3
00015076|ATP binding cassette subfamily G member 2|ATP binding cassette subfamily G member 2|0|03.27780I|0
00015077|limbal stem cell deficiency|limbal stem cell deficiency|0|06.379191|3
00015079|complicated bacterial intra-abdominal infection|complicated bacterial intra-abdominal infection|0|10.599039|1
00015080|non-muscle invasive bladder cancer and carcinoma in situ|non-muscle invasive bladder cancer with carcinoma in situ|0|02.233701|2
00015081|gBRCAm metastatic pancreatic adenocarcinoma|germline BRCA-mutated metastatic pancreatic adenocarcinoma|0|02.157001|2
00015082|burning sensation on penis|burning sensation on penis|0|16.782015|2
00015083|pruritis of tongue|pruritis of tongue|0|12.698904|1
00015084|increased pulse rate|increased pulse rate|0|16.785901|1
00015085|decreased pulse rate|decreased pulse rate|0|16.785902|1
00015087|PDGFRA exon 18 mutation+ gastrointestinal stromal tumor|platelet-derived growth factor receptor alpha exon 18 mutation(+) gastrointestinal stromal tumor|0|02.171500|2
00015088|mesenteric artery thrombosis|mesenteric artery thrombosis|0|07.444902|1
00015089|labile hypertension|labile hypertension|0|10.796400|1
00015090|human papillomavirus infection|human papillomavirus infection|0|01.079400|3
00015091|flaccid paralysis|flaccid paralysis|0|16.781400|3
00015092|implant site reaction|implant site reaction|0|17.995218|3
00015093|presyncope|presyncope|0|16.780204|1
00015096|swelling of ankles|swelling of ankles|0|13.729811|3
00015097|swelling of feet|swelling of feet|0|13.729812|3
00015098|swelling of wrists|swelling of wrists|0|13.729813|3
00015100|swelling of hands|swelling of hands|0|13.729814|3
00015101|dysdiadochokinesis|dysdiadochokinesis|0|16.781303|3
00015102|alpha-mannosidosis|alpha-mannosidosis|0|03.272703|2
00015103|exophthalmos|exophthalmos|0|06.376300|1
00015104|Loeys-Dietz syndrome|Loeys-Dietz syndrome|0|14.759897|2
00015105|epithelioid sarcoma|epithelioid sarcoma|0|02.171906|2
00015106|disorder of connective tissue|disorder of connective tissue|0|13.710902|3
00015107|peanut allergy|peanut allergy|0|18.V15010|2
00015108|endometrial thickening|endometrial thickening|0|10.621302|1
00015110|dry hair|dry hair|0|12.704200|2
00015111|oculogyric crisis|oculogyric crisis|0|06.378871|1
00015112|nephropathic cystinosis|nephropathic cystinosis|0|03.270005|2
00015113|meningioma|meningioma|0|02.225000|2
00015114|severe chronic pain|severe chronic pain|0|06.338000|2
00015115|severe chronic pain requiring long-term opioid treatment|severe chronic pain requiring long-term opioid treatment|0|06.338001|2
00015116|severe chronic pain with opioid tolerance|severe chronic pain with opioid tolerance|0|06.338002|2
00015117|TPMT possible intermediate metabolizer|TPMT possible intermediate metabolizer|0|03.277211|2
00015118|PGX combination 12|PGX combination 12|0|00.000012|0
00015119|PGX combination 13|PGX combination 13|0|00.000013|0
00015120|PGX combination 14|PGX combination 14|0|03.277214|0
00015121|PGX combination 15|PGX combination 15|0|00.000015|0
00015122|NUDT15 possible intermediate metabolizer|NUDT15 possible intermediate metabolizer|0|03.277216|2
00015123|NUDT15 intermediate metabolizer|NUDT15 intermediate metabolizer|0|03.277217|2
00015125|NUDT15|NUDT15|0|03.277218|0
00015127|angiosarcoma of breast|angiosarcoma of breast|0|02.174915|2
00015128|progressive fibrosing interstitial lung disease|progressive fibrosing interstitial lung disease|0|08.515002|2
00015129|increased pigmentation of skin pigmentary lesion|increased pigmentation of skin pigmentary lesion|0|02.216902|3
00015133|pituitary-dependent Cushing's disease|pituitary-dependent Cushing's disease|0|03.255001|2
00015136|fluorescein sodium stain procedure on the eye|fluorescein sodium stain procedure on the eye|0|16. 15121|1
00015137|corneal endothelial cell loss|corneal endothelial cell loss|0|06.371902|2
00015138|DPYD intermediate metabolizer (activity score 1)|DPYD intermediate metabolizer (activity score 1)|0|03.277219|2
00015139|DPYD intermediate metabolizer (activity score 1.5)|DPYD intermediate metabolizer (activity score 1.5)|0|03.277220|2
00015140|DPYD poor metabolizer (activity score 0.5)|DPYD poor metabolizer (activity score 0.5)|0|03.277221|2
00015141|DPYD poor metabolizer (activity score 0)|DPYD poor metabolizer (activity score 0)|0|03.277223|1
00015144|UGT1A1 intermediate metabolizer|UGT1A1 intermediate metabolizer|0|03.277403|2
00015145|UGT1A1 poor metabolizer|UGT1A1 poor metabolizer|0|03.277404|2
00015146|CYP3A5 normal metabolizer|CYP3A5 normal metabolizer|0|03.27780J|2
00015147|CYP3A5 intermediate metabolizer|CYP3A5 intermediate metabolizer|0|03.27780K|2
00015148|CYP3A5 poor metabolizer|CYP3A5 poor metabolizer|0|03.27780L|2
00015149|COVID-19|COVID-19|0|01.079820|1
00015150|COVID-19 (emergency use authorization)|COVID-19 (emergency use authorization)|0|01.079821|1
00015151|cytochrome p450 CYP3A5|cytochrome p450 CYP3A5|0|03.27780M|0
00015152|dihydropyrimidine dehydrogenase (DPD)|dihydropyrimidine dehydrogenase (DPD)|0|03.277224|0
00015153|radiation recall hemorrhagic cystitis|radiation recall hemorrhagic cystitis|0|12.692822|1
00015154|PGX combination 16|PGX combination 16|0|00.000016|0
00015155|PGX combination 17|PGX combination 17|0|00.000017|0
00015156|PGX combination 18|PGX combination 18|0|00.000018|0
00015157|PGX combination 19|PGX combination 19|0|00.000019|0
00015158|PGX combination 20|PGX combination 20|0|00.000020|0
00015160|PGX combination 21|PGX combination 21|0|00.000021|0
00015161|PGX combination 22|PGX combination 22|0|00.000022|0
00015162|PGX combination 23|PGX combination 23|0|00.000023|0
00015163|PGX combination 24|PGX combination 24|0|00.000024|0
00015165|PGX combination 25|PGX combination 25|0|00.000025|0
00015166|PGX combination 26|PGX combination 26|0|00.000026|0
00015167|PGX combination 27|PGX combination 27|0|00.000027|0
00015168|PGX combination 28|PGX combination 28|0|00.000028|0
00015169|PGX combination 29|PGX combination 29|0|00.000029|0
00015170|PGX combination 30|PGX combination 30|0|00.000030|0
00015171|PGX combination 31|PGX combination 31|0|00.000031|0
00015172|PGX combination 32|PGX combination 32|0|00.000032|0
00015173|PGX combination 33|PGX combination 33|0|00.000033|0
00015174|orbital myositis|orbital myositis|0|13.729107|1
00015175|extensive-stage small cell lung cancer|extensive-stage small cell lung cancer|0|02.162900|2
00015176|breath-holding spell|breath-holding spell|0|16.786002|3
00015180|Zaire ebolavirus vaccination|Zaire ebolavirus vaccination|0|18.V05900|1
00015181|injection site infection|injection site infection|0|17.999390|1
00015182|application site infection|application site infection|0|12.686950|1
00015183|metastatic colorectal cancer with BRAF V600E mutation|metastatic colorectal cancer with BRAF V600E mutation|0|02.154001|2
00015184|anemia in myelodysplastic syndrome with ring sideroblast|anemia in myelodysplastic syndrome with ring sideroblasts|0|02.238703|3
00015188|anemia in MDS/MPN with ring sideroblasts, thrombocytosis|anemia in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis|0|02.238704|3
00015189|neurofibromatosis type 1 with plexiform neurofibromas|neurofibromatosis type 1 with plexiform neurofibromas|0|02.237710|2
00015190|acquired melanocytic nevus|acquired melanocytic nevus|0|02.216800|2
00015191|onychomadesis|onychomadesis|0|12.703803|1
00015193|NUDT15 no result on file, not currently ordered|NUDT15 no result on file, not currently ordered|0|03.27721A|0
00015194|NUDT15 ordered, result pending|NUDT15 ordered, result pending|0|03.27721B|0
00015195|CYP2C9 intermediate metabolizer (activity score 1.5)|CYP2C9 intermediate metabolizer (activity score 1.5)|0|03.27781A|0
00015196|CYP2C9 ordered, result pending|CYP2C9 ordered, result pending|0|03.27780N|0
00015197|CYP2C9 no result on file, not currently ordered|CYP2C9 no result on file, not currently ordered|0|03.27780O|0
00015198|CYP2C9 intermediate metabolizer (activity score 1)|CYP2C9 intermediate metabolizer (activity score 1)|0|03.27781B|0
00015199|cholangiocarcinoma with FGFR2 fusion or rearrangement|cholangiocarcinoma with fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement|0|02.155100|2
00015200|metastatic triple-negative breast cancer|metastatic triple-negative breast cancer|0|02.174916|2
00015202|low-grade upper tract urothelial cancer|low-grade upper tract urothelial cancer|0|02.189007|2
00015203|obstruction of ureter|obstruction of ureter|0|10.593401|3
00015204|non-proliferative diabetic retinopathy|non-proliferative diabetic retinopathy|0|06.362030|2
00015205| heart failure with reduced ejection fraction|heart failure with reduced ejection fraction|0|07.428200|2
00015206|non-small cell lung cancer with MET exon 14 skipping|non-small cell lung cancer with mesenchymal-epithelial transition (MET) exon 14 skipping|0|02.162901|2
00015207|increased alkaline phosphatase|increased alkaline phosphatase|0|16.790502|1
00015208|RET fusion-positive metastatic NSCLC|RET fusion-positive metastatic non-small cell lung cancer|0|02.162000|2
00015209|RET-mutant medullary thyroid cancer|RET-mutant medullary thyroid cancer|0|02.193005|2
00015211|RET fusion-positive thyroid cancer|RET fusion-positive thyroid cancer|0|02.193006|2
00015212|corneal transplant present|corneal transplant present|0|17.996809|2
00015215|BRCA-mutated metastat castration-resist prostate cancer|metastatic castration-resistant prostate cancer with BRCA mutation|0|02.233408|2
00015222|PD-L1 positive, EGFR-negative, ALK-negative metast NSCLC|PD-L1 positive, EGFR-negative, ALK-negative metastatic non-small cell lung cancer|0|02.162001|2
00015223|met castration-resist prostate cancer with HRR gene mut|metastatic castration-resistant prostate cancer with HRR gene mutation|0|02.185000|2
00015225|EGFR negative, ALK negative, non-small cell lung cancer|EGFR negative, ALK negative, non-small cell lung cancer|0|02.162002|2
00015226|infection of bone, joint, skin, or soft tissue of knee|infection of bone, joint, skin, or soft tissue of knee|0|13.730901|3
00015227|hemoglobinuria|hemoglobinuria|0|16.791200|1
00015229|heavy menstrual bleeding assoc. with uterine leiomyoma|heavy menstrual bleeding associated with uterine leiomyoma|0|02.218901|1
00015230|vulvovaginal pruritus|vulvovaginal pruritus|0|12.698905|1
00015232|vulvovaginal pain|vulvovaginal pain|0|10.625902|1
00015233|esophageal squamous cell carcinoma|esophageal squamous cell carcinoma|0|02.150903|2
00015234|UGT1A1 no result on file, not currently ordered|UGT1A1 no result on file, not currently ordered|0|03.277862|0
00015235|UGT1A1 ordered, result pending|UGT1A1 ordered, result pending|0|03.277863|0
00015237|tumor mutational burden-high solid malignant tumor|tumor mutational burden-high solid malignant tumor|0|02.140000|2
00015238|retinal vasculitis|retinal vasculitis|0|06.362180|1
00015239|NUDT15 normal metabolizer|NUDT15 normal metabolizer|0|03.277212|2
00015240|DPYD normal metabolizer|DPYD normal metabolizer|0|03.277225|2
00015242|UGT1A1 normal metabolizer|UGT1A1 normal metabolizer|0|03.277405|2
00015243|CYP2B6 normal metabolizer|CYP2B6 normal metabolizer|0|03.27780P|2
00015244|HLA-B *57:01 negative|HLA-B *57:01 negative|0|17.995219|0
00015245|HLA-A *31:01 negative|HLA-A *31:01 negative|0|17.99521A|2
00015246|follicular lymphoma with EZH2 mutation|follicular lymphoma with EZH2 mutation|0|02.202002|2
00015247|FGF23-related hypophosphatemia in TIO due to PMT|FGF23-related hypophosphatemia in tumor-induced osteomalacia due to phosphaturic mesenchymal tumor|0|03.268202|2
00015248|prevention of oropharyngeal cancer due to HPV|prevention of oropharyngeal cancer due to human papillomavirus|0|18.V73810|2
00015249|prevention of head and neck cancer due to HPV|prevention of head and neck cancer due to human papillomavirus|0|18.V73811|2
00015250|retinal depigmentation|retinal depigmentation|0|06.362902|2
00015251|PGX combination 34|PGX combination 34|0|00.000034|0
00015253|increased libido in male patient|increased libido in male patient|0|05.302703|3
00015254|DPYD ordered, result pending|DPYD ordered, result pending|0|03.277864|0
00015255|DPYD no result on file, not currently ordered|DPYD no result on file, not currently ordered|0|03.277865|0
00015256|diastolic hypertension|diastolic hypertension|0|16.796200|1
00015257|systolic hypertension|systolic hypertension|0|16.796201|3
00015258|diastolic hypotension|diastolic hypotension|0|16.796300|1
00015259|amniotic fluid embolism in childbirth|amniotic fluid embolism in childbirth|0|11.673110|1
00015260|CYP3A5 ordered, result pending|CYP3A5 ordered, result pending|0|03.277866|0
00015261|CYP3A5 no result on file, not currently ordered|CYP3A5 no result on file, not currently ordered|0|03.277867|0
00015262|moderate to severe cellulite of the buttocks in women|moderate to severe cellulite of the buttocks in women|0|12.682500|2
00015263|chronic myelomonocytic leukemia|chronic myelomonocytic leukemia|0|02.206001|2
00015264|acquired blepharoptosis|acquired blepharoptosis|0|06.374301|1
00015265|adjunct tx for COVID-19 requiring oxygen or ventilation|adjunct therapy for COVID-19 requiring oxygen or ventilatory support|0|01.079822|1
00015266|parasomnia|parasomnia|0|06.327400|3
00015267|reduced sensation of skin|reduced sensation of skin|0|16.782016|3
00015268|motor dysfunction|motor dysfunction|0|16.781304|3
00015269|B cell aplasia|B cell aplasia|0|04.288803|2
00015270|seizures associated with tuberous sclerosis complex|seizures associated with tuberous sclerosis complex|0|14.759503|2
00015271|malignant melanoma with BRAF V600 mutation|malignant melanoma with BRAF V600 mutation|0|02.172908|2
00015272|castration-resistant prostate cancer|castration-resistant prostate cancer|0|02.185001|2
00015273|smallpox vaccination|smallpox vaccination|0|18.V05901|1
00015274|Mpox vaccination|Mpox vaccination|0|18.V05902|1
00015275|CYP2C19 likely poor metabolizer|CYP2C19 likely poor metabolizer|0|03.27780Q|2
00015277|CYP2C19 likely intermediate metabolizer|CYP2C19 likely intermediate metabolizer|0|03.27780R|2
00015278|Streptococcus pneumoniae vaccination|Streptococcus pneumoniae vaccination|0|18.V05903|1
00015279|Haemophilus influenzae type b vaccination|Haemophilus influenzae type b vaccination|0|18.V05904|1
00015280|anthrax vaccination|anthrax vaccination|0|18.V04891|1
00015282|influenza vaccination|influenza vaccination|0|18.V04900|1
00015283|hepatitis B vaccination|hepatitis B vaccination|0|18.V05303|1
00015284|hepatitis A vaccination|hepatitis A vaccination|0|18.V05905|1
00015285|wild-type KRAS, EGFR-positive colorectal cancer|wild-type KRAS, EGFR-positive colorectal cancer|0|02.153913|2
00015287|allergic rhinitis due to birch, alder, hazel tree pollen|allergic rhinitis due to birch, alder or hazel tree pollen|0|08.477909|2
00015288|osteonecrosis of external auditory canal|osteonecrosis of external auditory canal|0|13.733405|3
00015289|cutaneous lupus erythematosus|cutaneous lupus erythematosus|0|12.695402|3
00015290|heart failure with rEF due to dilated cardiomyopathy|heart failure with reduced ejection fraction due to dilated cardiomyopathy|0|07.428010|2
00015291|follicle stimulation for fertility preservation|follicle stimulation for fertility preservation|0|18.V26808|1
00015292|galactosemia|galactosemia|0|03.271100|2
00015293|glucose-galactose malabsorption|glucose-galactose malabsorption|0|03.271101|2
00015294|PGX combination 35|PGX combination 35|0|00.000035|0
00015295|PGX combination 36|PGX combination 36|0|00.000036|0
00015296|PGX combination 37|PGX combination 37|0|00.000037|0
00015297|PGX combination 38|PGX combination 38|0|00.000038|0
00015298|PGX combination 39|PGX combination 39|0|00.000039|0
00015299|PGX combination 40|PGX combination 40|0|00.000040|0
00015300|PGX combination 41|PGX combination 41|0|00.000041|0
00015301|PGX combination 42|PGX combination 42|0|00.000042|0
00015302|TPMT variant not found|thiopurine S-methyltransferase variant not found|0|03.27720A|0
00015303|NUDT15 variant not found|NUDT15 variant not found|0|03.27721C|0
00015304|CYP2D6 variant not found|CYP2D6 variant not found|0|03.27782A|0
00015305|CYP2C9 variant not found|CYP2C9 variant not found|0|03.27781C|0
00015306|CYP2C19 variant not found|CYP2C19 variant not found|0|03.27781D|0
00015307|CYP3A5 variant not found|CYP3A5 variant not found|0|03.27780S|0
00015309|DPYD variant not found|DPYD variant not found|0|03.277226|0
00015310|SLCO1B1 variant not found|SLCO1B1 variant not found|0|03.27782B|0
00015312|HLA-B *57:01 variant not found|HLA-B *57:01 variant not found|0|03.27783A|0
00015313|HLA-B *15:02 variant not found|HLA-B *15:02 variant not found|0|03.27784A|0
00015314|HLA-B *58:01 variant not found|HLA-B *58:01 variant not found|0|17.99521B|0
00015315|VKORC1 variant not found|VKORC1 variant not found|0|03.27785A|0
00015317|HLA-A *31:01 variant not found|HLA-A *31:01 variant not found|0|17.995222|0
00015318|paresis of extraocular muscles|paresis of extraocular muscles|0|06.376820|3
00015319|acute post-op pain following open inguinal hernia repair|acute postoperative pain following open inguinal hernia repair|0|09.553901|1
00015321|progressive vaccinia|progressive vaccinia|0|01.051020|3
00015322|generalized vaccinia|generalized vaccinia|0|17.999000|3
00015323|pharmacogenomic variant not found|pharmacogenomic variant not found|0|03.27783B|0
00015324|history of kidney donation|history of kidney donation|0|18.V58400|3
00015325|DPYD intermediate metabolizer|DPYD intermediate metabolizer|0|03.277227|2
00015326|DPYD poor metabolizer|DPYD poor metabolizer|0|03.277228|2
00015327|large granular lymphocytic leukemia|large granular lymphocytic leukemia|0|02.204109|2
00015328|labial adhesion|labial adhesion|0|10.624801|3
00015329|piloerection|piloerection|0|12.704901|1
00015332|Zaire ebolavirus infection|Zaire ebolavirus infection|0|01.078893|3
00015333|COVID-19 vaccination|COVID-19 vaccination|0|18.V04892|0
00015335|germline BRCA-mutated, HER2(-) negative breast cancer|germline BRCA-mutated, HER2-negative breast cancer|0|02.174917|2
00015339|madarosis of eyelid|madarosis of eyelid|0|06.374551|3
00015340|trichorrhexis of eyelashes|trichorrhexis of eyelashes|0|12.704201|3
00015341|COVID-19 vaccination (emergency use authorization)|COVID-19 vaccination (emergency use authorization)|0|18.V04893|0
00015342|worsening of seizure|worsening of seizure|0|06.345800|1
00015343|Hutchinson-Gilford progeria syndrome|Hutchinson-Gilford progeria syndrome|0|03.259801|2
00015344|processing-deficient PL w heterozygous LMNA mutation|processing-deficient progeroid laminopathy with heterozygous LMNA mutation|0|03.259802|2
00015345|processing-def PL w ZMPSTE24 mutation|processing-deficient progeroid laminopathy with ZMPSTE24 mutation|0|03.259803|2
00015346|swelling of scrotum|swelling of scrotum|0|10.608400|1
00015347|postprocedural seroma|postprocedural seroma|0|17.998130|1
00015348|spontaneous penile erection|spontaneous penile erection|0|10.607841|1
00015349|CYP2C9 *1/*1 genotype|CYP2C9 *1/*1 genotype|0|03.27785B|2
00015350|VKORC1 -1639 G/G genotype|VKORC1 -1639 G/G genotype|0|03.27785C|1
00015351|PGX combination 43|PGX combination 43|0|00.000043|0
00015352|PGX combination 44|PGX combination 44|0|00.000044|0
00015353|PGX combination 45|PGX combination 45|2|00.000045|0
00015354|obesity due to proopiomelanocortin deficiency|obesity due to proopiomelanocortin (POMC) deficiency|0|03.278007|2
00015355|PGX combination 46|PGX combination 46|0|00.000046|0
00015359|obesity due to leptin receptor deficiency|obesity due to leptin receptor (LEPR) deficiency|0|03.278008|2
00015360|obesity due to PCSK1 deficiency|obesity due to proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency|0|03.278009|2
00015361|primary hyperoxaluria type I|primary hyperoxaluria type I|0|03.271801|2
00015362|high-risk neuroblastoma in bone or bone marrow|high-risk neuroblastoma in bone or bone marrow|0|02.194002|2
00015363|nighttime sleep disturbance in Smith-Magenis Syndrome|nighttime sleep disturbance in Smith-Magenis Syndrome|0|14.758330|2
00015364|arteriovenous fistula thrombosis|arteriovenous fistula thrombosis|0|17.996743|1
00015365|PGX combination 47|PGX combination 47|0|00.000047|0
00015366|PGX combination 48|PGX combination 48|0|00.000048|0
00015367|PGX combination 49|PGX combination 49|0|00.000049|0
00015368|PGX combination 50|PGX combination 50|0|00.000050|0
00015369|gastrointestinal vascular ischemia|gastrointestinal vascular ischemia|0|09.557901|3
00015370|pityriasis rubra pilaris|pityriasis rubra pilaris|0|12.696400|2
00015371|anemia due to myelodysplastic syndrome|anemia due to myelodysplastic syndrome|0|02.238705|2
00015372|cachexia due to malignant neoplastic disease|cachexia due to malignant neoplastic disease|0|16.799402|2
00015374|cerebrotendinous xanthomatosis|cerebrotendinous xanthomatosis|0|03.272802|2
00015375|patient at risk of anaphylaxis|patient at risk of anaphylaxis|0|18.138100|1
00015376|patient with diabetes mellitus at risk of hypoglycemia|patient with diabetes mellitus at risk of hypoglycemia|0|19.E08000|1
00015377|chronic kidney disease with albuminuria|chronic kidney disease with albuminuria|0|16.791001|2
00015378|non-small cell lung cancer with EGFR exon 19 deletion|non-small cell lung cancer with EGFR exon 19 deletion|0|02.231214|2
00015379|NSCLC with EGFR exon 21 L858R substitution mutation|non-small cell lung cancer with EGFR exon 21 L858R substitution mutation|0|02.231215|2
00015380|deficiency of interleukin-1 receptor antagonist|deficiency of interleukin-1 receptor antagonist|0|13.710800|2
00015381|active lupus nephritis|active lupus nephritis|0|13.710005|3
00015382|squamous cell carcinoma of cervix|squamous cell carcinoma of cervix|0|02.189008|2
00015383|cystic fibrosis with responsive CFTR mutation|cystic fibrosis with responsive CFTR mutation|0|03.277012|2
00015384|metastatic HER2-positive carcinoma of breast|metastatic HER2-positive carcinoma of breast|0|02.233007|2
00015385|residual urine volume increased|residual urine volume increased|0|16.788201|3
00015387|self-injurious ideation|self-injurious ideation|0|19.E95800|1
00015388|Castleman's disease|Castleman's disease|0|02.203800|2
00015389|amyloid light-chain amyloidosis|amyloid light-chain amyloidosis|0|03.277302|2
00015390|ALK-positive systemic anaplastic large cell lymphoma|anaplastic lymphoma kinase (ALK)-positive systemic anaplastic large cell lymphoma|0|02.200602|3
00015398|multidrug and toxin extrusion protein 2|multidrug and toxin extrusion (MATE) protein 2|0|03.27783C|0
00015400|multidrug and toxin extrusion protein 1|multidrug and toxin extrusion (MATE) protein 1|0|03.27783D|0
00015401|IgA vasculitis|IgA vasculitis|0|04.287000|1
00015403|hyperammonemia due to propionic acidemia|hyperammonemia due to propionic acidemia|0|03.270608|2
00015404|hyperammonemia due to methylmalonic acidemia|hyperammonemia due to methylmalonic acidemia|0|03.270609|2
00015405|PGX combination 51|PGX combination 51|0|00.000051|0
00015406|PGX combination 52|PGX combination 52|0|00.000052|0
00015407|PGX combination 53|PGX combination 53|0|00.000053|0
00015408|PGX combination 54|PGX combination 54|0|00.000054|0
00015409|PGX combination 55|PGX combination 55|0|00.000055|0
00015410|PGX combination 56|PGX combination 56|0|00.000056|0
00015411|PGX combination 57|PGX combination 57|0|00.000057|0
00015412|PGX combination 58|PGX combination 58|0|00.000058|0
00015413|PGX combination 59|PGX combination 59|0|00.000059|0
00015414|PGX combination 60|PGX combination 60|0|00.000060|0
00015415|PGX combination 61|PGX combination 61|0|00.000061|0
00015416|PGX combination 62|PGX combination 62|0|00.000062|0
00015417|PGX combination 63|PGX combination 63|0|00.000063|0
00015418|PGX combination 64|PGX combination 64|0|00.000064|0
00015419|PGX combination 65|PGX combination 65|0|00.000065|0
00015420|PGX combination 66|PGX combination 66|0|00.000066|0
00015421|PGX combination 67|PGX combination 67|0|00.000067|0
00015422|PGX combination 68|PGX combination 68|0|00.000068|0
00015423|HLA-A *31:01 ordered, result pending|HLA-A *31:01 ordered, result pending|0|17.995223|0
00015424|PGX combination 69|PGX combination 69|0|00.000069|0
00015425|HER2+ adenocarcinoma of gastroesophageal junction|HER2-positive adenocarcinoma of gastroesophageal junction|0|02.151000|2
00015426|HER2-positive gastric adenocarcinoma|HER2-positive gastric adenocarcinoma|0|02.151001|2
00015427|cytochrome p450 CYP1A1|cytochrome p450 CYP1A1|0|03.27781E|0
00015428|prevent chemotherapy-induced myelosuppression in ESCLC|prevention of chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer|0|04.284808|1
00015429|tumor lysis syndrome|tumor lysis syndrome|0|03.277880|1
00015430|injection site erythema|injection site erythema|0|17.909300|1
00015431|PD-L1(+) EGFR(-) ALK(-) ROS1(-) non-small cell lung CA|PD-L1 positive, EGFR-negative, ALK-negative, ROS1-negative non-small cell lung cancer|0|02.162003|2
00015436|Duchenne dystrophy amenable to exon 45 skipping therapy|Duchenne muscular dystrophy due to genetic mutation amenable to exon 45 skipping therapy|0|06.359103|2
00015437|molybdenum cofactor deficiency type A|molybdenum cofactor deficiency type A|0|03.270407|2
00015438|choroidal effusion|choroidal effusion|0|06.363701|1
00015439|N-acetyltransferase 2 (NAT2)|N-acetyltransferase 2 (NAT2)|0|03.277903|2
00015440|NAT2 intermediate metabolizer|NAT2 intermediate metabolizer|0|03.277904|2
00015441|NAT2 rapid metabolizer|NAT2 rapid metabolizer|0|03.277905|2
00015442|N-acetyltransferase 2 (NAT2) normal acetylator|N-acetyltransferase 2 (NAT2) normal acetylator|0|03.277906|2
00015445|NAT2 no result on file, not currently ordered|N-acetyltransferase 2 (NAT2) no result on file, not currently ordered|0|03.27780T|0
00015446|N-acetyltransferase 2 (NAT2) ordered, result pending|N-acetyltransferase 2 (NAT2) ordered, result pending|0|03.27780U|0
00015447|recurrent pericarditis|recurrent pericarditis|0|07.423906|2
00015449|history of pulmonary embolism|history of pulmonary embolism|0|18.V12550|2
00015451|history of deep vein thrombosis|history of deep vein thrombosis|0|18.V12510|2
00015452|history of venous thromboembolism|history of venous thromboembolism|0|18.V12511|2
00015462|history of retinal vein thrombosis|history of retinal vein thrombosis|0|18.V12512|2
00015463|neurogenic detrusor overactivity|neurogenic detrusor overactivity|0|10.596511|2
00015464|acute myeloid leukemia w/ myelodysplasia-related changes|acute myeloid leukemia with myelodysplasia-related changes|0|02.205007|2
00015465|pulmonary hypertension due to interstitial lung disease|pulmonary hypertension associated with interstitial lung disease|0|07.416800|2
00015466|cerebral amyloid angiopathy|cerebral amyloid angiopathy|0|07.437800|2
00015468|hemorrhagic enteritis|hemorrhagic enteritis|0|09.558912|3
00015471|adjunct therapy for obsessive compulsive disorder|adjunct therapy for obsessive compulsive disorder|0|05.300301|2
00015472|injection site pain|injection site pain|0|17.999904|1
00015473|mismatch repair deficient endometrial cancer|mismatch repair deficient endometrial cancer|0|02.233306|2
00015474|history of gout|history of gout|0|03.274905|2
00015475|thrombosis with thrombocytopenia syndrome|thrombosis with thrombocytopenia syndrome|0|07.453919|1
00015476|distal limb ischemia|distal limb ischemia|0|07.459905|1
00015477|erythema of nasal mucosa|erythema of nasal mucosa|0|08.478107|1
00015478|acute postoperative pain following bunionectomy|acute postoperative pain following bunionectomy|0|16.780925|1
00015479|acute postoperative pain after total knee arthroplasty|acute postoperative pain following total knee arthroplasty|0|16.780926|1
00015480|non-small cell lung cancer with EGFR exon 20 insertion|non-small cell lung cancer with EGFR exon 20 insertion mutation|0|02.231216|2
00015481|symmetrical drug-rel. intertriginous, flexural exanthema|symmetrical drug-related intertriginous and flexural exanthema|0|12.695903|1
00015482|trichiasis|trichiasis|0|06.374050|2
00015484|trichomegaly|trichomegaly|0|06.374897|2
00015485|calcification of vascular system|calcification of vascular system|0|03.275492|2
00015486|calcinosis cutis|calcinosis cutis|0|12.709807|2
00015487|non-small cell lung cancer with KRAS G12C mutation|non-small cell lung cancer with KRAS G12C mutation|0|02.231217|2
00015488|amyloid-related imaging abnormality|amyloid-related imaging abnormality|0|16.793000|1
00015490|MT-RNR1 inc risk of aminoglycoside-induced hearing loss|MT-RNR1 increased risk of aminoglycoside-induced hearing loss|0|03.27784B|0
00015492|plasminogen deficiency type 1|plasminogen deficiency type 1|0|03.273803|2
00015493|gastrojejunal ulcer|gastrojejunal ulcer|0|09.534903|3
00015496|MT-RNR1 normal risk aminoglycoside-induced hearing loss|MT-RNR1 normal risk of aminoglycoside-induced hearing loss|0|03.27784C|0
00015497|MT-RNR1 unc risk of aminoglycoside-induced hearing loss|MT-RNR1 uncertain risk of aminoglycoside-induced hearing loss|0|03.27784D|0
00015498|MT-RNR1 ordered, result pending|MT-RNR1 ordered, result pending|0|03.27784E|0
00015499|MT-RNR1 no result on file, not currently ordered|MT-RNR1 no result on file, not currently ordered|0|03.27784F|0
00015500|amyloid-related imaging abnormality with edema|amyloid-related imaging abnormality with edema|0|16.793001|1
00015501|amyloid-related imaging abnormality with microhemorrhage|amyloid-related imaging abnormality with microhemorrhage|0|16.763002|1
00015502|amyloid-related image abnormality, superficial siderosis|amyloid-related imaging abnormality with superficial siderosis|0|16.763003|1
00015503|prevent early ejaculation due to penile oversensitivity|prevention of premature ejaculation due to penile oversensitivity|0|05.302751|0
00015504|microscopic colitis|microscopic colitis|0|09.558913|2
00015505|glomerular microangiopathy|glomerular microangiopathy|0|07.447500|2
00015506|chronic kidney disease associated with type 2 diabetes|chronic kidney disease associated with type 2 diabetes mellitus|0|03.250401|2
00015507|lymphoblastic lymphoma|lymphoblastic lymphoma|0|02.202814|2
00015508|adverse reactions from redundant medications|adverse reactions from redundant medications|0|99.999996|0
00015509|administrative action needed|administrative action needed|0|99.999997|0
00015510|chronic graft-versus-host disease|chronic graft-versus-host disease|0|17.996852|2
00015512|fluoroquinolone toxicity|fluoroquinolone toxicity|0|17.960604|1
00015517|pruritus in progressive familial intrahepat. cholestasis|pruritus due to progressive familial intrahepatic cholestasis|0|09.576815|2
00015518|early-stage triple-negative breast cancer|early-stage triple-negative breast cancer|0|02.174918|2
00015519|triple-negative breast cancer|triple-negative breast cancer|0|02.174919|2
00015520|gamma-glutamyl transferase raised|gamma-glutamyl transferase raised|0|16.790608|1
00015521|COVID-19 post-exposure prophylaxis (EUA)|COVID-19 post-exposure prophylaxis (EUA)|0|01.079823|1
00015522|overdiuresis|overdiuresis|0|17.960605|3
00015523|excess angiotensin inhibition|excess angiotensin inhibition|0|17.960606|3
00015524|excessive CNS stimulation|excessive CNS stimulation|0|17.960607|3
00015526|mechanical prosthetic heart valve present|mechanical prosthetic heart valve present|0|07. 35201|2
00015527|bioprosthetic heart valve present|bioprosthetic heart valve present|0|07. 35202|2
00015528|opioid-CNS depressant-induced respiratory depression|opioid-CNS depressant-induced respiratory depression|0|19.E93525|1
00015529|neoplasm associated with von Hippel-Lindau disease|neoplasm associated with von Hippel-Lindau disease|0|14.759600|2
00015530|idiopathic hypersomnia|idiopathic hypersomnia|0|06.327110|2
00015531|aminoglycoside toxicity|aminoglycoside toxicity|0|17.960804|1
00015532|history of intracranial hemorrhage|history of intracranial hemorrhage|0|18.V12590|2
00015533|cholangiocarcinoma with IDH1 mutation|cholangiocarcinoma with isocitrate dehydrogenase-1 (IDH1) mutation|0|02.155101|2
00015534|pruritus in hemodialysis-dependent CKD|pruritus in hemodialysis-dependent chronic kidney disease|0|10.585600|2
00015535|calcium channel blocker toxicity|calcium channel blocker toxicity|0|17.972902|1
00015536|reduced diuretic response|reduced diuretic response|0|18.V87402|1
00015537|double risk opioid-induced respiratory depression|double risk opioid-induced respiratory depression|0|19.E93522|1
00015538|triple risk opioid-induced respiratory depression|triple risk opioid-induced respiratory depression|0|19.E93523|1
00015539|opioid-muscle relaxant-induced respiratory depression|opioid-muscle relaxant-induced respiratory depression|0|19.E93524|1
00015544|opioid-induced resp depression & elevated opioid levels|opioid-induced respiratory depression with elevated opioid levels|0|19.E93526|1
00015551|opioid-muscle relaxant-inc resp dep & high opioid levels|opioid-muscle relaxant-induced respiratory depression with elevated opioid levels|0|19.E93527|1
00015555|opioid-CNS depressant-ind resp depres &high opioid level|opioid-CNS depressant-induced respiratory depression with elevated opioid levels|0|19.E93528|1
00015556|double risk opioid-CNS depressant-induced resp depr|double risk opioid-CNS depressant-induced respiratory depression|0|19.E93529|1
00015557|double risk opioid-ind resp dep & high opioid levels|double risk opioid-induced respiratory depression with elevated opioid levels|0|19.E9352A|1
00015558|double risk opioid-CNS depres-resp depress &high level|double risk opioid-CNS depressant-induced respiratory depression with elevated opioid levels|0|19.E9352B|1
00015559|triple risk opioid-CNS depress-ind respiratory depress|triple risk opioid-CNS depressant-induced respiratory depression|0|19.E9352C|1
00015560|triple risk opioid-ind resp dep & high opioid levels|triple risk opioid-induced respiratory depression with elevated opioid levels|0|19.E9352D|1
00015561|triple risk opioid-CNS depres-resp depress &high level|triple risk opioid-CNS depressant-induced respiratory depression with elevated opioid levels|0|19.E9352E|1
00015562|benzodiazepine toxicity and serotonin syndrome|benzodiazepine toxicity and serotonin syndrome|0|19.E93942|1
00015564|hypotension, myopathy and rhabdomyolysis|hypotension, myopathy and rhabdomyolysis|0|07.458906|1
00015565|acetaminophen toxicity and bleeding|acetaminophen toxicity and bleeding|0|17.965401|1
00015566|acetaminophen toxicity and excessive sedation|acetaminophen toxicity and excessive sedation|0|17.965402|1
00015567|opioid-induced respiratory depression and APAP toxicity|opioid-induced respiratory depression and acetaminophen toxicity|0|19.E9352F|1
00015568|opioid-induced respiratory depression and bleeding|opioid-induced respiratory depression and bleeding|0|19.E9352G|1
00015570|antipsychotic agent toxicity|antipsychotic agent toxicity|0|17.969300|1
00015571|opioid-CNS depressant-ind resp depress&acetaminophen tox|opioid-CNS depressant-induced respiratory depression and acetaminophen toxicity|0|19.E9352H|1
00015572|benzodiazepine-CNS depressant-ind respiratory depression|benzodiazepine-CNS depressant-induced respiratory depression|0|19.E93943|1
00015573|Amanita phalloides mushroom poisoning|Amanita phalloides mushroom poisoning|0|17.988101|1
00015574|cholestatic pruritus in patients with Alagille syndrome|cholestatic pruritus in patients with Alagille syndrome|0|09.576204|2
00015575|envenomation by Sydney funnel-web spider|envenomation by Sydney funnel-web spider|0|17.989520|1
00015576|HR-positive, HER2-negative early-stage breast cancer|hormone receptor (HR)-positive, HER2-negative early-stage breast cancer|0|02.17491A|2
00015577|recipient of hematopoietic stem cell transplant|recipient of hematopoietic stem cell transplant|0|08. 41008|2
00015578|hematologic malignancy|hematologic malignancy|0|02.202815|2
00015579|neutropenic sepsis|neutropenic sepsis|0|04.288018|1
00015580|DPP-4 inhibitor toxicity|DPP-4 inhibitor toxicity|0|99.999998|1
00015581|adverse reactions from redundant combination inhalers|adverse reactions from redundant combination inhalers|0|99.999999|0
00015582|antibiotic overuse|antibiotic overuse|0|99.999910|0
00015584|proton pump inhibitor overuse|proton pump inhibitor overuse|0|99.999911|0
00015585|lamotrigine toxicity|lamotrigine toxicity|0|17.966303|1
00015586|recipient of chimeric antigen receptor T-cell therapy|recipient of chimeric antigen receptor T-cell therapy|0|08. 41009|2
00015587|congenital athymia|congenital athymia|0|14.759201|2
00015588|QT prolongation and serotonin syndrome|QT prolongation and serotonin syndrome|0|07.42789B|1
00015589|rhegmatogenous retinal detachment|rhegmatogenous retinal detachment|0|06.361000|1
00015590|conjunctival bleb|conjunctival bleb|0|06.372901|1
00015591|allopurinol toxicity|allopurinol toxicity|0|17.97796A|1
00015592|UGT1A1 *28/*28 genotype|UGT1A1 *28/*28 genotype|0|03.277406|2
00015593|chronic phase Philadelphia chromosome (+) CML with T315I|chronic phase Philadelphia chromosome positive chronic myelocytic leukemia with T315I mutation|0|02.205112|2
00015594|childbearing age|childbearing age|0|15.779903|2
00015595|presbyopia|presbyopia|0|06.367400|2
00015596|acute inflammatory syndrome|acute inflammatory syndrome|0|17.995225|1
00015597|QT prolongation, respiratory depress and serotonin syd|QT prolongation and respiratory depression and serotonin syndrome|0|07.42789C|1
00015598|QT prolongation and respiratory depression|QT prolongation and respiratory depression|0|07.42789D|1
00015599|QT prolongation and bradycardia|QT prolongation and bradycardia|0|07.42789E|1
00015600|antipsychotic agent treatment failure|antipsychotic agent treatment failure|0|18.V87403|0
00015601|antibiotic treatment failure|antibiotic treatment failure|0|18.V87404|0
00015602|opioid treatment failure|opioid treatment failure|0|18.V87405|0
00015603|QT prolongation & antipsychotic agent treatment failure|QT prolongation and antipsychotic agent treatment failure|0|07.42789F|1
00015604|QT prolongation and antibiotic treatment failure|QT prolongation and antibiotic treatment failure|0|07.42789G|1
00015605|QT prolongation and opioid treatment failure|QT prolongation and opioid treatment failure|0|07.42789H|1
00015606|QT prolongation and bleeding|QT prolongation and bleeding|0|07.42789I|1
00015607|QT prolongation and neutropenia|QT prolongation and neutropenia|0|07.42789J|1
00015608|QT prolongation and bleeding and neutropenia|QT prolongation and bleeding and neutropenia|0|07.42789K|1
00015609|bleeding and serotonin syndrome|bleeding and serotonin syndrome|0|07.45900A|1
00015610|QT prolongation, bleeding and serotonin syndrome|QT prolongation, bleeding and serotonin syndrome|0|07.42789M|1
00015611|fetal developmental toxicity|fetal developmental toxicity|0|18.V22206|0
00015612|contraindicated due to fetal developmental toxicity|contraindicated due to fetal developmental toxicity|0|18.V22207|0
00015613|childbearing age: contraindicated in pregnancy|childbearing age: contraindicated in pregnancy|0|18.V22208|0
00015614|severe fetal developmental toxicity possible|severe fetal developmental toxicity possible|0|18.V22209|0
00015615|childbearing age: severe risk in pregnancy|childbearing age: severe risk in pregnancy|0|18.V22210|0
00015616|severe fetal developmental toxicity but with benefit|severe fetal developmental toxicity possible but with significant maternal treatment benefit|0|18.V22211|0
00015617|severe post-birth complications possible|severe post-birth complications possible|0|18.V22212|0
00015618|severe post-birth complications with benefit|severe post-birth complications possible but with significant maternal treatment benefit|0|18.V22213|0
00015619|unclear fetal developmental risk due to limited data|unclear fetal developmental risk due to limited or no human data|0|18.V22214|0
00015622|childbearing age: unclear risk in pregnancy|childbearing age: unclear risk in pregnancy|0|18.V22215|0
00015623|unclear fetal developmental risk with post birth compl|unclear fetal developmental risk but with post birth infant complications|0|18.V22216|0
00015624|bleeding and phenytoin toxicity|bleeding and phenytoin toxicity|0|07.45900B|1
00015625|clozapine toxicity|clozapine toxicity|0|17.969301|1
00015627|rhabdomyolysis and myopathy|rhabdomyolysis and myopathy|0|13.728892|1
00015628|corticosteroid toxicity and salmeterol toxicity|corticosteroid toxicity and salmeterol toxicity|0|17.975701|1
00015629|encorafenib toxicity|encorafenib toxicity|0|17.977800|1
00015630|nilotinib toxicity|nilotinib toxicity|0|17.977801|1
00015631|lapatinib toxicity|lapatinib toxicity|0|17.977802|1
00015632|dasatinib toxicity|dasatinib toxicity|0|17.977803|1
00015633|entrectinib toxicity|entrectinib toxicity|0|17.977804|1
00015634|crizotinib toxicity|crizotinib toxicity|0|17.977805|1
00015635|fexinidazole toxicity|fexinidazole toxicity|0|17.977806|1
00015636|ivosidenib toxicity|ivosidenib toxicity|0|17.977807|1
00015637|osilodrostat toxicity|osilodrostat toxicity|0|17.977808|1
00015638|encorafenib treatment failure|encorafenib treatment failure|0|18.V87406|0
00015640|crizotinib treatment failure|crizotinib treatment failure|0|18.V87407|0
00015641|fedratinib treatment failure|fedratinib treatment failure|0|18.V87408|0
00015642|tucatinib treatment failure|tucatinib treatment failure|0|18.V87409|0
00015643|azole antifungal treatment failure|azole antifungal treatment failure|0|18.V8740A|0
00015644|glasdegib treatment failure|glasdegib treatment failure|0|18.V8740B|0
00015645|selective serotonin reuptake inhibitor treatment failure|selective serotonin reuptake inhibitor treatment failure|0|18.V8740C|0
00015646|tuberculosis drug treatment failure|tuberculosis drug treatment failure|0|18.V8740D|0
00015647|entrectinib treatment failure|entrectinib treatment failure|0|18.V8740E|0
00015648|bosutinib toxicity|bosutinib toxicity|0|17.977809|1
00015649|QT prolongation and hepatotoxicity|QT prolongation and hepatotoxicity|0|07.42789L|1
00015651|QT prolongation and myelosuppression|QT prolongation and myelosuppression|0|07.42789N|1
00015652|antiparasitic treatment failure|antiparasitic treatment failure|0|18.V8740G|0
00015653|QT prolongation and glasdegib treatment failure|QT prolongation and glasdegib treatment failure|0|07.42789O|1
00015654|QT prolongation and crizotinib treatment failure|QT prolongation and crizotinib treatment failure|0|07.42789P|1
00015656|QT prolongation and encorafenib treatment failure|QT prolongation and encorafenib treatment failure|0|07.42789Q|1
00015657|QT prolongation and SSRI treatment failure|QT prolongation and selective serotonin reuptake inhibitor treatment failure|0|07.42789R|1
00015658|QT prolongation and tuberculosis drug treatment failure|QT prolongation and tuberculosis drug treatment failure|0|07.42789S|1
00015659|QT prolongation and antiparasitic treatment failure|QT prolongation and antiparasitic treatment failure|0|07.42789T|1
00015661|QT prolongation and entrectinib treatment failure|QT prolongation and entrectinib treatment failure|0|07.42789U|1
00015662|ivosidenib toxicity and tucatinib treatment failure|ivosidenib toxicity and tucatinib treatment failure|0|17.97780B|1
00015663|ivosidenib toxicity & azole antifungal treatment failure|ivosidenib toxicity and azole antifungal treatment failure|0|17.97780C|1
00015664|ivosidenib toxicity and fedratinib treatment failure|ivosidenib toxicity and fedratinib treatment failure|0|17.97780D|1
00015665|ivosidenib toxicity and crizotinib treatment failure|ivosidenib toxicity and crizotinib treatment failure|0|17.97780E|1
00015666|istradefylline treatment failure|istradefylline treatment failure|0|18.V8740H|0
00015667|ivosidenib toxicity and istradefylline treatment failure|ivosidenib toxicity and istradefylline treatment failure|0|17.97780G|1
00015668|history of thrombosis with thrombocytopenia syndrome|history of thrombosis with thrombocytopenia syndrome|0|07.45391A|2
00015669|application site rash|application site rash|0|16.782104|1
00015670|encephalomyelitis|encephalomyelitis|0|06.323904|1
00015671|injection site necrosis|injection site necrosis|0|17.999905|1
00015672|skin atrophy due to topical corticosteroid|skin atrophy due to topical corticosteroid|0|12.701805|1
00015674|growth failure due to achondroplasia|growth failure due to achondroplasia|0|16.783436|2
00015675|adverse reactions from redundant H2-receptor antagonists|adverse reactions from redundant H2-receptor antagonists|0|99.999912|0
00015676|adverse reactions of redundant second-gen antihistamines|adverse reactions from redundant second-generation antihistamines|0|99.999913|0
00015677|malignant perivascular epithelioid cell tumor|malignant perivascular epithelioid cell tumor|0|02.171907|2
00015678|QT prolong and opioid-CNS depressant-ind resp depression|QT prolongation and opioid-CNS depressant-induced respiratory depression|0|07.42789V|1
00015679|QT prolongation, bradycardia and immunosuppression|QT prolongation, bradycardia and immunosuppression|0|07.42789W|1
00015680|QT prolongation and anticholinergic toxicity|QT prolongation and anticholinergic toxicity|0|07.42789X|1
00015681|acetaminophen toxicity and anticholinergic toxicity|acetaminophen toxicity and anticholinergic toxicity|0|17.965403|1
00015682|acetaminophen toxicity and CNS depression|acetaminophen toxicity and CNS depression|0|17.965404|1
00015683|post-transplant cytomegalovirus infection|post-transplant cytomegalovirus infection|0|01.078506|1
00015684|application site skin reactions|application site skin reactions|0|16.782105|1
00015686|gastrointestinal adverse effects|gastrointestinal adverse effects|0|09.536903|1
00015687|COVID-19 pre-exposure prophylaxis (EUA)|COVID-19 pre-exposure prophylaxis (EUA)|0|01.079824|1
00015691|contraindicated in breastfeeding with known infant AE|contraindicated in breastfeeding with known infant adverse effects|0|18.V24101|0
00015692|contraindicated in breastfeeding with excretion & unk AE|contraindicated in breastfeeding with known breastmilk excretion and unclear infant effects|0|18.V24102|0
00015693|contraindicated in breastfeeding with unclear infant AE|contraindicated in breastfeeding with unclear infant adverse effects|0|18.V24103|0
00015694|contraindicated in breastfeeding due to HIV transmn risk|contraindicated in breastfeeding due to the risk of HIV transmission to the infant|0|18.V24104|0
00015695|contraindicated in breastfeeding, risk mitigation rec|contraindicated in breastfeeding but a mitigation action could minimize risk to the breastfed infant|0|18.V24105|0
00015718|precautions exist for breastfeeding with known infant AE|precautions exist for breastfeeding with known infant adverse effects|0|18.V24106|0
00015720|precautions exist for breastfeeding with reports of AE|precautions exist for breastfeeding with few reports of infant adverse effects|0|18.V24107|0
00015721|breastfeeding precautions with excretion and unknown AE|precautions exist for breastfeeding with known breastmilk excretion and unclear infant effects|0|18.V24108|0
00015722|precautions exist for breastfeeding with no known AE|precautions exist for breastfeeding with no known infant effects|0|18.V24109|0
00015723|breastfeeding precaution from uterine perf, no knwn AE|breastfeeding precautions exist due to uterine perforation risk but with no known infant effects|0|18.V2410A|0
00015724|breastfeeding precautions exist, unkwn excrtn & unkwn AE|precautions exist for breastfeeding with unknown breastmilk excretion and unclear infant effects|0|18.V2410B|0
00015725|QT prolongation and antipsychotic agent toxicity|QT prolongation and antipsychotic agent toxicity|0|07.42789Y|1
00015727|lonafarnib toxicity|lonafarnib toxicity|0|17.97780H|1
00015728|lapatinib toxicity and lonafarnib toxicity|lapatinib toxicity and lonafarnib toxicity|0|17.97780I|1
00015729|selpercatinib toxicity|selpercatinib toxicity|0|17.97780J|1
00015730|selpercatinib toxicity and lonafarnib toxicity|selpercatinib toxicity and lonafarnib toxicity|0|17.97780K|1
00015731|selpercatinib toxicity and berotralstat toxicity|selpercatinib toxicity and berotralstat toxicity|0|17.97780L|1
00015732|pazopanib toxicity|pazopanib toxicity|0|17.97780M|1
00015733|sunitinib toxicity|sunitinib toxicity|0|17.97780N|1
00015734|selpercatinib treatment failure|selpercatinib treatment failure|0|18.V8740F|0
00015776|QT prolongation and selpercatinib treatment failure|QT prolongation and selpercatinib treatment failure|0|07.42789Z|1
00015777|adverse reactions from elevated drug levels|adverse reactions from elevated drug levels|0|99.999914|1
00015778|myelosuppression and diarrhea|myelosuppression and diarrhea|0|04.28480A|1
00015779|hepatotoxicity and anemia|hepatotoxicity and anemia|0|09.573305|1
00015780|panobinostat toxicity|panobinostat toxicity|0|17.97780O|1
00015781|siponimod toxicity|siponimod toxicity|0|17.97780P|1
00015782|ozanimod toxicity|ozanimod toxicity|0|17.97780Q|1
00015783|ribociclib toxicity|ribociclib toxicity|0|17.97780R|1
00015784|conivaptan toxicity|conivaptan toxicity|0|17.97780S|1
00015785|ribociclib toxicity and conivaptan toxicity|ribociclib toxicity and conivaptan toxicity|0|17.97780T|1
00015786|pazopanib toxicity and lonafarnib toxicity|pazopanib toxicity and lonafarnib toxicity|0|17.97780U|1
00015787|futibatinib toxicity|futibatinib toxicity|0|17.97780V|1
00015788|sodium phenylbutyrate-taurursodiol toxicity|sodium phenylbutyrate-taurursodiol toxicity|0|17.97780W|1
00015789|adagrasib toxicity|adagrasib toxicity|0|17.97780X|1
00015790|lefamulin toxicity|lefamulin toxicity|0|17.97780Y|1
00015791|pralatrexate toxicity|pralatrexate toxicity|0|17.97780Z|1
00015792|lefamulin treatment failure|lefamulin treatment failure|0|18.V8740I|0
00015793|anticoagulant drug treatment failure|anticoagulant drug treatment failure|0|18.V8740J|0
00015794|HIV antiretroviral treatment failure|HIV antiretroviral treatment failure|0|18.V8740K|0
00015795|hepatitis C antiviral treatment failure|hepatitis C antiviral treatment failure|0|18.V8740L|0
00015796|corticosteroid treatment failure|corticosteroid treatment failure|0|18.V8740M|0
00015797|calcium channel blocker treatment failure|calcium channel blocker treatment failure|0|18.V8740N|0
00015798|pimavanserin treatment failure|pimavanserin treatment failure|0|18.V8740O|0
00015799|pitolisant treatment failure|pitolisant treatment failure|0|18.V8740P|0
00015800|romidepsin treatment failure|romidepsin treatment failure|0|18.V8740Q|0
00015801|benzodiazepine treatment failure|benzodiazepine treatment failure|0|18.V8740R|0
00015802|immunosuppressive drug treatment failure|immunosuppressive drug treatment failure|0|18.V8740S|1
00015803|siponimod treatment failure|siponimod treatment failure|0|18.V8740T|0
00015804|antiplatelet drug treatment failure|antiplatelet drug treatment failure|0|18.V8740U|0
00015805|phosphodiesterase-5 (PDE5) inhibitor treatment failure|phosphodiesterase-5 (PDE5) inhibitor treatment failure|0|18.V8740V|0
00015806|treatment failure due to drug binding|treatment failure due to drug binding|0|18.V8740W|0
00015807|treatment failure due to acid suppression|treatment failure due to acid suppression|0|18.V8740X|0
00015808|QT prolongation and lefamulin treatment failure|QT prolongation and lefamulin treatment failure|0|07.427910|1
00015809|QT prolongation and pimavanserin treatment failure|QT prolongation and pimavanserin treatment failure|0|07.427911|1
00015810|QT prolongation and pitolisant treatment failure|QT prolongation and pitolisant treatment failure|0|07.427912|1
00015811|QT prolongation and romidepsin treatment failure|QT prolongation and romidepsin treatment failure|0|07.427913|1
00015812|QT prolongation and siponimod treatment failure|QT prolongation and siponimod treatment failure|0|07.427914|1
00015813|abemaciclib treatment failure|abemaciclib treatment failure|0|18.V8740Y|0
00015814|acalabrutinib treatment failure|acalabrutinib treatment failure|0|18.V8740Z|0
00015815|afatinib treatment failure|afatinib treatment failure|0|18.V87410|0
00015816|amiodarone treatment failure|amiodarone treatment failure|0|18.V87411|0
00015817|dronedarone treatment failure|dronedarone treatment failure|0|18.V87412|0
00015818|apremilast treatment failure|apremilast treatment failure|0|18.V87413|0
00015819|roflumilast treatment failure|roflumilast treatment failure|0|18.V87414|0
00015820|aprepitant treatment failure|aprepitant treatment failure|0|18.V87415|0
00015821|avapritinib treatment failure|avapritinib treatment failure|0|18.V87417|0
00015822|avatrombopag treatment failure|avatrombopag treatment failure|0|18.V87418|0
00015823|belumosudil treatment failure|belumosudil treatment failure|0|18.V87419|0
00015824|netupitant treatment failure|netupitant treatment failure|0|18.V87416|0
00015825|bortezomib treatment failure|bortezomib treatment failure|0|18.V8741A|0
00015826|bosutinib treatment failure|bosutinib treatment failure|0|18.V8741B|0
00015827|brigatinib treatment failure|brigatinib treatment failure|0|18.V8741C|0
00015828|canagliflozin treatment failure|canagliflozin treatment failure|0|18.V8741D|0
00015829|capmatinib treatment failure|capmatinib treatment failure|0|18.V8741E|0
00015830|copanlisib treatment failure|copanlisib treatment failure|0|18.V8741F|0
00015831|darolutamide treatment failure|darolutamide treatment failure|0|18.V8741G|0
00015832|deferasirox treatment failure|deferasirox treatment failure|0|18.V8741H|0
00015833|duvelisib treatment failure|duvelisib treatment failure|0|18.V8741I|0
00015834|eliglustat treatment failure|eliglustat treatment failure|0|18.V8741J|0
00015835|enzalutamide treatment failure|enzalutamide treatment failure|0|18.V8741K|0
00015836|erdafitinib treatment failure|erdafitinib treatment failure|0|18.V8741L|0
00015837|exemestane treatment failure|exemestane treatment failure|0|18.V8741M|0
00015838|flibanserin treatment failure|flibanserin treatment failure|0|18.V8741N|0
00015839|fostamatinib treatment failure|fostamatinib treatment failure|0|18.V8741O|0
00015840|gilteritinib treatment failure|gilteritinib treatment failure|0|18.V8741P|0
00015841|tacrolimus toxicity|tacrolimus toxicity|0|17.97780A|1
00015842|butyrylcholinesterase|butyrylcholinesterase|0|03.27760A|0
00015843|BChE poor metabolizer|BChE poor metabolizer|0|03.27760B|2
00015844|BChE intermediate metabolizer|BChE intermediate metabolizer|0|03.27760C|2
00015845|cytochrome p450 CYP4F2|cytochrome p450 CYP4F2|0|03.27781F|0
00015846|CYP4F2 V433M variant carrier|CYP4F2 V433M variant carrier|0|03.27781G|2
00015847|AChR antibody positive generalized myasthenia gravis|anti-acetylcholine receptor (AChR) antibody positive generalized myasthenia gravis|0|06.358003|2
00015848|thrombosis prevention after Fontan procedure|thrombosis prevention after Fontan procedure|0|07.45391B|2
00015849|tizanidine toxicity|tizanidine toxicity|0|17.97780F|1
00015850|trazodone toxicity|trazodone toxicity|0|17.977810|1
00015851|ebastine toxicity|ebastine toxicity|0|17.977865|1
00015852|elvitegravir toxicity|elvitegravir toxicity|0|17.977866|1
00015853|alfentanil toxicity|alfentanil toxicity|0|17.977860|1
00015854|midazolam toxicity|midazolam toxicity|0|17.977867|1
00015855|alprazolam toxicity|alprazolam toxicity|0|17.977861|1
00015856|nisoldipine toxicity|nisoldipine toxicity|0|17.977868|1
00015857|paritaprevir toxicity|paritaprevir toxicity|0|17.977869|1
00015858|sirolimus toxicity|sirolimus toxicity|0|17.97781A|1
00015859|brotizolam toxicity|brotizolam toxicity|0|17.977862|1
00015860|ticagrelor toxicity|ticagrelor toxicity|0|17.97781B|1
00015861|triazolam toxicity|triazolam toxicity|0|17.97781C|1
00015862|budesonide toxicity|budesonide toxicity|0|17.977863|1
00015863|ulipristal toxicity|ulipristal toxicity|0|17.97781D|1
00015864|darifenacin toxicity|darifenacin toxicity|0|17.977864|1
00015865|cilostazol toxicity|cilostazol toxicity|0|17.97781E|1
00015866|tolterodine toxicity|tolterodine toxicity|0|17.97781F|1
00015867|aripiprazole toxicity|aripiprazole toxicity|0|17.97781G|1
00015868|abemaciclib toxicity|abemaciclib toxicity|0|17.97781H|1
00015869|acalabrutinib toxicity|acalabrutinib toxicity|0|17.97781I|1
00015870|alfuzosin toxicity|alfuzosin toxicity|0|17.97781J|1
00015871|silodosin toxicity|silodosin toxicity|0|17.97781K|1
00015872|tamsulosin toxicity|tamsulosin toxicity|0|17.97781L|1
00015873|atomoxetine toxicity|atomoxetine toxicity|0|17.97781M|1
00015874|vortioxetine toxicity|vortioxetine toxicity|0|17.97781N|1
00015875|pirtobrutinib toxicity|pirtobrutinib toxicity|0|17.97781O|1
00015876|avapritinib toxicity|avapritinib toxicity|0|17.97781P|1
00015877|avatrombopag toxicity|avatrombopag toxicity|0|17.97781Q|1
00015878|axitinib toxicity|axitinib toxicity|0|17.97781R|1
00015879|bedaquiline toxicity|bedaquiline toxicity|0|17.97781S|1
00015880|belinostat toxicity|belinostat toxicity|0|17.97781T|1
00015881|berotralstat toxicity|berotralstat toxicity|0|17.97781U|1
00015882|brexpiprazole toxicity|brexpiprazole toxicity|0|17.97781V|1
00015883|brigatinib toxicity|brigatinib toxicity|0|17.97781W|1
00015884|brincidofovir toxicity|brincidofovir toxicity|0|17.97781X|1
00015885|bromocriptine toxicity|bromocriptine toxicity|0|17.97781Y|1
00015886|cabergoline toxicity|cabergoline toxicity|0|17.97781Z|1
00015887|cabazitaxel toxicity|cabazitaxel toxicity|0|17.977820|1
00015888|eluxadoline toxicity|eluxadoline toxicity|0|17.97782P|1
00015889|enzalutamide toxicity|enzalutamide toxicity|0|17.97782Q|1
00015890|erlotinib toxicity|erlotinib toxicity|0|17.97782R|1
00015891|escitalopram toxicity|escitalopram toxicity|0|17.97782S|1
00015892|everolimus toxicity|everolimus toxicity|0|17.97782T|1
00015893|fedratinib toxicity|fedratinib toxicity|0|17.97782U|1
00015894|flibanserin toxicity|flibanserin toxicity|0|17.97782V|1
00015895|fostamatinib toxicity|fostamatinib toxicity|0|17.97782W|1
00015896|glasdegib toxicity|glasdegib toxicity|0|17.97782X|1
00015897|ibrexafungerp toxicity|ibrexafungerp toxicity|0|17.97782Y|1
00015898|ibrutinib toxicity|ibrutinib toxicity|0|17.97782Z|1
00015899|idelalisib toxicity|idelalisib toxicity|0|17.977830|1
00015900|infigratinib toxicity|infigratinib toxicity|0|17.977831|1
00015901|ivacaftor toxicity|ivacaftor toxicity|0|17.977832|1
00015902|ixabepilone toxicity|ixabepilone toxicity|0|17.977833|1
00015903|larotrectinib toxicity|larotrectinib toxicity|0|17.977834|1
00015904|lemborexant toxicity|lemborexant toxicity|0|17.977835|1
00015905|lomitapide toxicity|lomitapide toxicity|0|17.977836|1
00015906|lorlatinib toxicity|lorlatinib toxicity|0|17.977837|1
00015907|lumacaftor and ivacaftor toxicity|lumacaftor and ivacaftor toxicity|0|17.977838|1
00015908|ibrexafungerp treatment failure|ibrexafungerp treatment failure|0|18.V8741Q|0
00015909|ibrutinib treatment failure|ibrutinib treatment failure|0|18.V8741R|0
00015910|antifungal treatment failure|antifungal treatment failure|0|18.V8741S|0
00015911|ivabradine treatment failure|ivabradine treatment failure|0|18.V8741T|0
00015912|cystic fibrosis treatment failure|cystic fibrosis treatment failure|0|18.V8741U|0
00015913|lemborexant treatment failure|lemborexant treatment failure|0|18.V8741V|0
00015914|letermovir treatment failure|letermovir treatment failure|0|18.V8741W|0
00015915|lonafarnib treatment failure|lonafarnib treatment failure|0|18.V8741X|0
00015916|lumateperone treatment failure|lumateperone treatment failure|0|18.V8741Y|0
00015917|macimorelin treatment failure|macimorelin treatment failure|0|18.V8741Z|0
00015918|macitentan treatment failure|macitentan treatment failure|0|18.V87420|0
00015919|nintedanib treatment failure|nintedanib treatment failure|0|18.V87421|0
00015920|ozanimod treatment failure|ozanimod treatment failure|0|18.V87422|0
00015921|ranolazine treatment failure|ranolazine treatment failure|0|18.V87423|0
00015922|relugolix treatment failure|relugolix treatment failure|0|18.V87424|0
00015923|rimegepant treatment failure|rimegepant treatment failure|0|18.V87425|0
00015924|rolapitant treatment failure|rolapitant treatment failure|0|18.V87426|0
00015925|tofacitinib treatment failure|tofacitinib treatment failure|0|18.V87427|0
00015926|tolvaptan treatment failure|tolvaptan treatment failure|0|18.V87428|0
00015927|ubrogepant treatment failure|ubrogepant treatment failure|0|18.V87429|0
00015928|ulipristal treatment failure|ulipristal treatment failure|0|18.V8742A|0
00015929|upadacitinib treatment failure|upadacitinib treatment failure|0|18.V8742B|0
00015930|valbenazine treatment failure|valbenazine treatment failure|0|18.V87439|0
00015931|vilazodone treatment failure|vilazodone treatment failure|0|18.V8743A|0
00015932|voclosporin treatment failure|voclosporin treatment failure|0|18.V8743B|0
00015933|voxelotor treatment failure|voxelotor treatment failure|0|18.V8743C|0
00015934|proton pump inhibitor treatment failure|proton pump inhibitor treatment failure|0|18.V8743D|0
00015935|perampanel treatment failure|perampanel treatment failure|0|18.V8743E|0
00015936|guanfacine treatment failure|guanfacine treatment failure|0|18.V8743F|0
00015937|oxcarbazepine treatment failure|oxcarbazepine treatment failure|0|18.V8743G|0
00015938|naloxegol treatment failure|naloxegol treatment failure|0|18.V8743H|0
00015939|cannabidiol treatment failure|cannabidiol treatment failure|0|18.V8743I|0
00015940|linagliptin treatment failure|linagliptin treatment failure|0|18.V8743J|0
00015941|buspirone treatment failure|buspirone treatment failure|0|18.V8743K|0
00015942|insomnia agent treatment failure|insomnia agent treatment failure|0|18.V8743L|0
00015943|treatment failure due to decreased drug levels|treatment failure due to decreased drug levels|0|18.V8743M|0
00015944|BChE normal metabolizer|BChE normal metabolizer|0|03.27760D|2
00015945|BCHE ordered, result pending|BCHE ordered, result pending|0|03.27760E|0
00015946|BCHE no result on file, not currently ordered|BCHE no result on file, not currently ordered|0|03.27760F|0
00015947|lumateperone toxicity|lumateperone toxicity|0|17.977839|1
00015948|lurasidone toxicity|lurasidone toxicity|0|17.97783A|1
00015949|lurbinectedin toxicity|lurbinectedin toxicity|0|17.97783B|1
00015950|maraviroc toxicity|maraviroc toxicity|0|17.97783C|1
00015951|midostaurin toxicity|midostaurin toxicity|0|17.97783D|1
00015952|mifepristone toxicity|mifepristone toxicity|0|17.97783E|1
00015953|naldemedine toxicity|naldemedine toxicity|0|17.97783F|1
00015954|naloxegol toxicity|naloxegol toxicity|0|17.97783G|1
00015955|neratinib toxicity|neratinib toxicity|0|17.97783H|1
00015956|nintedanib toxicity|nintedanib toxicity|0|17.97783I|1
00015957|paclitaxel toxicity|paclitaxel toxicity|0|17.97783J|1
00015958|palbociclib toxicity|palbociclib toxicity|0|17.97783K|1
00015959|pemigatinib toxicity|pemigatinib toxicity|0|17.97783L|1
00015960|pexidartinib toxicity|pexidartinib toxicity|0|17.97783M|1
00015961|pirfenidone toxicity|pirfenidone toxicity|0|17.97783N|1
00015962|macitentan toxicity|macitentan toxicity|0|17.97783O|1
00015963|immunoglobulin A nephropathy|immunoglobulin A nephropathy|0|16.791002|3
00015964|pomalidomide toxicity|pomalidomide toxicity|0|17.97783P|1
00015965|ponatinib toxicity|ponatinib toxicity|0|17.97783Q|1
00015966|pralsetinib toxicity|pralsetinib toxicity|0|17.97783R|1
00015967|quetiapine toxicity|quetiapine toxicity|0|17.97783S|1
00015968|rasagiline toxicity|rasagiline toxicity|0|17.97783T|1
00015969|regorafenib toxicity|regorafenib toxicity|0|17.97783U|1
00015970|romidepsin toxicity|romidepsin toxicity|0|17.97783V|1
00015971|ruxolitinib toxicity|ruxolitinib toxicity|0|17.97783W|1
00015972|sacituzumab govitecan toxicity|sacituzumab govitecan toxicity|0|17.97783X|1
00015973|enthesitis-related juvenile idiopathic arthritis|enthesitis-related juvenile idiopathic arthritis|0|13.714305|2
00015974|QT prolongation and adrenocortical insufficiency|QT prolongation and adrenocortical insufficiency|0|07.427915|1
00015975|QT prolongation and cancer drug treatment failure|QT prolongation and cancer drug treatment failure|0|07.427916|1
00015976|tenofovir treatment failure|tenofovir treatment failure|0|18.V8742C|0
00015977|anticonvulsant drug treatment failure|anticonvulsant drug treatment failure|0|18.V8742D|0
00015978|HIV ARV tx failure & anticonvulsant treatment failure|HIV antiretroviral treatment failure and anticonvulsant drug treatment failure|0|18.V8742E|0
00015979|HIV ARV tx failure and tuberculosis drug tx failure|HIV antiretroviral treatment failure and tuberculosis drug treatment failure|0|18.V8742F|0
00015980|HIV antiretroviral treatment failure &rifabutin toxicity|HIV antiretroviral treatment failure and rifabutin toxicity|0|18.V8742G|0
00015981|cabozantinib toxicity|cabozantinib toxicity|0|17.977821|1
00015982|carbamazepine toxicity|carbamazepine toxicity|0|17.977822|1
00015983|rifabutin toxicity|rifabutin toxicity|0|17.97784U|1
00015984|rifapentine toxicity|rifapentine toxicity|0|17.97784V|1
00015985|levoketoconazole toxicity|levoketoconazole toxicity|0|17.97784W|1
00015986|mobocertinib toxicity|mobocertinib toxicity|0|17.97784X|1
00015987|HIV ARV treatment failure and rifapentine toxicity|HIV antiretroviral treatment failure and rifapentine toxicity|0|18.V8742H|0
00015988|HIV ARV treatment failure and carbamazepine toxicity|HIV antiretroviral treatment failure and carbamazepine toxicity|0|18.V8742I|0
00015989|opioid treatment failure and meperidine toxicity|opioid treatment failure and meperidine toxicity|0|18.V8742J|0
00015990|meperidine toxicity|meperidine toxicity|0|17.977850|1
00015991|antifungal treatment failure and rifabutin toxicity|antifungal treatment failure and rifabutin toxicity|0|18.V8742K|1
00015992|lefamulin treatment failure and carbamazepine toxicity|lefamulin treatment failure and carbamazepine toxicity|0|18.V8742L|0
00015993|selexipag toxicity|selexipag toxicity|0|17.97783Y|1
00015994|cariprazine toxicity|cariprazine toxicity|0|17.977823|1
00015995|selumetinib toxicity|selumetinib toxicity|0|17.97783Z|1
00015996|ceritinib toxicity|ceritinib toxicity|0|17.977824|1
00015997|citalopram toxicity|citalopram toxicity|0|17.977825|1
00015998|simeprevir toxicity|simeprevir toxicity|0|17.977840|1
00015999|cladribine toxicity|cladribine toxicity|0|17.977826|1
00016000|clobazam toxicity|clobazam toxicity|0|17.977827|1
00016001|clonazepam toxicity|clonazepam toxicity|0|17.977828|1
00016002|suvorexant toxicity|suvorexant toxicity|0|17.977841|1
00016003|cobimetinib toxicity|cobimetinib toxicity|0|17.977829|1
00016004|olaparib toxicity|olaparib toxicity|0|17.97782A|1
00016005|talazoparib toxicity|talazoparib toxicity|0|17.977842|1
00016006|sonidegib toxicity|sonidegib toxicity|0|17.97782B|1
00016007|tolvaptan toxicity|tolvaptan toxicity|0|17.97782C|1
00016008|copanlisib toxicity|copanlisib toxicity|0|17.97782D|1
00016009|dabrafenib toxicity|dabrafenib toxicity|0|17.97782E|1
00016010|dasabuvir toxicity|dasabuvir toxicity|0|17.97782F|1
00016011|deflazacort toxicity|deflazacort toxicity|0|17.97782G|1
00016012|tepotinib toxicity|tepotinib toxicity|0|17.977843|1
00016013|tofacitinib toxicity|tofacitinib toxicity|0|17.977844|1
00016014|docetaxel toxicity|docetaxel toxicity|0|17.97782H|1
00016015|doxorubicin toxicity|doxorubicin toxicity|0|17.97782I|1
00016016|duloxetine toxicity|duloxetine toxicity|0|17.97782J|1
00016017|duvelisib toxicity|duvelisib toxicity|0|17.97782K|1
00016018|elagolix toxicity|elagolix toxicity|0|17.97782L|1
00016019|elbasvir and grazoprevir toxicity|elbasvir and grazoprevir toxicity|0|17.97782M|1
00016020|triptan drug toxicity|triptan drug toxicity|0|17.97782N|1
00016021|elexacaftor, tezacaftor, and ivacaftor toxicity|elexacaftor, tezacaftor, and ivacaftor toxicity|0|17.97782O|1
00016022|zolpidem toxicity|zolpidem toxicity|0|17.97784N|1
00016023|methadone toxicity|methadone toxicity|0|17.97784O|1
00016024|metoprolol toxicity|metoprolol toxicity|0|17.97784P|1
00016025|nimodipine toxicity|nimodipine toxicity|0|17.97784Q|1
00016026|pioglitazone toxicity|pioglitazone toxicity|0|17.97784R|1
00016027|saxagliptin toxicity|saxagliptin toxicity|0|17.97784S|1
00016028|entrectinib toxicity and lonafarnib toxicity|entrectinib toxicity and lonafarnib toxicity|0|17.97784T|1
00016029|nonsteroidal anti-inflammatory drug (NSAID) toxicity|nonsteroidal anti-inflammatory drug (NSAID) toxicity|0|17.97784Y|1
00016030|rimegepant toxicity|rimegepant toxicity|0|17.97784Z|1
00016031|riociguat toxicity|riociguat toxicity|0|17.977851|1
00016032|levoketoconazole toxicity and lonafarnib toxicity|levoketoconazole toxicity and lonafarnib toxicity|0|17.977852|1
00016033|levoketoconazole toxicity and mifepristone toxicity|levoketoconazole toxicity and mifepristone toxicity|0|17.977853|1
00016034|lefamulin toxicity and conivaptan toxicity|lefamulin toxicity and conivaptan toxicity|0|17.977811|1
00016035|lefamulin toxicity and indinavir toxicity|lefamulin toxicity and indinavir toxicity|0|17.977812|1
00016036|indinavir toxicity|indinavir toxicity|0|17.97785B|1
00016037|lefamulin toxicity and lopinavir toxicity|lefamulin toxicity and lopinavir toxicity|0|17.977813|1
00016038|lopinavir toxicity|lopinavir toxicity|0|17.97785C|1
00016039|lefamulin toxicity and asunaprevir toxicity|lefamulin toxicity and asunaprevir toxicity|0|17.977814|1
00016040|asunaprevir toxicity|asunaprevir toxicity|0|17.97785D|1
00016041|lefamulin toxicity and felodipine toxicity|lefamulin toxicity and felodipine toxicity|0|17.977815|1
00016042|felodipine toxicity|felodipine toxicity|0|17.97785E|1
00016043|lefamulin toxicity and ivacaftor toxicity|lefamulin toxicity and ivacaftor toxicity|0|17.977816|1
00016044|lefamulin toxicity and neratinib toxicity|lefamulin toxicity and neratinib toxicity|0|17.977817|1
00016045|lefamulin toxicity and dronedarone toxicity|lefamulin toxicity and dronedarone toxicity|0|17.977818|1
00016046|dronedarone toxicity|dronedarone toxicity|0|17.97785F|1
00016047|trabectedin toxicity|trabectedin toxicity|0|17.977845|1
00016048|trastuzumab toxicity|trastuzumab toxicity|0|17.977846|1
00016049|tucatinib toxicity|tucatinib toxicity|0|17.977847|1
00016050|ubrogepant toxicity|ubrogepant toxicity|0|17.977848|1
00016051|vemurafenib toxicity|vemurafenib toxicity|0|17.977849|1
00016052|lefamulin toxicity and saquinavir toxicity|lefamulin toxicity and saquinavir toxicity|0|17.977819|1
00016053|saquinavir toxicity|saquinavir toxicity|0|17.97785G|1
00016054|lefamulin toxicity and tacrolimus toxicity|lefamulin toxicity and tacrolimus toxicity|0|17.977854|1
00016055|lefamulin toxicity and aprepitant toxicity|lefamulin toxicity and aprepitant toxicity|0|17.977855|1
00016056|aprepitant toxicity|aprepitant toxicity|0|17.97785H|1
00016057|lefamulin toxicity and atazanavir toxicity|lefamulin toxicity and atazanavir toxicity|0|17.977856|1
00016058|atazanavir toxicity|atazanavir toxicity|0|17.97785I|1
00016059|lefamulin toxicity and darunavir toxicity|lefamulin toxicity and darunavir toxicity|0|17.977857|1
00016060|darunavir toxicity|darunavir toxicity|0|17.97785J|1
00016061|lefamulin toxicity and diltiazem toxicity|lefamulin toxicity and diltiazem toxicity|0|17.977858|1
00016062|diltiazem toxicity|diltiazem toxicity|0|17.97785K|1
00016063|lefamulin toxicity and isavuconazonium toxicity|lefamulin toxicity and isavuconazonium toxicity|0|17.977859|1
00016064|isavuconazonium toxicity|isavuconazonium toxicity|0|17.97785L|1
00016065|lefamulin toxicity and verapamil toxicity|lefamulin toxicity and verapamil toxicity|0|17.97785A|1
00016066|verapamil toxicity|verapamil toxicity|0|17.97785M|1
00016067|barbiturate toxicity|barbiturate toxicity|0|17.97785N|1
00016068|busulfan toxicity|busulfan toxicity|0|17.97785O|1
00016069|gefitinib toxicity|gefitinib toxicity|0|17.97785P|1
00016070|imatinib toxicity|imatinib toxicity|0|17.97785Q|1
00016071|vindesine toxicity|vindesine toxicity|0|17.97785R|1
00016072|vinorelbine toxicity|vinorelbine toxicity|0|17.97785S|1
00016073|vincristine toxicity|vincristine toxicity|0|17.97785T|1
00016074|daridorexant toxicity|daridorexant toxicity|0|17.97785U|1
00016075|temsirolimus toxicity|temsirolimus toxicity|0|17.97785V|1
00016076|rifamycin treatment failure|rifamycin treatment failure|0|18.V8742M|0
00016077|Sezary disease|Sezary disease|0|02.202200|2
00016078|sloughing of tissue at mucosal lesion|sloughing of tissue at mucosal lesion|0|17.959801|1
00016079|valbenazine toxicity|valbenazine toxicity|0|17.97785W|1
00016080|toremifene toxicity|toremifene toxicity|0|17.97785X|1
00016081|antiemetic drug treatment failure|antiemetic drug treatment failure|0|18.V8742R|0
00016082|antifungal treatment failure and phenytoin toxicity|antifungal treatment failure and phenytoin toxicity|0|18.V8742N|1
00016083|antifungal tx failure and rifamycin treatment failure|antifungal treatment failure and rifamycin treatment failure|0|18.V8742O|1
00016084|antifungal treatment failure and carbamazepine toxicity|antifungal treatment failure and carbamazepine toxicity|0|18.V8742P|1
00016085|antifungal treatment failure and barbiturate toxicity|antifungal treatment failure and barbiturate toxicity|0|18.V8742Q|1
00016086|QT prolongation and levoketoconazole tx failure|QT prolongation and levoketoconazole treatment failure|0|07.427917|1
00016087|pimozide toxicity|pimozide toxicity|0|17.97785Y|1
00016088|unpredictable phenytoin response|unpredictable phenytoin response|0|18.V8742S|0
00016089|venetoclax toxicity|venetoclax toxicity|0|17.97784A|1
00016090|vinblastine toxicity|vinblastine toxicity|0|17.97784B|1
00016091|voclosporin toxicity|voclosporin toxicity|0|17.97784C|1
00016092|zanubrutinib toxicity|zanubrutinib toxicity|0|17.97784D|1
00016093|afatinib toxicity|afatinib toxicity|0|17.97784E|1
00016094|buspirone toxicity|buspirone toxicity|0|17.97784F|1
00016095|cinacalcet toxicity|cinacalcet toxicity|0|17.97784G|0
00016096|dapoxetine toxicity|dapoxetine toxicity|0|17.97784H|1
00016097|levomilnacipran toxicity|levomilnacipran toxicity|0|17.97784I|1
00016098|vilazodone toxicity|vilazodone toxicity|0|17.97784J|1
00016099|darolutamide toxicity|darolutamide toxicity|0|17.97784K|1
00016100|eszopiclone toxicity|eszopiclone toxicity|0|17.97784L|1
00016101|zopiclone toxicity|zopiclone toxicity|0|17.97784M|1
00016102|precautions exist for breastfeeding, excrt, no knw AE|precautions exist for breastfeeding with known excretion and no known effects in breastfed infant|0|18.V2410C|0
00016103|gabapentin treatment failure|gabapentin treatment failure|0|18.V8742T|0
00016104|eltrombopag treatment failure|eltrombopag treatment failure|0|18.V8742U|0
00016105|deferiprone treatment failure|deferiprone treatment failure|0|18.V8742V|0
00016106|riociguat treatment failure|riociguat treatment failure|0|18.V8742W|0
00016107|bisphosphonate treatment failure|bisphosphonate treatment failure|0|18.V8742Y|0
00016108|antimalarial treatment failure|antimalarial treatment failure|0|18.V8742Z|0
00016109|hydroxychloroquine treatment failure|hydroxychloroquine treatment failure|0|18.V87430|0
00016110|digoxin treatment failure|digoxin treatment failure|0|18.V87431|0
00016111|quinidine treatment failure|quinidine treatment failure|0|18.V87432|0
00016112|thyroid hormone treatment failure|thyroid hormone treatment failure|0|18.V8742X|0
00016113|thioridazine toxicity|thioridazine toxicity|0|17.97785Z|1
00016114|ivosidenib toxicity and voxelotor treatment failure|ivosidenib toxicity and voxelotor treatment failure|0|17.97786A|1
00016115|hypersensitivity to COVID-19 vaccine|hypersensitivity to COVID-19 vaccine|0|17.99520A|0
00016116|exposure to COVID-19|exposure to COVID-19|0|01.079825|1
00016117|contraindicated in pregnancy no tx rationale|contraindicated in pregnancy due to lack of treatment rationale|0|18.V22217|0
00016118|levoketoconazole toxicity and idelalisib toxicity|levoketoconazole toxicity and idelalisib toxicity|0|17.97786B|1
00016119|abrocitinib toxicity|abrocitinib toxicity|0|17.97786C|1
00016120|tricyclic antidepressant toxicity|tricyclic antidepressant toxicity|0|17.97786D|1
00016121|thioridazine toxicity &antiemetic drug treatment failure|thioridazine toxicity and antiemetic drug treatment failure|0|17.97786E|1
00016122|serotonin syndrome and tricyclic antidepressant toxicity|serotonin syndrome and tricyclic antidepressant toxicity|0|06.333994|1
00016123|hyperthermia|hyperthermia|0|17.995862|1
00016124|uveal melanoma in HLA-A *02:01 positive patient|uveal melanoma in HLA-A *02:01 positive patient|0|02.172909|2
00016125|abrocitinib treatment failure|abrocitinib treatment failure|0|18.V87433|0
00016126|ACE inhibitor treatment failure|angiotensin-converting enzyme (ACE) inhibitor treatment failure|0|18.V87434|0
00016127|angiotensin II receptor blocker (ARB) treatment failure|angiotensin II receptor blocker (ARB) treatment failure|0|18.V87435|0
00016128|beta blocker treatment failure|beta blocker treatment failure|0|18.V87436|0
00016129|diabetes treatment failure|diabetes treatment failure|0|18.V87437|0
00016130|penicillamine treatment failure|penicillamine treatment failure|0|18.V87438|0
00016131|nefazodone toxicity|nefazodone toxicity|0|17.97786F|1
00016132|mirtazapine toxicity|mirtazapine toxicity|0|17.97786G|1
00016133|selective serotonin reuptake inhibitor toxicity|selective serotonin reuptake inhibitor toxicity|0|17.97786T|1
00016134|stiripentol toxicity|stiripentol toxicity|0|17.97786H|1
00016135|amiodarone toxicity|amiodarone toxicity|0|17.97786I|1
00016136|chlorpromazine toxicity|chlorpromazine toxicity|0|17.97786J|1
00016137|pegvaliase toxicity|pegvaliase toxicity|0|17.97786K|1
00016138|fluphenazine toxicity|fluphenazine toxicity|0|17.97786L|1
00016139|haloperidol toxicity|haloperidol toxicity|0|17.97786M|1
00016140|levomepromazine toxicity|levomepromazine toxicity|0|17.97786N|1
00016141|perphenazine toxicity|perphenazine toxicity|0|17.97786O|1
00016142|prochlorperazine toxicity|prochlorperazine toxicity|0|17.97786P|1
00016143|tesamorelin toxicity|tesamorelin toxicity|0|17.97786Q|1
00016144|promethazine toxicity|promethazine toxicity|0|17.97786R|1
00016145|risperidone toxicity|risperidone toxicity|0|17.97786S|1
00016146|venlafaxine toxicity|venlafaxine toxicity|0|17.97786U|1
00016147|rilpivirine toxicity|rilpivirine toxicity|0|17.97786V|1
00016148|rivoceranib toxicity|rivoceranib toxicity|0|17.97786W|1
00016149|cyclobenzaprine toxicity|cyclobenzaprine toxicity|0|17.97786X|1
00016150|carbamazepine toxicity and voxelotor treatment failure|carbamazepine toxicity and voxelotor treatment failure|0|17.97786Y|1
00016151|phenytoin toxicity and cancer drug treatment failure|phenytoin toxicity and cancer drug treatment failure|0|17.97786Z|1
00016152|phenytoin toxicity and amiodarone treatment failure|phenytoin toxicity and amiodarone treatment failure|0|17.977870|1
00016153|unpredictable response to drug|unpredictable response to drug|0|18.V8743N|0
00016154|unpredictable anticoagulant response|unpredictable anticoagulant response|0|18.V8743O|0
00016155|variable hormonal contraceptive effectiveness|variable hormonal contraceptive effectiveness|0|18.V8743P|0
00016158|corticosteroid tx fail &unpredictable phenytoin response|corticosteroid treatment failure and unpredictable phenytoin response|0|18.V8743Q|1
00016159|HIV ARV tx failure and unpredictable phenytoin response|HIV antiretroviral treatment failure and unpredictable phenytoin response|0|18.V8743R|1
00016160|mexiletine treatment failure|mexiletine treatment failure|0|18.V8743S|0
00016161|enzalutamide tx failure and phenytoin treatment failure|enzalutamide tx failure and phenytoin treatment failure|0|18.V8743T|1
00016162|hydantoin treatment failure|hydantoin treatment failure|0|18.V8743U|0
00016163|multiple sclerosis treatment failure|multiple sclerosis treatment failure|0|18.V8743V|0
00016164|theophylline treatment failure|theophylline treatment failure|0|18.V8743W|0
00016165|antiarrhythmic treatment failure|antiarrhythmic treatment failure|0|18.V8743X|0
00016166|phosphodiesterase type 5 (PDE5) inhibitor toxicity|phosphodiesterase type 5 (PDE5) inhibitor toxicity|0|17.977871|1
00016167|disulfiram-ethanol reaction|disulfiram-ethanol reaction|0|17.977872|1
00016168|nephrotoxicity and ACE inhibitor treatment failure|nephrotoxicity and angiotensin-converting enzyme (ACE) inhibitor treatment failure|0|10.583903|1
00016169|nephrotoxicity and ARB treatment failure|nephrotoxicity and angiotensin II receptor blocker (ARB) treatment failure|0|10.583904|1
00016170|serotonin syndrome and hypertension|serotonin syndrome and hypertension|0|06.333995|1
00016171|serotonin syndrome and seizure|serotonin syndrome and seizure|0|06.333996|1
00016172|serotonin syndrome and SSRI treatment failure|serotonin syndrome and selective serotonin reuptake inhibitor treatment failure|0|06.333997|1
00016173|rhabdomyolysis, myopathy and digoxin toxicity|rhabdomyolysis, myopathy and digoxin toxicity|0|13.728893|1
00016174|inaccurate diagnostic testing|inaccurate diagnostic testing|0|16. 9999Y|0
00016175|bleeding prevention in von Willebrand disease type 3|bleeding prevention in von Willebrand disease type 3|0|04.286403|2
00016176|reduce blood transfusions in cold agglutinin diease|reduction of blood transfusions in cold agglutinin disease|0|04.283001|2
00016177|azathioprine toxicity|azathioprine toxicity|0|17.977873|1
00016178|mercaptopurine toxicity|mercaptopurine toxicity|0|17.977874|1
00016179|fluorouracil toxicity|fluorouracil toxicity|0|17.977875|1
00016180|irinotecan toxicity|irinotecan toxicity|0|17.977876|1
00016181|pemetrexed toxicity|pemetrexed toxicity|0|17.977877|1
00016182|bexarotene toxicity|bexarotene toxicity|0|17.977878|1
00016183|quinidine toxicity|quinidine toxicity|0|17.977879|1
00016184|tacrolimus toxicity and lonafarnib toxicity|tacrolimus toxicity and lonafarnib toxicity|0|17.97787A|1
00016185|everolimus toxicity and lonafarnib toxicity|everolimus toxicity and lonafarnib toxicity|0|17.97787B|1
00016186|letermovir toxicity|letermovir toxicity|0|17.97787C|1
00016187|cyclosporine toxicity and letermovir toxicity|cyclosporine toxicity and letermovir toxicity|0|17.97787D|1
00016188|cyclosporine toxicity|cyclosporine toxicity|0|17.97787U|1
00016189|ambrisentan toxicity|ambrisentan toxicity|0|17.97787E|1
00016190|daclatasvir toxicity|daclatasvir toxicity|0|17.97787N|1
00016191|avacopan toxicity|avacopan toxicity|0|17.97787S|1
00016192|thiazolidinedione toxicity|thiazolidinedione toxicity|0|17.97787T|1
00016193|eplerenone toxicity|eplerenone toxicity|0|17.97787V|1
00016194|larotrectinib toxicity and lonafarnib toxicity|larotrectinib toxicity and lonafarnib toxicity|0|17.97787F|1
00016195|osilodrostat toxicity and lonafarnib toxicity|osilodrostat toxicity and lonafarnib toxicity|0|17.97787G|1
00016196|daclatasvir toxicity and lonafarnib toxicity|daclatasvir toxicity and lonafarnib toxicity|0|17.97787H|1
00016197|rimegepant toxicity and lonafarnib toxicity|rimegepant toxicity and lonafarnib toxicity|0|17.97787I|1
00016198|fostamatinib toxicity and lonafarnib toxicity|fostamatinib toxicity and lonafarnib toxicity|0|17.97787J|1
00016199|lumateperone toxicity and lonafarnib toxicity|lumateperone toxicity and lonafarnib toxicity|0|17.97787K|1
00016200|ivacaftor toxicity and lonafarnib toxicity|ivacaftor toxicity and lonafarnib toxicity|0|17.97787L|1
00016201|cilostazol toxicity and lonafarnib toxicity|cilostazol toxicity and lonafarnib toxicity|0|17.97787M|1
00016202|suvorexant toxicity and lonafarnib toxicity|suvorexant toxicity and lonafarnib toxicity|0|17.97787O|1
00016203|olaparib toxicity and lonafarnib toxicity|olaparib toxicity and lonafarnib toxicity|0|17.97787P|1
00016208|palbociclib toxicity and lonafarnib toxicity|palbociclib toxicity and lonafarnib toxicity|0|17.97787Q|1
00016209|avacopan toxicity and lonafarnib toxicity|avacopan toxicity and lonafarnib toxicity|0|17.97787R|1
00016210|mifepristone toxicity and idelalisib toxicity|mifepristone toxicity and idelalisib toxicity|0|17.97787W|1
00016211|apalutamide toxicity|apalutamide toxicity|0|17.97787X|1
00016212|topiramate toxicity|topiramate toxicity|0|17.97787Y|1
00016213|yohimbine toxicity|yohimbine toxicity|0|17.977880|1
00016214|carbamazepine toxicity and lefamulin treatment failure|carbamazepine toxicity and lefamulin treatment failure|0|17.97787Z|1
00016215|hormonal contraception failure&anticonvulsant tx failure|hormonal contraception failure and anticonvulsant drug treatment failure|0|18.V8743Y|1
00016216|samidorphan treatment failure|samidorphan treatment failure|0|18.V8743Z|0
00016217|finerenone treatment failure|finerenone treatment failure|0|18.V87440|0
00016218|avacopan treatment failure|avacopan treatment failure|0|18.V87441|0
00016219|berotralstat treatment failure|berotralstat treatment failure|0|18.V87442|0
00016220|antibiotic treatment failure and phenytoin toxicity|antibiotic treatment failure and phenytoin toxicity|0|18.V87443|1
00016221|naldemedine treatment failure|naldemedine treatment failure|0|18.V87444|0
00016222|ospemifene treatment failure|ospemifene treatment failure|0|18.V87445|0
00016223|HIV antiretroviral tx fail & hormonal contraception fail|HIV antiretroviral treatment failure and hormonal contraception failure|0|18.V87446|1
00016224|fesoterodine treatment failure|fesoterodine treatment failure|0|18.V87447|0
00016225|leflunomide treatment failure|leflunomide treatment failure|0|18.V87448|0
00016226|bupropion treatment failure|bupropion treatment failure|0|18.V87449|0
00016227|HIV antiretroviral treatment failure and apalutamide tox|HIV antiretroviral treatment failure and apalutamide toxicity|0|18.V8744A|1
00016228|elagolix treatment failure|elagolix treatment failure|0|18.V8744B|0
00016229|atogepant treatment failure|atogepant treatment failure|0|18.V8744C|0
00016230|beta-2 agonist treatment failure|beta-2 agonist treatment failure|0|18.V8744E|0
00016231|beta-2 agonist tx failure and beta blocker tx failure|beta-2 agonist treatment failure and beta blocker treatment failure|0|18.V8744D|1
00016232|antiparkinson drug treatment failure|antiparkinson drug treatment failure|0|18.V8744F|0
00016233|antiparkinson tx failure and antipsychotic tx failure|antiparkinson drug treatment failure and antipsychotic agent treatment failure|0|18.V8744G|1
00016234|sympathomimetic drug treatment failure|sympathomimetic drug treatment failure|0|18.V8744H|0
00016235|QT prolongation and antimalarial treatment failure|QT prolongation and antimalarial treatment failure|0|07.427918|1
00016236|QT prolongation and HIV antiretroviral treatment failure|QT prolongation and HIV antiretroviral treatment failure|0|07.427919|1
00016237|finerenone toxicity|finerenone toxicity|0|17.977881|1
00016238|opioid treatment failure and antiemetic drug tx failure|opioid treatment failure and antiemetic drug treatment failure|0|18.V8744I|1
00016239|ivacaftor toxicity and berotralstat toxicity|ivacaftor toxicity and berotralstat toxicity|0|17.977882|1
00016240|ivacaftor toxicity and cancer drug treatment failure|ivacaftor toxicity and cancer drug treatment failure|0|17.977883|1
00016241|ivacaftor toxicity and antibiotic treatment failure|ivacaftor toxicity and antibiotic treatment failure|0|17.977884|1
00016242|ivacaftor toxicity and conivaptan treatment failure|ivacaftor toxicity and conivaptan treatment failure|0|17.977885|1
00016243|ivacaftor toxicity &HIV antiretroviral treatment failure|ivacaftor toxicity and HIV antiretroviral treatment failure|0|17.977886|1
00016244|ivacaftor toxicity and antifungal treatment failure|ivacaftor toxicity and antifungal treatment failure|0|17.977887|1
00016245|ivacaftor toxicity and nefazodone treatment failure|ivacaftor toxicity and nefazodone treatment failure|0|17.977888|1
00016246|ivacaftor toxicity and antiviral treatment failure|ivacaftor toxicity and antiviral treatment failure|0|17.977889|1
00016247|mitapivat toxicity|mitapivat toxicity|0|17.97788A|1
00016248|metoclopramide toxicity|metoclopramide toxicity|0|17.97788D|1
00016249|relugolix toxicity|relugolix toxicity|0|17.97788G|1
00016250|melatonin toxicity|melatonin toxicity|0|17.97788I|1
00016251|phenytoin toxicity and anticonvulsant treatment failure|phenytoin toxicity and anticonvulsant treatment failure|0|17.97788B|1
00016252|barbiturate toxicity & anticonvulsant treatment failure|barbiturate toxicity and anticonvulsant drug treatment failure|0|17.97788C|1
00016253|mitapivat toxicity and cancer drug treatment failure|mitapivat toxicity and cancer drug treatment failure|0|17.97788E|1
00016254|mitapivat toxicity and lonafarnib treatment failure|mitapivat toxicity and lonafarnib treatment failure|0|17.97788F|1
00016255|carbamazepine toxicity and PPI treatment failure|carbamazepine toxicity and proton pump inhibitor treatment failure|0|17.97788H|1
00016256|cisplatin toxicity|cisplatin toxicity|0|17.97788J|1
00016257|clofarabine toxicity|clofarabine toxicity|0|17.97788K|1
00016258|deutetrabenazine toxicity|deutetrabenazine toxicity|0|17.97788L|1
00016259|flecainide toxicity|flecainide toxicity|0|17.97788M|1
00016260|propafenone toxicity|propafenone toxicity|0|17.97788N|1
00016261|tetrabenazine toxicity|tetrabenazine toxicity|0|17.97788O|1
00016262|carbamazepine toxicity &anticonvulsant treatment failure|carbamazepine toxicity and anticonvulsant drug treatment failure|0|17.97788P|1
00016263|conivaptan treatment failure|conivaptan treatment failure|0|18.V8744O|0
00016264|nefazodone treatment failure|nefazodone treatment failure|0|18.V8744P|0
00016265|antiviral treatment failure|antiviral treatment failure|0|18.V8744Q|0
00016266|mitapivat treatment failure|mitapivat treatment failure|0|18.V8744R|0
00016267|mitapivat treatment failure and cancer treatment failure|mitapivat treatment failure and cancer drug treatment failure|0|18.V8744T|1
00016268|mitapivat tx failure and enzalutamide treatment failure|mitapivat treatment failure and enzalutamide treatment failure|0|18.V8744U|1
00016269|SLCO1B1 increased function|SLCO1B1 increased function|0|03.27782C|2
00016270|SLCO1B1 possible decreased function|SLCO1B1 possible decreased function|0|03.27782D|2
00016271|SLCO1B1 decreased function|SLCO1B1 decreased function|0|03.27782E|2
00016272|SLCO1B1 poor function|SLCO1B1 poor function|0|03.27782F|2
00016273|SLCO1B1 indeterminate|SLCO1B1 indeterminate|0|03.27782G|2
00016274|ABCG2 normal function|ABCG2 normal function|0|03.27780V|2
00016275|ABCG2 decreased function|ABCG2 decreased function|0|03.27780W|2
00016276|ABCG2 poor function|ABCG2 poor function|0|03.27780X|2
00016277|ABCG2 no result on file, not currently ordered|ABCG2 no result on file, not currently ordered|0|03.27780Y|0
00016278|ABCG2 ordered, result pending|ABCG2 ordered, result pending|0|03.27780Z|0
00016279|PGX combination 70|PGX combination 70|0|00.000070|0
00016280|PGX combination 71|PGX combination 71|0|00.000071|0
00016281|PGX combination 72|PGX combination 72|0|00.000072|0
00016282|PGX combination 73|PGX combination 73|0|00.000073|0
00016283|PGX combination 74|PGX combination 74|0|00.000074|0
00016284|PGX combination 75|PGX combination 75|0|00.000075|0
00016285|PGX combination 76|PGX combination 76|0|00.000076|0
00016286|PGX combination 77|PGX combination 77|0|00.000077|0
00016287|PGX combination 78|PGX combination 78|0|00.000078|0
00016288|PGX combination 79|PGX combination 79|0|00.000079|0
00016289|PGX combination 80|PGX combination 80|0|00.000080|0
00016290|PGX combination 81|PGX combination 81|0|00.000081|0
00016291|PGX combination 82|PGX combination 82|0|00.000082|0
00016292|PGX combination 83|PGX combination 83|0|00.000083|0
00016293|PGX combination 84|PGX combination 84|0|00.000084|0
00016294|PGX combination 85|PGX combination 85|0|00.000085|0
00016295|PGX combination 86|PGX combination 86|0|00.000086|0
00016296|PGX combination 87|PGX combination 87|0|00.000087|0
00016297|PGX combination 88|PGX combination 88|0|00.000088|0
00016298|PGX combination 89|PGX combination 89|0|00.000089|0
00016299|PGX combination 90|PGX combination 90|0|00.000090|0
00016300|PGX combination 91|PGX combination 91|0|00.000091|0
00016301|PGX combination 92|PGX combination 92|0|00.000092|0
00016302|PGX combination 93|PGX combination 93|0|00.000093|0
00016303|PGX combination 94|PGX combination 94|0|00.000094|0
00016304|PGX combination 95|PGX combination 95|0|00.000095|0
00016305|PGX combination 96|PGX combination 96|0|00.000096|0
00016306|PGX combination 97|PGX combination 97|0|00.000097|0
00016307|PGX combination 98|PGX combination 98|0|00.000098|0
00016308|PGX combination 99|PGX combination 99|0|00.000099|0
00016309|prevention of venous thromboembolism recurrence|prevention of venous thromboembolism recurrence|0|07.45391C|3
00016310|lymphatic filariasis|lymphatic filariasis|0|01.125001|1
00016311|ropinirole toxicity|ropinirole toxicity|0|17.97788Q|1
00016312|tenofovir toxicity|tenofovir toxicity|0|17.97788R|1
00016313|guanfacine toxicity|guanfacine toxicity|0|17.97788S|1
00016314|memantine toxicity|memantine toxicity|0|17.97788T|1
00016315|amantadine toxicity|amantadine toxicity|0|17.97788U|1
00016316|ivacaftor tx failure and cancer drug treatment failure|ivacaftor treatment failure and cancer drug treatment failure|0|18.V8744J|1
00016317|carbamazepine tx failure &theophylline treatment failure|carbamazepine treatment failure and theophylline treatment failure|0|18.V87453|1
00016318|stimulant drug treatment failure|stimulant drug treatment failure|0|18.V8744K|0
00016319|chenodiol treatment failure|chenodiol treatment failure|0|18.V8744L|0
00016320|cholic acid treatment failure|cholic acid treatment failure|0|18.V8744M|0
00016321|mesalamine treatment failure|mesalamine treatment failure|0|18.V8744N|0
00016322|aliskiren treatment failure|aliskiren treatment failure|0|18.V8744S|0
00016323|dopamine agonist treatment failure|dopamine agonist treatment failure|0|18.V8744V|0
00016324|cholinesterase inhibitor treatment failure|cholinesterase inhibitor treatment failure|0|18.V8744W|0
00016325|nitrate vasodilator drug treatment failure|nitrate vasodilator drug treatment failure|0|18.V8744Z|0
00016326|aromatase inhibitor treatment failure|aromatase inhibitor treatment failure|0|18.V87450|0
00016327|carbamazepine treatment failure|carbamazepine treatment failure|0|18.V87451|0
00016328|carbonic anhydrase inhibitor drug treatment failure|carbonic anhydrase inhibitor drug treatment failure|0|18.V87452|0
00016329|serotonin syndrome and bupropion treatment failure|serotonin syndrome and bupropion treatment failure|0|06.333998|1
00016330|excessive angiotensin inhibition and additive nephrotox|excessive angiotensin inhibition and additive nephrotoxicity|0|17.960608|1
00016331|excessive angiotensin inhibition & additive hyperkalemia|excessive angiotensin inhibition and additive hyperkalemia|0|17.960609|1
00016332|excess angiotensin inhib & additive hypotensive effects|excessive angiotensin inhibition and additive hypotensive effects|0|17.96060A|1
00016333|excessive CNS depression and additive sedation|excessive CNS depression and additive sedation|0|17.96060B|1
00016334|excessive diuresis and additive hypotensive effects|excessive diuresis and additive hypotensive effects|0|17.96060C|1
00016335|beta blocker toxicity|beta blocker toxicity|0|17.97788V|1
00016336|beta blocker toxicity and additive hypotensive effects|beta blocker toxicity and additive hypotensive effects|0|17.97788W|1
00016337|calcium channel blocker toxicity &add hypotensive effect|calcium channel blocker toxicity and additive hypotensive effects|0|17.97788X|1
00016338|antipsychotic agent tox &additive anticholinergic effect|antipsychotic agent toxicity and additive anticholinergic effects|0|17.97788Y|1
00016339|aminoglycoside toxicity and additive nephrotoxicity|aminoglycoside toxicity and additive nephrotoxicity|0|17.97788Z|1
00016340|myelosuppression and additive immunosuppression|myelosuppression and additive immunosuppression|0|04.28480B|1
00016341|myelosuppression and additive neutropenia|myelosuppression and additive neutropenia|0|04.28480C|1
00016342|chronic heart failure and hypoglycemia|chronic heart failure and hypoglycemia|0|07.42800A|3
00016343|nephrotoxicity and hyperkalemia|nephrotoxicity and hyperkalemia|0|10.583905|1
00016344|nephrotoxicity and aliskiren treatment failure|nephrotoxicity and aliskiren treatment failure|0|10.583906|1
00016345|hyperkalemia and hypotension|hyperkalemia and hypotension|0|03.276704|1
00016346|hyperkalemia &variable hormonal contracept effectiveness|hyperkalemia and variable hormonal contraceptive effectiveness|0|03.276705|1
00016347|hypokalemia and topiramate toxicity|hypokalemia and topiramate toxicity|0|03.276804|1
00016348|unpredictable quinine response|unpredictable quinine response|0|18.V87454|0
00016349|pexidartinib treatment failure|pexidartinib treatment failure|0|18.V87455|0
00016350|hemolytic anemia due to pyruvate kinase deficiency|hemolytic anemia due to pyruvate kinase deficiency|0|04.282302|1
00016351|beta blocker toxicity and additive bradycardia|beta blocker toxicity and additive bradycardia|0|17.97789Q|1
00016352|cardiac arrhythmia and QT prolongation|cardiac arrhythmia and QT prolongation|0|07.427907|1
00016353|serotonin syndrome and antipsychotic agent toxicity|serotonin syndrome and antipsychotic agent toxicity|0|06.333999|1
00016354|carbamazepine tox and calcium channel blocker tx failure|carbamazepine toxicity and calcium channel blocker treatment failure|0|17.977890|1
00016355|pexidartinib toxicity and dronedarone treatment failure|pexidartinib toxicity and dronedarone treatment failure|0|17.977891|1
00016356|pexidartinib toxicity and crizotinib treatment failure|pexidartinib toxicity and crizotinib treatment failure|0|17.977892|1
00016357|pexidartinib toxicity and idelalisib treatment failure|pexidartinib toxicity and idelalisib treatment failure|0|17.977893|1
00016358|pexidartinib toxicity and duvelisib treatment failure|pexidartinib toxicity and duvelisib treatment failure|0|17.977894|1
00016359|carbamazepine toxicity and letermovir treatment failure|carbamazepine toxicity and letermovir treatment failure|0|17.97789B|1
00016360|rifabutin toxicity and letermovir treatment failure|rifabutin toxicity and letermovir treatment failure|0|17.97789C|1
00016361|carbamazepine toxicity and istradefylline treatment fail|carbamazepine toxicity and istradefylline treatment failure|0|17.97789D|1
00016362|rifabutin toxicity and voxelotor treatment failure|rifabutin toxicity and voxelotor treatment failure|0|17.97789E|1
00016363|carbamazepine toxicity and cancer drug treatment failure|carbamazepine toxicity and cancer drug treatment failure|0|17.97789F|1
00016364|enzalutamide toxicity and clopidogrel toxicity|enzalutamide toxicity and clopidogrel toxicity|0|17.97789I|1
00016365|spinal cord edema|spinal cord edema|0|06.336100|1
00016366|pacritinib toxicity|pacritinib toxicity|0|17.97789R|1
00016367|pacritinib treatment failure|pacritinib treatment failure|0|18.V87456|0
00016368|decreased estrogen level in male patient|decreased estrogen level in male patient|0|16.790990|1
00016369|dextromethorphan toxicity|dextromethorphan toxicity|0|17.977895|1
00016370|theophylline toxicity|theophylline toxicity|0|17.977896|1
00016371|carbonic anhydrase inhibitor toxicity|carbonic anhydrase inhibitor toxicity|0|17.977898|1
00016372|rosiglitazone toxicity|rosiglitazone toxicity|0|17.977899|1
00016373|repaglinide toxicity|repaglinide toxicity|0|17.97789A|1
00016374|chloroquine toxicity|chloroquine toxicity|0|17.97789G|1
00016375|hydroxychloroquine toxicity|hydroxychloroquine toxicity|0|17.97789H|1
00016376|clopidogrel toxicity|clopidogrel toxicity|0|17.97789J|1
00016377|alosetron toxicity|alosetron toxicity|0|17.97789K|1
00016378|aminophylline toxicity|aminophylline toxicity|0|17.97789L|1
00016379|ramelteon toxicity|ramelteon toxicity|0|17.97789M|1
00016380|tasimelteon toxicity|tasimelteon toxicity|0|17.97789N|1
00016381|caffeine toxicity|caffeine toxicity|0|17.97789O|1
00016382|riluzole toxicity|riluzole toxicity|0|17.97789P|1
00016383|tramadol toxicity|tramadol toxicity|0|17.977934|1
00016384|excessive adrenergic effects|excessive adrenergic effects|0|17.97789S|1
00016385|CNS toxicity and antipsychotic agent treatment failure|CNS toxicity and antipsychotic agent treatment failure|0|06.349909|1
00016386|CNS toxicity and cardiotoxicity|CNS toxicity and cardiotoxicity|0|06.34990A|1
00016387|etoposide toxicity|etoposide toxicity|0|17.97789T|1
00016388|loperamide toxicity|loperamide toxicity|0|17.97789U|1
00016389|belzutifan toxicity|belzutifan toxicity|0|17.97789V|1
00016390|secnidazole toxicity|secnidazole toxicity|0|17.97789W|1
00016391|atogepant toxicity|atogepant toxicity|0|17.97789X|1
00016392|eliglustat toxicity|eliglustat toxicity|0|17.97789Y|1
00016393|sulfonylurea toxicity|sulfonylurea toxicity|0|17.97789Z|1
00016394|esketamine toxicity|esketamine toxicity|0|17.977901|1
00016395|upadacitinib toxicity|upadacitinib toxicity|0|17.977902|1
00016396|oxaliplatin toxicity|oxaliplatin toxicity|0|17.977903|1
00016397|bosentan toxicity|bosentan toxicity|0|17.977904|1
00016398|ospemifene toxicity|ospemifene toxicity|0|17.977905|1
00016399|pitolisant toxicity|pitolisant toxicity|0|17.977906|1
00016400|mitoxantrone toxicity|mitoxantrone toxicity|0|17.977907|1
00016401|sulfasalazine toxicity|sulfasalazine toxicity|0|17.977908|1
00016402|topotecan toxicity|topotecan toxicity|0|17.977909|1
00016403|ciprofloxacin toxicity|ciprofloxacin toxicity|0|17.97790A|1
00016404|guarana toxicity|guarana toxicity|0|17.97790B|1
00016405|procainamide toxicity|procainamide toxicity|0|17.97790C|1
00016406|lidocaine toxicity|lidocaine toxicity|0|17.97790D|1
00016407|didanosine toxicity|didanosine toxicity|0|17.97790E|1
00016408|penicillamine toxicity|penicillamine toxicity|0|17.97790F|1
00016409|ranolazine toxicity|ranolazine toxicity|0|17.97790G|1
00016410|adenosine toxicity|adenosine toxicity|0|17.97790H|1
00016411|diethyltoluamide toxicity|diethyltoluamide toxicity|0|17.97790I|1
00016412|ritonavir toxicity|ritonavir toxicity|0|17.97790J|1
00016413|baricitinib toxicity|baricitinib toxicity|0|17.97790K|1
00016414|cyclophosphamide toxicity|cyclophosphamide toxicity|0|17.97790L|1
00016415|dalfampridine toxicity|dalfampridine toxicity|0|17.97790M|1
00016416|deferiprone toxicity|deferiprone toxicity|0|17.97790N|1
00016417|fingolimod toxicity|fingolimod toxicity|0|17.97790O|1
00016418|cocaine toxicity|cocaine toxicity|0|17.97790P|1
00016419|carbapenem toxicity|carbapenem toxicity|0|17.97790Q|1
00016420|droxidopa toxicity|droxidopa toxicity|0|17.97790R|1
00016421|epirubicin toxicity|epirubicin toxicity|0|17.97790S|1
00016422|fexofenadine toxicity|fexofenadine toxicity|0|17.97790T|1
00016423|itraconazole toxicity|itraconazole toxicity|0|17.97790U|1
00016424|ketoconazole toxicity|ketoconazole toxicity|0|17.97790V|1
00016425|lesinurad toxicity|lesinurad toxicity|0|17.97790W|1
00016426|levodopa toxicity|levodopa toxicity|0|17.97790X|1
00016427|mefloquine toxicity|mefloquine toxicity|0|17.97790Y|1
00016428|mexiletine toxicity|mexiletine toxicity|0|17.97790Z|1
00016429|unpredictable venetoclax response|unpredictable venetoclax response|0|18.V87457|0
00016430|unpredictable everolimus response|unpredictable everolimus response|0|18.V87458|0
00016431|unpredictable lefamulin response|unpredictable lefamulin response|0|18.V87459|0
00016432|bosentan toxicity and cancer drug treatment failure|bosentan toxicity and cancer drug treatment failure|0|17.977911|1
00016433|pexidartinib toxicity and cancer drug treatment failure|pexidartinib toxicity and cancer drug treatment failure|0|17.911912|1
00016434|immune globulin therapy failure|immune globulin therapy failure|0|18.V8745A|0
00016435|aducanumab treatment failure|aducanumab treatment failure|0|18.V8745B|0
00016436|hemophilia therapy failure|hemophilia therapy failure|0|18.V8745C|0
00016437|selexipag treatment failure|selexipag treatment failure|0|18.V8745D|0
00016438|bamlanivimab treatment failure|bamlanivimab treatment failure|0|18.V8745E|0
00016439|basiliximab treatment failure|basiliximab treatment failure|0|18.V8745F|0
00016440|belimumab treatment failure|belimumab treatment failure|0|18.V8745G|0
00016441|benralizumab treatment failure|benralizumab treatment failure|0|18.V8745H|0
00016442|bezlotoxumab treatment failure|bezlotoxumab treatment failure|0|18.V8745I|0
00016443|brodalumab treatment failure|brodalumab treatment failure|0|18.V8745J|0
00016444|casirivimab treatment failure|casirivimab treatment failure|0|18.V8745K|0
00016445|cilgavimab treatment failure|cilgavimab treatment failure|0|18.V8745L|0
00016446|dupilumab treatment failure|dupilumab treatment failure|0|18.V8745M|0
00016447|eculizumab treatment failure|eculizumab treatment failure|0|18.V8745N|0
00016448|etesevimab treatment failure|etesevimab treatment failure|0|18.V8745O|0
00016449|evinacumab treatment failure|evinacumab treatment failure|0|18.V8745P|0
00016450|hormonal contraception failure & progesterone failure|hormonal contraception failure and progesterone therapy failure|0|18.V8745Q|1
00016451|progesterone therapy failure|progesterone therapy failure|0|18.V8745R|0
00016452|collagenase treatment failure|collagenase treatment failure|0|18.V8745S|0
00016453|papain treatment failure|papain treatment failure|0|18.V8745T|0
00016454|collagenase treatment failure & papain treatment failure|collagenase treatment failure and papain treatment failure|0|18.V8745U|1
00016455|keratinocyte-fibroblast skin tissue failure|keratinocyte-fibroblast skin tissue failure|0|18.V8745V|0
00016456|ileal bile acid transporter inhibitor treatment failure|ileal bile acid transporter inhibitor treatment failure|0|18.V8745W|0
00016457|galcanezumab treatment failure|galcanezumab treatment failure|0|18.V8745X|0
00016458|guselkumab treatment failure|guselkumab treatment failure|0|18.V8745Y|0
00016459|imdevimab treatment failure|imdevimab treatment failure|0|18.V8745Z|0
00016460|ixekizumab treatment failure|ixekizumab treatment failure|0|18.V87460|0
00016461|omalizumab treatment failure|omalizumab treatment failure|0|18.V87461|0
00016462|risankizumab treatment failure|risankizumab treatment failure|0|18.V87462|0
00016463|romosozumab treatment failure|romosozumab treatment failure|0|18.V87463|0
00016464|sarilumab treatment failure|sarilumab treatment failure|0|18.V87464|0
00016465|secukinumab treatment failure|secukinumab treatment failure|0|18.V87465|0
00016466|sotrovimab treatment failure|sotrovimab treatment failure|0|18.V87466|0
00016467|sutimlimab treatment failure|sutimlimab treatment failure|0|18.V87467|0
00016468|ustekinumab treatment failure|ustekinumab treatment failure|0|18.V87468|0
00016469|vedolizumab treatment failure|vedolizumab treatment failure|0|18.V87469|0
00016470|dopamine agonist tx failure & antipsychotic tx failure|dopamine agonist treatment failure and antipsychotic agent treatment failure|0|18.V8746A|1
00016471|vortioxetine treatment failure|vortioxetine treatment failure|0|18.V8746B|0
00016472|lithium treatment failure|lithium treatment failure|0|18.V8746C|0
00016473|cisapride treatment failure|cisapride treatment failure|0|18.V8746D|0
00016474|cyclosporine treatment failure|cyclosporine treatment failure|0|18.V8746E|0
00016475|pimozide treatment failure|pimozide treatment failure|0|18.V8746F|0
00016476|ergot alkaloid treatment failure|ergot alkaloid treatment failure|0|18.V8746G|0
00016477|estrogen therapy failure|estrogen therapy failure|0|18.V87473|0
00016478|estrogen therapy failure & progesterone therapy failure|estrogen therapy failure and progesterone therapy failure|0|18.V8744Y|1
00016479|regadenoson treatment failure|regadenoson treatment failure|0|18.V8746H|0
00016480|adenosine treatment failure|adenosine treatment failure|0|18.V8746I|0
00016481|agalsidase treatment failure|agalsidase treatment failure|0|18.V8746J|0
00016482|cysteamine treatment failure|cysteamine treatment failure|0|18.V8746K|0
00016483|leucovorin treatment failure|leucovorin treatment failure|0|18.V8746L|0
00016484|methenamine treatment failure|methenamine treatment failure|0|18.V8746M|0
00016485|metyrapone treatment failure|metyrapone treatment failure|0|18.V8746N|0
00016486|mifepristone treatment failure|mifepristone treatment failure|0|18.V8746O|0
00016487|starch-based thickener failure|starch-based thickener failure|0|18.V8746P|0
00016488|cancer drug tx failure and HIV antiretroviral tx failure|cancer drug treatment failure and HIV antiretroviral treatment failure|0|18.V8746Q|1
00016489|sulindac treatment failure|sulindac treatment failure|0|18.V8746R|0
00016490|chimeric antigen receptor T-cell immunotherapy failure|chimeric antigen receptor T-cell immunotherapy failure|0|18.V8746S|0
00016491|talimogene laherparepvec treatment failure|talimogene laherparepvec treatment failure|0|18.V8746T|0
00016492|telotristat treatment failure|telotristat treatment failure|0|18.V8746U|0
00016493|tricyclic antidepressant treatment failure|tricyclic antidepressant treatment failure|0|18.V8746W|0
00016494|trientine treatment failure|trientine treatment failure|0|18.V8746X|0
00016495|triheptanoin treatment failure|triheptanoin treatment failure|0|18.V8746Y|0
00016496|aminophylline treatment failure|aminophylline treatment failure|0|18.V8746Z|0
00016497|acarbose treatment failure|acarbose treatment failure|0|18.V87470|0
00016498|miglitol treatment failure|miglitol treatment failure|0|18.V87471|0
00016499|thiazide diuretic treatment failure|thiazide diuretic treatment failure|0|18.V87472|0
00016500|topical silver treatment failure|topical silver treatment failure|0|18.V87475|0
00016501|topical sulfacetamide treatment failure|topical sulfacetamide treatment failure|0|18.V87474|0
00016502|topical sulfacetamide and topical silver tx failure|topical sulfacetamide treatment failure and topical silver treatment failure|0|18.V8746V|1
00016503|opioid-muscle relaxant-ind resp depress & serotonin synd|opioid-muscle relaxant-induced respiratory depression and serotonin syndrome|0|19.E9352I|1
00016504|electrolyte abnormalities and intestinal obstruction|electrolyte abnormalities and intestinal obstruction|0|03.276907|1
00016505|reduced vaccine effectiveness|reduced vaccine effectiveness|0|18.V87476|0
00016506|vaccine-derived infection &reduced vaccine effectiveness|vaccine-derived infection and reduced vaccine effectiveness|0|03.279305|1
00016507|vaccine-derived infection|vaccine-derived infection|0|01.13690A|1
00016508|skin burn caused by transdermal patch worn during MRI|skin burn caused by transdermal patch worn during MRI|0|17.949002|1
00016509|neuroleptic malignant syndrome &extrapyramidal reactions|neuroleptic malignant syndrome and extrapyramidal reactions|0|06.333921|1
00016510|decreased absorption of oral iron|decreased absorption of oral iron|0|09.579903|1
00016511|non-cutaneous solid malignancy|non-cutaneous solid malignancy|0|02.199105|2
00016512|rebound hypertension|rebound hypertension|0|07.401917|1
00016513|nephrotoxicity and ototoxicity|nephrotoxicity and ototoxicity|0|10.583907|3
00016514|reduced epinephrine response|reduced epinephrine response|0|18.V87477|1
00016515|microangiopathic hemolytic anemia|microangiopathic hemolytic anemia|0|04.282901|1
00016516|suspected exposure to high-potency opioid from a weapon|suspected exposure to high-potency opioid from a chemical weapon|0|19.E9352J|1
00016517|CNS toxicity, cardiotoxicity and methemoglobinemia|CNS toxicity, cardiotoxicity and methemoglobinemia|0|06.34990B|1
00016518|decreased alcohol tolerance|decreased alcohol tolerance|0|03.277907|1
00016519|disulfiram-ethanol reaction and fomepizole toxicity|disulfiram-ethanol reaction and fomepizole toxicity|0|17.977912|1
00016520|cardiogenic shock and hyperkalemia|cardiogenic shock and hyperkalemia|0|16.785511|1
00016521|vasculitic ulcer|vasculitic ulcer|0|07.447604|1
00016522|hepatotoxicity, pancreatitis and peripheral neuropathy|hepatotoxicity, pancreatitis and peripheral neuropathy|0|09.573306|1
00016523|decreased phosphate absorption|decreased phosphate absorption|0|09.579904|1
00016524|peripheral neuropathy and sulindac treatment failure|peripheral neuropathy and sulindac treatment failure|0|06.356905|1
00016525|cardiogenic shock and sedation|cardiogenic shock and sedation|0|16.785512|1
00016526|decreased potassium absorption|decreased potassium absorption|0|09.579905|1
00016527|decreased absorption of oral iron & trientine tx failure|decreased absorption of oral iron and trientine treatment failure|0|09.579906|1
00016528|osmotic demyelination|osmotic demyelination|0|06.341902|1
00016529|critical illness polyneuropathy|critical illness polyneuropathy|0|06.356906|1
00016530|hypertensive crisis and serotonin syndrome|hypertensive crisis and serotonin syndrome|0|07.401918|1
00016531|tramadol toxicity and opioid treatment failure|tramadol toxicity and opioid treatment failure|0|17.977913|1
00016532|physical incompatibility of medications|physical incompatibility of medications|0|07. 38993|0
00016533|neuromuscular blockade and nephrotoxicity|neuromuscular blockade and nephrotoxicity|0|06.358907|1
00016535|isocarboxazid toxicity|isocarboxazid toxicity|0|17.977915|1
00016536|anthracycline-induced cardiotoxicity|anthracycline-induced cardiotoxicity|0|07.429894|1
00016537|decreased absorption of fat-soluble vitamins|decreased absorption of fat-soluble vitamins|0|09.579907|1
00016538|methylene blue toxicity|methylene blue toxicity|0|17.977916|1
00016539|phenelzine toxicity|phenelzine toxicity|0|17.977917|1
00016540|procarbazine toxicity|procarbazine toxicity|0|17.977918|1
00016541|selegiline toxicity|selegiline toxicity|0|17.977919|1
00016542|safinamide toxicity|safinamide toxicity|0|17.97791A|1
00016543|tranylcypromine toxicity|tranylcypromine toxicity|0|17.97791B|1
00016547|oliceridine toxicity|oliceridine toxicity|0|17.97791E|1
00016548|propylene glycol toxicity|propylene glycol toxicity|0|17.97791F|1
00016549|ropivacaine toxicity|ropivacaine toxicity|0|17.97791G|1
00016550|rufinamide toxicity|rufinamide toxicity|0|17.97791H|1
00016551|salmeterol toxicity|salmeterol toxicity|0|17.97791I|1
00016552|dapsone toxicity|dapsone toxicity|0|17.97791J|1
00016553|angiotensin receptor blocker (ARB) toxicity|angiotensin receptor blocker (ARB) toxicity|0|17.97791K|1
00016554|metformin toxicity|metformin toxicity|0|17.97791L|1
00016556|tipiracil toxicity|tipiracil toxicity|0|17.97791N|1
00016558|acyclovir toxicity|acyclovir toxicity|0|17.97791P|1
00016559|lumefantrine toxicity|lumefantrine toxicity|0|17.97791Q|1
00016562|tipranavir toxicity|tipranavir toxicity|0|17.97791T|1
00016564|fosaprepitant toxicity|fosaprepitant toxicity|0|17.97791V|1
00016566|fesoterodine toxicity|fesoterodine toxicity|0|17.97791X|1
00016568|solifenacin toxicity|solifenacin toxicity|0|17.97791Z|1
00016569|unpredictable erdafitinib response|unpredictable erdafitinib response|0|18.V87479|0
00016570|unpredictable theophylline response|unpredictable theophylline response|0|18.V87478|0
00016572|unpredictable amphetamine response|unpredictable amphetamine response|0|18.V8747A|0
00016573|unpredictable thyroid hormone response|unpredictable thyroid hormone response|0|18.V8747B|0
00016574|unpredictable estrogen response|unpredictable estrogen response|0|18.V8747C|0
00016576|neuromuscular blockade reversal failure|neuromuscular blockade reversal failure|0|18.V8747D|1
00016578|esketamine treatment failure|esketamine treatment failure|0|18.V8747E|0
00016579|methyldopa treatment failure|methyldopa treatment failure|0|18.V8747N|0
00016580|guanethidine therapy failure|guanethidine therapy failure|0|18.V8747F|1
00016581|BCG treatment failure|BCG treatment failure|0|18.V8747G|0
00016583|tiopronin toxicity|tiopronin toxicity|0|17.977922|1
00016585|lipid lowering drug treatment failure|lipid lowering drug treatment failure|0|18.V8747H|0
00016587|treprostinil toxicity|treprostinil toxicity|0|17.977925|1
00016588|obeticholic acid treatment failure|obeticholic acid treatment failure|0|18.V8747I|0
00016589|salicylate treatment failure|salicylate treatment failure|0|18.V8747J|0
00016591|vitamin A toxicity|vitamin A toxicity|0|17.977926|1
00016592|myasthenia gravis treatment failure|myasthenia gravis treatment failure|0|18.V8747K|0
00016593|rituximab treatment failure|rituximab treatment failure|0|18.V8747L|0
00016594|zaleplon toxicity|zaleplon toxicity|0|17.977928|1
00016596|zidovudine toxicity|zidovudine toxicity|0|17.97792A|1
00016597|tildrakizumab treatment failure|tildrakizumab treatment failure|0|18.V8747M|0
00016598|neuromuscular blocking agent treatment failure|neuromuscular blocking agent treatment failure|0|18.V8747O|0
00016599|ceritinib toxicity and ribociclib toxicity|ceritinib toxicity and ribociclib toxicity|0|17.977921|1
00016600|ceritinib toxicity and mifepristone toxicity|ceritinib toxicity and mifepristone toxicity|0|17.977923|1
00016601|ceritinib toxicity and idelalisib toxicity|ceritinib toxicity and idelalisib toxicity|0|17.977924|1
00016602|carbamazepine toxicity and nefazodone treatment failure|carbamazepine toxicity and nefazodone treatment failure|0|17.977927|1
00016603|chlorpromazine toxicity and beta blocker toxicity|chlorpromazine toxicity and beta blocker toxicity|0|17.977929|1
00016604|istradefylline toxicity|istradefylline toxicity|0|17.977914|1
00016605|leflunomide toxicity|leflunomide toxicity|0|17.97791C|1
00016606|ganciclovir toxicity|ganciclovir toxicity|0|17.97791D|1
00016607|tazemetostat toxicity|tazemetostat toxicity|0|17.97791M|1
00016608|voriconazole toxicity|voriconazole toxicity|0|17.97791O|1
00016609|efavirenz toxicity|efavirenz toxicity|0|17.97791Y|1
00016610|sympathomimetic agent toxicity|sympathomimetic agent toxicity|0|17.977910|1
00016611|olanzapine toxicity|olanzapine toxicity|0|17.97791R|1
00016612|disopyramide toxicity|disopyramide toxicity|0|17.97791U|1
00016613|regadenoson toxicity|regadenoson toxicity|0|17.97791W|1
00016614|acitretin toxicity|acitretin toxicity|0|17.977920|1
00016615|carbamazepine toxicity and fedratinib treatment failure|carbamazepine toxicity and fedratinib treatment failure|0|17.97792B|1
00016616|carbamazepine toxicity & antiemetic drug treatment fail|carbamazepine toxicity and antiemetic drug treatment failure|0|17.97792C|1
00016617|benzodiazepine treatment failure and stimulant tx fail|benzodiazepine treatment failure and stimulant treatment failure|0|17.97792D|1
00016618|elagolix toxicity and cancer drug treatment failure|elagolix toxicity and cancer drug treatment failure|0|17.97792E|1
00016619|lorlatinib toxicity and cancer drug treatment failure|lorlatinib toxicity and cancer drug treatment failure|0|17.97792F|1
00016620|ribociclib toxicity and idelalisib toxicity|ribociclib toxicity and idelalisib toxicity|0|17.97792G|1
00016621|rifabutin toxicity and antibiotic treatment failure|rifabutin toxicity and antibiotic treatment failure|0|17.97792H|1
00016622|bosentan toxicity and cyclosporine treatment failure|bosentan toxicity and cyclosporine treatment failure|0|17.97792I|1
00016623|efavirenz toxicity and antifungal treatment failure|efavirenz toxicity and antifungal treatment failure|0|17.97792J|1
00016624|dronedarone toxicity and calcium channel blocker tox|dronedarone toxicity and calcium channel blocker toxicity|0|17.97792K|1
00016625|ezetimibe toxicity|ezetimibe toxicity|0|17.97792L|1
00016626|cyclosporine toxicity and ezetimibe toxicity|cyclosporine toxicity and ezetimibe toxicity|0|17.97792M|1
00016627|salicylate toxicity|salicylate toxicity|0|17.97792N|1
00016628|salicylate toxicity and carbonic anhydrase inhibitor tox|salicylate toxicity and carbonic anhydrase inhibitor toxicity|0|17.97792O|1
00016629|theophylline toxicity and antibiotic treatment failure|theophylline toxicity and antibiotic treatment failure|0|17.97792P|1
00016630|aminophylline toxicity and antibiotic treatment failure|aminophylline toxicity and antibiotic treatment failure|0|17.97792Q|1
00016631|cyclophosphamide toxicity and voclosporin toxicity|cyclophosphamide toxicity and voclosporin toxicity|0|17.97792R|1
00016632|selective serotonin reup inhibitor tox & dextrometh tox|selective serotonin reuptake inhibitor toxicity and dextromethorphan toxicity|0|17.97792S|1
00016633|loperamide toxicity and HIV treatment failure|loperamide toxicity and HIV antiretroviral treatment failure|0|17.97792T|1
00016634|nelfinavir toxicity and HIV treatment failure|nelfinavir toxicity and HIV antiretroviral treatment failure|0|17.97792U|1
00016635|nelfinavir toxicity|nelfinavir toxicity|0|17.97792V|1
00016636|lopinavir toxicity and amprenavir toxicity|lopinavir toxicity and amprenavir toxicity|0|17.97792W|1
00016637|amprenavir toxicity|amprenavir toxicity|0|17.97792X|1
00016638|lopinavir toxicity and fosamprenavir toxicity|lopinavir toxicity and fosamprenavir toxicity|0|17.97792Y|1
00016639|fosamprenavir toxicity|fosamprenavir toxicity|0|17.97792Z|1
00016642|zidovudine toxicity and ganciclovir toxicity|zidovudine toxicity and ganciclovir toxicity|0|17.977933|1
00016645|zidovudine toxicity and valganciclovir toxicity|zidovudine toxicity and valganciclovir toxicity|0|17.977936|1
00016647|valganciclovir toxicity|valganciclovir toxicity|0|17.977938|1
00016648|dabrafenib toxicity and cancer drug treatment failure|dabrafenib toxicity and cancer drug treatment failure|0|17.977939|1
00016649|ribociclib toxicity and mifepristone toxicity|ribociclib toxicity and mifepristone toxicity|0|17.97793A|1
00016650|adefovir toxicity and tenofovir toxicity|adefovir toxicity and tenofovir toxicity|0|17.97793B|1
00016651|adefovir toxicity|adefovir toxicity|0|17.97793C|1
00016652|unpredictable response to anticonvulsant|unpredictable response to anticonvulsant|0|18.V8747P|0
00016653|barbiturate tox & unpredictable anticonvulsant response|barbiturate toxicity and unpredictable response to anticonvulsant|0|17.977930|1
00016654|lamotrigine toxicity and anticonvulsant drug tx failure|lamotrigine toxicity and anticonvulsant drug treatment failure|0|17.977932|1
00016655|hydantoin tox & unpredictable response to anticonvulsant|hydantoin toxicity and unpredictable response to anticonvulsant|0|17.977931|1
00016656|unpredictable response to sympathomimetic|unpredictable response to sympathomimetic|0|18.V8747S|0
00016657|unpredictable response to corticosteroid|unpredictable response to corticosteroid|0|18.V8747R|0
00016658|masked symptoms of anaphylaxis|masked symptoms of anaphylaxis|0|17.995003|0
00016659|bleeding and nephrotoxicity|bleeding and nephrotoxicity|0|07.45900C|1
00016660|antipsychotic tx fail & additive anticholinergic effect|antipsychotic agent treatment failure and additive anticholinergic effects|0|18.V8747Q|1
00016661|myelosuppression and gastrointestinal adverse effects|myelosuppression and gastrointestinal adverse effects|0|04.28480D|1
00016662|adrenocortical insufficiency and HIV ARV tx failure|adrenocortical insufficiency and HIV antiretroviral treatment failure|0|03.255407|1
00016663|serotonin syndrome, seizure & tramadol treatment failure|serotonin syndrome, seizure and tramadol treatment failure|0|06.33399A|1
00016664|QT prolongation and hypotension|QT prolongation and hypotension|0|07.42791A|1
00016665|cholelithiasis and ezetimibe toxicity|cholelithiasis and ezetimibe toxicity|0|09.574202|1
00016666|tramadol treatment failure|tramadol treatment failure|0|18.V8747V|0
00016667|ursodiol treatment failure|ursodiol treatment failure|0|18.V8747W|0
00016668|raloxifene treatment failure|raloxifene treatment failure|0|18.V8747X|0
00016669|elagolix tx failure and hormonal contraception failure|elagolix treatment failure and hormonal contraception failure|0|18.V8747T|0
00016670|estrogen therapy failure and anticonvulsant tx failure|estrogen therapy failure and anticonvulsant drug treatment failure|0|18.V8747U|0
00016671|anticonvulsant drug tx failure and rifamycin tx failure|anticonvulsant drug treatment failure and rifamycin treatment failure|0|18.V8747Y|0
00016672|cimetidine toxicity|cimetidine toxicity|0|17.977935|1
00016673|opposing effects on potassium levels|opposing effects on potassium levels|0|18.V8747Z|1
00016674|serotonin syndrome and ozanimod treatment failure|serotonin syndrome and ozanimod treatment failure|0|06.33399B|1
00016675|long QT, antiparkinson tx fail & antipsychotic tx fail|QT prolongation, antiparkinson drug treatment failure and antipsychotic agent treatment failure|0|07.42791B|1
00016676|metaxalone toxicity|metaxalone toxicity|0|17.97793D|1
00016677|linezolid toxicity|linezolid toxicity|0|17.97793E|1
00016678|levofloxacin toxicity|levofloxacin toxicity|0|17.97793F|1
00016679|levomethadyl toxicity|levomethadyl toxicity|0|17.97793G|1
00016680|cannabidiol toxicity|cannabidiol toxicity|0|17.97793H|1
00016681|seizures associated with CDKL5 deficiency disorder|seizures associated with cyclin-dependent kinase-like 5 deficiency disorder|0|06.345909|2
00016682|immune-mediated adverse reactions|immune-mediated adverse reactions|0|03.279402|1
00016683|injection site hyperpigmentation|injection site hyperpigmentation|0|17.999906|1
00016684|injection site inflammation|injection site inflammation|0|17.999907|1
00016685|PSMA(+) metastatic castration-resistant prostate cancer|prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer|0|02.233409|0
00016686|gilteritinib toxicity|gilteritinib toxicity|0|17.97793I|1
00016687|unpredictable opioid response|unpredictable opioid response|0|18.V87480|1
00016688|drugs exhibit opposing effects on a patient parameter|drugs exhibit opposing effects on a patient parameter|0|18.V87481|1
00016689|opposing effects on the central nervous system|opposing effects on the central nervous system|0|18.V87482|1
00016690|lamivudine treatment failure|lamivudine treatment failure|0|18.V87483|0
00016691|facial angiofibroma with tuberous sclerosis complex|facial angiofibroma associated with tuberous sclerosis complex|0|14.759504|2
00016692|PIK3CA-related overgrowth spectrum|PIK3CA-related overgrowth spectrum|0|14.759898|0
00016693|hyperestrogenism|hyperestrogenism|0|03.256102|0
00016694|enophthalmos|enophthalmos|0|06.376500|3
00016695|vesicular rash|vesicular rash|0|16.782903|1
00016696|vinflunine toxicity|vinflunine toxicity|0|17.97793J|1
00016697|hypertrophic obstructive cardiomyopathy|hypertrophic obstructive cardiomyopathy|0|07.425407|2
00016698|mavacamten toxicity|mavacamten toxicity|0|17.97793K|1
00016699|mavacamten treatment failure|mavacamten treatment failure|0|18.V87484|1
00016700|possible subtherapeutic effect|possible subtherapeutic effect|0|18.V87485|1
00016701|agomelatine toxicity|agomelatine toxicity|0|17.97793L|1
00016702|surufatinib toxicity|surufatinib toxicity|0|17.97793M|1
00016703|PDE5 inhibitor toxicity and additive hypotension|phosphodiesterase type 5 (PDE5) inhibitor toxicity and additive hypotension|0|07.458907|1
00016704|NSAID toxicity and additive bleeding|nonsteroidal anti-inflammatory drug (NSAID) toxicity and additive bleeding|0|07.45900D|1
00016705|surufatinib treatment failure|surufatinib treatment failure|0|18.V87486|1
00016706|roxadustat treatment failure|roxadustat treatment failure|0|18.V87487|1
00016707|alpelisib treatment failure|alpelisib treatment failure|0|18.V87488|1
00016708|rupatadine toxicity|rupatadine toxicity|0|17.97793N|1
00016709|fenfluramine toxicity|fenfluramine toxicity|0|17.97793O|1
00016710|ambenonium toxicity|ambenonium toxicity|0|17.97793P|1
00016711|masked symptoms of ambenonium toxicity|masked symptoms of ambenonium toxicity|0|17.97793Q|1
00016712|carbamazepine toxicity and antibiotic treatment failure|carbamazepine toxicity and antibiotic treatment failure|0|17.97793R|1
00016713|QT prolongation and antifungal treatment failure|QT prolongation and antifungal treatment failure|0|07.42791C|1
00016714|lonafarnib toxicity and simeprevir toxicity|lonafarnib toxicity and simeprevir toxicity|0|17.97793S|1
00016715|mavacamten toxicity and duvelisib treatment failure|mavacamten toxicity and duvelisib treatment failure|0|17.97793T|1
00016716|mavacamten toxicity and rolapitant treatment failure|mavacamten toxicity and rolapitant treatment failure|0|17.97793U|1
00016717|mavacamten toxicity and voxelotor treatment failure|mavacamten toxicity and voxelotor treatment failure|0|17.97793V|1
00016718|mavacamten toxicity and hormonal contraception failure|mavacamten toxicity and hormonal contraception failure|0|17.97793W|1
00016719|mavacamten toxicity and crizotinib treatment failure|mavacamten toxicity and crizotinib treatment failure|0|17.97793X|1
00016720|mavacamten toxicity and lefamulin treatment failure|mavacamten toxicity and lefamulin treatment failure|0|17.97793Y|1
00016721|idelalisib treatment failure|idelalisib treatment failure|0|18.V87489|1
00016722|excess progestin effects|excess progestin effects|0|17.97793Z|1
00016723|metyrosine toxicity|metyrosine toxicity|0|17.977940|1
00016724|adverse reactions from exceeding max antiretroviral dose|adverse reactions from exceeding maximum antiretroviral dose|0|17.977941|1
00016725|acquired acanthosis nigricans|acquired acanthosis nigricans|0|12.701200|3
00016726|Helicobacter pylori treatment failure|Helicobacter pylori treatment failure|0|18.V8748A|1
00016727|QT prolongation & Helicobacter pylori treatment failure|QT prolongation and Helicobacter pylori treatment failure|0|07.42791D|1
00016728|Helicobacter pylori tx failure & adverse drug reactions|Helicobacter pylori treatment failure and adverse drug reactions|0|18.V8748B|1
00016729|bosentan toxicity and Helicobacter pylori treatment fail|bosentan toxicity and Helicobacter pylori treatment failure|0|17.977942|1
00016730|carbamazepine toxicity & Helicobacter pylori tx failure|carbamazepine toxicity and Helicobacter pylori treatment failure|0|17.977943|1
00016731|dabrafenib toxicity & Helicobacter pylori tx failure|dabrafenib toxicity and Helicobacter pylori treatment failure|0|17.977944|1
00016732|elagolix toxicity & Helicobacter pylori tx failure|elagolix toxicity and Helicobacter pylori treatment failure|0|17.977945|1
00016733|ivosidenib toxicity and Helicobacter pylori tx failure|ivosidenib toxicity and Helicobacter pylori treatment failure|0|17.977946|1
00016734|lorlatinib toxicity & Helicobacter pylori treatment fail|lorlatinib toxicity and Helicobacter pylori treatment failure|0|17.977947|1
00016735|mitapivat toxicity & Helicobacter pylori treatment fail|mitapivat toxicity and Helicobacter pylori treatment failure|0|17.977948|1
00016736|ivacaftor toxicity and Helicobacter pylori tx failure|ivacaftor toxicity and Helicobacter pylori treatment failure|0|17.977949|1
00016737|Helicobacter pylori tx failure & cancer drug tx failure|Helicobacter pylori treatment failure and cancer drug treatment failure|0|18.V8748C|1
00016738|Helicobacter pylori tx failure & pexidartinib tx failure|Helicobacter pylori treatment failure and pexidartinib treatment failure|0|18.V8748D|1
00016739|malignant neoplasm of gastroesophageal junction|malignant neoplasm of gastroesophageal junction|0|02.230915|2
00016740|rifabutin toxicity & Helicobacter pylori treatment fail|rifabutin toxicity and Helicobacter pylori treatment failure|0|17.97794A|1
00016741|excess CNS stim & corticosteroid toxicity|excessive CNS stimulation and corticosteroid toxicity|0|17.96060D|1
00016742|unpredictable ubrogepant response|unpredictable ubrogepant response|0|18.V8748E|0
00016743|bleeding and abrocitinib toxicity|bleeding and abrocitinib toxicity|0|07.45900E|1
00016744|drug-induced phospholipidosis|drug-induced phospholipidosis|0|03.272901|2
00016745|unpredictable immunosuppressant drug response|unpredictable immunosuppressant drug response|0|18.V8748F|0
00016746|juvenile myelomonocytic leukemia|juvenile myelomonocytic leukemia|0|02.206002|2
00016747|excessive CNS stimulation and anticholinergic toxicity|excessive CNS stimulation and anticholinergic toxicity|0|17.96060E|1
00016748|exces CNS stim, corticosteroid tox & anticholinergic tox|excessive CNS stimulation, corticosteroid toxicity and anticholinergic toxicity|0|17.96060F|1
00016749|autoimmune encephalitis|autoimmune encephalitis|0|06.323800|3
00016750|UGT2B17 poor metabolizer|UGT2B17 poor metabolizer|0|03.277407|2
00016751|PGX combination 100|PGX combination 100|0|00.000100|0
00016752|UGT2B17 normal metabolizer|UGT2B17 normal metabolizer|0|03.277408|2
00016753|UGT2B17 ordered, result pending|UGT2B17 ordered, result pending|0|03.277868|0
00016754|UGT2B17 no result on file, not currently ordered|UGT2B17 no result on file, not currently ordered|0|03.277869|0
00016755|macular edema associated with non-infectious uveitis|macular edema associated with non-infectious uveitis|0|06.362832|3
00016756|moderate persistent asthma|moderate persistent asthma|0|08.493002|2
00016757|severe persistent asthma|severe persistent asthma|0|08.493003|2
00016758|mild persistent asthma|mild persistent asthma|0|08.493004|2
00016759|septum dislodgement of ocular implant|septum dislodgement of ocular implant|0|17.996593|3
00016760|tacrolimus toxicity and pazopanib toxicity|tacrolimus toxicity and pazopanib toxicity|0|17.97794B|1
00016761|heart failure associated with type 2 diabetes mellitus|heart failure associated with type 2 diabetes mellitus|0|03.250700|2
00016762|QT prolongation & immunosuppressant drug treatment fail|QT prolongation and immunosuppressant drug treatment failure|0|07.42791E|1
00016763|obesity due to Bardet-Biedl syndrome|obesity due to Bardet-Biedl syndrome|0|14.759899|3
00016764|excessive CNS stimulation and neurocognitive disorder|excessive CNS stimulation and neurocognitive disorder|0|17.96060G|1
00016765|unpredictable cannabidiol response|unpredictable cannabidiol response|0|18.V8748G|0
00016766|carbamazepine toxicity and dronedarone treatment failure|carbamazepine toxicity and dronedarone treatment failure|0|17.97794C|1
00016767|malignant solid tumor with BRAF V600E mutation|malignant solid tumor with BRAF V600E mutation|0|02.199106|2
00016768|bleeding skin|bleeding skin|0|16.782904|1
00016769|serotonin syndrome and anticonvulsant treatment failure|serotonin syndrome and anticonvulsant treatment failure|0|06.33399C|1
00016770|excessive cholinergic effects|excessive cholinergic effects|0|17.97794D|1
00016771|abiraterone toxicity|abiraterone toxicity|0|17.97794E|1
00016772|alpelisib toxicity|alpelisib toxicity|0|17.97794F|1
00016773|asfotase alfa toxicity|asfotase alfa toxicity|0|17.97794G|1
00016774|belumosudil toxicity|belumosudil toxicity|0|17.97794H|1
00016775|burosumab toxicity|burosumab toxicity|0|17.97794I|1
00016776|denosumab toxicity|denosumab toxicity|0|17.97794J|1
00016777|excessive CNS stimulation and acetaminophen toxicity|excessive CNS stimulation and acetaminophen toxicity|0|17.96060H|1
00016778|anticholinergic toxicity and benzodiazepine toxicity|anticholinergic toxicity and benzodiazepine toxicity|0|17.97794K|1
00016779|hepatotoxicity, excessive sedation & resp depression|hepatotoxicity, excessive sedation and respiratory depression|0|09.573307|1
00016780|adverse reactions from exceeding maximum vaccine dose|adverse reactions from exceeding maximum vaccine dose|0|17.97794L|1
00016781|adverse CNS effects and falls|adverse CNS effects and falls|0|06.34990C|1
00016782|cardiotoxicity and gastrointestinal adverse effects|cardiotoxicity and gastrointestinal adverse effects|0|07.429895|1
00016783|hepatotoxicity and nephrotoxicity|hepatotoxicity and nephrotoxicity|0|09.573308|1
00016784|pulmonary adverse effects|pulmonary adverse effects|0|08.519904|3
00016785|teriflunomide toxicity|teriflunomide toxicity|0|17.97794M|1
00016786|unpredictable blood pressure|unpredictable blood pressure|0|18.V8748H|1
00016787|unpredictable lithium response|unpredictable lithium response|0|18.V8748I|1
00016788|unpredictable gastrointestinal output|unpredictable gastrointestinal output|0|18.V8748J|1
00016789|unpredictable glucose levels|unpredictable glucose levels|0|18.V8748K|1
00016790|unpredictable vitamin A levels|unpredictable vitamin A levels|0|18.V8748L|1
00016791|unpredictable phosphorus levels|unpredictable phosphorus levels|0|18.V8748M|1
00016792|unpredictable angiotensin receptor blocker response|unpredictable angiotensin receptor blocker response|0|18.V8748N|0
00016793|unpredictable carbonic anhydrase inhibitor response|unpredictable carbonic anhydrase inhibitor response|0|18.V8748O|0
00016794|unpredictable phosphodiesterase type5 inhibitor response|unpredictable phosphodiesterase type 5 inhibitor response|0|18.V8748P|0
00016795|unpredictable SSRI response|unpredictable selective serotonin reuptake inhibitor response|0|18.V8748Q|0
00016796|unpredictable tricyclic antidepressant response|unpredictable tricyclic antidepressant response|0|18.V8748R|0
00016797|unpredictable benzodiazepine response|unpredictable benzodiazepine response|0|18.V8748S|0
00016798|unpredictable antifungal response|unpredictable antifungal response|0|18.V8748T|0
00016799|unpredictable antimalarial response|unpredictable antimalarial response|0|18.V8748U|0
00016800|unpredictable antibiotic response|unpredictable antibiotic response|0|18.V8748V|0
00016801|unpredictable antiparkinson drug response|unpredictable antiparkinson drug response|0|18.V8748W|0
00016802|unpredictable antipsychotic agent response|unpredictable antipsychotic agent response|0|18.V8748X|0
00016803|unpredictable antiarrhythmic agent response|unpredictable antiarrhythmic agent response|0|18.V8748Y|0
00016804|unpredictable beta blocker response|unpredictable beta blocker response|0|18.V8748Z|0
00016805|unpredictable ergot alkaloid response|unpredictable ergot alkaloid response|0|18.V87490|0
00016806|unpredictable abemaciclib response|unpredictable abemaciclib response|0|18.V87491|0
00016807|unpredictable abrocitinib response|unpredictable abrocitinib response|0|18.V87492|0
00016808|unpredictable adenosine response|unpredictable adenosine response|0|18.V87493|0
00016809|unpredictable afatinib response|unpredictable afatinib response|0|18.V87494|0
00016810|unpredictable amiodarone response|unpredictable amiodarone response|0|18.V87495|0
00016811|unpredictable atogepant response|unpredictable atogepant response|0|18.V87496|0
00016812|unpredictable avacopan response|unpredictable avacopan response|0|18.V87497|0
00016813|unpredictable avapritinib response|unpredictable avapritinib response|0|18.V87498|0
00016814|unpredictable avatrombopag response|unpredictable avatrombopag response|0|18.V87499|0
00016815|unpredictable buspirone response|unpredictable buspirone response|0|18.V8749A|0
00016816|unpredictable berotralstat response|unpredictable berotralstat response|0|18.V8749B|0
00016817|unpredictable copanlisib response|unpredictable copanlisib response|0|18.V8749C|0
00016818|unpredictable darolutamide response|unpredictable darolutamide response|0|18.V8749D|0
00016819|unpredictable deferiprone response|unpredictable deferiprone response|0|18.V8749E|0
00016820|unpredictable dronedarone response|unpredictable dronedarone response|0|18.V8749F|0
00016821|unpredictable duvelisib response|unpredictable duvelisib response|0|18.V8749G|0
00016822|unpredictable eliglustat response|unpredictable eliglustat response|0|18.V8749H|0
00016823|unpredictable enzalutamide response|unpredictable enzalutamide response|0|18.V8749I|0
00016824|unpredictable fedratinib response|unpredictable fedratinib response|0|18.V8749J|0
00016825|unpredictable fesoterodine response|unpredictable fesoterodine response|0|18.V8749K|0
00016826|unpredictable finerenone response|unpredictable finerenone response|0|18.V8749L|0
00016827|unpredictable flibanserin response|unpredictable flibanserin response|0|18.V8749M|0
00016828|unpredictable fostamatinib response|unpredictable fostamatinib response|0|18.V8749N|0
00016829|unpredictable gilteritinib response|unpredictable gilteritinib response|0|18.V8749O|0
00016830|unpredictable guanfacine response|unpredictable guanfacine response|0|18.V8749P|0
00016831|unpredictable hydroxychloroquine response|unpredictable hydroxychloroquine response|0|18.V8749Q|0
00016832|unpredictable ibrexafungerp response|unpredictable ibrexafungerp response|0|18.V8749R|0
00016833|unpredictable ibrutinib response|unpredictable ibrutinib response|0|18.V8749S|0
00016834|unpredictable istradefylline response|unpredictable istradefylline response|0|18.V8749T|0
00016835|unpredictable ivacaftor response|unpredictable ivacaftor response|0|18.V8749U|0
00016836|unpredictable leflunomide response|unpredictable leflunomide response|0|18.V8749V|0
00016837|unpredictable letermovir response|unpredictable letermovir response|0|18.V8749W|0
00016838|unpredictable lonafarnib response|unpredictable lonafarnib response|0|18.V8749X|0
00016839|unpredictable lumateperone response|unpredictable lumateperone response|0|18.V8749Y|0
00016840|unpredictable macitentan response|unpredictable macitentan response|0|18.V8749Z|0
00016841|unpredictable mifepristone response|unpredictable mifepristone response|0|18.V87500|0
00016842|unpredictable mitapivat response|unpredictable mitapivat response|0|18.V87501|0
00016843|unpredictable naldemedine response|unpredictable naldemedine response|0|18.V87502|0
00016844|unpredictable nintedanib response|unpredictable nintedanib response|0|18.V87503|0
00016845|unpredictable ospemifene response|unpredictable ospemifene response|0|18.V87504|0
00016846|unpredictable ozanimod response|unpredictable ozanimod response|0|18.V87505|0
00016847|unpredictable pacritinib response|unpredictable pacritinib response|0|18.V87506|0
00016848|unpredictable pexidartinib response|unpredictable pexidartinib response|0|18.V87507|0
00016849|unpredictable pimozide response|unpredictable pimozide response|0|18.V87508|0
00016850|unpredictable pitolisant response|unpredictable pitolisant response|0|18.V87509|0
00016851|unpredictable penicillamine response|unpredictable penicillamine response|0|18.V8750A|0
00016852|unpredictable quinidine response|unpredictable quinidine response|0|18.V8750B|0
00016853|unpredictable ranolazine response|unpredictable ranolazine response|0|18.V8750C|0
00016854|unpredictable regadenoson response|unpredictable regadenoson response|0|18.V8750D|0
00016855|unpredictable rimegepant response|unpredictable rimegepant response|0|18.V8750E|0
00016856|emtricitabine toxicity|emtricitabine toxicity|0|17.97794N|1
00016857|lactic acidosis and hypoglycemic disorder|lactic acidosis and hypoglycemic disorder|0|03.276207|1
00016858|unpredictable selexipag response|unpredictable selexipag response|0|18.V8750F|0
00016859|unpredictable siponimod response|unpredictable siponimod response|0|18.V8750G|0
00016860|unpredictable tenofovir response|unpredictable tenofovir response|0|18.V8750H|0
00016861|unpredictable tofacitinib response|unpredictable tofacitinib response|0|18.V8750I|0
00016862|unpredictable tolvaptan response|unpredictable tolvaptan response|0|18.V8750J|0
00016863|unpredictable upadacitinib response|unpredictable upadacitinib response|0|18.V8750K|0
00016864|unpredictable valbenazine response|unpredictable valbenazine response|0|18.V8750L|0
00016865|unpredictable vortioxetine response|unpredictable vortioxetine response|0|18.V8750M|0
00016866|unpredictable voclosporin response|unpredictable voclosporin response|0|18.V8750N|0
00016867|ribavirin toxicity|ribavirin toxicity|0|17.97794O|1
00016868|drospirenone toxicity|drospirenone toxicity|0|17.97794P|1
00016869|clomiphene citrate toxicity|clomiphene citrate toxicity|0|17.97794Q|1
00016870|hyperestrogenism and hyperandrogenism|hyperestrogenism and hyperandrogenism|0|03.256103|1
00016871|hyperestrogenism and drospirenone toxicity|hyperestrogenism and drospirenone toxicity|0|03.256104|1
00016872|myelosuppression and hepatotoxicity|myelosuppression and hepatotoxicity|0|04.28480E|1
00016873|ALK-positive inflammatory myofibroblastic tumor|ALK-positive inflammatory myofibroblastic tumor|0|02.171908|2
00016874|aromatase inhibitor toxicity|aromatase inhibitor toxicity|0|17.97794R|1
00016875|nafarelin toxicity|nafarelin toxicity|0|17.97794S|1
00016876|octreotide toxicity|octreotide toxicity|0|17.97794T|1
00016877|pasireotide toxicity|pasireotide toxicity|0|17.97794U|1
00016878|alprostadil toxicity|alprostadil toxicity|0|17.97794V|1
00016879|benzonatate toxicity|benzonatate toxicity|0|17.97794W|1
00016880|dornase alfa toxicity|dornase alfa toxicity|0|17.97794X|1
00016881|misoprostol toxicity|misoprostol toxicity|0|17.97794Y|1
00016882|atovaquone toxicity|atovaquone toxicity|0|17.97794Z|1
00016883|interferon toxicity|interferon toxicity|0|17.977950|1
00016884|ponesimod toxicity|ponesimod toxicity|0|17.977951|1
00016885|dasiglucagon toxicity|dasiglucagon toxicity|0|17.977952|1
00016886|diazoxide toxicity|diazoxide toxicity|0|17.977953|1
00016887|amifampridine toxicity|amifampridine toxicity|0|17.977954|1
00016888|capmatinib toxicity|capmatinib toxicity|0|17.977955|1
00016889|adverse reactions from exceeding maximum dose|adverse reactions from exceeding maximum dose|0|17.977956|1
00016890|lactic acidosis and body fluid retention|lactic acidosis and body fluid retention|0|03.276208|1
00016891|body fluid retention and hypoglycemic disorder|body fluid retention and hypoglycemic disorder|0|03.276606|1
00016892|bleeding and sedation|bleeding and sedation|0|07.45900F|1
00016893|leukopenia and thrombocytopenia|leukopenia and thrombocytopenia|0|04.28800A|1
00016894|sedation and NSAID toxicity|sedation and NSAID toxicity|0|16.78009H|1
00016895|lactic acidosis and DPP-4 inhibitor toxicity|lactic acidosis and DPP-4 inhibitor toxicity|0|03.276209|1
00016896|niraparib toxicity|niraparib toxicity|0|17.977957|1
00016897|pioglitazone toxicity and DPP-4 inhibitor toxicity|pioglitazone toxicity and DPP-4 inhibitor toxicity|0|17.977958|1
00016898|miglustat toxicity|miglustat toxicity|0|17.977959|1
00016899|excessive diuresis and DPP-4 inhibitor toxicity|excessive diuresis and DPP-4 inhibitor toxicity|0|10.599040|1
00016900|lactic acidosis and excessive diuresis|lactic acidosis and excessive diuresis|0|03.276210|1
00016901|lactic acidosis, overdiuresis and DPP-4 inhibitor tox|lactic acidosis, excessive diuresis and DPP-4 inhibitor toxicity|0|03.276211|1
00016902|tumor flare reaction|tumor flare reaction|0|19.E9331A|1
00016903|carglumic acid toxicity|carglumic acid toxicity|0|17.97795A|1
00016904|memantine toxicity and excessive cholinergic effects|memantine toxicity and excessive cholinergic effects|0|17.97795B|1
00016905|nifurtimox toxicity|nifurtimox toxicity|0|17.97795C|1
00016906|benznidazole toxicity|benznidazole toxicity|0|17.97795D|1
00016907|lumacaftor-ivacaftor toxicity|lumacaftor-ivacaftor toxicity|0|17.97795E|1
00016908|binimetinib toxicity|binimetinib toxicity|0|17.97795F|1
00016909|osimertinib mesylate toxicity|osimertinib mesylate toxicity|0|17.97795G|1
00016910|alectinib toxicity|alectinib toxicity|0|17.97795H|1
00016911|antibiotic overuse and proton pump inhibitor overuse|antibiotic overuse and proton pump inhibitor overuse|0|99.999915|0
00016912|deferoxamine toxicity|deferoxamine toxicity|0|17.97795I|1
00016913|acquired dilation of bile duct|acquired dilation of bile duct|0|09.576816|3
00016914|bleeding and proton pump inhibitor overuse|bleeding and proton pump inhibitor overuse|0|07.45900G|1
00016915|dupilumab toxicity|dupilumab toxicity|0|17.97795J|1
00016916|abaloparatide toxicity|abaloparatide toxicity|0|17.97795K|1
00016917|ethambutol toxicity|ethambutol toxicity|0|17.97795L|1
00016918|chorioretinal atrophy|chorioretinal atrophy|0|06.363800|3
00016919|megestrol toxicity|megestrol toxicity|0|17.97795M|1
00016920|hypotension and NSAID toxicity|hypotension and NSAID toxicity|0|07.458908|1
00016921|bleeding, sedation and acetaminophen toxicity|bleeding, sedation and acetaminophen toxicity|0|07.45900H|1
00016922|erdafitinib toxicity|erdafitinib toxicity|0|17.97795N|1
00016923|bremelanotide toxicity|bremelanotide toxicity|0|17.97795O|1
00016924|erenumab toxicity|erenumab toxicity|0|17.97795P|1
00016925|bempedoic acid toxicity|bempedoic acid toxicity|0|17.97795Q|1
00016926|hepatotoxicity and diarrhea|hepatotoxicity and diarrhea|0|09.573309|1
00016927|bleeding prevention in hereditary factor IX deficiency|bleeding prevention in hereditary factor IX deficiency|0|04.286102|1
00016928|extramedullary hematopoietic mass|extramedullary hematopoietic mass|0|02.237906|3
00016929|opioid-induced-respiratory depression and falls|opioid-induced-respiratory depression and falls|0|19.E9352K|1
00016930|excessive anticholinergic side effects and falls|excessive anticholinergic side effects and falls|0|17.97795R|1
00016931|hypotension and falls|hypotension and falls|0|07.458909|1
00016932|delirium and insomnia|delirium and insomnia|0|16.78009I|1
00016933|sedation, extrapyramidal reactions, and falls|sedation, extrapyramidal reactions, and falls|0|16.78009J|1
00016934|sedation, cognitive impairment, hypotension & falls|sedation, cognitive impairment, hypotension and falls|0|16.78009K|1
00016935|steroid-induced hyperglycemia|steroid-induced hyperglycemia|0|16.790291|1
00016936|metastatic HER2-low carcinoma of breast|metastatic HER2-low carcinoma of breast|0|02.17491B|2
00016937|pain associated with endometriosis|pain associated with endometriosis|0|10.617901|2
00016938|bempedoic acid toxicity and ezetimibe toxicity|bempedoic acid toxicity and ezetimibe toxicity|0|17.97795S|1
00016939|hypercalcemia and hypermagnesemia|hypercalcemia and hypermagnesemia|0|03.275421|1
00016940|fluoride toxicity|fluoride toxicity|0|17.97795T|1
00016941|extrapyramidal rxn, excs anticholinergic effects & falls|extrapyramidal reactions, excessive anticholinergic effects and falls|0|06.333821|1
00016942|TCA toxicity, anticholinergic side effects and falls|tricyclic antidepressant toxicity, anticholinergic side effects and falls|0|17.97795U|1
00016943|excs anticholinergic effects, antipsych tx fail & falls|excessive anticholinergic effects, antipsychotic treatment failure and falls|0|17.97795V|1
00016944|EPS, anticholinergic effects, antipsych tx fail & falls|extrapyramidal reactions, anticholinergic effects, antipsychotic treatment failure and falls|0|06.333822|1
00016945|rhabdomyolysis, hypotension, myopathy and falls|rhabdomyolysis, hypotension, myopathy and falls|0|13.728894|1
00016946|urinary retention, anticholinergic side effects and fall|urinary retention, anticholinergic side effects and falls|0|16.788202|1
00016947|bone loss|bone loss|0|13.733004|2
00016948|sedation, extrapyramidal rxns, hypotension and falls|sedation, extrapyramidal reactions, hypotension and falls|0|16.78009L|1
00016949|increased mortality in older adults with dementia|increased mortality in older adults with dementia|0|05.294801|0
00016950|cardiac arrhythmia and dextromethorphan toxicity|cardiac arrhythmia and dextromethorphan toxicity|0|07.427908|1
00016951|CYP2C19 *1/*17 genotype|CYP2C19 *1/*17 genotype|0|03.27784G|2
00016952|HER2-mutant non-small cell lung cancer|HER2-mutant non-small cell lung cancer|0|02.162004|2
00016953|sedation, delirium and falls|sedation, delirium and falls|0|16.78009M|1
00016954|ixazomib toxicity|ixazomib toxicity|0|17.97795W|1
00016955|lanreotide toxicity|lanreotide toxicity|0|17.97795X|1
00016956|bleeding and anticholinergic toxicity|bleeding and anticholinergic toxicity|0|07.45900I|1
00016957|excessive CNS stimulation and NSAID toxicity|excessive CNS stimulation and NSAID toxicity|0|17.96060I|1
00016958|acetaminophen toxicity and dextromethorphan toxicity|acetaminophen toxicity and dextromethorphan toxicity|0|17.97795Y|1
00016959|hyponatremia and falls|hyponatremia and falls|0|03.276102|1
00016960|thiotepa toxicity|thiotepa toxicity|0|17.97795Z|1
00016961|hypotension and hypercalcemia|hypotension and hypercalcemia|0|07.458910|1
00016962|status epilepticus and CNS toxicity|status epilepticus and CNS toxicity|0|16.780301|1
00016963|triptan drug toxicity and NSAID toxicity|triptan drug toxicity and NSAID toxicity|0|17.977960|1
00016964|bleeding and excessive CNS stimulation|bleeding and excessive CNS stimulation|0|07.45900J|1
00016965|trametinib toxicity|trametinib toxicity|0|17.977961|1
00016966|hypotension, hyponatremia, and falls|hypotension, hyponatremia, and falls|0|07.458911|1
00016967|sedation, hypotension, and falls|sedation, hypotension, and falls|0|16.78009N|1
00016968|lofexidine toxicity|lofexidine toxicity|0|17.977962|1
00016969|setmelanotide toxicity|setmelanotide toxicity|0|17.977963|1
00016970|sotorasib toxicity|sotorasib toxicity|0|17.977964|1
00016971|satralizumab toxicity|satralizumab toxicity|0|17.977965|1
00016972|benzodiazepine toxicity and falls|benzodiazepine toxicity and falls|0|17.977966|1
00016973|unpredictable gene therapy treatment response|unpredictable gene therapy treatment response|0|18.V8750O|0
00016974|hyponatremia, excessive anticholinergic effects & falls|hyponatremia, excessive anticholinergic side effects, and falls|0|03.276103|1
00016975|hypotension, EPS, anticholinergic tox & falls|hypotension, extrapyramidal reactions, anticholinergic effects and falls|0|07.458912|1
00016976|nitrofurantoin toxicity|nitrofurantoin toxicity|0|17.977967|1
00016977|bleeding and dextromethorphan toxicity|bleeding and dextromethorphan toxicity|0|07.45900K|1
00016978|zileuton toxicity|zileuton toxicity|0|17.977968|1
00016979|corticosteroid toxicity|corticosteroid toxicity|0|17.977969|3
00016980|myeloid/lymphoid neoplasm with FGFR1 rearrangement|myeloid/lymphoid neoplasm with fibroblast growth factor receptor 1 (FGFR1) rearrangement|0|02.205008|2
00016981|torsade de pointes and sudden death|torsade de pointes and sudden death|0|07.427106|1
00016982|myelosuppression and nephrotoxicity|myelosuppression and nephrotoxicity|0|04.28480F|1
00016983|generalized pustular psoriasis flare|generalized pustular psoriasis flare|0|12.69610A|1
00016984|non-CNS manifestations of ASMD|non-CNS manifestations of acid sphingomyelinase deficiency|0|03.272704|2
00016985|uterine leiomyoma degeneration|uterine leiomyoma degeneration|0|02.218902|3
00016986|angina exacerbation|angina exacerbation|0|07.413914|1
00016987|sedation, delirium, hyponatremia, and falls|sedation, delirium, hyponatremia, and falls|0|16.78009O|1
00016988|sedation and falls|sedation and falls|0|16.78009P|1
00016989|adverse CNS effects, hyponatremia, and falls|adverse CNS effects, hyponatremia, and falls|0|06.34990D|1
00016990|QT prolongation and ozanimod treatment failure|QT prolongation and ozanimod treatment failure|0|07.42791F|1
00016991|QT prolongation and pacritinib treatment failure|QT prolongation and pacritinib treatment failure|0|07.42791G|1
00016992|unpredictable alpelisib response|unpredictable alpelisib response|0|18.V8750P|0
00016993|unpredictable aromatase inhibitor response|unpredictable aromatase inhibitor response|0|18.V8750Q|0
00016994|unpredictable belumosudil response|unpredictable belumosudil response|0|18.V8750R|0
00016995|unpredictable capmatinib response|unpredictable capmatinib response|0|18.V8750S|0
00016996|unpredictable dupilumab response|unpredictable dupilumab response|0|18.V8750T|0
00016997|unpredictable elagolix response|unpredictable elagolix response|0|18.V8750U|0
00016998|unpredictable cholinergic response|unpredictable cholinergic response|0|18.V8750V|0
00016999|unpredictable mavacamten response|unpredictable mavacamten response|0|18.V8750W|0
00017000|unpredictable cancer drug treatment response|unpredictable cancer drug treatment response|0|18.V8750X|0
00017001|unpredictable Helicobacter pylori treatment response|unpredictable Helicobacter pylori treatment response|0|18.V8750Y|0
00017002|unpredictable HIV treatment response|unpredictable HIV treatment response|0|18.V8750Z|0
00017003|QT prolongation & unpredictable cancer drug tx response|QT prolongation and unpredictable cancer drug treatment response|0|07.42791H|1
00017004|QT prolongation & unpredictable H pylori tx response|QT prolongation and unpredictable Helicobacter pylori treatment response|0|07.42791I|1
00017005|QT prolongation and unpredictable HIV treatment response|QT prolongation and unpredictable HIV treatment response|0|07.42791J|1
00017006|bipolar manic or hypomanic episode precipitation|bipolar manic or hypomanic episode precipitation|0|05.296403|1
00017007|hypertension exacerbation|hypertension exacerbation|0|07.401919|1
00017008|thrombotic microangiography|thrombotic microangiography|0|07.443906|1
00017009|gene therapy treatment failure|gene therapy treatment failure|0|18.V87510|1
00017010|RET-fusion positive solid tumor|RET-fusion positive solid tumor|0|02.199107|2
00017011|prevention of cisplatin-induced ototoxicity|prevention of cisplatin-induced ototoxicity|0|18.V07800|1
00017012|undiagnosed gynecological condition exacerbation|undiagnosed gynecological condition exacerbation|0|10.626902|3
00017013|levoketoconazole treatment failure|levoketoconazole treatment failure|0|18.V87511|1
00017014|ivosidenib toxicity and levoketoconazole tx failure|ivosidenib toxicity and levoketoconazole treatment failure|0|17.97796B|1
00017015|dementia with lewy bodies|dementia with lewy bodies|0|06.331821|2
00017016|increased gastrointestinal absorption|increased gastrointestinal absorption|0|09.579908|1
00017017|sodium phenylbutyrate-taurursodiol treatment failure|sodium phenylbutyrate-taurursodiol treatment failure|0|18.V87512|1
00017018|nasal ulcer|nasal ulcer|0|08.478116|1
00017019|seizure disorder and dextromethorphan toxicity|seizure disorder and dextromethorphan toxicity|0|16.780302|1
00017020|unpredictable sodium phenylbutyrate-taurursodiol respons|unpredictable sodium phenylbutyrate-taurursodiol response|0|18.V87513|0
00017021|adverse reactions from systemic estrogen|adverse reactions from systemic estrogen|0|03.256105|1
00017022|glucose-6-phosphate dehydrogenase deficient with CNSHA|glucose-6-phosphate dehydrogenase (G6PD) deficient with chronic nonspherocytic hemolytic anemia|0|04.282202|2
00017023|glucose-6-phosphate dehydrogenase variable activity|glucose-6-phosphate dehydrogenase (G6PD) variable activity|0|03.271002|2
00017024|glucose-6-phosphate dehydrogenase|glucose-6-phosphate dehydrogenase|0|03.27760G|0
00017025|glucose-6-phosphate dehydrogenase (G6PD) normal activity|glucose-6-phosphate dehydrogenase (G6PD) normal activity|0|03.271003|2
00017026|glucose-6-phosphate dehydrogenase indeterminate activity|glucose-6-phosphate dehydrogenase (G6PD) indeterminate activity|0|03.271004|2
00017027|unpredictable antiplatelet drug response|unpredictable antiplatelet drug response|0|18.V87514|0
00017028|unpredictable antithrombotic drug response|unpredictable antithrombotic drug response|0|18.V87515|0
00017029|excessive CNS depression and falls|excessive CNS depression and falls|0|16.799104|1
00017030|unpredictable levoketoconazole response|unpredictable levoketoconazole response|0|18.V87516|0
00017031|ivacaftor toxicity and levoketoconazole treatment fail|ivacaftor toxicity and levoketoconazole treatment failure|0|17.97796C|1
00017032|glucose-6-phosphate dehydrogenase (G6PD) deficient|glucose-6-phosphate dehydrogenase (G6PD) deficient|0|03.271005|2
00017033|G6PD ordered, result pending|glucose-6-phosphate dehydrogenase (G6PD) test ordered, result pending|0|03.277872|0
00017034|G6PD no result on file, not ordered|glucose-6-phosphate dehydrogenase (G6PD) no result on file, not currently ordered|0|03.277873|0
00017035|yellow fever vaccine adverse effects|yellow fever vaccine adverse effects|0|17.979302|1
00017036|sedation and hypotension|sedation and hypotension|0|16.78009Q|1
00017037|corticobasal degeneration|corticobasal degeneration|0|06.331600|2
00017038|acceleration of fetal lung maturation|acceleration of fetal lung maturation|0|18.V28890|1
00017039|acute bronchospasm|acute bronchospasm|0|08.519110|1
00017040|double risk opioid-induced resp depression & APAP tox|double risk opioid-induced respiratory depression and acetaminophen toxicity|0|19.E9352L|1
00017041|immune effector cell-associated neurotoxicity syndrome|immune effector cell-associated neurotoxicity syndrome|0|06.349820|1
00017042|hypoprolactinemia|hypoprolactinemia|0|03.253701|1
00017043|lack of treatment rationale in anuria|lack of treatment rationale in anuria|0|16.788503|0
00017044|unpredictable acalabrutinib response|unpredictable acalabrutinib response|0|18.V87517|0
00017045|histiocytic neoplasm|histiocytic neoplasm|0|02.202901|3
00017046|worsening depression and suicidality|worsening depression and suicidality|0|05.311004|1
00017047|EGFR-negative, ALK-negative, ROS1-negative NSCLC|EGFR-negative, ALK-negative, ROS1-negative non-small cell lung cancer|0|02.162005|2
00017048|QT prolongation and lithium toxicity|QT prolongation and lithium toxicity|0|07.42791K|1
00017049|infantile hypertrophic pyloric stenosis|infantile hypertrophic pyloric stenosis|0|14.750500|1
00017050|incorrect vaccine product for patient's age|incorrect vaccine product for patient's age|0|18.V64090|0
00017051|CNS depression and paradoxical excitation|CNS depression and paradoxical excitation|0|16.799105|1
00017052|inappropriate pediatric dose|inappropriate pediatric dose|0|18.V64100|0
00017053|methemoglobinemia and extrapyramidal reactions|methemoglobinemia and extrapyramidal reactions|0|04.289701|1
00017054|folate receptor alpha positive epithelial ovarian cancer|folate receptor alpha positive epithelial ovarian cancer|0|02.183004|2
00017055|seizures due to drug accumulation in renal impairment|seizures due to drug accumulation in renal impairment|0|06.34590A|1
00017056|delay onset of stage 3 type 1 diabetes mellitus|delay onset of stage 3 type 1 diabetes mellitus|0|03.250012|2
00017057|exposure to berkelium radiation|exposure to berkelium radiation|0|19.E92654|1
00017058|exposure to californium radiation|exposure to californium radiation|0|19.E92655|1
00017059|lack of tx rationale in ARV tx-experienced pts with CKD5|lack of treatment rationale in antiretroviral treatment-experienced patients with CKD 5 on dialysis|0|10.585502|0
00017060|accel of barium meal transit through the small bowel|acceleration of barium meal transit through the small bowel|0|16. 87630|1
00017061|lactic acidosis and gastrointestinal adverse reactions|lactic acidosis and gastrointestinal adverse reactions|0|03.276212|1
00017062|lack of treatment rationale in CKD stages 4 and 5|lack of treatment rationale in chronic kidney disease stages 4 and 5|0|10.585401|0
00017063|neonatal seizure|neonatal seizure|0|14.779000|3
00017064|recurrent Clostridioides difficile infection|recurrent Clostridioides difficile infection|0|01.008452|2
00017065|CYP2C gene cluster|CYP2C gene cluster|0|03.27785I|2
00017066|CYP2C gene rs12777823 A carrier|CYP2C gene rs12777823 A carrier|0|03.27785H|0
00017067|PGX combination 147|PGX combination 147|0|00.000147|2
00017068|PGX combination 148|PGX combination 148|0|00.000148|2
00017069|CYP2C9 *5 carrier|CYP2C9 *5 carrier|0|03.27785D|2
00017070|CYP2C9 *6 carrier|CYP2C9 *6 carrier|0|03.27785E|2
00017071|CYP2C9 *8 carrier|CYP2C9 *8 carrier|0|03.27785F|2
00017072|CYP2C9 *11 carrier|CYP2C9 *11 carrier|0|03.27785G|0
00017073|VKORC1 test ordered, result pending|VKORC1 test ordered, result pending|0|03.277874|0
00017074|VKORC1 no result on file, not currently ordered|VKORC1 no result on file, not currently ordered|0|03.277875|0
00017075|PGX combination 101|PGX combination 101|0|00.000101|2
00017076|PGX combination 102|PGX combination 102|0|00.000102|2
00017077|PGX combination 103|PGX combination 103|0|00.000103|2
00017078|PGX combination 104|PGX combination 104|0|00.000104|2
00017079|PGX combination 105|PGX combination 105|0|00.000105|2
00017080|PGX combination 106|PGX combination 106|0|00.000106|2
00017081|PGX combination 107|PGX combination 107|0|00.000107|2
00017082|PGX combination 108|PGX combination 108|0|00.000108|2
00017083|PGX combination 109|PGX combination 109|0|00.000109|2
00017084|PGX combination 110|PGX combination 110|0|00.000110|2
00017085|PGX combination 111|PGX combination 111|0|00.000111|2
00017086|PGX combination 112|PGX combination 112|0|00.000112|2
00017087|PGX combination 113|PGX combination 113|0|00.000113|3
00017088|PGX combination 114|PGX combination 114|0|00.000114|2
00017089|PGX combination 115|PGX combination 115|0|00.000115|2
00017090|PGX combination 116|PGX combination 116|0|00.000116|2
00017091|PGX combination 117|PGX combination 117|0|00.000117|2
00017092|alveolar soft part sarcoma|alveolar soft part sarcoma|0|02.171909|3
00017093|PGX combination 118|PGX combination 118|0|00.000118|2
00017094|PGX combination 119|PGX combination 119|0|00.000119|2
00017095|PGX combination 120|PGX combination 120|0|00.000120|2
00017096|PGX combination 121|PGX combination 121|0|00.000121|2
00017097|PGX combination 122|PGX combination 122|0|00.000122|2
00017098|PGX combination 123|PGX combination 123|0|00.000123|2
00017099|PGX combination 124|PGX combination 124|0|00.000124|2
00017100|PGX combination 125|PGX combination 125|0|00.000125|2
00017101|PGX combination 126|PGX combination 126|0|00.000126|2
00017102|PGX combination 127|PGX combination 127|0|00.000127|2
00017103|PGX combination 128|PGX combination 128|0|00.000128|2
00017104|PGX combination 129|PGX combination 129|0|00.000129|2
00017105|PGX combination 130|PGX combination 130|0|00.000130|2
00017106|PGX combination 131|PGX combination 131|0|00.000131|2
00017107|PGX combination 132|PGX combination 132|0|00.000132|2
00017108|PGX combination 133|PGX combination 133|0|00.000133|2
00017109|PGX combination 134|PGX combination 134|0|00.000134|2
00017110|PGX combination 135|PGX combination 135|0|00.000135|2
00017111|PGX combination 136|PGX combination 136|0|00.000136|2
00017112|PGX combination 137|PGX combination 137|0|00.000137|2
00017113|PGX combination 138|PGX combination 138|0|00.000138|2
00017114|PGX combination 139|PGX combination 139|0|00.000139|2
00017115|PGX combination 140|PGX combination 140|0|00.000140|2
00017116|PGX combination 141|PGX combination 141|0|00.000141|2
00017117|PGX combination 142|PGX combination 142|0|00.000142|2
00017118|PGX combination 143|PGX combination 143|0|00.000143|2
00017119|PGX combination 144|PGX combination 144|0|00.000144|2
00017120|PGX combination 145|PGX combination 145|0|00.000145|2
00017121|PGX combination 146|PGX combination 146|0|00.000146|2
00017122|PGX combination 149|PGX combination 149|0|00.000149|2
00017123|PGX combination 150|PGX combination 150|0|00.000150|2
00017124|PGX combination 151|PGX combination 151|0|00.000151|2
00017125|PGX combination 152|PGX combination 152|0|00.000152|2
00017126|PGX combination 153|PGX combination 153|0|00.000153|2
00017127|PGX combination 154|PGX combination 154|0|00.000154|2
00017128|PGX combination 155|PGX combination 155|0|00.000155|2
00017129|PGX combination 156|PGX combination 156|0|00.000156|2
00017130|PGX combination 157|PGX combination 157|0|00.000157|2
00017131|PGX combination 158|PGX combination 158|0|00.000158|2
00017132|PGX combination 159|PGX combination 159|0|00.000159|2
00017133|PGX combination 160|PGX combination 160|0|00.000160|2
00017134|PGX combination 161|PGX combination 161|0|00.000161|2
00017135|PGX combination 162|PGX combination 162|0|00.000162|2
00017136|PGX combination 163|PGX combination 163|0|00.000163|2
00017137|PGX combination 164|PGX combination 164|0|00.000164|2
00017138|PGX combination 165|PGX combination 165|0|00.000165|2
00017139|PGX combination 166|PGX combination 166|0|00.000166|2
00017140|PGX combination 167|PGX combination 167|0|00.000167|2
00017141|PGX combination 168|PGX combination 168|0|00.000168|2
00017142|PGX combination 169|PGX combination 169|0|00.000169|2
00017143|PGX combination 170|PGX combination 170|0|00.000170|2
00017144|PGX combination 171|PGX combination 171|0|00.000171|2
00017145|PGX combination 172|PGX combination 172|0|00.000172|2
00017146|PGX combination 173|PGX combination 173|0|00.000173|2
00017147|PGX combination 174|PGX combination 174|0|00.000174|2
00017148|PGX combination 175|PGX combination 175|0|00.000175|2
00017149|PGX combination 176|PGX combination 176|0|00.000176|2
00017150|PGX combination 177|PGX combination 177|0|00.000177|2
00017151|PGX combination 178|PGX combination 178|0|00.000178|2
00017152|PGX combination 179|PGX combination 179|0|00.000179|2
00017153|PGX combination 180|PGX combination 180|0|00.000180|2
00017154|PGX combination 181|PGX combination 181|0|00.000181|2
00017155|PGX combination 182|PGX combination 182|0|00.000182|2
00017156|PGX combination 183|PGX combination 183|0|00.000183|2
00017157|PGX combination 184|PGX combination 184|0|00.000184|2
00017158|PGX combination 185|PGX combination 185|0|00.000185|2
00017159|PGX combination 186|PGX combination 186|0|00.000186|2
00017160|PGX combination 187|PGX combination 187|0|00.000187|2
00017161|PGX combination 188|PGX combination 188|0|00.000188|2
00017162|PGX combination 189|PGX combination 189|0|00.000189|2
00017163|PGX combination 190|PGX combination 190|0|00.000190|2
00017164|PGX combination 191|PGX combination 191|0|00.000191|2
00017165|PGX combination 192|PGX combination 192|0|00.000192|2
00017166|PGX combination 193|PGX combination 193|0|00.000193|2
00017167|PGX combination 194|PGX combination 194|0|00.000194|2
00017168|PGX combination 195|PGX combination 195|0|00.000195|2
00017169|PGX combination 196|PGX combination 196|0|00.000196|2
00017170|PGX combination 197|PGX combination 197|0|00.000197|2
00017171|PGX combination 198|PGX combination 198|0|00.000198|2
00017172|PGX combination 199|PGX combination 199|0|00.000199|2
00017173|PGX combination 200|PGX combination 200|0|00.000200|2
00017174|alprostadil treatment failure|alprostadil treatment failure|0|18.V87518|1
00017175|disseminated adenovirus infection|disseminated adenovirus infection|0|01.079000|1
00017176|pexidartinib toxicity and HIV treatment failure|pexidartinib toxicity and HIV treatment failure|0|17.97796D|1
00017177|mitapivat toxicity and HIV treatment failure|mitapivat toxicity and HIV treatment failure|0|17.97796E|1
00017178|bosentan toxicity and HIV treatment failure|bosentan toxicity and HIV treatment failure|0|17.97796F|1
00017179|immunoglobulin M deficiency|immunoglobulin M deficiency|0|03.279020|3
00017180|weight loss management, obese adolescent|weight loss management, obese adolescent (BMI 95th percentile or greater for age and sex)|0|03.27800A|3
00017181|inc autologous blood from pts in predonation programs|increase yield of autologous blood from patients in predonation programs|0|04.285903|1
00017182|significant uterine bleeding|significant uterine bleeding|0|10.626802|1
00017183|disseminated infection|disseminated infection|0|01.136906|3
00017184|eschar removal from thermal burn wound|eschar removal from thermal burn wound|0|17.949003|1
00017185|severe bleeding|severe bleeding|0|07.459007|1
00017186|skin graft complication|skin graft complication|0|17.996521|3
00017187|3rd tri Tdap vaccination to prevent pertussis in infant|Tdap vaccination during third trimester pregnancy to prevent pertussis in infant|0|18.V06101|1
00017188|neonatal gasping syndrome|neonatal gasping syndrome|0|15.770890|1
00017189|unclear pediatric risk due to limited or no human data|unclear pediatric risk due to limited or no human data|0|18.V15900|0
00017190|hypertension and cardiac arrhythmia|hypertension and cardiac arrhythmia|0|07.401904|1
00017191|bronchospasm prevention with asthma|bronchospasm prevention with asthma|0|08.49390A|2
00017192|wild-type RAS, HER2-positive colorectal cancer|wild-type RAS, HER2-positive colorectal cancer|0|02.154002|2
00017193|compulsive gambling|compulsive gambling|0|05.312310|3
00017194|penile injury|penile injury|0|10.607902|1
00017195|hepatotoxicity and chenodiol treatment failure|hepatotoxicity and chenodiol treatment failure|0|09.573310|1
00017196|elacestrant toxicity|elacestrant toxicity|0|17.97796G|1
00017197|ER-positive, HER2-negative, ESR1-mutated breast cancer|ER-positive, HER2-negative, ESR1-mutated breast cancer|0|02.17491C|2
00017198|pirtobrutinib toxicity and lonafarnib toxicity|pirtobrutinib toxicity and lonafarnib toxicity|0|17.97796H|1
00017199|eczema vaccinatum|eczema vaccinatum|0|19.E94900|1
00017200|inappropriate dose form|inappropriate dose form|0|18.V64101|0
00017201|thromboembolism and hypertension|thromboembolism and hypertension|0|07.444903|1
00017202|decreased systemic drug level due to tobacco smoking|decreased systemic drug level due to tobacco smoking|0|09.579909|1
00017203|tenofovir alafenamide toxicity|tenofovir alafenamide toxicity|0|17.97796I|1
00017204|lactic acidosis due to hypoxic states|lactic acidosis due to hypoxic states|0|03.276213|1
00017205|bleeding due to drug accumulation in chronic kidney dx|bleeding due to drug accumulation in chronic kidney disease|0|04.28690A|1
00017206|thromboembolic event d/t acq or genetic predisposition|thromboembolic event due to acquired or genetic predisposition|0|17.996711|1
00017207|TE due to atherosclerosis from tobacco smoking|thromboembolic event due to atherosclerosis from tobacco smoking|0|17.996712|1
00017208|opioid induced resp dep d/t drug accumu in renal imp|opioid induced respiratory depression due to drug accumulation in renal impairment|0|19.E9352M|1
00017209|seizures due to chronic alcoholism|seizures due to chronic alcoholism|0|06.34590B|1
00017210|sulfasalazine tox d/t urinary tract obstructive uropathy|sulfasalazine toxicity due to urinary tract obstructive uropathy|0|17.97796J|1
00017211|sulfasalazine toxicity due to GI obstruction|sulfasalazine toxicity due to gastrointestinal obstruction|0|17.97796K|1
00017212|hyperkalemia d/t drug accum in severe hepatic impairment|hyperkalemia due to drug accumulation in severe hepatic impairment|0|03.276706|1
00017213|hyperkalemia due to drug accumulation in CKD|hyperkalemia due to drug accumulation in chronic kidney disease|0|03.276707|1
00017214|arrhythmia d/t drug accum in hepatic impairment|cardiac arrhythmia due to drug accumulation in hepatic impairment|0|07.427909|1
00017215|cardiac arrhythmia due to drug accumulation in CKD|cardiac arrhythmia due to drug accumulation in chronic kidney disease|0|07.42790A|1
00017216|severe hypersensitivity reaction|severe hypersensitivity reaction|0|17.995270|2
00017217|critical intolerance reaction|critical intolerance reaction|0|17.995271|2
00017218|hypersensitivity reaction|hypersensitivity reaction|0|17.995272|2
00017219|moderate hypersensitivity reaction|moderate hypersensitivity reaction|0|17.995273|2
00017220|mild hypersensitivity reaction|mild hypersensitivity reaction|0|17.995274|2
00017221|allergic reaction with unclear reaction history|allergic reaction with unclear reaction history|0|17.995275|2
00017222|adv rxn that may be hypersensitivity or intolerance|adverse reaction that may be hypersensitivity or intolerance|0|17.995276|2
00017223|severe intolerance reaction|severe intolerance reaction|0|17.995277|2
00017224|intolerance reaction|intolerance reaction|0|17.995278|2
00017225|moderate intolerance reaction|moderate intolerance reaction|0|17.995279|2
00017226|mild intolerance reaction|mild intolerance reaction|0|17.99527A|2
00017227|opioid ind resp dep d/t drug accum in hepatic impairment|opioid induced respiratory depression due to drug accumulation in hepatic impairment|0|19.E9352N|1
00017228|pitolisant tox due to drug accum in severe hepatic dx|pitolisant toxicity due to drug accumulation in severe hepatic disease|0|17.97796L|1
00017229|pitolisant toxicity due to drug accumulation in CKD|pitolisant toxicity due to drug accumulation in chronic kidney disease|0|17.97796M|1
00017230|triptan drug tox d/t drug accum in hepatic impairment|triptan drug toxicity due to drug accumulation in hepatic impairment|0|17.97796N|1
00017231|triptan drug toxicity due to drug accumulation in CKD|triptan drug toxicity due to drug accumulation in chronic kidney disease|0|17.97796O|1
00017232|thromboembolic event due to drug accumulation in CKD|thromboembolic event due to drug accumulation in chronic kidney disease|0|17.996713|1
00017233|risperidone tox d/t drug accum in hepatic impairment|risperidone toxicity due to drug accumulation in hepatic impairment|0|17.97796P|1
00017234|risperidone toxicity due to drug accumulation in CKD|risperidone toxicity due to drug accumulation in chronic kidney disease|0|17.97796Q|1
00017235|thromboembolic event due to risks related to obesity|thromboembolic event due to risk factors related to obesity|0|17.996714|1
00017236|lurasidone tox d/t drug accum in severe hepatic dx|lurasidone toxicity due to drug accumulation in severe hepatic disease|0|17.97796R|1
00017237|lurasidone toxicity due to drug accumulation in CKD|lurasidone toxicity due to drug accumulation in chronic kidney disease|0|17.97796S|1
00017238|metoclopramide tox d/t drug accum in hepatic dx|metoclopramide toxicity due to drug accumulation in hepatic disease|0|17.97796T|1
00017239|metoclopramide toxicity due to drug accumulation in CKD|metoclopramide toxicity due to drug accumulation in chronic kidney disease|0|17.97796U|1
00017240|rhabdo & myopathy d/t drug accum in severe hepatic dx|rhabdomyolysis and myopathy due to drug accumulation in severe hepatic disease|0|13.728895|1
00017241|rhabdomyolysis and myopathy d/t drug accum in CKD|rhabdomyolysis and myopathy due to drug accumulation in chronic kidney disease|0|13.728896|1
00017242|respiratory depression and aspiration pneumonia|respiratory depression and aspiration pneumonia|0|08.518825|1
00017243|ruxolitinib tox d/t drug accum in severe hepatic dx|ruxolitinib toxicity due to drug accumulation in severe hepatic disease|0|17.97796V|1
00017244|ruxolitinib toxicity due to drug accumulation in CKD|ruxolitinib toxicity due to drug accumulation in chronic kidney disease|0|17.97796X|1
00017245|ixazomib tox d/t drug accumulation in hepatic dx|ixazomib toxicity due to drug accumulation in hepatic disease|0|17.97796Y|1
00017246|ixazomib toxicity due to drug accumulation in CKD|ixazomib toxicity due to drug accumulation in chronic kidney disease|0|17.97796Z|1
00017247|lomitapide toxicity due to drug accumulation in CKD|lomitapide toxicity due to drug accumulation in chronic kidney disease|0|17.977970|1
00017248|pemigatinib tox d/t drug accum in severe hepatic dx|pemigatinib toxicity due to drug accumulation in severe hepatic disease|0|17.977971|1
00017249|pemigatinib toxicity due to drug accumulation in CKD|pemigatinib toxicity due to drug accumulation in chronic kidney disease|0|17.977972|1
00017250|solifenacin toxicity due to drug accumulation in CKD|solifenacin toxicity due to drug accumulation in chronic kidney disease|0|17.977973|1
00017251|solifenacin tox d/t drug accum in hepatic dx|solifenacin toxicity due to drug accumulation in hepatic disease|0|17.977974|2
00017252|thromboembolic event d/t drug accum in severe hepatic dx|thromboembolic event due to drug accumulation in severe hepatic disease|0|17.996715|1
00017253|beta blocker toxicity due to drug accumulation in CKD|beta blocker toxicity due to drug accumulation in chronic kidney disease|0|17.977975|1
00017254|bleeding due to severe uncontrolled hypertension|bleeding due to severe uncontrolled hypertension|0|04.28690B|1
00017255|hepatotoxicity and excessive angiotensin inhibition|hepatotoxicity and excessive angiotensin inhibition|0|09.573303|1
00017256|opioid-induced resp dep due to decreased resp reserve|opioid-induced resp dep due to decreased respiratory reserve|0|19.E9352O|1
00017257|sparsentan treatment failure|sparsentan treatment failure|0|18.V87519|1
00017258|hepatotoxicity due to alcoholism|hepatotoxicity due to alcoholism|0|09.573311|1
00017259|acute pancreatitis due to alcoholism|acute pancreatitis due to alcoholism|0|09.577003|1
00017260|gastrointestinal bleeding due to alcoholism|gastrointestinal bleeding due to alcoholism|0|09.578908|1
00017261|methotrexate toxicity due to renal impairment|methotrexate toxicity due to renal impairment|0|17.977976|1
00017262|nonexudative age-related macular degeneration|nonexudative age-related macular degeneration|0|06.362510|2
00017263|seizures associated with CNS disorder|seizures associated with CNS disorder|0|06.34590C|1
00017264|hepatotoxicity due to acetaminophen overdose|hepatotoxicity due to acetaminophen overdose|0|09.573312|1
00017265|bleeding due to bacterial endocarditis|bleeding due to bacterial endocarditis|0|07.45900L|1
00017266|seizures d/t drug accumulation in severe hepatic disease|seizures due to drug accumulation in severe hepatic disease|0|06.34590D|1
00017267|seizures due to alcohol withdrawal|seizures due to alcohol withdrawal|0|06.34590E|1
00017268|acute pancreatitis due to severe hypertriglyceridemia|acute pancreatitis due to severe hypertriglyceridemia|0|09.577004|1
00017269|increased lung absorption|increased lung absorption|0|09.579910|3
00017270|excessive CNS depression due to alcoholism|excessive CNS depression due to alcoholism|0|16.799106|1
00017271|worsening suicidality or overdosage|worsening suicidality or overdosage|0|05.300904|1
00017272|postoperative opioid-induced respiratory depression|postoperative opioid-induced respiratory depression|0|19.E9352P|1
00017273|myocarditis and pericarditis|myocarditis and pericarditis|0|07.429002|3
00017274|drug dependence or improper use|drug dependence or improper use|0|05.304902|3
00017275|omaveloxolone treatment failure|omaveloxolone treatment failure|0|18.V8751A|1
00017276|hepatotoxicity and hyperlipidemia|hepatotoxicity and hyperlipidemia|0|09.573302|1
00017277|opioid-induced resp depression d/t hypoventilation|opioid-induced respiratory depression due to hypoventilation|0|19.E9352Q|1
00017278|zidovudine toxicity d/t drug accum in severe hepatic dx|zidovudine toxicity due to drug accumulation in severe hepatic disease|0|17.977977|1
00017279|zidovudine toxicity due to drug accumulation in CKD|zidovudine toxicity due to drug accumulation in chronic kidney disease|0|17.977978|1
00017280|peripheral vasospasm|peripheral vasospasm|0|07.443901|1
00017281|quinine toxicity due to drug accum in renal impairment|quinine toxicity due to drug accumulation in renal impairment|0|17.977979|1
00017282|quinidine toxicity due to drug accum in renal impairment|quinidine toxicity due to drug accumulation in renal impairment|0|17.97797A|1
00017283|Rett syndrome|Rett syndrome|0|06.330802|2
00017284|adverse reaction from elevated drug levels in renal imp|adverse reaction from elevated drug levels in renal impairment|0|99.999916|1
00017285|gastrointestinal bleeding due to gastrointestinal ulcer|gastrointestinal bleeding due to gastrointestinal ulcer|0|09.578909|1
00017286|zavegepant treatment failure|zavegepant treatment failure|0|18.V8751B|1
00017287|organic anion transporting polypeptide 1B3|organic anion transporting polypeptide 1B3 (OATP1B3)|0|03.27782H|0
00017288|lonafarnib toxicity and lefamulin toxicity|lonafarnib toxicity and lefamulin toxicity|0|17.97797B|1
00017289|mitapivat toxicity and fedratinib treatment failure|mitapivat toxicity and fedratinib treatment failure|0|17.97797C|1
00017290|bosentan toxicity and fedratinib treatment failure|bosentan toxicity and fedratinib treatment failure|0|17.97797D|1
00017291|low grade glioma with BRAF V600E mutation|low grade glioma with BRAF V600E mutation|0|02.191904|2
00017292|amifampridine tox d/t drug accum in hepatic impairment|amifampridine toxicity due to drug accumulation in hepatic impairment|0|17.97797E|1
00017293|excess sedation d/t drug accum in hepatic impairment|excessive sedation due to drug accumulation in hepatic impairment|0|16.78009R|1
00017294|QT prolongation d/t drug accum in hepatic imp|QT prolongation due to drug accumulation in hepatic impairment|0|07.42791L|1
00017295|eluxadoline tox d/t drug accum in hepatic impairment|eluxadoline toxicity due to drug accumulation in hepatic impairment|0|17.97797F|1
00017296|opioid induced respiratory depression due to COPD|opioid induced respiratory depression due to COPD|0|19.E9352R|1
00017297|excess cholinergic effects d/t drug accum in hepatic dx|excessive cholinergic effects due to drug accumulation in hepatic impairment|0|17.97797G|1
00017298|GI adv effects d/t drug accum in hepatic impairment|gastrointestinal adverse effects due to drug accumulation in hepatic impairment|0|09.536904|1
00017299|excess CNS depression d/t drug accum in hepatic impair|excessive CNS depression due to drug accumulation in hepatic impairment|0|16.799107|1
00017300|excess angiotensin inhib d/t drug accum in hepat impair|excessive angiotensin inhibition due to drug accumulation in hepatic impairment|0|17.96060J|1
00017301|PDE5 inhibitor tox d/t drug accum in hepatic disease|phosphodiesterase type 5 inhibitor toxicity due to drug accumulation in hepatic disease|0|17.97797H|1
00017302|venlafaxine tox d/t drug accum in hepatic impairment|venlafaxine toxicity due to drug accumulation in hepatic impairment|0|17.97797I|1
00017303|ribociclib toxicity due to drug accumul in hepatic imp|ribociclib toxicity due to drug accumulation in hepatic impairment|0|17.97797J|1
00017304|bosutinib toxicity d/t drug accum in hepatic impairment|bosutinib toxicity due to drug accumulation in hepatic impairment|0|17.97797K|1
00017305|opioid-induced resp depression, bleeding, and APAP tox|opioid-induced respiratory depression, bleeding, and acetaminophen toxicity|0|19.E9352S|1
00017306|opioid use disorder|opioid use disorder|0|05.305500|3
00017307|lamotrigine induced skin reactions|lamotrigine induced skin reactions|0|17.966304|1
00017308|lamotrigine treatment failure|lamotrigine treatment failure|0|18.V8751C|1
00017309|leniolisib treatment failure|leniolisib treatment failure|0|18.V8751D|1
00017310|activated phosphoinositide 3-kinase delta syndrome|activated phosphoinositide 3-kinase delta syndrome|0|03.279202|2
00017311|anticoagulant-related nephropathy|anticoagulant-related nephropathy|0|10.583892|3
00017312|unpredictable lamotrigine response|unpredictable lamotrigine response|0|18.V8751E|0
00017313|tolterodine toxicity due to drug accumulation in hep imp|tolterodine toxicity due to drug accumulation in hepatic impairment|0|17.97797L|1
00017314|gold toxicity due to drug accumulation in CKD|gold toxicity due to drug accumulation in chronic kidney disease|0|17.97797M|1
00017315|duloxetine toxicity due to drug accum in hepatic disease|duloxetine toxicity due to drug accumulation in severe hepatic disease|0|17.97797N|1
00017316|mercaptopurine tox d/t drug accum in hepatic disease|mercaptopurine toxicity due to drug accumulation in severe hepatic disease|0|17.97797O|1
00017317|hypotension due to drug accum in severe hepatic disease|hypotension due to drug accumulation in severe hepatic disease|0|07.458913|1
00017318|nausea d/t drug accumulation in severe hepatic disease|nausea due to drug accumulation in severe hepatic disease|0|16.787021|1
00017319|pexidartinib toxicity d/t drug accu in severe hepatic dx|pexidartinib toxicity due to drug accumulation in severe hepatic disease|0|17.97797P|1
00017320|bleeding and thromboembolic event|bleeding and thromboembolic event|0|07.45900M|1
00017321|adjunct therapy for chronic hepatic failure|adjunct therapy for chronic hepatic failure|0|09.572801|2
00017322|opioid induced respiratory depression prophylaxis|opioid induced respiratory depression prophylaxis|0|18.V07801|0
00017323|opioid induced hyperalgesia|opioid induced hyperalgesia|0|19.E9352T|3
00017324|opioid induced allodynia|opioid induced allodynia|0|19.E9352U|3
00017325|bortezomib toxicity|bortezomib toxicity|0|17.97797Q|1
00017326|allogeneic HSCT neutrophil recovery|allogeneic hematopoietic stem cell transplant neutrophil recovery|0|18.V49830|1
00017327|engraftment syndrome|engraftment syndrome|0|17.996853|1
00017328|unpredictable cancer drug tx and antibiotic response|unpredictable cancer drug treatment response and unpredictable antibiotic response|0|18.V8751F|0
00017329|unpredictable voxelotor response|unpredictable voxelotor response|0|18.V8751G|0
00017330|unpredictable pexidartinib and voxelotor response|unpredictable pexidartinib response and unpredictable voxelotor response|0|18.V8751H|0
00017331|amyotrophic lateral sclerosis with SOD1 gene mutation|amyotrophic lateral sclerosis with superoxide dismutase gene mutation|0|06.335201|2
00017332|radiculitis|radiculitis|0|13.729203|1
00017333|palilalia|palilalia|0|16.784504|3
00017334|CYP2D6 indeterminate activity|CYP2D6 indeterminate activity|0|03.277891|2
00017335|CYP2C19 indeterminate activity|CYP2C19 indeterminate activity|0|03.277892|2
00017336|CYP2B6 indeterminate activity|CYP2B6 indeterminate activity|0|03.277893|2
00017337|PGX combination 201|PGX combination 201|0|00.000201|2
00017338|PGX combination 202|PGX combination 202|0|00.000202|2
00017339|PGX combination 203|PGX combination 203|0|00.000203|2
00017340|PGX combination 204|PGX combination 204|0|00.000204|2
00017341|PGX combination 205|PGX combination 205|0|00.000205|2
00017342|PGX combination 206|PGX combination 206|0|00.000206|2
00017343|PGX combination 207|PGX combination 207|0|00.000207|2
00017344|PGX combination 208|PGX combination 208|0|00.000208|2
00017345|dystrophic epidermolysis bullosa|dystrophic epidermolysis bullosa|0|14.757392|2
00017346|eumycotic mycetoma|eumycotic mycetoma|0|01.117400|3
00017347|functional constipation|functional constipation|0|09.564005|3
00017348|ritlecitinib treatment failure|ritlecitinib treatment failure|0|18.V8751I|1
00017349|MuSK antibody positive generalized myasthenia gravis|anti-muscle-specific tyrosine kinase (MuSK) antibody positive generalized myasthenia gravis|0|06.358004|2
00017350|ivosidenib toxicity and imatinib treatment failure|ivosidenib toxicity and imatinib treatment failure|0|17.97797R|1
00017351|palovarotene toxicity|palovarotene toxicity|0|17.97797S|1
00017352|palovarotene treatment failure|palovarotene treatment failure|0|18.V8751J|1
00017353|colchicine toxicity d/t drug accum in severe hepatic dx|colchicine toxicity due to drug accumulation in severe hepatic disease|0|17.97797T|1
00017354|unpredictable palovarotene response|unpredictable palovarotene response|0|18.V8751K|0
00017355|cardiovascular disease associated with T2DM|cardiovascular disease associated with type 2 diabetes mellitus|0|03.250701|2
00017356|ivosidenib toxicity and nilotinib treatment failure|ivosidenib toxicity and nilotinib treatment failure|0|17.97797U|1
00017357|ivosidenib toxicity and ceritinib treatment failure|ivosidenib toxicity and ceritinib treatment failure|0|17.97797V|1
00017358|ivosidenib toxicity and idelalisib treatment failure|ivosidenib toxicity and idelalisib treatment failure|0|17.97797W|1
00017359|presence of cochlear implant|presence of cochlear implant|0|18.V45890|2
00017360|hyposplenism|hyposplenism|0|04.289593|2
00017361|cerebrospinal fluid leak|cerebrospinal fluid leak|0|06.349893|3
00017362|incontinence|incontinence|0|16.788301|3
00017363|anal fistula|anal fistula|0|09.565101|3
00017364|Demodex blepharitis|Demodex blepharitis|0|06.373003|1
00017365|Kounis syndrome|Kounis syndrome|0|07.411891|1
00017366|ivosidenib toxicity and adagrasib treatment failure|ivosidenib toxicity and adagrasib treatment failure|0|17.97797X|1
00017367|risk mitigation for opioid overdose|risk mitigation for opioid overdose|0|17.965002|0
00017368|foveolar hyperplasia|foveolar hyperplasia|0|09.537891|3
00017369|nosocomial pneumonia due to Acinetobacter baumannii|nosocomial pneumonia due to Acinetobacter baumannii-calcoaceticus complex|0|08.482834|1
00017370|ventilator-associated pneumonia due to Acinetobacter|ventilator-associated pneumonia due to Acinetobacter|0|17.997311|1
00017371|lactic acidosis and adv rxn from exceeding max ARV dose|lactic acidosis and adverse reactions from exceeding maximum antiretroviral dose|0|03.276214|1
00017372|zuranolone treatment failure|zuranolone treatment failure|0|18.V8751L|1
00017373|vascular dementia|vascular dementia|0|05.290400|2
00017374|niraparib toxicity and abiraterone toxicity|niraparib toxicity and abiraterone toxicity|0|17.97797Y|1
00017375|adv reactions from elevated antiretroviral drug levels|adverse reactions from elevated antiretroviral drug levels|0|17.97797Z|1
00017376|adv rxn fr exceed max ARV dose & elevated ARV drug lvls|adverse reactions from exceeding maximum antiretroviral dose and elevated antiretroviral drug levels|0|17.977980|1
00017377|fibrodysplasia ossificans progressiva|fibrodysplasia ossificans progressiva|0|13.728110|2
00017378|complement hyperactivation angiopathic thrombosis PLE|complement hyperactivation angiopathic thrombosis protein losing enteropathy|0|03.279805|2
00017379|inferred pregnancy: contraindicated in pregnancy|inferred pregnancy: contraindicated in pregnancy|0|18.V22218|1
00017380|inferred pregnancy: severe risk in pregnancy|inferred pregnancy: severe risk in pregnancy|0|18.V22219|1
00017381|inferred pregnancy: unclear risk in pregnancy|inferred pregnancy: unclear risk in pregnancy|0|18.V22220|1
00017382|pozelimab treatment failure|pozelimab treatment failure|0|18.V8751M|1
00017383|RSV vaccine at 32-36 wks gest to prevent RSV in infant|RSV vaccination at 32 to 36 weeks gestation to prevent RSV in infant|0|18.V04820|1
00017384|migalastat treatment failure|migalastat treatment failure|0|18.V8751N|1
00017385|mianserin treatment failure|mianserin treatment failure|0|18.V8751O|1
00017386|reduced biologic treatment effectiveness|reduced biologic treatment effectiveness|0|18.V8751P|1
00017387|acute kidney injury|acute kidney injury|0|10.584900|1
00017388|diabetic neuropathic or ischemic foot ulcer|diabetic neuropathic or ischemic foot ulcer|0|03.250801|3
00017389|gepirone treatment failure|gepirone treatment failure|0|18.V8751Q|1
00017390|QT prolongation and gepirone treatment failure|QT prolongation and gepirone treatment failure|0|07.42791M|1
00017391|cocaine use disorder|cocaine use disorder|0|05.292901|3
00017392|berotralstat toxicity and voclosporin toxicity|berotralstat toxicity and voclosporin toxicity|0|17.977981|1
00017393|acute disseminated candidiasis|acute disseminated candidiasis|0|01.112504|1
00017394|injection site abscess|injection site abscess|0|17.999391|1
00017395|prenatal vitamin screening for inferred pregnancy|prenatal vitamin screening for inferred pregnancy|0|15.779904|0
00017396|not recommended in breastfeeding d/t HIV transmn risk|generally not recommended in breastfeeding due to risk of HIV transmission to the infant|0|18.V2410D|0
00017397|etrasimod toxicity|etrasimod toxicity|0|17.977982|1
00017398|etrasimod treatment failure|etrasimod treatment failure|0|18.V8751R|1
00017399|unpredictable etrasimod response|unpredictable etrasimod response|0|18.V8751S|0
00017400|incorrect lamotrigine starter kit|incorrect lamotrigine starter kit|0|18.V64091|0
00017401|long QT, beta-2 agonist tx fail & beta blocker tx fail|QT prolongation, beta-2 agonist treatment failure and beta blocker treatment failure|0|07.42791N|1
00017402|MDS with isocitrate dehydrogenase-1 (IDH1) mutation|myelodysplastic syndrome with isocitrate dehydrogenase-1 (IDH1) mutation|0|02.238750|2
00017403|lamotrigine dose screening pass|lamotrigine dose screening pass|0|18.V64092|0
00017404|nasopharyngeal carcinoma|nasopharyngeal carcinoma|0|02.147900|2
00017405|cyclosporine toxicity and dronedarone toxicity|cyclosporine toxicity and dronedarone toxicity|0|17.977983|1
00017406|congenital thrombotic thrombocytopenic purpura|congenital thrombotic thrombocytopenic purpura|0|04.287312|2
00017407|fruquintinib toxicity|fruquintinib toxicity|0|17.977984|1
00017408|long QT & serotonin syndrome d/t drug accum in CKD|QT prolongation and serotonin syndrome due to drug accumulation in CKD|0|07.42791O|1
00017409|serotonin syndrome and gepirone treatment failure|serotonin syndrome and gepirone treatment failure|0|06.33399D|1
00017410|hepatotoxicity, rhabdomyolysis and myopathy|hepatotoxicity, rhabdomyolysis and myopathy|0|09.57330A|1
00017411|nmCSPC with biochem recurrence at high risk for mets|non-metastatic castration-sensitive prostate cancer with biochem recurrence at high risk for mets|0|02.185002|2
00017412|repotrectinib toxicity|repotrectinib toxicity|0|17.977985|1
00017413|excessive immunosuppression & siponimod tx failure|excessive immunosuppression and siponimod treatment failure|0|03.279306|1
00017414|chikungunya virus vaccination|chikungunya virus vaccination|0|18.V05906|0
00017415|capivasertib toxicity|capivasertib toxicity|0|17.977986|1
00017416|capivasertib toxicity and lonafarnib toxicity|capivasertib toxicity and lonafarnib toxicity|0|17.977987|1
00017417|unpredictable cancer drug tx and HIV tx response|unpredictable cancer drug treatment and HIV treatment response|0|18.V8751T|0
00017418|unpredictable cancer drug tx and voxelotor response|unpredictable cancer drug treatment and voxelotor response|0|18.V8751U|0
00017419|prevention of CRBSI in patients receiving HD via CVC|prevention of CRBSI in patients receiving hemodialysis through a central venous catheter|0|18.V45101|2
00017420|prevent infection in NMM receiving myelosuppressive tx|prevention of infection in non-myeloid malignancies receiving myelosuppressive treatment|0|01.041903|1
00017421|prevent infection & maintain patency of intravenous cath|prevent infection and maintain patency of indwelling intravenous catheter|0|18.V58810|3
00017422|phenytoin toxicity and PPI treatment failure|phenytoin toxicity and proton pump inhibitor treatment failure|0|17.977988|1
00017423|desmoid tumor|desmoid tumor|0|02.238100|2
00017424|unpredictable cancer drug tx and H pylori tx response|unpredictable cancer drug treatment and Helicobacter pylori treatment response|0|18.V8751V|0
00017425|nirogacestat treatment failure|nirogacestat treatment failure|0|18.V8751W|1
00017426|mitapivat toxicity and nirogacestat treatment failure|mitapivat toxicity and nirogacestat treatment failure|0|17.977989|1
00017427|nirogacestat toxicity|nirogacestat toxicity|0|17.97798A|1
00017428|unpredictable nirogacestat response|unpredictable nirogacestat response|0|18.V8751X|0
00017429|darolutamide toxicity due to drug accum in hepatic dx|darolutamide toxicity due to drug accumulation in hepatic disease|0|17.97798B|1
00017430|HER2-neg gastric or GE junction adenocarcinoma|HER2-negative gastric or gastroesophageal junction adenocarcinoma|0|02.151002|2
00017431|verbal tic|verbal tic|0|05.307201|3
00017432|triple risk opioid-induced resp depression & APAP tox|triple risk opioid-induced respiratory depression & acetaminophen toxicity|0|19.E9352V|1
00017433|corneal neovascularization|corneal neovascularization|0|06.370600|1
00017434|vadadustat treatment failure|vadadustat treatment failure|0|18.V8751Y|1
00017435|eflornithine toxicity|eflornithine toxicity|0|17.97798C|1
00017436|chronic hepatitis D|chronic hepatitis D|0|01.070306|2
00017437|ivosidenib toxicity and HIV treatment failure|ivosidenib toxicity and HIV treatment failure|0|17.97798D|1
00017438|elagolix toxicity and HIV treatment failure|elagolix toxicity and HIV treatment failure|0|17.97798E|1
00017439|Hemoglobin H disease|Hemoglobin H disease|0|04.282402|2
00017440|prevention of corneal graft rejection|prevention of corneal graft rejection|0|17.996813|2
00017441|prevention of recurrent atrial flutter|prevention of recurrent atrial flutter|0|07.427321|2
00017442|envenomation by box jellyfish (chironex fleckeri)|envenomation by box jellyfish (chironex fleckeri)|0|17.989521|1
00017443|HIV treatment failure & insomnia agent treatment failure|HIV treatment failure and insomnia agent treatment failure|0|18.V8751Z|1
00017444|unresectable hepatic metastatic uveal melanoma|unresectable hepatic metastatic uveal melanoma|0|02.190600|2
00017445|frostbite|frostbite|0|17.991000|1
00017446|IgE-mediated food allergy|IgE-mediated food allergy|0|18.V15050|2
00017447|reversible cerebral vasoconstriction syndrome|reversible cerebral vasoconstriction syndrome|0|07.435901|1
00017448|administration of inhaled anesthesia|administration of inhaled anesthesia|0|16. 93940|1
00017449|pseudo-Bartter syndrome|pseudo-Bartter syndrome|0|03.255141|1
00017450|CD22 positive B-cell acute lymphoblastic leukemia|CD22 positive B-cell acute lymphoblastic leukemia|0|02.204005|2
00017451|excess immunosuppression & ritlecitinib treatment fail|excessive immunosuppression and ritlecitinib treatment failure|0|03.279307|1
00017452|excess immunosuppression & upadacitinib treatment fail|excessive immunosuppression and upadacitinib treatment failure|0|03.279308|1
00017453|juvenile metachromatic leukodystrophy|juvenile metachromatic leukodystrophy|0|06.330000|2
00017454|infantile metachromatic leukodystrophy|infantile metachromatic leukodystrophy|0|06.330001|2
00017455|low serum concentration of T4 with normal TSH and T3|low serum concentration of free T4 with normal thyroid-stimulating hormone (TSH) and T3|0|16.794501|1
00017456|encorafenib toxicity and HIV treatment failure|encorafenib toxicity and HIV treatment failure|0|17.97798F|1
00017457|acquired Pelger-Huet anomaly|acquired Pelger-Huet anomaly|0|04.288200|1
00017458|chronic rhinosinusitis without nasal polyps|chronic rhinosinusitis without nasal polyps|0|08.473903|2
00017459|phosphodiesterase type 5 inhibitor & macitentan toxicity|phosphodiesterase type 5 (PDE5) inhibitor toxicity and macitentan toxicity|0|17.97798G|1
00017460|erythrocytosis and thrombocytopenia|erythrocytosis and thrombocytopenia|0|04.289002|1
00017461|HER2-positive colorectal cancer|HER2-positive colorectal cancer|0|02.154003|2
00017462|encorafenib toxicity and cancer drug treatment failure|encorafenib toxicity and cancer drug treatment failure|0|17.97798H|1
00017463|ivosidenib toxicity and cancer drug treatment failure|ivosidenib toxicity and cancer drug treatment failure|0|17.97798I|1
00017464|encorafenib toxicity and antiemetic drug tx failure|encorafenib toxicity and antiemetic drug treatment failure|0|17.97798J|1
00017465|ivosidenib toxicity and antiemetic drug tx failure|ivosidenib toxicity and antiemetic drug treatment failure|0|17.97798K|1
00017466|encorafenib toxicity and antibiotic treatment failure|encorafenib toxicity and antibiotic treatment failure|0|17.97798L|1
00017467|ivosidenib toxicity and antibiotic treatment failure|ivosidenib toxicity and antibiotic treatment failure|0|17.97798M|1
00017468|ivosidenib toxicity and lefamulin treatment failure|ivosidenib toxicity and lefamulin treatment failure|0|17.97798N|1
00017469|encorafenib toxicity and lefamulin treatment failure|encorafenib toxicity and lefamulin treatment failure|0|17.97798O|1
00017470|encorafenib toxicity and istradefylline treatment fail|encorafenib toxicity and istradefylline treatment failure|0|17.97798P|1
00017471|encorafenib toxicity and antifungal treatment failure|encorafenib toxicity and antifungal treatment failure|0|17.97798Q|1
00017472|ivosidenib toxicity and mifepristone treatment failure|ivosidenib toxicity and mifepristone treatment failure|0|17.97798R|1
00017473|encorafenib toxicity and mifepristone treatment failure|encorafenib toxicity and mifepristone treatment failure|0|17.97798S|1
00017474|encorafenib toxicity and voxelotor treatment failure|encorafenib toxicity and voxelotor treatment failure|0|17.97798T|1
00017475|encorafenib toxicity and dronedarone treatment failure|encorafenib toxicity and dronedarone treatment failure|0|17.97798U|1
00017476|encorafenib toxicity and antipsychotic treatment failure|encorafenib toxicity and antipsychotic treatment failure|0|17.97798V|1
00017477|encorafenib toxicity and levoketoconazole treatment fail|encorafenib toxicity and levoketoconazole treatment failure|0|17.97798W|1
00017478|ivosidenib toxicity and dronedarone treatment failure|ivosidenib toxicity and dronedarone treatment failure|0|17.97798X|1
00017479|QT prolongation and amiodarone treatment failure|QT prolongation and amiodarone treatment failure|0|07.42791P|1
00017480|QT prolongation and quinidine treatment failure|QT prolongation and quinidine treatment failure|0|07.42791Q|1
00017481|QT prolongation and ivabradine treatment failure|QT prolongation and ivabradine treatment failure|0|07.42791R|1
00017482|QT prolongation and macimorelin treatment failure|QT prolongation and macimorelin treatment failure|0|07.42791S|1
00017483|Angelman syndrome|Angelman syndrome|0|14.758890|2
00017484|hyperammonemic encephalopathy|hyperammonemic encephalopathy|0|06.348303|1
00017485|low grade glioma with BRAF fusion or mutation|low grade glioma with BRAF fusion or mutation|0|02.191905|2
00017486|tovorafenib toxicity|tovorafenib toxicity|0|17.97798Y|1
00017487|atypical stress fracture|atypical stress fracture|0|13.733950|3
00017489|warts, hypogammaglobulinemia, infections, myelokathexis|warts, hypogammaglobulinemia, infections, myelokathexis syndrome|0|03.279204|2
00017490|acquired Horner syndrome|acquired Horner syndrome|0|06.337902|1
00017491|mavorixafor treatment failure|mavorixafor treatment failure|0|18.V87520|1
00017492|QT prolongation and mavorixafor treatment failure|QT prolongation and mavorixafor treatment failure|0|07.42791T|1
00017493|unpredictable mavorixafor response|unpredictable mavorixafor response|0|18.V87521|0
00017494|QT prolongation and lonafarnib toxicity|QT prolongation and lonafarnib toxicity|0|07.42791U|1
00017495|QT prolongation and venetoclax toxicity|QT prolongation and venetoclax toxicity|0|07.42791V|1
00017496|aprocitentan toxicity|aprocitentan toxicity|0|17.97798Z|1
00017497|cardiovascular event risk reduction in obesity|cardiovascular event risk reduction in obesity|0|03.27800B|2
00017498|amiodarone toxicity and lonafarnib toxicity|amiodarone toxicity and lonafarnib toxicity|0|17.977990|1
00017499|gastrointestinal perforation and excessive immunosuppres|gastrointestinal perforation and excessive immunosuppression|0|09.534502|1
00017500|Brugada pattern|Brugada pattern|0|07.42791W|1
00017501|carbamazepine toxicity & mifepristone treatment failure|carbamazepine toxicity and mifepristone treatment failure|0|17.977991|1
00017502|enteroviral meningoencephalitis|enteroviral meningoencephalitis|0|01.049800|1
00017503|PGX combination 209|PGX combination 209|0|00.000209|2
00017504|PGX combination 210|PGX combination 210|0|00.000210|2
00017505|PGX combination 211|PGX combination 211|0|00.000211|2
00017506|PGX combination 212|PGX combination 212|0|00.000212|2
00017507|PGX combination 213|PGX combination 213|0|00.000213|2
00017508|immunosuppression and tofacitinib treatment failure|excessive immunosuppression and tofacitinib treatment failure|0|03.279309|1
00017509|hormone receptor positive early breast cancer|hormone receptor positive early breast cancer|0|02.17491D|2
00017510|mavacamten treatment fail & cancer drug treatment fail|mavacamten treatment failure and cancer drug treatment failure|0|18.V87522|1
00017511|mavacamten treatment fail and mitapivat treatment fail|mavacamten treatment failure and mitapivat treatment failure|0|18.V87523|1
00017513|myelosuppression d/t drug accum in hepatic disease|myelosuppression due to drug accumulation in hepatic disease|0|04.28480G|1
00017514|ceritinib toxicity and lonafarnib toxicity|ceritinib toxicity and lonafarnib toxicity|0|17.977992|1
00017515|ribociclib toxicity and lonafarnib toxicity|ribociclib toxicity and lonafarnib toxicity|0|17.977993|1
00017516|QT prolongation and lonafarnib treatment failure|QT prolongation and lonafarnib treatment failure|0|07.42791X|1
00017517|dronedarone toxicity and lonafarnib toxicity|dronedarone toxicity and lonafarnib toxicity|0|17.977994|1
00017518|seizure and risperidone toxicity|seizure and risperidone toxicity|0|06.34590F|1
00017519|tofacitinib toxicity d/t drug accumulation in hepatic dx|tofacitinib toxicity due to drug accumulation in hepatic disease|0|17.977995|1
00017520|male transgender hormone therapy|male transgender hormone therapy|0|05.302511|0
00017521|female transgender hormone therapy|female transgender hormone therapy|0|05.302512|0
00017522|high grade glioma with BRAF V600E mutation|high grade glioma with BRAF V600E mutation|0|02.191906|2
00017523|elafibranor treatment failure|elafibranor treatment failure|0|18.V87524|1
00017524|elafibranor toxicity|elafibranor toxicity|0|17.977996|1
00017525|givinostat toxicity|givinostat toxicity|0|17.977997|1
00017526|unpredictable elafibranor response|unpredictable elafibranor response|0|18.V87525|0
00017527|crizotinib toxicity due to drug accum in hepatic disease|crizotinib toxicity due to drug accumulation in hepatic disease|0|17.977998|1
00017528|long COVID-19|long COVID-19|0|01.079826|2
00017529|elagolix toxicity and voclosporin treatment failure|elagolix toxicity and voclosporin treatment failure|0|17.977999|1
00017530|colorectal cancer with KRAS G12C mutation|colorectal cancer with KRAS G12C mutation|0|02.154004|2
00017531|fluctuating response to drug|fluctuating response to drug|0|18.V87526|0
00017532|fluctuating colchicine response|fluctuating colchicine response|0|18.V87527|0
00017533|fluctuating benzodiazepine response|fluctuating benzodiazepine response|0|18.V87528|0
00017534|letermovir toxicity and voclosporin toxicity|letermovir toxicity and voclosporin toxicity|0|17.97799A|1
00017535|letermovir toxicity and simeprevir toxicity|letermovir toxicity and simeprevir toxicity|0|17.97799B|1
00017536|opposing effects on the CNS and serotonin syndrome|opposing effects on the central nervous system and serotonin syndrome|0|18.V87529|1
00017537|tachycardia and headache|tachycardia and headache|0|16.785007|1
00017538|high grade B-cell lymphoma|high grade B-cell lymphoma|0|02.200000|2
00017539|vadadustat toxicity|vadadustat toxicity|0|17.97799C|1
00017540|deuruxolitinib toxicity|deuruxolitinib toxicity|0|17.97799D|1
00017541|deuruxolitinib treatment failure|deuruxolitinib treatment failure|0|18.V8752A|1
00017542|unpredictable deuruxolitinib response|unpredictable deuruxolitinib response|0|18.V8752B|0
00017543|excess immunosuppression & deuruxolitinib tx failure|excessive immunosuppression and deuruxolitinib treatment failure|0|03.279310|1
00017544|benzgalantamine toxicity|benzgalantamine toxicity|0|17.97799E|1
00017545|endometrial carcinoma adjunct treatment|endometrial carcinoma adjunct treatment|0|02.182000|0
00017546|postmenopause hormone dependent breast cancer adjunct tx|postmenopausal hormone dependent breast cancer adjunct treatment|0|02.17491E|0
00017547|pexidartinib toxicity and avacopan treatment failure|pexidartinib toxicity and avacopan treatment failure|0|17.97799F|1
00017548|repotrectinib toxicity and avacopan treatment failure|repotrectinib toxicity and avacopan treatment failure|0|17.97799G|1
00017549|mavacamten toxicity and avacopan treatment failure|mavacamten toxicity and avacopan treatment failure|0|17.97799H|1
00017550|mitapivat toxicity and avacopan treatment failure|mitapivat toxicity and avacopan treatment failure|0|17.97799I|0
00017551|synovial sarcoma|synovial sarcoma|0|02.171910|2
00017552|encorafenib toxicity and avacopan treatment failure|encorafenib toxicity and avacopan treatment failure|0|17.97799J|1
00017553|bosentan toxicity and avacopan treatment failure|bosentan toxicity and avacopan treatment failure|0|17.97799K|1
00017554|ivosidenib toxicity and avacopan treatment failure|ivosidenib toxicity and avacopan treatment failure|0|17.97799L|1
00017555|diffuse astrocytoma|diffuse astrocytoma|0|02.191907|2
00017556|oligodendroglioma|oligodendroglioma|0|02.191908|2
00017557|hepatotoxicity and hormonal contraceptive failure|hepatotoxicity and hormonal contraceptive failure|0|09.57330B|1
00017558|enzalutamide toxicity and mifepristone treatment failure|enzalutamide toxicity and mifepristone treatment failure|0|17.97799M|1
00017559|phenytoin toxicity and mifepristone treatment failure|phenytoin toxicity and mifepristone treatment failure|0|17.97799N|1
00017560|brigatinib toxicity d/t drug accumulation in hepatic dx|brigatinib toxicity due to drug accumulation in hepatic disease|0|17.97799O|1
00017561|upadacitinib toxicity due to drug accum in hepatic dx|upadacitinib toxicity due to drug accumulation in hepatic disease|0|17.97799P|1
00017562|seladelpar treatment failure|seladelpar treatment failure|0|18.V8752C|1
00017563|seladelpar toxicity|seladelpar toxicity|0|17.97799Q|1
00017564|unpredictable seladelpar response|unpredictable seladelpar response|0|18.V8752D|0
00017565|unpredictable antiviral response|unpredictable antiviral response|0|18.V8752E|0
00017566|encorafenib toxicity and CCB treatment failure|encorafenib toxicity and calcium channel blocker treatment failure|0|17.97799R|1
00017567|ivosidenib toxicity and calcium channel blocker tx fail|ivosidenib toxicity and calcium channel blocker treatment failure|0|17.97799S|1
00017568|nirmatrelvir treatment failure|nirmatrelvir treatment failure|0|18.V8752F|1
00017569|nirmatrelvir toxicity|nirmatrelvir toxicity|0|17.97799T|1
00017570|nirmatrelvir toxicity and ritonavir toxicity|nirmatrelvir toxicity and ritonavir toxicity|0|17.97799U|1
00017571|lazertinib toxicity|lazertinib toxicity|0|17.97799V|1
00017572|adjunct treatment in palliative care|adjunct treatment in palliative care|0|18.V66700|2
00017573|Niemann-Pick disease type C|Niemann-Pick disease type C|0|18.V66701|2
00017574|levacetylleucine treatment failure|levacetylleucine treatment failure|0|18.V8752G|0
00017575|risk of measles exposure|risk of measles exposure|0|18.V66702|0
00017576|excess immunosuppression & cancer drug tx failure|excessive immunosuppression and cancer drug treatment failure|0|03.27931A|1
00017577|unpredictable cholinergic response due to hepatic dx|unpredictable cholinergic response due to drug accumulation in hepatic disease|0|18.V8752H|0
00017578|tovorafenib toxicity and cancer drug treatment failure|tovorafenib toxicity and cancer drug treatment failure|0|17.97799W|1
00017579|inavolisib toxicity|inavolisib toxicity|0|17.97799X|1
00017580|platysma bands|platysma bands|0|12.701806|2
00017581|HER2-neg and CLDN 18.2 pos gastric or GE junct adenocarc|HER2-neg and CLDN 18.2 pos gastric or gastroesophageal junction adenocarcinoma|0|02.151003|2
00017582|premature infant|premature infant|0|18.V00010|0
00017583|CYP3A4 intermediate metabolizer|CYP3A4 intermediate metabolizer|0|03.277894|2
00017584|CYP3A4 normal metabolizer|CYP3A4 normal metabolizer|0|03.277895|2
00017585|CYP3A4 no result on file, not currently ordered|CYP3A4 no result on file, not currently ordered|0|03.277896|0
00017586|CYP3A4 ordered, result pending|CYP3A4 ordered, result pending|0|03.277897|0
00017587|nephrectomy|nephrectomy|0|10.555001|1
00017588|acute leukemia w lysine methyltransfer 2A gene transloc|acute leukemia with lysine methyltransferase 2A gene (KMT2A) translocation|0|02.208002|2
00017589|aromatic L-amino acid decarboxylase deficiency|aromatic L-amino acid decarboxylase deficiency|0|03.277908|2
00017590|revumenib toxicity|revumenib toxicity|0|17.97799Y|1
00017591|pacritinib toxicity and cancer drug treatment failure|pacritinib toxicity and cancer drug treatment failure|0|17.97799Z|1
00017592|pacritinib toxicity and lonafarnib treatment failure|pacritinib toxicity and lonafarnib treatment failure|0|17.978001|1
00017593|pacritinib toxicity and lefamulin treatment failure|pacritinib toxicity and lefamulin treatment failure|0|17.978002|1
00017594|HER2-positive biliary tract malignancy|HER2-positive biliary tract malignancy|0|02.230916|2
00017595|increased lactate acid dehydrogenase|increased lactate acid dehydrogenase|0|16.794802|1
00017596|pacritinib toxicity and fedratinib treatment failure|pacritinib toxicity and fedratinib treatment failure|0|17.978003|1
00017597|pacritinib toxicity and HIV treatment failure|pacritinib toxicity and HIV treatment failure|0|17.978004|1
00017598|pacritinib toxicity and duvelisib treatment failure|pacritinib toxicity and duvelisib treatment failure|0|17.978005|1
00017599|chronic heart failure and diarrhea|chronic heart failure and diarrhea|2|17.978006|3
00017600|tizanidine toxicity due to drug accum in renal impair|tizanidine toxicity due to drug accumulation in renal impairment|0|17.978007|1
00017601|fludarabine-induced pulmonary toxicity|fludarabine-induced pulmonary toxicity|0|08.519906|3
00017602|acoramidis treatment failure|acoramidis treatment failure|0|17.V8752I|1
00017603|phenytoin tox and calcium channel blocker tx failure|phenytoin toxicity and calcium channel blocker treatment failure|0|17.978008|1
00017604|postpartum sepsis|postpartum sepsis|0|01.038905|1
00017605|Neuregulin 1 gene fusion pos pancreatic adenocarcinoma|Neuregulin 1 gene fusion positive pancreatic adenocarcinoma|0|02.157002|2
00017606|Neuregulin 1 gene fusion pos non-small cell lung cancer|Neuregulin 1 gene fusion positive non-small cell lung cancer|0|02.231218|2
00017607|chronic hypertension in pregnancy|chronic hypertension in pregnancy|2|07.401920|2
00017608|CYP2C no result on file, not currently ordered|CYP2C no result on file, not currently ordered|0|03.277909|0
00017609|CYP4F2 no result on file, not currently ordered|CYP4F2 no result on file, not currently ordered|0|03.277910|0
00017610|HLA-A *31:01 no result on file, not currently ordered|HLA-A *31:01 no result on file, not currently ordered|0|03.277911|0
00017611|PGX combination 214|PGX combination 214|0|00.000214|0
00017612|PGX combination 215|PGX combination 215|0|00.000215|0
00017613|PGX Combination 216|PGX Combination 216|0|00.000216|0
00017614|PGX Combination 217|PGX Combination 217|0|00.000217|0
00017615|PGX Combination 218|PGX Combination 218|0|00.000218|0
00017616|PGX Combination 219|PGX Combination 219|0|00.000219|0
00017617|crinecerfont treatment failure|crinecerfont treatment failure|0|18.V8752I|0
00017618|phenazopyradine toxicity due to drug accum in kidney|phenazopyradine toxicity due to drug accumulation in kidney disease|0|17.978009|1
00017619|Familial chylomicronemia syndrome|Familial chylomicronemia syndrome|0|03.272102|2
00017620|ensartinib toxicity|ensartinib toxicity|0|17.978010|1
00017621|unpredictable ensartinib response|unpredictable ensartinib response|0|18.V8752J|0
00017622|vanzacaftor-tezacaftor-deutivacaftor toxicity|vanzacaftor-tezacaftor-deutivacaftor toxicity|0|17.978011|1
00017623|vanzacaftor-tezacaftor-deutivacaftor and lefamulin tox|vanzacaftor-tezacaftor-deutivacaftor toxicity and lefamulin toxicity|0|17.978012|1
00017626|metastatic urothelial carcinoma|metastatic urothelial carcinoma|0|02.189009|2
00017627|aortic ectasia|aortic ectasia|0|07.459894|3
00017628|atovaquone treatment failure|atovaquone treatment failure|0|18.V8752K|0
00017629|hepatotoxicity and letermovir toxicity|hepatotoxicity and letermovir toxicity|0|09.57330C|1
00017630|suzetrigine toxicity|suzetrigine toxicity|0|17.978013|1
00017631|suzetrigine treatment failure|suzetrigine treatment failure|0|18.V8752L|0
00017632|HER2-Positive Solid Tumor|HER2-Positive Solid Tumor|0|02.199108|2
00017633|acute myeloid leukemia treatment adjunct|acute myeloid leukemia treatment adjunct|0|02.205009|2
00017634|acute promyelocytic leukemia treatment adjunct|acute promyelocytic leukemia treatment adjunct|0|02.205010|2
00017635|mirdametinib toxicity|mirdametinib toxicity|0|17.978014|1
00017636|chronic hand eczema|chronic hand eczema|0|12.692905|2
00017637|QT prolongation and ranolazine treatment failure|QT prolongation and ranolazine treatment failure|0|07.42791Y|1
00017638|occipital neuralgia|occipital neuralgia|0|13.723800|3
00017639|bleeding prevention in hereditary factor XI deficiency|bleeding prevention in hereditary factor XI deficiency|0|04.286005|1
00017640|hemophilia C|hemophilia C|0|04.286006|2
00017641|bleeding episode in hemophilia C|bleeding episode in hemophilia C|0|04.286007|1
00017642|primaquine toxicity|primaquine toxicity|0|17.978015|1
00017643|prolonged QT and additional effects|prolonged QT and additional effects|0|07.42791Z|3
00017644|miscarriage in first trimester|miscarriage in first trimester|0|11.637902|1
00017645|prolonged QT - additive|prolonged QT - additive|0|07.427920|3
00017646|Shy-Drager syndrome|Shy-Drager syndrome|0|06.358908|2
00017647|idiopathic macular telangiectasia type 2|idiopathic macular telangiectasia type 2|0|07.448902|2
00017648|complement component 3 glomerulopathy|complement component 3 glomerulopathy|0|10.599801|2
00017649|PD-L1+, HER2-pos gastric or GE junction adenocarcinoma|PD-L1+, HER2-positive gastric or gastroesophageal junction adenocarcinoma|0|02.230917|2
00017650|ubrogepant tox d/t to drug accum in hepatic impairment|ubrogepant toxicity due to drug accumulation in hepatic disease|0|17.978016|1
00017651|excessive immunosuppression and hepatotoxicity|excessive immunosuppression and hepatotoxicity|0|03.27931B|1
00017652|QT prolongation and cholinergic toxicity|QT prolongation and cholinergic toxicity|0|07.42792A|1
00017653|QT prolong and cholinergic tox d/t drug accum in hep dx|QT prolongation and cholinergic toxicity due to drug accumulation in hepatic disease|0|07.42792B|1
00017654|hyperphagia in Prader-Willi syndrome|hyperphagia in Prader-Willi syndrome|0|14.759811|2
00017655|diazoxide treatment failure|diazoxide treatment failure|0|18.V8752M|1
00017656|seasonal allergic conjunctivitis|seasonal allergic conjunctivitis|0|06.372050|2
00017657|fitusiran toxicity|fitusiran toxicity|0|17.978017|1
00017658|extra-pancreatic neuroendocrine tumor|extra-pancreatic neuroendocrine tumor|0|02.230918|2
00017659|atrasentan treatment failure|atrasentan treatment failure|0|18.V8752N|1
00017660|unpredictable atrasentan response|unpredictable atrasentan response|0|18.V8752O|0
00017661|atrasentan toxicity|atrasentan toxicity|0|17.97801A|1
00017662|female with 46, XY karyotype|female with 46, XY karyotype|0|02.758810|2
00017663|46,XX disorder of sex development|46,XX disorder of sex development|0|02.758811|2
00017664|Immunoglobulin G4-related disease|Immunoglobulin G4-related disease|0|03.279403|2
00017665|PD-L1+, HER2-neg gastric or GE junction adenocarcinoma|PD-L1+, HER2-negative gastric or gastroesophageal junction adenocarcinoma|0|02.151004|2
00017666|Non-Keratinizing Nasopharyngeal Carcinoma|Non-Keratinizing Nasopharyngeal Carcinoma|0|02.147901|2
00017667|avutometinib toxicity and defactinib toxicity|avutometinib toxicity and defactinib toxicity|0|17.978018|1
00017668|low-grade serous ovarian cancer with KRAS mutation|low-grade serous ovarian cancer with KRAS mutation|0|02.233307|2
00017669|chikungunya vaccine adverse effects|chikungunya vaccine adverse effects|0|18.V05907|1
00017670|leukocytosis and bone pain|leukocytosis and bone pain|0|04.288804|1
00017671|non-squamous NSCLC with high c-Met protein|non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression|0|02.231219|2
00017672|malignant paraganglioma|malignant paraganglioma|0|02.194601|2
00017673|malignant pheochromocytoma|malignant pheochromocytoma|0|02.227905|2
00017674|squamous cell carcinoma of the anal canal|squamous cell carcinoma of the anal canal|0|02.173922|2
00017676|hypotension and bleeding|hypotension and bleeding|0|07.458914|1
00017677|fertility preservation in female|fertility preservation in female|0|18.V26809|1
00017678|HR positive breast cancer in a male patient|hormone receptor positive breast cancer in a male patient|0|02.233008|2
00017679|elagolix toxicity and leniolisib treatment failure|elagolix toxicity and leniolisib treatment failure|0|17.978019|1
00017680|bosentan toxicity and leniolisib treatment failure|bosentan toxicity and leniolisib treatment failure|0|17.97801B|1
00017681|conjunctival erosion|conjunctival erosion|0|06.372902|3
00017682|conjunctival retraction|conjunctival retraction|0|06.372903|3
00017683|eosinophilic chronic obstructive pulmonary disease|eosinophilic chronic obstructive pulmonary disease|0|08.496007|2
00017684|taletrectinib toxicity|taletrectinib toxicity|0|17.97801C|1
00017685|PD-L1 positive squamous cell carcinoma of head and neck|PD-L1 positive squamous cell carcinoma of head and neck|0|02.173923|2
00017686|PD-L1 positive esophageal carcinoma|PD-L1 positive esophageal carcinoma|0|02.150904|2
00017687|mismatch repair proficient endometrial cancer|mismatch repair proficient endometrial cancer|0|02.233308|2
00017688|non-muscle invasive bladder cancer|non-muscle invasive bladder cancer|0|02.233702|2
00017689|loop diuretic toxicity|loop diuretic toxicity|0|17.97801D|1
00017690|ovarian suppression in HR+ breast cancer|ovarian suppression in hormone receptor positive breast cancer|0|02.17491F|2
00017691|umbilical cord prolapse|umbilical cord prolapse|0|18.V24002|1
00017692|vasa previa|vasa previa|0|18.V2220A|2
00017693|polyhydramnios|polyhydramnios|0|18.V2220B|3
00017694|anticholinergic toxicity and hyperthermia|anticholinergic toxicity and hyperthermia|0|17.97801E|1
00017695|prevent thromboembolism in rheumatic heart disease|prevention of thromboembolism in rheumatic heart disease|0|07.398901|2
00017696|claustrophobia|claustrophobia|0|05.300291|2
00017697|sebetralstat treatment failure|sebetralstat treatment failure|0|18.V8752P|1
00017698|linvoseltamab toxicity|linvoseltamab toxicity|0|17.97801F|1
00017699|sunvozertinib toxicity|sunvozertinib toxicity|0|17.97801G|1
00017700|hyperuricemia and clostridioides difficile infection|hyperuricemia and clostridioides difficile infection|0|16.790609|3
00017701|homologous recombination deficiency pos ovarian cancer|homologous recombination deficiency positive ovarian cancer|0|02.183005|2
00017702|puerperium hypertension|puerperium hypertension|0|11.642741|1
00017703|prctns for bfeeding d/t r/o HIV transmission to infant|precautions exist for breastfeeding due to risk of HIV transmission to the infant|0|18.V2410E|0
00017704|anamorelin toxicity|anamorelin toxicity|0|17.97801H|1
00017705|amivantamab toxicity|amivantamab toxicity|0|17.97801I|1
00017706|sepiapterin treatment failure|sepiapterin treatment failure|0|18.V8752Q|1
00017707|bleeding and hypophenylalaninemia|bleeding and hypophenylalaninemia|0|07.45900N|1
00017708|hypophenylalaninemia|hypophenylalaninemia|0|03.270102|3
00017709|tisotumab vedotin toxicity|tisotumab vedotin toxicity|0|17.97801J|1
00017710|ramucirumab toxicity|ramucirumab toxicity|0|17.97801K|1
00017711|zongertinib toxicity|zongertinib toxicity|0|17.97801L|1
00017712|diffuse midline glioma with H3 K27M mutation|diffuse midline glioma with H3 K27M mutation|0|02.239601|2
00017713|HER2 (+) non-squamous NSCLC with ERBB2|HER2 positive non-squamous non-small cell lung cancer w/ tyrosine kinase domain activating mutations|0|02.23121A|2
00017714|neurologic toxicity and myelosuppression|neurologic toxicity and myelosuppression|0|07.45900O|1
00017715|brensocatib toxicity|brensocatib toxicity|0|17.97801M|1
00017716|non-cystic fibrosis bronchiectasis|non-cystic fibrosis bronchiectasis|0|08.494001|3
00017717|bevacizumab toxicity|bevacizumab toxicity|0|17.97801N|1
00017718|ifosfamide toxicity|ifosfamide toxicity|0|17.97801O|1
00017719|bupivacaine toxicity|bupivacaine toxicity|0|17.97801P|1
00017720|recurrent respiratory papillomatosis|recurrent respiratory papillomatosis|0|02.212101|3
00017721|donanemab-azbt toxicity|donanemab-azbt toxicity|0|17.97801Q|1
00017722|headache and fatigue|headache and fatigue|0|07.45900P|1
00017723|immune-complex membranoproliferative glomerulonephritis|primary immune-complex membranoproliferative glomerulonephritis|0|10.599802|2
00017724|CD30-positive Hodgkin's lymphoma|CD30-positive Hodgkin's lymphoma|0|02.201901|2
00017725|rilzabrutinib toxicity|rilzabrutinib toxicity|0|17.97801R|1
00017726|rilzabrutinib treatment failure|rilzabrutinib treatment failure|0|18.V8752R|1
00017727|rilzabrutinib toxicity and lonafarnib toxicity|rilzabrutinib toxicity and lonafarnib toxicity|0|17.978020|1
00017728|lefamulin toxicity and rilzabrutinib toxicity|lefamulin toxicity and rilzabrutinib toxicity|0|17.978021|1
00017729|repotrectinib toxicity and rilzabrutinib treatment failu|repotrectinib toxicity and rilzabrutinib treatment failure|0|17.978032|1
00017730|rilzabrutinib toxicity and nirogacestat toxicity|rilzabrutinib toxicity and nirogacestat toxicity|0|17.978022|1
00017731|carbamazepine toxicity and rilzabrutinib treatment fail|carbamazepine toxicity and rilzabrutinib treatment failure|0|17.978023|1
00017732|pexidartinib toxicity and rilzabrutinib treatment failur|pexidartinib toxicity and rilzabrutinib treatment failure|0|17.978031|1
00017733|encorafenib toxicity and rilzabrutinib treatment failure|encorafenib toxicity and rilzabrutinib treatment failure|0|17.978024|1
00017734|ivosidenib toxicity and rilzabrutinib treatment failure|ivosidenib toxicity and rilzabrutinib treatment failure|0|17.978025|1
00017735|pacritinib toxicity and rilzabrutinib treatment failure|pacritinib toxicity and rilzabrutinib treatment failure|0|17.978030|1
00017736|mitapivat toxicity and rilzabrutinib treatment failure|mitapivat toxicity and rilzabrutinib treatment failure|0|17.978029|0
00017737|mavacamten toxicity and rilzabrutinib treatment failure|mavacamten toxicity and rilzabrutinib treatment failure|0|17.978028|1
00017738|excess immunosuppression & rilzabrutinib tx failure|excessive immunosuppression and rilzabrutinib treatment failure|0|17.978027|1
00017739|bosentan toxicity and rilzabrutinib treatment failure|bosentan toxicity and rilzabrutinib treatment failure|0|17.978026|1
00017740|lecanemab-irmb toxicity|lecanemab-irmb toxicity|0|17.97801S|1
00017741|peripheral neuropathy and neutropenia|peripheral neuropathy and neutropenia|0|07.45900Q|1
00017742|severe local tissue injury and tendon rupture|severe local tissue injury and tendon rupture|0|16.782809|1
00017743|severe local tissue injury|severe local tissue injury|0|16.782808|1
00017744|enfortumab toxicity|enfortumab toxicity|0|17.97801T|1
00017745|barbiturate toxicity and antibiotic treatment failure|barbiturate toxicity and antibiotic treatment failure|0|17.97801U|1
00017746|growth hormone treatment failure|growth hormone treatment failure|0|18.V8752S|1
00017747|cardiovascular event risk reduction in T2DM|cardiovascular event risk reduction in type 2 diabetes mellitus|0|03.250005|2
00017748|heart failure with mid range ejection fraction|heart failure with mid range ejection fraction|0|07.428301|3
00017749|muscle weakness in Barth syndrome|muscle weakness in Barth syndrome|0|03.277876|2
00017750|adjuvant treatment of biliary tract carcinoma|adjuvant treatment of biliary tract carcinoma|0|02.155102|2
00017751|paltusotine treatment failure|paltusotine treatment failure|0|18.V8752T|1
00017752|imlunestrant toxicity|imlunestrant toxicity|0|17.97801V|1
00017753|long-chain fatty acid oxidation disorder|long-chain fatty acid oxidation disorder|0|03.27785J|2
00017754|remibrutinib treatment failure|remibrutinib treatment failure|0|18.V8752U|1
00017755|paltusotine toxicity|paltusotine toxicity|0|17.97801W|1
00017756|probiotic treatment failure|probiotic treatment failure|0|18.V8752V|1
00017757|iron overload cardiomyopathy|iron overload cardiomyopathy|0|07.425408|2
00017758|lenvatinib toxicity|lenvatinib toxicity|0|17.97801X|1
00017759|NAT2 indeterminate activity|NAT2 indeterminate activity|0|03.277912|2
00017760|nerandomilast treatment failure|nerandomilast treatment failure|0|18.V8752W|1
00017761|pacritinib tox d/t drug accum in hepatic disease|pacritinib toxicity due to drug accumulation in hepatic disease|0|17.97801Y|1
00017762|PGX Combination 220|PGX Combination 220|0|00.000220|0
00017763|PGX Combination 221|PGX Combination 221|0|00.000221|0
00017764|acute myeloid leukemia with NPM1 somatic mutation|acute myeloid leukemia with NPM1 somatic mutation|0|02.208003|2
00017765|adverse CNS effects and hepatotoxicity|adverse CNS effects and hepatotoxicity|0|06.349902|1
00017766|sodium phenylbutyrate toxicity|sodium phenylbutyrate toxicity|0|17.97801Z|1
00017767|elinzanetant treatment failure|elinzanetant treatment failure|0|18.V8752X|1
00017768|adv CNS effects and hepatotox d/t drug accum hepatic dx|adverse CNS effects and hepatotoxicity due to drug accumulation in hepatic disease|0|06.349903|1
00017769|dental and skeletal fluorosis|dental and skeletal fluorosis|0|09.521004|2
00017770|mitapivat toxicity and lefamulin treatment failure|mitapivat toxicity and lefamulin treatment failure|0|17.97802A|1
00017771|mitapivat toxicity and voxelotor treatment failure|mitapivat toxicity and voxelotor treatment failure|0|17.97802B|1
00017772|smoldering myeloma|smoldering myeloma|0|02.203004|2
00017773|mavacamten toxicity and cancer drug treatment failure|mavacamten toxicity and cancer drug treatment failure|0|17.97802D|1
00017774|ziftomenib toxicity|ziftomenib toxicity|0|17.97802C|1
00017775|sevabertinib toxicity|sevabertinib toxicity|0|17.97802E|1
